Citrus Sinensis ID: 040677

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70-------
Protein Sequence
MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT
Secondary Structure (PSIPRED)
cccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccccccccccccccccHHHHHcccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccEccccccEEEEEEEEcc
Coil and Loop (DISEMBL)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVlldhemnpkisdfgmarifggnqseantnrivgt
Flexible Loop (DISEMBL)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARifggnqseantnrivgt
Low Complexity Region (SEG)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT
Disordered region (IsUnstruct)
*****LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF***************
Disordered Region (DISOPRED)
*RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT
Disordered Region (DISEMBL)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT
Disordered Region (DISPRO)
***VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	77	2.2.26 [Sep-21-2011]
O81833	815	G-type lectin S-receptor-	yes	no	0.987	0.093	0.75	2e-31
O81906	849	G-type lectin S-receptor-	no	no	0.935	0.084	0.847	1e-30
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.948	0.085	0.780	4e-30
O65479	666	Putative cysteine-rich re	no	no	0.948	0.109	0.753	3e-29
O65482	830	Putative cysteine-rich re	no	no	0.948	0.087	0.753	4e-29
Q9LDQ3	669	Putative cysteine-rich re	no	no	0.948	0.109	0.767	4e-29
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.948	0.109	0.767	5e-29
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.935	0.106	0.777	1e-28
Q9ZP16	667	Cysteine-rich receptor-li	no	no	0.987	0.113	0.723	1e-28
Q9C5S9	674	Cysteine-rich receptor-li	no	no	0.987	0.112	0.710	2e-28

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  134 bits (337), Expect = 2e-31,   Method: Composition-based stats.
 Identities = 57/76 (75%), Positives = 73/76 (96%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           RS +LDWK+R++IING+ARG+LYLH+DSRL+IIHRDLKA NVLLD++MNPKISDFG+A+ 
Sbjct: 590 RSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKS 649

Query: 62  FGGNQSEANTNRIVGT 77
           FGG+QSE++TNR+VGT
Sbjct: 650 FGGDQSESSTNRVVGT 665

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  131 bits (329), Expect = 1e-30,   Method: Composition-based stats.
 Identities = 61/72 (84%), Positives = 65/72 (90%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           +DWK R SII GIARGLLYLH DSRL+IIHRDLK SNVLLD EMNPKISDFGMARIFGGN
Sbjct: 623 IDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGN 682

Query: 66  QSEANTNRIVGT 77
           Q+EANT R+VGT
Sbjct: 683 QNEANTVRVVGT 694

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  129 bits (325), Expect = 4e-30,   Method: Composition-based stats.
 Identities = 57/73 (78%), Positives = 67/73 (91%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           +LDWK R +II GIARGLLYLH+DSRL+IIHRDLK SN+LLD EMNPKISDFG+ARIFGG
Sbjct: 625 RLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGG 684

Query: 65  NQSEANTNRIVGT 77
           +++ ANTNR+VGT
Sbjct: 685 SETSANTNRVVGT 697

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2

 Score =  126 bits (317), Expect = 3e-29,   Method: Composition-based stats.
 Identities = 55/73 (75%), Positives = 64/73 (87%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           QLDW RR  II GIARG+LYLH+DSRL IIHRDLKA N+LLD +MNPK++DFGMARIFG 
Sbjct: 437 QLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGM 496

Query: 65  NQSEANTNRIVGT 77
           +Q+EANT R+VGT
Sbjct: 497 DQTEANTRRVVGT 509

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65482|CRK23_ARATH Putative cysteine-rich receptor-like protein kinase 23 OS=Arabidopsis thaliana GN=CRK23 PE=2 SV=1

 Score =  126 bits (317), Expect = 4e-29,   Method: Composition-based stats.
 Identities = 55/73 (75%), Positives = 64/73 (87%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           QLDW RR  II GIARG+LYLH+DSRL IIHRDLKA N+LLD +MNPK++DFGMARIFG 
Sbjct: 601 QLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGM 660

Query: 65  NQSEANTNRIVGT 77
           +Q+EANT R+VGT
Sbjct: 661 DQTEANTRRVVGT 673

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3

 Score =  126 bits (316), Expect = 4e-29,   Method: Composition-based stats.
 Identities = 56/73 (76%), Positives = 65/73 (89%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           +LDW RR +II GIARG+LYLH+DSRL IIHRDLKASN+LLD +MNPKI+DFGMARIFG 
Sbjct: 438 ELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGV 497

Query: 65  NQSEANTNRIVGT 77
           +QS+ANT RI GT
Sbjct: 498 DQSQANTRRIAGT 510

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  126 bits (316), Expect = 5e-29,   Method: Composition-based stats.
 Identities = 56/73 (76%), Positives = 65/73 (89%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           QLDW RR  II G+ARG+LYLH+DSRL IIHRDLKASN+LLD +MNPKI+DFGMARIFG 
Sbjct: 441 QLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGL 500

Query: 65  NQSEANTNRIVGT 77
           +Q+E NT+RIVGT
Sbjct: 501 DQTEENTSRIVGT 513

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  125 bits (313), Expect = 1e-28,   Method: Composition-based stats.
 Identities = 56/72 (77%), Positives = 64/72 (88%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LDW+RR  II GIARG+LYLH DSRL IIHRDLKASN+LLD +M+PKISDFGMARIFG +
Sbjct: 441 LDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVD 500

Query: 66  QSEANTNRIVGT 77
           Q++ANT RIVGT
Sbjct: 501 QTQANTKRIVGT 512

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2

 Score =  124 bits (312), Expect = 1e-28,   Method: Composition-based stats.
 Identities = 55/76 (72%), Positives = 64/76 (84%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           +  QLDW RR  II GIARG+LYLH+DSRLKIIHRDLKASN+LLD +MNPKI+DFG+A I
Sbjct: 440 KQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATI 499

Query: 62  FGGNQSEANTNRIVGT 77
           FG  Q++ NTNRI GT
Sbjct: 500 FGVEQTQGNTNRIAGT 515

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  124 bits (310), Expect = 2e-28,   Method: Composition-based stats.
 Identities = 54/76 (71%), Positives = 68/76 (89%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           + +QLDW +R +II GIARG+LYLH+DSRL IIHRDLKASN+LLD ++NPKI+DFGMARI
Sbjct: 441 KQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARI 500

Query: 62  FGGNQSEANTNRIVGT 77
           FG +Q++ NT+RIVGT
Sbjct: 501 FGLDQTQDNTSRIVGT 516

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	77
224076400	666	predicted protein [Populus trichocarpa]	0.961	0.111	0.918	1e-34
224113927	381	predicted protein [Populus trichocarpa]	0.961	0.194	0.905	7e-33
224100081	468	predicted protein [Populus trichocarpa]	0.961	0.158	0.891	2e-32
356519528	849	PREDICTED: G-type lectin S-receptor-like	1.0	0.090	0.792	7e-31
224115102	784	predicted protein [Populus trichocarpa]	0.987	0.096	0.842	1e-30
255575986	1597	ATP binding protein, putative [Ricinus c	1.0	0.048	0.818	1e-30
224076584	815	predicted protein [Populus trichocarpa]	0.935	0.088	0.847	1e-30
224076566	833	predicted protein [Populus trichocarpa]	0.935	0.086	0.847	2e-30
357116685	888	PREDICTED: G-type lectin S-receptor-like	0.935	0.081	0.805	2e-30
255555021	686	ATP binding protein, putative [Ricinus c	0.948	0.106	0.837	2e-30

>gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa]

 Score =  149 bits (377), Expect = 1e-34,   Method: Composition-based stats.
 Identities = 68/74 (91%), Positives = 73/74 (98%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           VQLDW+RR+SIINGIARGLLYLHEDSRL+IIHRDLKASN+LLD+EMNPKISDFGMARIFG
Sbjct: 441 VQLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGMARIFG 500

Query: 64  GNQSEANTNRIVGT 77
           GN SEANTNRIVGT
Sbjct: 501 GNHSEANTNRIVGT 514

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113927|ref|XP_002316616.1| predicted protein [Populus trichocarpa] gi|222859681|gb|EEE97228.1| predicted protein [Populus trichocarpa]

 Score =  144 bits (363), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 67/74 (90%), Positives = 72/74 (97%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           V LDW+RR+SIINGIARGLLYLHEDSRL+IIHRDLK SN+LLD+EMNPKISDFGMARIFG
Sbjct: 156 VLLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKTSNILLDYEMNPKISDFGMARIFG 215

Query: 64  GNQSEANTNRIVGT 77
           GNQSEANTNRIVGT
Sbjct: 216 GNQSEANTNRIVGT 229

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224100081|ref|XP_002334411.1| predicted protein [Populus trichocarpa] gi|222872074|gb|EEF09205.1| predicted protein [Populus trichocarpa]

 Score =  142 bits (359), Expect = 2e-32,   Method: Composition-based stats.
 Identities = 66/74 (89%), Positives = 71/74 (95%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           V LDW+RR+SIINGIARGLLYLHEDSRL+IIHRDLK SN+LLD+EMNPKISDFGMARIFG
Sbjct: 395 VLLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKTSNILLDYEMNPKISDFGMARIFG 454

Query: 64  GNQSEANTNRIVGT 77
           GN SEANTNRIVGT
Sbjct: 455 GNPSEANTNRIVGT 468

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356519528|ref|XP_003528424.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Glycine max]

 Score =  137 bits (345), Expect = 7e-31,   Method: Composition-based stats.
 Identities = 61/77 (79%), Positives = 69/77 (89%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++  QLDW RR  II GIARGLLYLH+DSRL+IIHRDLKASN+LLD  MNPKISDFG+AR
Sbjct: 622 VKQTQLDWARRFEIIEGIARGLLYLHQDSRLRIIHRDLKASNILLDESMNPKISDFGLAR 681

Query: 61  IFGGNQSEANTNRIVGT 77
           IFGGNQ+EANTNR+VGT
Sbjct: 682 IFGGNQNEANTNRVVGT 698

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa]

 Score =  137 bits (344), Expect = 1e-30,   Method: Composition-based stats.
 Identities = 64/76 (84%), Positives = 70/76 (92%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           RS  LDW  RISII+GIARGLLYLH+DSRL+IIHRDLKASNVLLD +MNPKISDFGMARI
Sbjct: 557 RSKLLDWPTRISIIDGIARGLLYLHQDSRLRIIHRDLKASNVLLDTDMNPKISDFGMARI 616

Query: 62  FGGNQSEANTNRIVGT 77
           FGGNQ+EANT R+VGT
Sbjct: 617 FGGNQTEANTKRVVGT 632

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255575986|ref|XP_002528889.1| ATP binding protein, putative [Ricinus communis] gi|223531688|gb|EEF33513.1| ATP binding protein, putative [Ricinus communis]

 Score =  137 bits (344), Expect = 1e-30,   Method: Composition-based stats.
 Identities = 63/77 (81%), Positives = 70/77 (90%)

Query: 1    MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            MRS  LDW +R  II GIARGLLYLH+DSRLKIIHRDLKASN+LLD+EMNPKISDFG+AR
Sbjct: 1369 MRSKLLDWHKRFHIIGGIARGLLYLHQDSRLKIIHRDLKASNILLDNEMNPKISDFGLAR 1428

Query: 61   IFGGNQSEANTNRIVGT 77
            IFG +Q+EANTNRIVGT
Sbjct: 1429 IFGADQTEANTNRIVGT 1445

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076584|ref|XP_002304965.1| predicted protein [Populus trichocarpa] gi|222847929|gb|EEE85476.1| predicted protein [Populus trichocarpa]

 Score =  137 bits (344), Expect = 1e-30,   Method: Composition-based stats.
 Identities = 61/72 (84%), Positives = 66/72 (91%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LDW +R +II GIARGLLYLH DSRL+IIHRDLKASN+LLD EMNPKISDFGMARIFGGN
Sbjct: 610 LDWSKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEEMNPKISDFGMARIFGGN 669

Query: 66  QSEANTNRIVGT 77
           QSE NTNR+VGT
Sbjct: 670 QSEINTNRVVGT 681

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076566|ref|XP_002304962.1| predicted protein [Populus trichocarpa] gi|222847926|gb|EEE85473.1| predicted protein [Populus trichocarpa]

 Score =  136 bits (342), Expect = 2e-30,   Method: Composition-based stats.
 Identities = 61/72 (84%), Positives = 66/72 (91%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LDW +R +II GIARGLLYLH DSRL+IIHRDLKASN+LLD EMNPKISDFGMARIFGGN
Sbjct: 610 LDWSKRFAIIEGIARGLLYLHRDSRLRIIHRDLKASNILLDEEMNPKISDFGMARIFGGN 669

Query: 66  QSEANTNRIVGT 77
           QSE NTNR+VGT
Sbjct: 670 QSEINTNRVVGT 681

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357116685|ref|XP_003560109.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Brachypodium distachyon]

 Score =  136 bits (342), Expect = 2e-30,   Method: Composition-based stats.
 Identities = 58/72 (80%), Positives = 67/72 (93%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LDWK R+SII GIARGLLYLH DSRL+++HRDLKASN+LLDH+MNPKISDFGMARIFGG+
Sbjct: 660 LDWKTRLSIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDHDMNPKISDFGMARIFGGD 719

Query: 66  QSEANTNRIVGT 77
           Q + NTNR+VGT
Sbjct: 720 QKQENTNRVVGT 731

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis]

 Score =  135 bits (341), Expect = 2e-30,   Method: Composition-based stats.
 Identities = 62/74 (83%), Positives = 72/74 (97%), Gaps = 1/74 (1%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           V+LDW+RR+SII+GIARGLLYLHEDSRL+IIHRDLKASN+LLD++MNPKISDFGMARIFG
Sbjct: 461 VRLDWQRRLSIISGIARGLLYLHEDSRLRIIHRDLKASNILLDYDMNPKISDFGMARIFG 520

Query: 64  GNQSEANTNRIVGT 77
           GN S++ TNRIVGT
Sbjct: 521 GNDSKS-TNRIVGT 533

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	77
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.987	0.093	0.75	4.9e-28
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.935	0.084	0.847	3e-27
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.935	0.084	0.75	9.6e-26
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.948	0.109	0.767	2e-25
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.948	0.109	0.767	2e-25
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.987	0.090	0.75	2e-25
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.987	0.089	0.75	2e-25
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.948	0.087	0.753	3.2e-25
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.987	0.097	0.723	3.6e-25
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.948	0.109	0.753	4.2e-25

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 323 (118.8 bits), Expect = 4.9e-28, P = 4.9e-28
 Identities = 57/76 (75%), Positives = 73/76 (96%)

Query:     2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
             RS +LDWK+R++IING+ARG+LYLH+DSRL+IIHRDLKA NVLLD++MNPKISDFG+A+ 
Sbjct:   590 RSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKS 649

Query:    62 FGGNQSEANTNRIVGT 77
             FGG+QSE++TNR+VGT
Sbjct:   650 FGGDQSESSTNRVVGT 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 316 (116.3 bits), Expect = 3.0e-27, P = 3.0e-27
 Identities = 61/72 (84%), Positives = 65/72 (90%)

Query:     6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
             +DWK R SII GIARGLLYLH DSRL+IIHRDLK SNVLLD EMNPKISDFGMARIFGGN
Sbjct:   623 IDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGN 682

Query:    66 QSEANTNRIVGT 77
             Q+EANT R+VGT
Sbjct:   683 QNEANTVRVVGT 694

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 302 (111.4 bits), Expect = 9.6e-26, P = 9.6e-26
 Identities = 54/72 (75%), Positives = 65/72 (90%)

Query:     6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
             LDWK+R  II GIARGLLYLH DSRL+++HRDLKASN+LLD +M PKISDFGMAR+FGG+
Sbjct:   624 LDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGD 683

Query:    66 QSEANTNRIVGT 77
             Q++ NTNR+VGT
Sbjct:   684 QNQFNTNRVVGT 695

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 297 (109.6 bits), Expect = 2.0e-25, P = 2.0e-25
 Identities = 56/73 (76%), Positives = 65/73 (89%)

Query:     5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
             +LDW RR +II GIARG+LYLH+DSRL IIHRDLKASN+LLD +MNPKI+DFGMARIFG 
Sbjct:   438 ELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGV 497

Query:    65 NQSEANTNRIVGT 77
             +QS+ANT RI GT
Sbjct:   498 DQSQANTRRIAGT 510

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 297 (109.6 bits), Expect = 2.0e-25, P = 2.0e-25
 Identities = 56/73 (76%), Positives = 65/73 (89%)

Query:     5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
             QLDW RR  II G+ARG+LYLH+DSRL IIHRDLKASN+LLD +MNPKI+DFGMARIFG 
Sbjct:   441 QLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGL 500

Query:    65 NQSEANTNRIVGT 77
             +Q+E NT+RIVGT
Sbjct:   501 DQTEENTSRIVGT 513

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 299 (110.3 bits), Expect = 2.0e-25, P = 2.0e-25
 Identities = 57/76 (75%), Positives = 65/76 (85%)

Query:     2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
             RS  L+W++R  IINGIARGLLYLH+DSR +IIHRDLKASNVLLD  M PKISDFGMARI
Sbjct:   609 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 668

Query:    62 FGGNQSEANTNRIVGT 77
             FG  ++EANT R+VGT
Sbjct:   669 FGREETEANTRRVVGT 684

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 299 (110.3 bits), Expect = 2.0e-25, P = 2.0e-25
 Identities = 57/76 (75%), Positives = 65/76 (85%)

Query:     2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
             RS  L+W++R  IINGIARGLLYLH+DSR +IIHRDLKASNVLLD  M PKISDFGMARI
Sbjct:   613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672

Query:    62 FGGNQSEANTNRIVGT 77
             FG  ++EANT R+VGT
Sbjct:   673 FGREETEANTRRVVGT 688

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 297 (109.6 bits), Expect = 3.2e-25, P = 3.2e-25
 Identities = 55/73 (75%), Positives = 64/73 (87%)

Query:     5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
             QLDW RR  II GIARG+LYLH+DSRL IIHRDLKA N+LLD +MNPK++DFGMARIFG 
Sbjct:   601 QLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGM 660

Query:    65 NQSEANTNRIVGT 77
             +Q+EANT R+VGT
Sbjct:   661 DQTEANTRRVVGT 673

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 296 (109.3 bits), Expect = 3.6e-25, P = 3.6e-25
 Identities = 55/76 (72%), Positives = 66/76 (86%)

Query:     2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
             R  +LDW +R+ II GIARG+LYLHEDSRL+IIHRDLKASNVLLD +MN KISDFG+AR 
Sbjct:   555 RRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLART 614

Query:    62 FGGNQSEANTNRIVGT 77
              GG+++EANT R+VGT
Sbjct:   615 LGGDETEANTTRVVGT 630

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 294 (108.6 bits), Expect = 4.2e-25, P = 4.2e-25
 Identities = 55/73 (75%), Positives = 63/73 (86%)

Query:     5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
             QLDW RR  II GIARG+LYLH+DSRLKIIHRDLKASN+LLD +MNPKI+DFG+A IFG 
Sbjct:   443 QLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGV 502

Query:    65 NQSEANTNRIVGT 77
              Q++ NTNRI GT
Sbjct:   503 EQTQGNTNRIAGT 515

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O81833	SD11_ARATH	2, ., 7, ., 1, 1, ., 1	0.75	0.9870	0.0932	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.IV.1878.1 hypothetical protein (648 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	77
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-19
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-18
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-16
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-16
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-16
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-15
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-14
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-14
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-13
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-13
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-13
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-12
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-09
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-08
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-08
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-08
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-08
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-08
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-07
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-07
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-07
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-06
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-06
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-06
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-05
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-05
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-05
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-05
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-05
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-04
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-04
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-04
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	0.001
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	0.001
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	0.001
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	0.002
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.002
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.002
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.002
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.004
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 78.4 bits (194), Expect = 1e-19
 Identities = 32/77 (41%), Positives = 37/77 (48%), Gaps = 5/77 (6%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            R   L       I   I RGL YLH      IIHRDLK  N+LLD     KI+DFG+A+
Sbjct: 90  SRGGPLSEDEAKKIALQILRGLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGLAK 146

Query: 61  IFGGNQSEANTNRIVGT 77
               + S   T   VGT
Sbjct: 147 KLLKSSSSLTT--FVGT 161

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 73.4 bits (181), Expect = 5e-18
 Identities = 29/77 (37%), Positives = 41/77 (53%), Gaps = 6/77 (7%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMAR 60
              +L     + I+  I  GL YLH      IIHRDLK  N+LLD      K++DFG+++
Sbjct: 85  NEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSK 141

Query: 61  IFGGNQSEANTNRIVGT 77
           +   ++S   T  IVGT
Sbjct: 142 LLTSDKSLLKT--IVGT 156

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 70.6 bits (174), Expect = 1e-16
 Identities = 23/55 (41%), Positives = 32/55 (58%), Gaps = 3/55 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           L  K  +S    IA+G+ YL      K +HRDL A N L+  ++  KISDFG++R
Sbjct: 102 LSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 70.6 bits (174), Expect = 1e-16
 Identities = 24/60 (40%), Positives = 32/60 (53%), Gaps = 6/60 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      I+HRDLK  N+LLD + + K++DFG+AR     +        VGT
Sbjct: 106 ILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGT 159

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 70.3 bits (173), Expect = 2e-16
 Identities = 24/59 (40%), Positives = 31/59 (52%), Gaps = 3/59 (5%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           R  +L     +S    IARG+ YL        IHRDL A N L+   +  KISDFG++R
Sbjct: 96  RPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 69.9 bits (172), Expect = 2e-16
 Identities = 23/56 (41%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +L     +S    IARG+ YL        IHRDL A N L+   +  KISDFG++R
Sbjct: 98  KLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 68.0 bits (167), Expect = 1e-15
 Identities = 25/60 (41%), Positives = 39/60 (65%), Gaps = 4/60 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I +GL YLH  ++  IIHRD+K SN+L++ +   KI+DFG++++      + NT   VGT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGT 163

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 68.0 bits (167), Expect = 1e-15
 Identities = 23/58 (39%), Positives = 38/58 (65%), Gaps = 3/58 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           +  GL YLH +    I+HRD+K SN+L++++   K++DFG+AR +    S   TNR++
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 65.7 bits (161), Expect = 1e-14
 Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 3/60 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I  GL YLH      I+HRD+K +N+L+D +   K++DFG A+  G  ++   T  + GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 65.2 bits (160), Expect = 1e-14
 Identities = 21/55 (38%), Positives = 30/55 (54%), Gaps = 3/55 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           L  K  + +   IA+G+ YL        +HRDL A N L+   +  KISDFG++R
Sbjct: 99  LTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 64.2 bits (157), Expect = 3e-14
 Identities = 25/64 (39%), Positives = 38/64 (59%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I+    +GL YLH     K IHRD+KA N+LL+ E   K++DFG++       ++ NT  
Sbjct: 104 ILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158

Query: 74  IVGT 77
           ++GT
Sbjct: 159 VIGT 162

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 62.5 bits (153), Expect = 2e-13
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           RGL Y H  S  +I+HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 109 RGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 62.3 bits (152), Expect = 2e-13
 Identities = 28/72 (38%), Positives = 37/72 (51%), Gaps = 10/72 (13%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIFGGN 65
           I   + +GL YLHE    KIIHRD+K SN+L++     K+ DFG        +A+ F G 
Sbjct: 105 IAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGT 162

Query: 66  QSEANTNRIVGT 77
            S     RI G 
Sbjct: 163 SSYMAPERIQGN 174

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 61.7 bits (151), Expect = 3e-13
 Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   L YLH     KI+HRD+K  N+ L      K+ DFG++++       A T  +VGT
Sbjct: 112 LCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 5e-13
 Identities = 26/60 (43%), Positives = 34/60 (56%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH    L II+RDLK  N+LLD + + K++DFG+A+      S  NT    GT
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 60.5 bits (147), Expect = 8e-13
 Identities = 23/57 (40%), Positives = 36/57 (63%), Gaps = 3/57 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           Q++ KR +   + I +G+ YL      + IHRDL A N+L++ E   KISDFG+A++
Sbjct: 105 QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 59.9 bits (146), Expect = 2e-12
 Identities = 25/55 (45%), Positives = 32/55 (58%), Gaps = 3/55 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           I   L YLH      IIHRDLK  N+LLD +M+ KI+DFG A++   N S  +  
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 59.1 bits (144), Expect = 2e-12
 Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 6/64 (9%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           +   + +GL YLH      IIHRD+KA+N+LL  +   K+ DFG++            N 
Sbjct: 103 VCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNT 156

Query: 74  IVGT 77
           +VGT
Sbjct: 157 MVGT 160

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.9 bits (143), Expect = 4e-12
 Identities = 22/45 (48%), Positives = 34/45 (75%), Gaps = 3/45 (6%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           G+ YLHE+    I+HRD+KA+N+L+D++   KI+DFG+AR + G 
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 57.9 bits (140), Expect = 1e-11
 Identities = 29/64 (45%), Positives = 40/64 (62%), Gaps = 9/64 (14%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I++GIA    YLH   R  I+HRD+K SN+L++   N KI+DFG++RI    Q+    N 
Sbjct: 177 ILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNS 227

Query: 74  IVGT 77
            VGT
Sbjct: 228 SVGT 231

Length = 353

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 1e-11
 Identities = 22/60 (36%), Positives = 35/60 (58%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           + +GL YLHE     +IHRD+KA+N+L   +   K++DFG+A        +  +  +VGT
Sbjct: 108 VLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 57.5 bits (140), Expect = 1e-11
 Identities = 24/53 (45%), Positives = 32/53 (60%), Gaps = 3/53 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEAN 70
           I RGL YLH      +IHRDLK SN+L++   + KI DFG+AR    ++ E  
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 3e-11
 Identities = 27/64 (42%), Positives = 39/64 (60%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I+  +  GL YLHE+     IHRD+KA+N+LL  E + K++DFG++       S+ NT  
Sbjct: 103 ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-- 157

Query: 74  IVGT 77
            VGT
Sbjct: 158 FVGT 161

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 56.0 bits (135), Expect = 3e-11
 Identities = 30/70 (42%), Positives = 42/70 (60%), Gaps = 9/70 (12%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           W+  I I+ G+A    +LH     KI+HRD+K+ N+ LD   N KI D G+A++   N +
Sbjct: 104 WRFFIQILLGLA----HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156

Query: 68  EANTNRIVGT 77
            ANT  IVGT
Sbjct: 157 FANT--IVGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.5 bits (134), Expect = 6e-11
 Identities = 25/58 (43%), Positives = 39/58 (67%), Gaps = 6/58 (10%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEAN---TNRIV 75
           GL Y+H   R KI+HRD+KA+N+L+  +   K++DFG+AR F  +++      TNR+V
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.6 bits (134), Expect = 6e-11
 Identities = 27/49 (55%), Positives = 33/49 (67%), Gaps = 5/49 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IFGG 64
           IA GL +LH      II+RDLK  NV+LD E + KI+DFGM +  IFGG
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 55.3 bits (134), Expect = 6e-11
 Identities = 21/46 (45%), Positives = 31/46 (67%), Gaps = 3/46 (6%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
            G+ +LH++    I+HRDLK SN+LL++    KI DFG+AR +G  
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 55.3 bits (134), Expect = 7e-11
 Identities = 23/60 (38%), Positives = 37/60 (61%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           + +GL YLH      +IHRD+K+ N+LL  + + K++DFG A      +S+ N+  +VGT
Sbjct: 125 VLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 55.5 bits (134), Expect = 7e-11
 Identities = 26/44 (59%), Positives = 32/44 (72%), Gaps = 3/44 (6%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           RGL YLHE+    IIHRDLK SN+LL  +   KI+DFG+AR +G
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 55.5 bits (134), Expect = 7e-11
 Identities = 30/62 (48%), Positives = 36/62 (58%), Gaps = 9/62 (14%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRIV 75
           I  GL +LHE     II+RDLK  NVLLD E + KI+DFGM +  I GG      T+   
Sbjct: 105 IVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFC 157

Query: 76  GT 77
           GT
Sbjct: 158 GT 159

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.7 bits (132), Expect = 1e-10
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 2/43 (4%)

Query: 17  GIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
            I + L YLH   +L +IHRD+K SNVL++     K+ DFG++
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 3e-10
 Identities = 22/51 (43%), Positives = 34/51 (66%), Gaps = 3/51 (5%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           S +  + +G+ Y H  S  +++HRDLK  N+L+D E   K++DFG+AR FG
Sbjct: 103 SYLYQLLQGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 53.5 bits (129), Expect = 3e-10
 Identities = 22/51 (43%), Positives = 27/51 (52%), Gaps = 3/51 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           +A G+ YL        +HRDL A NVLL +    KISDFGM+R  G     
Sbjct: 104 VAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 53.3 bits (129), Expect = 4e-10
 Identities = 23/51 (45%), Positives = 32/51 (62%), Gaps = 3/51 (5%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           S +    RGL YLH      I+HRDLK +N+L+  +   K++DFG+AR FG
Sbjct: 106 SYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.1 bits (128), Expect = 4e-10
 Identities = 19/43 (44%), Positives = 25/43 (58%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA G+ YL      K +HRDL A N ++  ++  KI DFGM R
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 53.2 bits (128), Expect = 5e-10
 Identities = 27/71 (38%), Positives = 34/71 (47%), Gaps = 11/71 (15%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIFGGN 65
           I   + +GL YLH     KIIHRD+K SN+LL  +   K+ DFG        +A  F G 
Sbjct: 110 IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGT 166

Query: 66  QSEANTNRIVG 76
                  RI G
Sbjct: 167 SFYMAPERIQG 177

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 53.1 bits (128), Expect = 5e-10
 Identities = 19/56 (33%), Positives = 35/56 (62%), Gaps = 3/56 (5%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           +G+ Y+H      I+HRDLK +N+L+  +   KI+DFG+AR+F   +    ++++ 
Sbjct: 110 KGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (128), Expect = 5e-10
 Identities = 21/47 (44%), Positives = 29/47 (61%), Gaps = 3/47 (6%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+    RGL YLHE+   K+IHRD+K  N+LL      K+ DFG++ 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.8 bits (126), Expect = 6e-10
 Identities = 24/55 (43%), Positives = 38/55 (69%), Gaps = 3/55 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           IA+G++YL E    +++HRDL A NVL+    + KI+DFG+AR+  G++ E N +
Sbjct: 118 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 52.6 bits (127), Expect = 6e-10
 Identities = 27/61 (44%), Positives = 36/61 (59%), Gaps = 7/61 (11%)

Query: 22  LLYLHE-----DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVG 76
           LL L+E     D    ++HRDLK +N+ LD   N K+ DFG+A+I G + S A T   VG
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVG 172

Query: 77  T 77
           T
Sbjct: 173 T 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 52.7 bits (127), Expect = 8e-10
 Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + RGL Y+H      +IHRDLK SN+L++ +   +I DFGMAR
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.5 bits (126), Expect = 8e-10
 Identities = 22/44 (50%), Positives = 30/44 (68%), Gaps = 3/44 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H      ++HRDLK SN+L++   + KI DFG+ARI
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 2e-09
 Identities = 21/54 (38%), Positives = 32/54 (59%), Gaps = 7/54 (12%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP----KISDFGMARIF 62
           S++  I  G+ YLH +    ++HRDLK +N+L+  E       KI D G+AR+F
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 51.2 bits (123), Expect = 2e-09
 Identities = 21/68 (30%), Positives = 39/68 (57%), Gaps = 3/68 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           +    + + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R    
Sbjct: 102 KFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158

Query: 65  NQSEANTN 72
           +++   T 
Sbjct: 159 SEATYTTK 166

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 51.0 bits (122), Expect = 2e-09
 Identities = 21/52 (40%), Positives = 33/52 (63%), Gaps = 3/52 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ ++    R   IHRDL+A+N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 111 IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 3e-09
 Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 3/60 (5%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            RS  L   + + I   I  GL YLH     +IIHRD+K  N+ ++      I D G A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 3e-09
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 3/66 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            R   L      S +  + +GL + H      I+HRDLK  N+L++ E   K++DFG+AR
Sbjct: 90  DRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR 146

Query: 61  IFGGNQ 66
            FG   
Sbjct: 147 SFGSPV 152

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 51.0 bits (122), Expect = 3e-09
 Identities = 21/48 (43%), Positives = 29/48 (60%), Gaps = 3/48 (6%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
                +  GL YLH      I+HRDLKA N+L+D +   KISDFG+++
Sbjct: 112 FFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 50.8 bits (122), Expect = 3e-09
 Identities = 22/60 (36%), Positives = 29/60 (48%), Gaps = 6/60 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRD+K  N+LLD + +  I+DF +A     +     T    GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 50.7 bits (122), Expect = 3e-09
 Identities = 27/66 (40%), Positives = 33/66 (50%), Gaps = 9/66 (13%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG------MARIFGGNQSEANT 71
           I   L YLH      IIHRDLK  N+L+D   + K++DFG      + R    N  E   
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158

Query: 72  NRIVGT 77
            RIVGT
Sbjct: 159 KRIVGT 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 3e-09
 Identities = 23/44 (52%), Positives = 31/44 (70%), Gaps = 3/44 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+ARI
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 50.5 bits (121), Expect = 4e-09
 Identities = 24/45 (53%), Positives = 30/45 (66%), Gaps = 7/45 (15%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLL--DHEMNPKISDFGMAR 60
           +ARG+ +L      K IHRDL A NVL+  DH M  KI+DFG+AR
Sbjct: 141 VARGMEFLASK---KCIHRDLAARNVLVTEDHVM--KIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 50.1 bits (120), Expect = 4e-09
 Identities = 19/44 (43%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           +A G+ YL E      IHRDL A N+L+  ++  K++DFG+AR+
Sbjct: 113 VAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 4e-09
 Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 3/52 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ YL        IHRDL A N+L+   +  KI+DFG+AR+   ++  A
Sbjct: 112 IAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 49.9 bits (120), Expect = 6e-09
 Identities = 20/50 (40%), Positives = 33/50 (66%), Gaps = 3/50 (6%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++  + RG+ +LH     +I+HRDLK  N+L+  +   KI+DFG+ARI+ 
Sbjct: 112 LMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 50.0 bits (119), Expect = 6e-09
 Identities = 28/65 (43%), Positives = 41/65 (63%), Gaps = 5/65 (7%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           +I+  I +GL YLH + +   IHRD+KA+NVLL  + + K++DFG+A      Q + NT 
Sbjct: 105 TILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT- 160

Query: 73  RIVGT 77
             VGT
Sbjct: 161 -FVGT 164

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 49.9 bits (120), Expect = 7e-09
 Identities = 21/47 (44%), Positives = 32/47 (68%), Gaps = 3/47 (6%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+  + + L Y+H  S   +IHRDLK SN+LL+ +   K++DFG+AR
Sbjct: 112 IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.5 bits (118), Expect = 9e-09
 Identities = 25/49 (51%), Positives = 33/49 (67%), Gaps = 5/49 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IFGG 64
           I   L++LH+     II+RDLK  NVLLDHE + K++DFGM +  IF G
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 49.6 bits (118), Expect = 9e-09
 Identities = 27/56 (48%), Positives = 37/56 (66%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL +K  +S    +ARG+ YL  +SR + IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 130 QLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 1e-08
 Identities = 23/51 (45%), Positives = 35/51 (68%), Gaps = 3/51 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL E+ RL  +HRDL A NVL+    + KI+DFG+A++   ++ E
Sbjct: 118 IAKGMSYL-EEKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 1e-08
 Identities = 21/54 (38%), Positives = 30/54 (55%), Gaps = 3/54 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +A G+ YL   +    IHRDL A NVL+      K++DFG+AR+   +  EA  
Sbjct: 112 VASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 49.4 bits (118), Expect = 1e-08
 Identities = 23/63 (36%), Positives = 41/63 (65%), Gaps = 3/63 (4%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           S +  +  GL Y H+ + L   HRD+K SN+LL+++   K++DFG+AR++   +S   TN
Sbjct: 120 SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 73  RIV 75
           +++
Sbjct: 177 KVI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 48.9 bits (117), Expect = 1e-08
 Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +  G+ YL E      +HRDL A NVL+  ++  K+SDFG+A+
Sbjct: 111 VCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.9 bits (117), Expect = 1e-08
 Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.8 bits (116), Expect = 1e-08
 Identities = 24/51 (47%), Positives = 36/51 (70%), Gaps = 3/51 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL E+ RL  +HRDL A NVL+    + KI+DFG+A++ G ++ E
Sbjct: 118 IAKGMNYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 49.0 bits (117), Expect = 1e-08
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 3/58 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           I RGL YLH      I+HRD+K  N+L++     KI DFG+AR+   ++S+  T  +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 48.7 bits (116), Expect = 2e-08
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 109 VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165

Query: 72  NR 73
            R
Sbjct: 166 TR 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 48.6 bits (116), Expect = 2e-08
 Identities = 30/75 (40%), Positives = 42/75 (56%), Gaps = 12/75 (16%)

Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           +ISI   + RGL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 103 KISI--AVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158

Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 159 VGTRSYMSPERLQGT 173

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.4 bits (115), Expect = 2e-08
 Identities = 20/51 (39%), Positives = 34/51 (66%), Gaps = 3/51 (5%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+ 
Sbjct: 110 VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.5 bits (115), Expect = 2e-08
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+ GL +LH      II+RDLK  NV+LD E + KI+DFGM +
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 48.3 bits (115), Expect = 2e-08
 Identities = 22/47 (46%), Positives = 31/47 (65%), Gaps = 4/47 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-KISDFGMARIFG 63
           I RG+ Y H     +++HRDLK  N+L+D   N  K++DFG+AR FG
Sbjct: 111 ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154

Length = 294

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 48.1 bits (115), Expect = 2e-08
 Identities = 25/66 (37%), Positives = 41/66 (62%), Gaps = 5/66 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM-ARIF-GGNQSEANT 71
           ++  + +GL YLH + +   IHRD+KA N+LL  + + KI+DFG+ A +  GG+++    
Sbjct: 107 VLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163

Query: 72  NRIVGT 77
              VGT
Sbjct: 164 KTFVGT 169

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 48.1 bits (114), Expect = 2e-08
 Identities = 30/77 (38%), Positives = 46/77 (59%), Gaps = 5/77 (6%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +R+   D  +  +++  I +GL YLH +   K IHRD+KA+NVLL  + + K++DFG+A 
Sbjct: 93  LRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAG 149

Query: 61  IFGGNQSEANTNRIVGT 77
                Q + NT   VGT
Sbjct: 150 QLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 48.3 bits (115), Expect = 3e-08
 Identities = 28/57 (49%), Positives = 38/57 (66%), Gaps = 4/57 (7%)

Query: 22  LLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           LL LH      I+HRDLK  N+LLD H+M  KI DFG+++I   ++S+A T  +VGT
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 47.8 bits (114), Expect = 3e-08
 Identities = 22/59 (37%), Positives = 38/59 (64%), Gaps = 3/59 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
            +D +   S +  I +G+L+ H     +++HRDLK  N+L+D++   K++DFG+AR FG
Sbjct: 97  YMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.1 bits (114), Expect = 3e-08
 Identities = 22/51 (43%), Positives = 36/51 (70%), Gaps = 3/51 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL E   ++++HRDL A NVL+    + KI+DFG+AR+   +++E
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 47.7 bits (114), Expect = 3e-08
 Identities = 22/42 (52%), Positives = 29/42 (69%), Gaps = 2/42 (4%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
             + L YL E+  LKIIHRD+K SN+LLD   N K+ DFG++
Sbjct: 116 TVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 47.8 bits (112), Expect = 4e-08
 Identities = 25/78 (32%), Positives = 37/78 (47%), Gaps = 4/78 (5%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN-PKISDFGMA 59
            R   L     + I+  I   L YLH      IIHRD+K  N+LLD +    K+ DFG+A
Sbjct: 93  GRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLA 149

Query: 60  RIFGGNQSEANTNRIVGT 77
           ++     S ++   +  T
Sbjct: 150 KLLPDPGSTSSIPALPST 167

Length = 384

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 47.7 bits (113), Expect = 4e-08
 Identities = 23/52 (44%), Positives = 33/52 (63%), Gaps = 3/52 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R   IHRDL+A+NVL+   +  KI+DFG+AR+   N+  A
Sbjct: 112 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 47.8 bits (113), Expect = 4e-08
 Identities = 28/72 (38%), Positives = 41/72 (56%), Gaps = 5/72 (6%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DFG+A      
Sbjct: 98  LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--T 152

Query: 66  QSEANTNRIVGT 77
            ++   N  VGT
Sbjct: 153 DTQIKRNTFVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 47.5 bits (113), Expect = 4e-08
 Identities = 25/60 (41%), Positives = 38/60 (63%), Gaps = 3/60 (5%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           + +  I +GL YLH  +R  IIHRD+K +N+L+D++   KISDFG+++    N     TN
Sbjct: 110 NFVRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.6 bits (113), Expect = 4e-08
 Identities = 22/57 (38%), Positives = 34/57 (59%), Gaps = 3/57 (5%)

Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
              L+ +R I     I  G+L+LH    + I++RD+K  NVLLD + N ++SD G+A
Sbjct: 89  ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 47.5 bits (113), Expect = 4e-08
 Identities = 26/62 (41%), Positives = 35/62 (56%), Gaps = 9/62 (14%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRIV 75
           I  GL +LH+     II+RDLK  NVLLD + + KI+DFGM +  + G    E   +   
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157

Query: 76  GT 77
           GT
Sbjct: 158 GT 159

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.4 bits (113), Expect = 5e-08
 Identities = 22/38 (57%), Positives = 28/38 (73%), Gaps = 3/38 (7%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM 58
           GL YLHE+   KI++RDLK  N+LLD E   KI+DFG+
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 5e-08
 Identities = 25/64 (39%), Positives = 39/64 (60%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           II  +   L Y+H+     +IHRD+KA+N+L+ +  N K+ DFG+A +   N S+ +T  
Sbjct: 106 IIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-- 160

Query: 74  IVGT 77
            VGT
Sbjct: 161 FVGT 164

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 47.3 bits (112), Expect = 5e-08
 Identities = 23/43 (53%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA GL +LH      II+RDLK  NV+LD E + KI+DFGM +
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 47.1 bits (112), Expect = 6e-08
 Identities = 21/42 (50%), Positives = 28/42 (66%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  GL +LH   + +I++RDLK  NVLLD   N +ISD G+A
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 6e-08
 Identities = 26/56 (46%), Positives = 35/56 (62%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL +K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 130 QLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 47.3 bits (113), Expect = 6e-08
 Identities = 22/47 (46%), Positives = 30/47 (63%), Gaps = 3/47 (6%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 123 LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 46.8 bits (111), Expect = 7e-08
 Identities = 21/57 (36%), Positives = 36/57 (63%), Gaps = 3/57 (5%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           + ++ GIA G+ YL E   +  +HRDL A N+L++  +  K+SDFG++R    + S+
Sbjct: 109 VGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 47.1 bits (112), Expect = 7e-08
 Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 4/43 (9%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARI 61
           RGL Y+H  +   ++HRDLK +NV ++ E +  KI DFG+ARI
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 46.8 bits (111), Expect = 8e-08
 Identities = 22/42 (52%), Positives = 30/42 (71%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  GL +LH+    +II+RDLK  NVLLD++ N +ISD G+A
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 46.6 bits (111), Expect = 8e-08
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  GL YLH+      +HRD+K +N+L+D     K++DFGMA+
Sbjct: 111 ILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 46.6 bits (111), Expect = 9e-08
 Identities = 18/41 (43%), Positives = 27/41 (65%), Gaps = 3/41 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           RGL Y H   + +++HRDLK  N+L+      K++DFG+AR
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 46.6 bits (111), Expect = 9e-08
 Identities = 20/48 (41%), Positives = 26/48 (54%), Gaps = 3/48 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           +  GL YLH      I+HRD+K +N+ LDH    K+ DFG A     N
Sbjct: 108 LLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 46.6 bits (110), Expect = 9e-08
 Identities = 22/52 (42%), Positives = 34/52 (65%), Gaps = 3/52 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  IHRDL+A+N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 111 IADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 46.6 bits (110), Expect = 1e-07
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 111 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 1e-07
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH       IHRDL A NVLLD++   KI DFG+A+
Sbjct: 116 ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 46.5 bits (110), Expect = 1e-07
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+RG+ YL E   +K++HRDL A NVL+      KISDFG++R
Sbjct: 136 ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 1e-07
 Identities = 18/48 (37%), Positives = 25/48 (52%), Gaps = 3/48 (6%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           S I  + + + Y H      IIHRD+K  N+L+      K+ DFG AR
Sbjct: 104 SYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 46.3 bits (110), Expect = 1e-07
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           IA  L YLH    L II+RDLK  N+LLD + +  ++DFG+ +   G +    T+   GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 46.4 bits (110), Expect = 1e-07
 Identities = 24/69 (34%), Positives = 37/69 (53%), Gaps = 4/69 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFG 63
            L    ++ I   +A G+ YL E    K +HRDL   N L+   M  KI+DFG++R I+ 
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 64  GNQSEANTN 72
            +  +A+ N
Sbjct: 183 ADYYKASEN 191

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 46.0 bits (110), Expect = 1e-07
 Identities = 24/60 (40%), Positives = 32/60 (53%), Gaps = 8/60 (13%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   L YLH    L I++RDLK  N+LLD +   KI+DFG A+   G      T  + GT
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGT 161

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.1 bits (109), Expect = 1e-07
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           +A G+ Y+    R+  IHRDL+++N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 111 VAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 46.0 bits (109), Expect = 1e-07
 Identities = 27/65 (41%), Positives = 37/65 (56%), Gaps = 9/65 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           +I +G  +GL YLH     + IHRD+KA N+LL      K++DFG A +     S AN+ 
Sbjct: 119 AICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS- 170

Query: 73  RIVGT 77
             VGT
Sbjct: 171 -FVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.9 bits (109), Expect = 2e-07
 Identities = 24/56 (42%), Positives = 33/56 (58%), Gaps = 3/56 (5%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           S I  I  GL Y+H  +   ++HRDLK  N+L++ +   KI DFG+AR F  N  E
Sbjct: 109 SFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.1 bits (109), Expect = 2e-07
 Identities = 23/57 (40%), Positives = 34/57 (59%), Gaps = 9/57 (15%)

Query: 9   KRRISIINGIA------RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           KR I+I + +A      R + YLHE+    IIHRD+KA N+ ++H  +  + DFG A
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 2e-07
 Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH +    I+HRD+K +N+L D   N K+ DFG ++
Sbjct: 113 ILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 45.8 bits (108), Expect = 2e-07
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 133 QMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 45.8 bits (109), Expect = 2e-07
 Identities = 21/48 (43%), Positives = 26/48 (54%), Gaps = 3/48 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           IA G+ YL      + IHRDL A N+LL  +   KI DFG+ R    N
Sbjct: 106 IANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 45.9 bits (109), Expect = 2e-07
 Identities = 18/44 (40%), Positives = 31/44 (70%), Gaps = 3/44 (6%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           +G+ + HE+   +++HRDLK  N+L++     K++DFG+AR FG
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 45.5 bits (108), Expect = 2e-07
 Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL      K +HRDL A N +LD     K++DFG+AR
Sbjct: 107 VAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 45.7 bits (109), Expect = 2e-07
 Identities = 22/54 (40%), Positives = 26/54 (48%), Gaps = 6/54 (11%)

Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           YLH      II+RDLK  N+LLD     K+ DFG A+     Q    T    GT
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 2e-07
 Identities = 18/39 (46%), Positives = 27/39 (69%), Gaps = 3/39 (7%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
            L +LH     K+IHRDLKA N+LL  + + K++DFG++
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 45.7 bits (108), Expect = 2e-07
 Identities = 23/49 (46%), Positives = 33/49 (67%), Gaps = 5/49 (10%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQS 67
           GL +LH      II+RDLK  NV+LD + + KI+DFGM +  +FG N++
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 45.6 bits (108), Expect = 2e-07
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 3/37 (8%)

Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           YLH      II+RDLK  N+LLD++ + K++DFG A+
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 45.5 bits (108), Expect = 3e-07
 Identities = 19/51 (37%), Positives = 31/51 (60%), Gaps = 3/51 (5%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           S +  + +GL + H      ++HRDLK  N+L++     K++DFG+AR FG
Sbjct: 103 SFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.4 bits (107), Expect = 3e-07
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)

Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 107 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162

Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 163 VGTRSYMSPERLQGT 177

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 45.2 bits (107), Expect = 3e-07
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.3 bits (107), Expect = 3e-07
 Identities = 19/41 (46%), Positives = 27/41 (65%), Gaps = 3/41 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           RGL Y+H      I+HRDLK  N+L+ +    K++DFG+AR
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 45.2 bits (107), Expect = 3e-07
 Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+  L +LHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 45.4 bits (107), Expect = 3e-07
 Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I RGL Y H   R K++HRDLK  N+L++     K++DFG+AR
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.0 bits (106), Expect = 3e-07
 Identities = 26/56 (46%), Positives = 35/56 (62%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL +K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 44.9 bits (106), Expect = 4e-07
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 4/49 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFGGN 65
           IA G+ YL   S    IHRDL A N +L+  M   ++DFG+++ I+ G+
Sbjct: 122 IASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 45.0 bits (106), Expect = 4e-07
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ ++ + +    IHRDL+A+N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 111 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 45.0 bits (106), Expect = 4e-07
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 45.0 bits (106), Expect = 4e-07
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 44.7 bits (106), Expect = 4e-07
 Identities = 20/45 (44%), Positives = 28/45 (62%), Gaps = 3/45 (6%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G +
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 44.8 bits (106), Expect = 4e-07
 Identities = 18/57 (31%), Positives = 33/57 (57%), Gaps = 3/57 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           +LD ++ +   + I +G+ YL      + +HRDL   N+L++ E   KI DFG+ ++
Sbjct: 104 RLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.9 bits (106), Expect = 5e-07
 Identities = 21/47 (44%), Positives = 33/47 (70%), Gaps = 3/47 (6%)

Query: 15  INGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I+ +A  L YLH   R  IIHRDLK  N+L+ +E + K++DFG++++
Sbjct: 110 ISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 44.6 bits (105), Expect = 5e-07
 Identities = 25/62 (40%), Positives = 35/62 (56%), Gaps = 9/62 (14%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRIV 75
           I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +  + G    +A T    
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFC 157

Query: 76  GT 77
           GT
Sbjct: 158 GT 159

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 44.4 bits (105), Expect = 6e-07
 Identities = 20/51 (39%), Positives = 32/51 (62%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA  +L L    +L II+RD+K  N+LLD E +  ++DFG+++ F   + E
Sbjct: 111 IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 44.4 bits (105), Expect = 6e-07
 Identities = 21/42 (50%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 19  ARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           A G+ YL  +S+   IHRDL A N L+      KISDFGM+R
Sbjct: 103 AAGMEYL--ESK-NCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 44.5 bits (105), Expect = 6e-07
 Identities = 22/49 (44%), Positives = 32/49 (65%), Gaps = 4/49 (8%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMA 59
           I+    + RGL YLHE+   +IIHRD+K +N+L+D      +I+DFG A
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 44.3 bits (104), Expect = 6e-07
 Identities = 21/55 (38%), Positives = 33/55 (60%), Gaps = 4/55 (7%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA-RIFGGN 65
           +  +  IA G+ YL   S    IHRDL A N +L+  MN  ++DFG++ +I+ G+
Sbjct: 115 VKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 44.2 bits (104), Expect = 6e-07
 Identities = 20/41 (48%), Positives = 29/41 (70%), Gaps = 3/41 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           RGL Y H   + KI+HRDLK  N+L++ +   K++DFG+AR
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 44.2 bits (104), Expect = 7e-07
 Identities = 20/41 (48%), Positives = 28/41 (68%), Gaps = 3/41 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           RGL Y H   R K++HRDLK  N+L++     K++DFG+AR
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.2 bits (104), Expect = 7e-07
 Identities = 20/56 (35%), Positives = 35/56 (62%), Gaps = 3/56 (5%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           + +++ ++ G+ YL   +    +HRDL A NVLL ++   KISDFG+++  G + S
Sbjct: 98  VELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 44.2 bits (104), Expect = 7e-07
 Identities = 20/54 (37%), Positives = 29/54 (53%), Gaps = 3/54 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +  G+ YL   +   +IHRDL A N L+      K+SDFGM R    +Q  ++T
Sbjct: 109 VCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 43.9 bits (103), Expect = 8e-07
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)

Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + RGL YL E  + +I+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 107 KVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162

Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 163 VGTRSYMSPERLQGT 177

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 8e-07
 Identities = 18/40 (45%), Positives = 28/40 (70%), Gaps = 3/40 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           +GL YLHE      IHRD+K +N+LL  + + K++DFG++
Sbjct: 112 KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.1 bits (104), Expect = 9e-07
 Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +ARG+ +L   SR K IHRDL A N+LL      KI DFG+AR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.9 bits (104), Expect = 9e-07
 Identities = 17/43 (39%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA G+ YLH   +  +IH+D+ A N ++D E+  KI+D  ++R
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 43.7 bits (103), Expect = 9e-07
 Identities = 21/48 (43%), Positives = 30/48 (62%), Gaps = 4/48 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFGG 64
           I  GL YLH+    +I+HRD+K  NVL++ +    KISDFG ++   G
Sbjct: 117 ILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 43.8 bits (103), Expect = 9e-07
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 43.7 bits (103), Expect = 9e-07
 Identities = 20/49 (40%), Positives = 27/49 (55%), Gaps = 3/49 (6%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +S+   +  G+ YL  +S    IHRDL A N L+      K+SDFGM R
Sbjct: 103 LSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.8 bits (103), Expect = 1e-06
 Identities = 22/56 (39%), Positives = 33/56 (58%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL   + ++I + IA G++YL   + L  +HRDL   N L+   +  KI DFGM+R
Sbjct: 118 QLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 43.6 bits (103), Expect = 1e-06
 Identities = 22/60 (36%), Positives = 33/60 (55%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   + Y+H+     I+HRD+K  N+ L      K+ DFG+++I G   S A T  +VGT
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 43.6 bits (103), Expect = 1e-06
 Identities = 17/43 (39%), Positives = 24/43 (55%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +   + YL  +     IHRDL A N L+  +   K+SDFG+AR
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 43.9 bits (103), Expect = 1e-06
 Identities = 26/65 (40%), Positives = 36/65 (55%), Gaps = 9/65 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           +I +G  +GL YLH  +   +IHRD+KA N+LL      K++DFG A I       +  N
Sbjct: 129 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIA------SPAN 179

Query: 73  RIVGT 77
             VGT
Sbjct: 180 SFVGT 184

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 43.6 bits (103), Expect = 1e-06
 Identities = 24/69 (34%), Positives = 39/69 (56%), Gaps = 5/69 (7%)

Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           +R  +I   +   L YLH++ R  I+HRDL  +N++L  +    I+DFG+A+     Q E
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPE 167

Query: 69  ANTNRIVGT 77
           +    +VGT
Sbjct: 168 SKLTSVVGT 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 43.6 bits (103), Expect = 1e-06
 Identities = 24/71 (33%), Positives = 35/71 (49%), Gaps = 10/71 (14%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIFGGN 65
           I   +  GL YL+   R  I+HRD+K SN+L++     K+ DFG        +A  F G 
Sbjct: 108 IAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGT 165

Query: 66  QSEANTNRIVG 76
            +  +  RI G
Sbjct: 166 STYMSPERIQG 176

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 43.5 bits (102), Expect = 1e-06
 Identities = 20/39 (51%), Positives = 28/39 (71%), Gaps = 3/39 (7%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
            L YLHE+   KIIHRDLKA N+L   + + K++DFG++
Sbjct: 115 ALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 43.4 bits (102), Expect = 1e-06
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)

Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K    +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++  G +++
Sbjct: 95  KNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.3 bits (102), Expect = 1e-06
 Identities = 19/39 (48%), Positives = 28/39 (71%), Gaps = 3/39 (7%)

Query: 22  LLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           L++LH   R  +I+RDLK  N+LLD E + K++DFGM +
Sbjct: 109 LMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.4 bits (102), Expect = 1e-06
 Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 3/60 (5%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           M+  +L   R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 110 MKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 1e-06
 Identities = 23/58 (39%), Positives = 30/58 (51%), Gaps = 3/58 (5%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           RS  L  ++ I+I   +   L YLH      IIHRD+K  N+ LD   N  + DFG A
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 43.5 bits (102), Expect = 1e-06
 Identities = 27/65 (41%), Positives = 37/65 (56%), Gaps = 9/65 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           +I +G  +GL YLH  +   +IHRD+KA N+LL      K++DFG A       S AN+ 
Sbjct: 125 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS- 176

Query: 73  RIVGT 77
             VGT
Sbjct: 177 -FVGT 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 43.1 bits (102), Expect = 1e-06
 Identities = 21/51 (41%), Positives = 30/51 (58%), Gaps = 6/51 (11%)

Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           K  ++I+      L YL E     +IHRD+K SN+LLD   N K+ DFG++
Sbjct: 118 KMTVAIVKA----LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 43.2 bits (102), Expect = 1e-06
 Identities = 21/48 (43%), Positives = 30/48 (62%), Gaps = 3/48 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           + RGL  LHE    KI+HRDLK++N+LL      KI D G++++   N
Sbjct: 112 LLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 43.1 bits (102), Expect = 1e-06
 Identities = 19/43 (44%), Positives = 24/43 (55%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA G+ YL     L  +HRDL   N L+      KI+DFGM+R
Sbjct: 139 IASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 43.5 bits (102), Expect = 1e-06
 Identities = 21/38 (55%), Positives = 28/38 (73%), Gaps = 3/38 (7%)

Query: 22  LLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           L YLH    +KIIHRDLKA NVLL  + + K++DFG++
Sbjct: 123 LQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.0 bits (101), Expect = 2e-06
 Identities = 20/49 (40%), Positives = 28/49 (57%), Gaps = 3/49 (6%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + +   IA G+ YL   S L  +HRDL   N L+   +  KI+DFGM+R
Sbjct: 141 LHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 43.2 bits (102), Expect = 2e-06
 Identities = 20/56 (35%), Positives = 33/56 (58%), Gaps = 5/56 (8%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
            DW ++   I  +  G+  LH+     IIHRD+K  N+L+D   + K++DFG++R 
Sbjct: 96  EDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 43.1 bits (101), Expect = 2e-06
 Identities = 26/65 (40%), Positives = 35/65 (53%), Gaps = 9/65 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           ++ +G  +GL YLH  +   +IHRD+KA N+LL      K+ DFG A I       A  N
Sbjct: 119 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169

Query: 73  RIVGT 77
             VGT
Sbjct: 170 XFVGT 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.0 bits (101), Expect = 2e-06
 Identities = 23/58 (39%), Positives = 33/58 (56%), Gaps = 3/58 (5%)

Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            + LD +  +S    +A+G+ +L   +    IHRDL A N+LL H    KI DFG+AR
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 262

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.1 bits (101), Expect = 2e-06
 Identities = 22/47 (46%), Positives = 30/47 (63%), Gaps = 3/47 (6%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  + RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 43.0 bits (101), Expect = 2e-06
 Identities = 25/60 (41%), Positives = 32/60 (53%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           IA  L YLHE     I+HRDLK  NV L      K+ D G+AR+       A+T  ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 43.0 bits (101), Expect = 2e-06
 Identities = 19/44 (43%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           +A G+ YL      K++HRDL A N+L+  +   K+SDFG+AR+
Sbjct: 109 VAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV 149

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 42.7 bits (100), Expect = 2e-06
 Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +A  + YLH    L II+RDLK  N+LLD + +  ++DFG+ +   G + E  T+   GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 42.9 bits (101), Expect = 2e-06
 Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A  L +LH    L II+RDLK  N+LLD E + K++DFG+++
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 42.4 bits (100), Expect = 2e-06
 Identities = 23/55 (41%), Positives = 30/55 (54%), Gaps = 3/55 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           LD    + I   IA G+ YL   S    +HRDL A N L+   +  KISDFG++R
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 42.7 bits (100), Expect = 3e-06
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +ARG+ YL   S+ + IHRDL A N+L+      KI+DFG++R
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 42.7 bits (100), Expect = 3e-06
 Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA G+ YL   + L  +HRDL   N L+ +    KI+DFGM+R
Sbjct: 138 IASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 42.5 bits (101), Expect = 3e-06
 Identities = 21/48 (43%), Positives = 29/48 (60%), Gaps = 3/48 (6%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           SII  I +GL ++H   +    HRDLK  N+L+      KI+DFG+AR
Sbjct: 103 SIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 42.3 bits (99), Expect = 3e-06
 Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH +    I+HRD+K +N+L D   N K+ DFG ++
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.1 bits (99), Expect = 3e-06
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 4/49 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFGGN 65
           IA G+ YL   S    IHRDL A N +L  +M   ++DFG+++ I+ G+
Sbjct: 122 IALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.4 bits (99), Expect = 4e-06
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.3 bits (99), Expect = 4e-06
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 41.9 bits (98), Expect = 4e-06
 Identities = 21/52 (40%), Positives = 30/52 (57%), Gaps = 3/52 (5%)

Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           K+ I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 4e-06
 Identities = 21/43 (48%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +    IHRDL A NVLL H    KI DFG+AR
Sbjct: 150 VAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.9 bits (98), Expect = 4e-06
 Identities = 22/57 (38%), Positives = 35/57 (61%), Gaps = 3/57 (5%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR
Sbjct: 118 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 42.1 bits (99), Expect = 4e-06
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 8/61 (13%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN--QSEANT 71
           I   + +GL +L E+    IIHRD+K +NVL++     K+ DFG++    GN   S A T
Sbjct: 107 ITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKT 160

Query: 72  N 72
           N
Sbjct: 161 N 161

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.1 bits (99), Expect = 4e-06
 Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I   L YLH      +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 42.1 bits (99), Expect = 5e-06
 Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           R L Y+H  +   + HRDLK  N+L + +   KI DFG+AR+
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 41.9 bits (98), Expect = 5e-06
 Identities = 21/52 (40%), Positives = 29/52 (55%), Gaps = 3/52 (5%)

Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +  I +   IA G+ YL+     K +HRDL A N ++ H+   KI DFGM R
Sbjct: 119 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 41.7 bits (98), Expect = 5e-06
 Identities = 21/60 (35%), Positives = 32/60 (53%), Gaps = 9/60 (15%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR--IVGT 77
           + L +LH      +IHRD+K+ ++LL  +   K+SDFG    F    S+    R  +VGT
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 5e-06
 Identities = 24/55 (43%), Positives = 33/55 (60%), Gaps = 7/55 (12%)

Query: 9   KRRISIINGIAR----GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           KR I++I G+ R    GL  LH   R+ I+HRD+K  N+L+  +   KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (97), Expect = 5e-06
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +G+ YLH +    I+HRD+K +N+L D   N K+ DFG ++
Sbjct: 115 ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 41.7 bits (98), Expect = 5e-06
 Identities = 19/50 (38%), Positives = 30/50 (60%), Gaps = 3/50 (6%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           I+  I  GL  LH+      +HRDL  +N+ ++ +   KI+DFG+AR +G
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170

Length = 335

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.5 bits (97), Expect = 6e-06
 Identities = 23/43 (53%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +ARG+ +L   SR K IHRDL A N+LL      KI DFG+AR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 41.7 bits (98), Expect = 6e-06
 Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA G++YL   +    +HRDL   N L+ +++  KI DFGM+R
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 41.6 bits (97), Expect = 6e-06
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+  L YLHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.6 bits (98), Expect = 7e-06
 Identities = 18/41 (43%), Positives = 27/41 (65%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM 58
           IA  +L +    +L  IHRD+K  N+LLD + + K+SDFG+
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 41.5 bits (97), Expect = 7e-06
 Identities = 25/64 (39%), Positives = 37/64 (57%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I+ G   GL +LH +   +IIHRD+K +N+LL  E   K+ DFG++      +   NT+ 
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188

Query: 74  IVGT 77
            VGT
Sbjct: 189 -VGT 191

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 41.5 bits (97), Expect = 7e-06
 Identities = 21/51 (41%), Positives = 33/51 (64%), Gaps = 4/51 (7%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           G+ Y+H+    +I+HRDLKA N+ L + +  KI DFG++R+  G+   A T
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 41.2 bits (96), Expect = 7e-06
 Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I   I RGL +LH+    K+IHRD+K  NVLL      K+ DFG++     +++    N 
Sbjct: 116 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNT 170

Query: 74  IVGT 77
            +GT
Sbjct: 171 FIGT 174

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 9e-06
 Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +    IHRD+ A NVLL      KI DFG+AR
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.2 bits (96), Expect = 1e-05
 Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   SR K IHRDL A N+LL      KI DFG+AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 40.9 bits (96), Expect = 1e-05
 Identities = 16/44 (36%), Positives = 27/44 (61%), Gaps = 4/44 (9%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-KISDFGMARIF 62
           +G+ + H   +  ++HRDLK  N+L+D +    KI+D G+ R F
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 40.8 bits (95), Expect = 1e-05
 Identities = 22/54 (40%), Positives = 33/54 (61%), Gaps = 4/54 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           IA  L YLH    + I++RDLK  N+LLD + +  ++DFG+ +  G  QS+  T
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTT 154

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 1e-05
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I   L YLH     +I++RDLK  N+LLD E + K++DFG A+
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 40.6 bits (95), Expect = 1e-05
 Identities = 20/50 (40%), Positives = 32/50 (64%), Gaps = 5/50 (10%)

Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           RI++   + +GL YL     LKI+HRD+K SN+L++     K+ DFG++ 
Sbjct: 99  RIAV--AVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 40.5 bits (95), Expect = 1e-05
 Identities = 18/60 (30%), Positives = 32/60 (53%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   L ++H     +I+HRD+K +NV +      K+ D G+ R F    + A++  +VGT
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 40.8 bits (95), Expect = 1e-05
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A G+ YL E    + IHRDL A NVL+   +  KI+DFG++R
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 40.7 bits (95), Expect = 1e-05
 Identities = 21/49 (42%), Positives = 27/49 (55%), Gaps = 3/49 (6%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +   IA G+ YL   S L  +HRDL   N L+      KI+DFGM+R
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 40.7 bits (95), Expect = 1e-05
 Identities = 19/41 (46%), Positives = 25/41 (60%), Gaps = 3/41 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 40.8 bits (95), Expect = 1e-05
 Identities = 23/56 (41%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +L  K  I ++   A G+ YL        IHRDL A N L+  +   KISDFGM+R
Sbjct: 90  RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 40.4 bits (95), Expect = 1e-05
 Identities = 17/42 (40%), Positives = 27/42 (64%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           IA  +L L    +L  IHRD+K  N+L+D + + K++DFG+ 
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 40.4 bits (94), Expect = 1e-05
 Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 19  ARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ARG+ YL +    + IHRDL A N+L+      KI+DFG++R
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 40.5 bits (94), Expect = 1e-05
 Identities = 22/58 (37%), Positives = 36/58 (62%), Gaps = 5/58 (8%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           + L +LH +   ++IHRD+K+ NVLL  + + K++DFG        QS+ +T  +VGT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 40.6 bits (95), Expect = 2e-05
 Identities = 20/49 (40%), Positives = 31/49 (63%), Gaps = 5/49 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IFGG 64
           I+  L +LH   +  II+RDLK  N+LLD + + K++DFG+ +  I  G
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 40.4 bits (94), Expect = 2e-05
 Identities = 23/57 (40%), Positives = 32/57 (56%), Gaps = 5/57 (8%)

Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           +++ DW   I     I RGL +LH     K+IHRD+K  NVLL      K+ DFG++
Sbjct: 117 ALKEDWIAYIC--REILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 40.2 bits (94), Expect = 2e-05
 Identities = 17/48 (35%), Positives = 28/48 (58%), Gaps = 3/48 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           I+  + YL + +    IHRDL A N L+      K++DFG++R+  G+
Sbjct: 113 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 40.4 bits (94), Expect = 2e-05
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + RGL Y+H+     I+HRDLK  N+L+      K++DFG+AR
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 40.1 bits (93), Expect = 2e-05
 Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH +    I+HRD+K +N+L D   N K+ DFG ++
Sbjct: 115 ILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 39.9 bits (93), Expect = 2e-05
 Identities = 21/55 (38%), Positives = 32/55 (58%), Gaps = 4/55 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQSEANT 71
           I+ GL ++H+    KI+HRD+K+ N+ L    M  K+ DFG+AR    +   A T
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 39.9 bits (93), Expect = 2e-05
 Identities = 18/42 (42%), Positives = 29/42 (69%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           IA+G+ YL E    +++HR+L A N+LL  +   +I+DFG+A
Sbjct: 118 IAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 40.0 bits (93), Expect = 2e-05
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA  L YLH    L I++RDLK  N+LLD + +  ++DFG+ +
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.0 bits (93), Expect = 2e-05
 Identities = 23/57 (40%), Positives = 33/57 (57%), Gaps = 5/57 (8%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           GL +LH +   K IHRD+K +N+LL  E   K+ DFG++      +   NT+  VGT
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 39.9 bits (93), Expect = 3e-05
 Identities = 17/54 (31%), Positives = 30/54 (55%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
            A  L  L    +  +I+RDLK  N+LLD++ +  + DFG+ ++   +  + NT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.6 bits (92), Expect = 3e-05
 Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 3/49 (6%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +S    +ARG+ +L   +    +HRDL A NVLL      KI DFG+AR
Sbjct: 240 LSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLAR 285

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 3e-05
 Identities = 16/35 (45%), Positives = 22/35 (62%), Gaps = 3/35 (8%)

Query: 25  LHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           LH    L  IHRDLK  N L+D   + K++DFG++
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 39.3 bits (92), Expect = 3e-05
 Identities = 21/55 (38%), Positives = 29/55 (52%), Gaps = 3/55 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           LD  R    +  I RG+ + H  +   IIHRD+K  N+L+      K+ DFG AR
Sbjct: 97  LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 39.6 bits (92), Expect = 3e-05
 Identities = 20/57 (35%), Positives = 32/57 (56%), Gaps = 5/57 (8%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G+ ++HE    +++HRD+K+ N+ L      K+ DFG AR+     + A T   VGT
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGT 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 39.6 bits (92), Expect = 3e-05
 Identities = 21/59 (35%), Positives = 32/59 (54%), Gaps = 3/59 (5%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           M     +  R +     I  GL  LH++   +I++RDLK  N+LLD   + +ISD G+A
Sbjct: 94  MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 39.3 bits (92), Expect = 3e-05
 Identities = 25/63 (39%), Positives = 32/63 (50%), Gaps = 8/63 (12%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP----KISDFG 57
           R   L  K  +     +A+G  YL E+     IHRD+ A N LL  +  P    KI+DFG
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFG 164

Query: 58  MAR 60
           MAR
Sbjct: 165 MAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 39.5 bits (92), Expect = 4e-05
 Identities = 18/43 (41%), Positives = 26/43 (60%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +  G+ YL      + IHRDL A N L+D +   K+SDFG++R
Sbjct: 109 VCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 39.5 bits (92), Expect = 4e-05
 Identities = 21/58 (36%), Positives = 36/58 (62%), Gaps = 5/58 (8%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           + L +LH +   ++IHRD+K+ N+LL  + + K++DFG        QS+ +T  +VGT
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 39.2 bits (91), Expect = 4e-05
 Identities = 17/40 (42%), Positives = 27/40 (67%), Gaps = 3/40 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           +GL YLH   ++   HRD+K +N+LL    + K++DFG+A
Sbjct: 117 QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.5 bits (92), Expect = 4e-05
 Identities = 17/45 (37%), Positives = 28/45 (62%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           +A  +L +    +L  IHRD+K  N+L+D   + K+SDFG++  F
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 4e-05
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  GL  LH   R +I++RDLK  N+LLD   + +ISD G+A
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 39.2 bits (91), Expect = 5e-05
 Identities = 19/51 (37%), Positives = 32/51 (62%), Gaps = 3/51 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           I   L +LH   +L I++RD+K  N+LLD E +  ++DFG+++ F   + E
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 38.9 bits (90), Expect = 5e-05
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I   L YLH     KI++RDLK  N++LD + + KI+DFG+ +
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 38.8 bits (90), Expect = 5e-05
 Identities = 20/42 (47%), Positives = 24/42 (57%), Gaps = 3/42 (7%)

Query: 19  ARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           A G+ YL   +    IHRDL A N L+      KISDFGM+R
Sbjct: 103 AAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.8 bits (90), Expect = 5e-05
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +G+ YL   SR + +HRDL A NVL++ E   KI DFG+ +
Sbjct: 118 ICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 38.9 bits (90), Expect = 5e-05
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I   L +LHE     II+RDLK  NVLLD + + K++D+GM +
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 38.7 bits (90), Expect = 6e-05
 Identities = 17/42 (40%), Positives = 25/42 (59%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           +A GLL+LH   +   IH DL   N  L  +++ KI D+G+A
Sbjct: 109 VASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 38.9 bits (91), Expect = 6e-05
 Identities = 18/52 (34%), Positives = 27/52 (51%), Gaps = 3/52 (5%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
            II    + + + H   +   IHRD+K  N+L+  +   K+ DFG ARI  G
Sbjct: 104 KIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 38.6 bits (90), Expect = 6e-05
 Identities = 15/52 (28%), Positives = 30/52 (57%), Gaps = 3/52 (5%)

Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           K+++++   IA G+ +L   S  + +HRDL A N L+  +   K+S   +++
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 38.5 bits (89), Expect = 7e-05
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 2/43 (4%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I   L YLH  S   +++RDLK  N++LD + + KI+DFG+ +
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 38.4 bits (89), Expect = 8e-05
 Identities = 20/60 (33%), Positives = 31/60 (51%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      +++RD+K  N++LD + + KI+DFG+ +   G    A      GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 38.3 bits (89), Expect = 8e-05
 Identities = 24/67 (35%), Positives = 34/67 (50%), Gaps = 7/67 (10%)

Query: 15  INGIARGLL----YLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEAN 70
           +  +AR LL    Y+H +    IIHRD+K  NVL++   +  + DFG A    G+ S   
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 71  TNRIVGT 77
              I GT
Sbjct: 319 HYGIAGT 325

Length = 461

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 38.1 bits (88), Expect = 1e-04
 Identities = 18/41 (43%), Positives = 27/41 (65%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM 58
           IA  +L +    +L  IHRD+K  N+LLD + + K+SDFG+
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.1 bits (88), Expect = 1e-04
 Identities = 19/49 (38%), Positives = 30/49 (61%), Gaps = 3/49 (6%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I+  IA G+ +L   S   ++H+DL   NVL+  ++N KISD G+ R
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 37.8 bits (87), Expect = 1e-04
 Identities = 21/58 (36%), Positives = 36/58 (62%), Gaps = 5/58 (8%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           + L +LH +   ++IHRD+K+ N+LL  + + K++DFG        QS+ +T  +VGT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 37.7 bits (87), Expect = 1e-04
 Identities = 19/51 (37%), Positives = 32/51 (62%), Gaps = 3/51 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           I   L +LH   +L II+RD+K  N+LLD   +  ++DFG+++ F  ++ E
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 37.7 bits (87), Expect = 2e-04
 Identities = 20/68 (29%), Positives = 31/68 (45%), Gaps = 4/68 (5%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           RSV L     +     +   + YL  ++    +HRDL A NVL+  +   K+SDFG+ + 
Sbjct: 96  RSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 151

Query: 62  FGGNQSEA 69
               Q   
Sbjct: 152 ASSTQDTG 159

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 37.6 bits (87), Expect = 2e-04
 Identities = 18/43 (41%), Positives = 26/43 (60%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH +    ++HRD+K +NV+L      K+ DFG AR
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 37.1 bits (86), Expect = 2e-04
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 9/66 (13%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LDW  +I +       L ++H+    KI+HRD+K+ N+ L  +   K+ DFG+AR+    
Sbjct: 104 LDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154

Query: 66  QSEANT 71
              A T
Sbjct: 155 VELART 160

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 37.3 bits (86), Expect = 2e-04
 Identities = 18/41 (43%), Positives = 27/41 (65%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM 58
           IA  +L +    +L  IHRD+K  N+LLD + + K+SDFG+
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 37.3 bits (86), Expect = 2e-04
 Identities = 20/56 (35%), Positives = 31/56 (55%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +L   + + I + IA G++YL   +    +HRDL   N L+   +  KI DFGM+R
Sbjct: 119 ELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 37.4 bits (86), Expect = 2e-04
 Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +L   + + I   IA G++YL   +    +HRDL   N L+   +  KI DFGM+R
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 36.9 bits (85), Expect = 2e-04
 Identities = 17/39 (43%), Positives = 25/39 (64%), Gaps = 3/39 (7%)

Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           GL  LH ++    ++RDLK  N+LLD   + +ISD G+A
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 37.0 bits (85), Expect = 2e-04
 Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 3/40 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           +GL YLH   +   +HRD+K +N+LL    + K++DFG++
Sbjct: 117 QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 36.9 bits (85), Expect = 2e-04
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA G+ YL   S    +H+DL A N+L+  +++ KISD G++R
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 36.9 bits (85), Expect = 3e-04
 Identities = 15/31 (48%), Positives = 23/31 (74%)

Query: 31  LKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           L I++RDLK  N+LLD +   K++DFG A++
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180

Length = 340

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 36.5 bits (84), Expect = 4e-04
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 7/60 (11%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 36.5 bits (84), Expect = 4e-04
 Identities = 17/40 (42%), Positives = 26/40 (65%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           IA  +L +H   +L  +HRD+K  NVLLD   + +++DFG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 36.3 bits (84), Expect = 4e-04
 Identities = 15/40 (37%), Positives = 25/40 (62%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           +A  +L +    +L  +HRD+K  NVLLD   + +++DFG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 36.5 bits (84), Expect = 4e-04
 Identities = 16/35 (45%), Positives = 24/35 (68%)

Query: 25  LHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           L +  R +I++RDLK  N+LLD   + +ISD G+A
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 36.2 bits (83), Expect = 4e-04
 Identities = 20/58 (34%), Positives = 35/58 (60%), Gaps = 5/58 (8%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           + L +LH +   ++IHRD+K+ N+LL  + + K++DFG        QS+   + +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 36.5 bits (84), Expect = 4e-04
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 7/60 (11%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 36.1 bits (83), Expect = 5e-04
 Identities = 18/42 (42%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           IA GLL+LH+++    IH DL   N LL  ++  KI D+G++
Sbjct: 109 IALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 36.2 bits (83), Expect = 5e-04
 Identities = 17/54 (31%), Positives = 32/54 (59%), Gaps = 3/54 (5%)

Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
            +L+ ++  ++   + + L YLH      +IHRD+K+ ++LL  +   K+SDFG
Sbjct: 112 TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFG 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 35.8 bits (82), Expect = 6e-04
 Identities = 18/52 (34%), Positives = 30/52 (57%), Gaps = 3/52 (5%)

Query: 26  HEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           H  SR +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 36.0 bits (83), Expect = 6e-04
 Identities = 20/48 (41%), Positives = 28/48 (58%), Gaps = 8/48 (16%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLL-----DHEMNPKISDFGMAR 60
           +A+G +YL    ++  IHRDL A N L+     D +   KI DFG+AR
Sbjct: 115 VAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 35.4 bits (81), Expect = 8e-04
 Identities = 25/66 (37%), Positives = 37/66 (56%), Gaps = 9/66 (13%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-----KISDF 56
           + VQL      S++  I  G+ YLH +    ++HRDLK +N+L+  E  P     KI+D 
Sbjct: 101 KPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADM 156

Query: 57  GMARIF 62
           G AR+F
Sbjct: 157 GFARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 35.5 bits (82), Expect = 8e-04
 Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)

Query: 22  LLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           L YLH      I+HRDLK  N+L+    + K++DFG+++I
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 35.4 bits (81), Expect = 0.001
 Identities = 17/40 (42%), Positives = 25/40 (62%), Gaps = 3/40 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + R L YLH      +IHRD+K+ ++LL  +   K+SDFG
Sbjct: 127 VLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 35.3 bits (81), Expect = 0.001
 Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 2/60 (3%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           IA  +L L    +  I++RDLK  N+LLD   +  + DFG+++          TN   GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGT 159

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 35.4 bits (81), Expect = 0.001
 Identities = 20/58 (34%), Positives = 32/58 (55%), Gaps = 7/58 (12%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEAN 70
           S I  + + + + H++    I+HRD+K  N+L+ H    K+ DFG AR    N SE +
Sbjct: 104 SYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFAR----NLSEGS 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 35.4 bits (81), Expect = 0.001
 Identities = 13/33 (39%), Positives = 23/33 (69%)

Query: 30  RLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           ++  IHRD+K  N+L+D + + K++DFG+   F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 35.2 bits (81), Expect = 0.001
 Identities = 16/47 (34%), Positives = 28/47 (59%)

Query: 22  LLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           LL +H      +IHRD+K++N+LL      K+ DFG ++++    S+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199

Length = 496

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 35.4 bits (81), Expect = 0.001
 Identities = 18/52 (34%), Positives = 30/52 (57%), Gaps = 3/52 (5%)

Query: 26  HEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           H  SR +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 35.0 bits (80), Expect = 0.001
 Identities = 16/45 (35%), Positives = 27/45 (60%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           IA   L +    ++  IHRD+K  N+L+D + + K++DFG+   F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 35.0 bits (80), Expect = 0.001
 Identities = 24/66 (36%), Positives = 37/66 (56%), Gaps = 9/66 (13%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-----KISDF 56
           + +QL      S++  I  G+ YLH +    ++HRDLK +N+L+  E  P     KI+D 
Sbjct: 101 KPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADM 156

Query: 57  GMARIF 62
           G AR+F
Sbjct: 157 GFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 34.8 bits (80), Expect = 0.001
 Identities = 12/29 (41%), Positives = 22/29 (75%)

Query: 30  RLKIIHRDLKASNVLLDHEMNPKISDFGM 58
           ++  IHRD+K  N+L+D + + K++DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 34.6 bits (79), Expect = 0.002
 Identities = 16/40 (40%), Positives = 25/40 (62%), Gaps = 3/40 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + + L  LH      +IHRD+K+ ++LL H+   K+SDFG
Sbjct: 125 VLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 34.7 bits (80), Expect = 0.002
 Identities = 15/43 (34%), Positives = 24/43 (55%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++  L YL      + +HRD+ A NVL+      K+ DFG++R
Sbjct: 116 LSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 34.6 bits (79), Expect = 0.002
 Identities = 20/52 (38%), Positives = 29/52 (55%), Gaps = 5/52 (9%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-KISDFGMAR-IFGGNQS 67
           + R L Y+H      I HRDLK  N+L+D   +  K+ DFG A+ +  G +S
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS 227

Length = 440

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 34.4 bits (79), Expect = 0.002
 Identities = 16/42 (38%), Positives = 27/42 (64%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           +A  +L +H   ++  +HRD+K  NVL+D   + K++DFG A
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 34.2 bits (78), Expect = 0.002
 Identities = 18/43 (41%), Positives = 25/43 (58%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A G+ +L   +    +HRDL A NVL+      KI DFG+AR
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLAR 287

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 34.2 bits (79), Expect = 0.002
 Identities = 13/43 (30%), Positives = 21/43 (48%), Gaps = 3/43 (6%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDF 56
           I+  +   L Y+H       IHR +KAS++LL  +    +S  
Sbjct: 106 ILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 33.7 bits (77), Expect = 0.004
 Identities = 17/53 (32%), Positives = 30/53 (56%), Gaps = 3/53 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           QL   + + ++ G+A G+ YL E   +  +H+ L A  VL++ ++  KIS F 
Sbjct: 103 QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 33.9 bits (77), Expect = 0.004
 Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 10/83 (12%)

Query: 1   MRSVQLDWKRRI------SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKIS 54
           M     DWK R       +I+  +   + Y+H+    K+IHRD+K  N+ L+ +    + 
Sbjct: 253 MYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLG 309

Query: 55  DFGMARIFGGNQSEANTNRIVGT 77
           DFG A  F   + EA     VGT
Sbjct: 310 DFGTAMPF-EKEREAFDYGWVGT 331

Length = 501

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	77
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.46
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.44
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.44
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.44
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.35
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.32
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.31
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.28
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.26
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.26
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.25
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.21
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.21
KOG0578	550	consensus p21-activated serine/threonine protein k	99.21
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.2
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.19
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.19
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.19
KOG0198	313	consensus MEKK and related serine/threonine protei	99.15
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.15
PHA03211	461	serine/threonine kinase US3; Provisional	99.14
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.12
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.12
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.09
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.09
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.08
PHA03207	392	serine/threonine kinase US3; Provisional	99.08
PTZ00267	478	NIMA-related protein kinase; Provisional	99.07
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.07
KOG0589	426	consensus Serine/threonine protein kinase [General	99.06
PTZ00283	496	serine/threonine protein kinase; Provisional	99.05
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.04
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.04
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.03
KOG0584	632	consensus Serine/threonine protein kinase [General	99.03
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.02
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.02
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.02
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.01
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.01
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.01
KOG3653	534	consensus Transforming growth factor beta/activin	99.01
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.01
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.01
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.01
PHA02882	294	putative serine/threonine kinase; Provisional	99.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	98.99
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	98.99
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	98.98
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	98.98
PHA03212	391	serine/threonine kinase US3; Provisional	98.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	98.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	98.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	98.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	98.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	98.96
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	98.96
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	98.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	98.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	98.95
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	98.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	98.94
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	98.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	98.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	98.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	98.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	98.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	98.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	98.93
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	98.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	98.93
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	98.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	98.93
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	98.93
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	98.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	98.92
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	98.92
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	98.92
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	98.92
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	98.92
KOG0582	516	consensus Ste20-like serine/threonine protein kina	98.92
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	98.92
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	98.91
KOG0605	550	consensus NDR and related serine/threonine kinases	98.9
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	98.9
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	98.89
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	98.89
PHA03209	357	serine/threonine kinase US3; Provisional	98.88
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	98.88
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	98.88
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	98.88
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	98.88
KOG2052	513	consensus Activin A type IB receptor, serine/threo	98.88
PTZ00036	440	glycogen synthase kinase; Provisional	98.88
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	98.87
PLN00034	353	mitogen-activated protein kinase kinase; Provision	98.87
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	98.87
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	98.87
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	98.86
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	98.86
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	98.86
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	98.86
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	98.86
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	98.86
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	98.86
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	98.86
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	98.85
PTZ00263	329	protein kinase A catalytic subunit; Provisional	98.85
PHA03210	501	serine/threonine kinase US3; Provisional	98.85
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	98.85
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	98.85
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	98.85
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	98.85
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	98.85
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	98.85
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	98.84
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	98.84
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	98.84
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	98.84
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	98.84
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	98.83
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	98.83
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.83
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	98.83
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	98.82
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	98.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	98.82
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	98.82
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	98.81
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	98.81
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	98.81
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	98.81
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	98.81
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	98.81
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	98.81
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	98.81
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	98.8
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	98.8
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	98.8
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	98.8
KOG0577	948	consensus Serine/threonine protein kinase [Signal	98.8
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	98.8
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	98.79
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	98.79
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	98.79
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	98.79
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	98.79
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	98.79
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.78
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	98.78
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	98.78
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	98.78
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	98.78
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	98.78
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	98.78
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	98.78
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	98.78
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	98.77
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	98.77
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	98.77
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	98.77
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	98.77
KOG4721	904	consensus Serine/threonine protein kinase, contain	98.76
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	98.76
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	98.76
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	98.76
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	98.76
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	98.75
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	98.75
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	98.75
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	98.74
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	98.74
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	98.74
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	98.74
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	98.74
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	98.74
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	98.74
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	98.73
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	98.73
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	98.72
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	98.72
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	98.72
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	98.72
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	98.71
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	98.71
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	98.71
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	98.71
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	98.71
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	98.7
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	98.7
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	98.7
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	98.7
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	98.7
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	98.7
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	98.7
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	98.7
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	98.69
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	98.69
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	98.69
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	98.69
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	98.69
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	98.69
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	98.69
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	98.69
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	98.69
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	98.69
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	98.68
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	98.68
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	98.68
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	98.68
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	98.68
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	98.67
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	98.67
PLN00181	793	protein SPA1-RELATED; Provisional	98.67
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	98.67
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	98.67
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	98.67
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	98.66
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	98.66
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	98.66
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	98.66
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	98.66
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	98.66
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	98.66
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	98.66
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	98.66
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	98.66
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	98.65
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	98.65
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	98.65
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	98.65
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	98.65
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	98.64
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	98.64
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	98.64
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	98.64
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	98.64
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	98.63
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	98.63
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	98.63
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	98.63
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	98.63
PRK09188	365	serine/threonine protein kinase; Provisional	98.63
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	98.63
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	98.63
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	98.63
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	98.63
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	98.63
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	98.62
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	98.62
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	98.62
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	98.62
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	98.62
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	98.62
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	98.62
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	98.62
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	98.62
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	98.62
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	98.62
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	98.62
KOG0610	459	consensus Putative serine/threonine protein kinase	98.61
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	98.61
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	98.61
KOG0690	516	consensus Serine/threonine protein kinase [Signal	98.61
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	98.61
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	98.61
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	98.61
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	98.6
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	98.6
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	98.6
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	98.6
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	98.59
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	98.59
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	98.59
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	98.59
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	98.59
PLN03224	507	probable serine/threonine protein kinase; Provisio	98.59
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	98.58
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	98.58
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	98.58
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	98.58
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	98.58
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	98.58
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	98.58
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	98.58
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	98.57
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	98.57
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	98.57
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	98.57
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	98.57
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	98.57
PTZ00284	467	protein kinase; Provisional	98.57
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	98.56
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	98.56
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	98.56
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	98.56
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	98.56
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	98.56
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	98.55
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	98.55
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	98.55
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	98.55
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	98.55
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	98.55
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	98.55
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	98.55
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	98.54
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	98.54
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	98.54
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	98.54
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	98.54
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	98.54
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	98.54
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	98.54
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	98.53
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	98.53
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	98.53
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	98.53
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	98.53
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	98.53
KOG0586	596	consensus Serine/threonine protein kinase [General	98.53
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	98.53
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	98.52
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	98.52
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	98.52
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	98.52
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	98.52
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	98.52
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	98.52
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	98.52
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	98.51
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	98.51
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	98.51
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	98.51
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	98.51
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	98.5
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	98.5
PHA02988	283	hypothetical protein; Provisional	98.5
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	98.5
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	98.5
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	98.5
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	98.5
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	98.49
KOG0596	677	consensus Dual specificity; serine/threonine and t	98.48
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	98.48
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	98.48
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	98.47
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	98.47
PTZ00024	335	cyclin-dependent protein kinase; Provisional	98.47
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	98.47
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	98.46
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	98.46
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	98.46
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	98.46
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	98.46
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	98.45
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	98.45
KOG0695	593	consensus Serine/threonine protein kinase [Signal	98.44
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	98.44
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	98.44
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	98.43
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	98.41
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	98.41
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	98.41
smart00090	237	RIO RIO-like kinase.	98.41
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.4
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	98.4
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	98.4
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	98.39
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	98.39
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	98.38
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	98.38
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	98.38
PRK12274	218	serine/threonine protein kinase; Provisional	98.38
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	98.37
KOG1152	772	consensus Signal transduction serine/threonine kin	98.37
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	98.36
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	98.36
PLN00009	294	cyclin-dependent kinase A; Provisional	98.35
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	98.34
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	98.34
KOG0201	467	consensus Serine/threonine protein kinase [Signal	98.34
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	98.33
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	98.32
KOG1027	903	consensus Serine/threonine protein kinase and endo	98.31
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	98.3
PTZ00266	1021	NIMA-related protein kinase; Provisional	98.29
KOG0696	683	consensus Serine/threonine protein kinase [Signal	98.29
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	98.29
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	98.28
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	98.27
KOG4717	864	consensus Serine/threonine protein kinase [Signal	98.26
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	98.25
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	98.24
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	98.24
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	98.21
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	98.17
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	98.15
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.14
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	98.13
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	98.12
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	98.12
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.07
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.02
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	98.02
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	98.0
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	97.98
PRK14879	211	serine/threonine protein kinase; Provisional	97.9
PRK09605	535	bifunctional UGMP family protein/serine/threonine	97.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	97.89
KOG0607	463	consensus MAP kinase-interacting kinase and relate	97.86
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	97.85
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	97.83
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	97.77
COG0515	384	SPS1 Serine/threonine protein kinase [General func	97.73
PRK10345	210	hypothetical protein; Provisional	97.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	97.62
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	97.6
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	97.54
KOG1290	590	consensus Serine/threonine protein kinase [Signal	97.53
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	97.39
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	97.35
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	97.31
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	97.24
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	97.21
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.0
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	96.98
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	96.82
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	96.82
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	96.8
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	96.7
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	96.21
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	96.19
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	95.85
KOG3087	229	consensus Serine/threonine protein kinase [General	95.42
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	95.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	95.14
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	94.9
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	94.08
PRK09902	216	hypothetical protein; Provisional	94.05
KOG0606	1205	consensus Microtubule-associated serine/threonine	93.85
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	93.49
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	92.14
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	91.54
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	90.23
KOG0590	601	consensus Checkpoint kinase and related serine/thr	89.98
KOG1243	690	consensus Protein kinase [General function predict	89.71
KOG2137	700	consensus Protein kinase [Signal transduction mech	89.12
COG0478	304	RIO-like serine/threonine protein kinase fused to	88.83
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	87.01
COG4248	637	Uncharacterized protein with protein kinase and he	86.63
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	85.99
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	85.97
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	84.49
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	84.42
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	81.03
PRK05231	319	homoserine kinase; Provisional	80.84

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=7.7e-13  Score=74.81  Aligned_cols=68  Identities=34%  Similarity=0.578  Sum_probs=59.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCCCcccce
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRI   74 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~   74 (77)
                      ..|+..++.-++.|++.|+.|+|.++   ++||+++..|++++.++.+++.|||+++++..+.....++++
T Consensus       213 vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rV  280 (560)
T KOG0600|consen  213 VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRV  280 (560)
T ss_pred             cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccce
Confidence            46788999999999999999999885   999999999999999999999999999988776644444443

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=4.6e-13  Score=74.02  Aligned_cols=59  Identities=54%  Similarity=0.921  Sum_probs=55.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +|+|..++.++.+++.|+.|+|..+..+++|+++++.|++++.+...+++|||+++...
T Consensus       170 ~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  170 PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP  228 (361)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence            78999999999999999999999877789999999999999999999999999996554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=2.8e-13  Score=72.55  Aligned_cols=73  Identities=27%  Similarity=0.430  Sum_probs=62.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCC-CCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCCCcccceecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDS-RLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT   77 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~g~   77 (77)
                      ++.+++.++++++.|++.++.++|... +..++|+++++.|+++..++..++.|||+++.+..+.+.+.+  +|||
T Consensus       118 kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S--~VGT  191 (375)
T KOG0591|consen  118 KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHS--LVGT  191 (375)
T ss_pred             cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHh--hcCC
Confidence            456899999999999999999999831 124999999999999999999999999999999877766655  5665

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.44  E-value=5.6e-13  Score=75.88  Aligned_cols=59  Identities=41%  Similarity=0.561  Sum_probs=53.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..|++.....++.+++.+++|+|.++   ++||+++++|++++.+..+++.|||.++.+...
T Consensus       169 Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  169 GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            45777888889999999999999885   999999999999999999999999999987654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=4.3e-12  Score=71.53  Aligned_cols=63  Identities=30%  Similarity=0.427  Sum_probs=56.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE   68 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~   68 (77)
                      +..|+...+..++.|++.|+.|+|.++   +.||+++++|+++.....+++.|||+||.....+..
T Consensus       104 ~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen  104 NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCCc
Confidence            467899999999999999999999885   999999999999998899999999999987655443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.32  E-value=4.6e-12  Score=69.25  Aligned_cols=68  Identities=41%  Similarity=0.585  Sum_probs=57.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCCCcccceecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT   77 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~g~   77 (77)
                      .++++...-.++.+++.|+.|+|..  .+++||++++.|+++...+.+|+.|||+++.+..+    ..++++||
T Consensus       173 g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT  240 (364)
T KOG0581|consen  173 GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGT  240 (364)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hccccccc
Confidence            4577888888999999999999963  36999999999999999999999999999887755    33345565

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.4e-11  Score=70.72  Aligned_cols=60  Identities=40%  Similarity=0.571  Sum_probs=55.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..++++.++..++.|++.|+.|+|+..   ++||+++..|+++..+..+|+.|||+|..+..+
T Consensus       112 rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen  112 RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            367899999999999999999999874   999999999999999999999999999887644

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.28  E-value=2.1e-11  Score=66.68  Aligned_cols=59  Identities=34%  Similarity=0.446  Sum_probs=52.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++..+.-++.+++.++.|+|..+   ++||+++++|++++..+.+++.|||+++....+
T Consensus       120 g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  120 GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            45778888889999999999999875   999999999999999999999999999865544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.26  E-value=5.6e-11  Score=65.88  Aligned_cols=61  Identities=44%  Similarity=0.628  Sum_probs=54.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-CeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-NPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~l~~~g~~~~~~~~   65 (77)
                      +..+++..++.++.+++.|+.|+|....  ++|+++++.|+++..+. .+++.|||+++.....
T Consensus       136 ~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  136 KRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            5789999999999999999999998742  99999999999999996 9999999999877643

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.26  E-value=3.5e-11  Score=65.34  Aligned_cols=56  Identities=39%  Similarity=0.636  Sum_probs=50.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      -++...+..++.|++.|+.|+|.+.   ++||++++.|+++...+.++++|||+++.+.
T Consensus       116 g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen  116 GLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            3566788899999999999999985   9999999999999999999999999998665

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.25  E-value=4.5e-11  Score=64.42  Aligned_cols=59  Identities=39%  Similarity=0.482  Sum_probs=53.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .++++.....-++.+++.+++|+|...   +++|+++++|+++++++.+++.|||+++....
T Consensus       138 ~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  138 SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            467888888999999999999999875   99999999999999999999999999987653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.21  E-value=3.7e-11  Score=65.09  Aligned_cols=56  Identities=25%  Similarity=0.481  Sum_probs=51.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ++...+..++.|++.++.|+|.++   ++||+++++|+++..+..+++.|||+|+.+..
T Consensus        98 ~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   98 VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            567788899999999999999885   99999999999999999999999999998874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=1.2e-10  Score=64.83  Aligned_cols=57  Identities=35%  Similarity=0.527  Sum_probs=52.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIF   62 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~   62 (77)
                      ..++.+.....++.|++.++.|+|+.+   +.||+++++|++++.+ ..++++|||++...
T Consensus       114 ~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen  114 KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            356778888899999999999999985   9999999999999988 99999999999876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=1.4e-10  Score=66.29  Aligned_cols=61  Identities=34%  Similarity=0.566  Sum_probs=54.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS   67 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~   67 (77)
                      ..+++.+.-.++.+++.|+.|+|..+   ++|++++..++++..++..++.|||++..+.+...
T Consensus       364 ~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  364 TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            34778888899999999999999985   99999999999999999999999999988876554

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.20  E-value=2.1e-10  Score=62.65  Aligned_cols=57  Identities=39%  Similarity=0.506  Sum_probs=51.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       169 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~  225 (338)
T cd05102         169 SPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  225 (338)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccc
Confidence            46888999999999999999999874   9999999999999988999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.19  E-value=6.2e-11  Score=67.03  Aligned_cols=60  Identities=40%  Similarity=0.693  Sum_probs=52.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...++....+.++.|++.|+.|+.+.   .++||++.++|++++.+..+|++|||+++....+
T Consensus       297 ~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  297 GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            35677888999999999999999877   4999999999999999999999999999944433

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.19  E-value=1.2e-10  Score=63.77  Aligned_cols=59  Identities=41%  Similarity=0.585  Sum_probs=54.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      +++...++..++.|++.|+.|+|.+-   ++||+++++|++....+.+++.|||+||.+...
T Consensus       172 q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  172 QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            67888899999999999999999875   999999999999999999999999999988754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.19  E-value=1.2e-10  Score=62.10  Aligned_cols=59  Identities=39%  Similarity=0.601  Sum_probs=53.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +..|+...+..++.+++.|+.|+|...   ++||++++.|+++..++.+++.|||+++.+..
T Consensus        95 ~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   95 NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            345678888899999999999999985   99999999999999999999999999998864

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.15  E-value=4.3e-10  Score=61.32  Aligned_cols=56  Identities=36%  Similarity=0.562  Sum_probs=51.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~~   63 (77)
                      .|++..+..+..+++.|+.|+|..+   ++|+++++.|+++.. +..++++|||.++...
T Consensus       113 ~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen  113 KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            6899999999999999999999875   999999999999998 6899999999887665

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.15  E-value=8.3e-11  Score=65.62  Aligned_cols=59  Identities=34%  Similarity=0.557  Sum_probs=50.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC---CCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~l~~~g~~~~~~~   64 (77)
                      +..+.+..-..++.|++.++.|+|..+   ++||++++.|+++..+   ..++++|||+++...+
T Consensus       270 nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~  331 (475)
T KOG0615|consen  270 NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE  331 (475)
T ss_pred             ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence            445667777888999999999999985   9999999999999766   6789999999998753

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.14  E-value=4.9e-10  Score=63.88  Aligned_cols=58  Identities=29%  Similarity=0.493  Sum_probs=52.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++..+..++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||+++.+..
T Consensus       255 ~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        255 RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            35889999999999999999999874   99999999999999889999999999876543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.12  E-value=3.4e-10  Score=62.99  Aligned_cols=60  Identities=38%  Similarity=0.566  Sum_probs=52.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC------CCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE------MNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~------~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++.....++.|++.+++++|.+.   ++|+++++.|+++...      ..+|+.|||+++.+....
T Consensus       104 ~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~  169 (429)
T KOG0595|consen  104 GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS  169 (429)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence            36888999999999999999999885   9999999999999764      458999999999887543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=4.2e-10  Score=65.77  Aligned_cols=58  Identities=38%  Similarity=0.476  Sum_probs=53.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...++.....-++..++.+++|+|.++   +++|+++..|++++..+.++++|||+++.-+
T Consensus       462 ~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  462 TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence            356888899999999999999999985   9999999999999999999999999998655

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.09  E-value=2.6e-10  Score=61.44  Aligned_cols=60  Identities=45%  Similarity=0.672  Sum_probs=53.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++.....++.++..++.|+|..+   ++|++++++|++++.+..++++|||++..+.+.+
T Consensus       118 VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge  177 (411)
T KOG0599|consen  118 VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE  177 (411)
T ss_pred             eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCch
Confidence            45678888899999999999999985   9999999999999999999999999998776554

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.09  E-value=1.5e-10  Score=67.08  Aligned_cols=55  Identities=44%  Similarity=0.784  Sum_probs=50.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      ...|++.....++.|++.|+.|+|.++   ++|++++..||+++.+..+++.|||++.
T Consensus       482 etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  482 ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence            346788899999999999999999885   9999999999999999999999999864

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.08  E-value=1.2e-09  Score=62.03  Aligned_cols=62  Identities=34%  Similarity=0.413  Sum_probs=55.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS   67 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~   67 (77)
                      +.-+++...+-++.+++.|+.++|...   +++|++++.|++++..+.++++|+|++..+...+.
T Consensus       281 ~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  281 NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            346789999999999999999999874   99999999999999999999999999987765543

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.08  E-value=7.5e-10  Score=61.79  Aligned_cols=59  Identities=37%  Similarity=0.573  Sum_probs=52.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++...+.++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||++..+..
T Consensus       179 ~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        179 SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            346789999999999999999999874   99999999999999999999999999875543

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.07  E-value=2e-09  Score=61.53  Aligned_cols=57  Identities=25%  Similarity=0.355  Sum_probs=51.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++.....+++.|||+++.+..
T Consensus       165 ~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        165 PFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            5778888889999999999999874   99999999999999999999999999987643

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.07  E-value=5.8e-10  Score=63.40  Aligned_cols=55  Identities=42%  Similarity=0.637  Sum_probs=51.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      |+..+...++..+..|+.|+|.++   ++|+++++.|+++...+..+++|||++-.+.
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~  261 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFP  261 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeecc
Confidence            788899999999999999999985   9999999999999999999999999987663

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.06  E-value=1.8e-10  Score=64.70  Aligned_cols=69  Identities=38%  Similarity=0.635  Sum_probs=58.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCCCcccceecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT   77 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~g~   77 (77)
                      ..++...++.++.|++.++.|+|..   .++|++++..|+++.++..+++.|||+++.+..+...+.+  ++||
T Consensus       101 ~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~t--vvGT  169 (426)
T KOG0589|consen  101 VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLAST--VVGT  169 (426)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhhe--ecCC
Confidence            4578899999999999999999966   5999999999999999988899999999988766533333  4554

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.05  E-value=1.9e-09  Score=61.98  Aligned_cols=57  Identities=23%  Similarity=0.398  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.+.
T Consensus       138 ~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~  194 (496)
T PTZ00283        138 RTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYA  194 (496)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeecc
Confidence            35778888889999999999999874   9999999999999999999999999987654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.04  E-value=5.4e-10  Score=62.99  Aligned_cols=60  Identities=32%  Similarity=0.608  Sum_probs=53.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...|++.+...+.+|+..++.|+|.+   ++.|++++.+|++++.+...++.|||++..+..+
T Consensus       147 r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  147 RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            35688899999999999999999987   4999999999999999999999999998766543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.04  E-value=2.2e-09  Score=58.52  Aligned_cols=56  Identities=32%  Similarity=0.402  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus        90 ~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          90 RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            45778888889999999999999874   999999999999999999999999988643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.03  E-value=4.9e-09  Score=57.16  Aligned_cols=57  Identities=32%  Similarity=0.421  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..  .+++|+++++.|+++..+..+++.|||+++..
T Consensus        90 ~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          90 RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            4578888999999999999999962  14999999999999999999999999988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.03  E-value=7.2e-10  Score=64.27  Aligned_cols=60  Identities=35%  Similarity=0.557  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~~   64 (77)
                      ..++...+..+++|++.|+.|+|.+ ..+++||+++..|+++..+ +.+|+.|+|+|.....
T Consensus       138 ~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  138 RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            3466778889999999999999998 4699999999999999765 7899999999976553

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=6.8e-10  Score=60.86  Aligned_cols=56  Identities=43%  Similarity=0.685  Sum_probs=50.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      |+..-...++.|++.|+.|+|+.+   ++|+++++.|+++..+..+++.|||+++....
T Consensus       122 L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  122 LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccc
Confidence            666777778899999999999975   99999999999999999999999999998754

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.02  E-value=3.9e-09  Score=58.70  Aligned_cols=57  Identities=37%  Similarity=0.524  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .++++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       207 ~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~  263 (374)
T cd05106         207 WPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIM  263 (374)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeecc
Confidence            35788899999999999999999874   9999999999999988889999999987653

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.02  E-value=9.9e-10  Score=60.32  Aligned_cols=61  Identities=33%  Similarity=0.486  Sum_probs=52.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeecCCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~~~~   66 (77)
                      ++.++...+.-+.+|+..|+.|+|..   +++||++++.|++++.. +.+|++|||.|+.+..++
T Consensus       119 ~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  119 NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            45666667777899999999999986   49999999999999865 889999999999876544

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.01  E-value=1e-09  Score=65.07  Aligned_cols=58  Identities=34%  Similarity=0.447  Sum_probs=52.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..|++.+++.++.+++.++.++|.. +.+++||+++.+|+++..++..++.|||.+...
T Consensus       139 ~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  139 TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            3488999999999999999999987 578999999999999999999999999977543

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.01  E-value=6e-09  Score=55.67  Aligned_cols=57  Identities=37%  Similarity=0.601  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.++...
T Consensus       104 ~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111         104 DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            45788899999999999999999874   9999999999999988899999999987654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.01  E-value=2.9e-09  Score=58.14  Aligned_cols=56  Identities=30%  Similarity=0.398  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||++...
T Consensus        91 ~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          91 GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            45788888999999999999999874   999999999999999999999999987643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.01  E-value=2e-09  Score=61.14  Aligned_cols=65  Identities=35%  Similarity=0.619  Sum_probs=56.7

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhC------CCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHED------SRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~------~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      +...++|.....++..++.|+.|+|..      -++.+.||++++.|+++..+..+.+.|||++..+....
T Consensus       300 ~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~  370 (534)
T KOG3653|consen  300 KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGK  370 (534)
T ss_pred             HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCC
Confidence            455689999999999999999999963      34478999999999999999999999999999887544

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.01  E-value=2.5e-09  Score=58.72  Aligned_cols=57  Identities=40%  Similarity=0.515  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+...++.|||++..+.
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~  224 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  224 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcc
Confidence            36889999999999999999999874   9999999999999988889999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.01  E-value=2.4e-09  Score=57.76  Aligned_cols=55  Identities=33%  Similarity=0.601  Sum_probs=49.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       134 ~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~  188 (304)
T cd05096         134 AISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNL  188 (304)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceec
Confidence            4678888999999999999999874   999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.01  E-value=3.1e-09  Score=58.10  Aligned_cols=56  Identities=34%  Similarity=0.429  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus        90 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          90 RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            45788889999999999999999874   999999999999999999999999988653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.00  E-value=4.9e-09  Score=56.47  Aligned_cols=55  Identities=31%  Similarity=0.460  Sum_probs=48.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .++..+..++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||+++.+.
T Consensus       123 ~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~  177 (294)
T PHA02882        123 KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFI  177 (294)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence            456677788999999999999874   9999999999999988889999999998764

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.00  E-value=4.2e-09  Score=57.30  Aligned_cols=57  Identities=42%  Similarity=0.518  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          91 GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            45778888889999999999999874   9999999999999999999999999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=98.99  E-value=4e-09  Score=57.50  Aligned_cols=56  Identities=34%  Similarity=0.420  Sum_probs=50.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          91 RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            45788888999999999999999874   999999999999999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=98.99  E-value=3.5e-09  Score=57.81  Aligned_cols=57  Identities=30%  Similarity=0.355  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..+.
T Consensus       100 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614         100 DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            45788888889999999999999874   9999999999999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=98.98  E-value=4.4e-09  Score=57.08  Aligned_cols=56  Identities=30%  Similarity=0.422  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus        88 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~  143 (312)
T cd05585          88 GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLN  143 (312)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence            45788888889999999999999874   999999999999999999999999988754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=98.98  E-value=7.7e-09  Score=57.54  Aligned_cols=57  Identities=40%  Similarity=0.610  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       209 ~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         209 LALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence            35789999999999999999999874   9999999999999988889999999987654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA03212 serine/threonine kinase US3; Provisional

Probab=98.97  E-value=4.3e-09  Score=58.95  Aligned_cols=56  Identities=34%  Similarity=0.567  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||++...
T Consensus       177 ~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        177 RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            45788889999999999999999874   999999999999998899999999998643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=98.97  E-value=1.2e-09  Score=64.08  Aligned_cols=59  Identities=41%  Similarity=0.519  Sum_probs=52.5

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ++.+|+..+...+++|++.++.|||...   ++|++++++|++++....+++.|||+|..-.
T Consensus       105 ~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen  105 RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            4667888999999999999999999864   9999999999999988779999999987543

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=98.97  E-value=6.2e-09  Score=56.52  Aligned_cols=57  Identities=37%  Similarity=0.651  Sum_probs=51.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||.++.+..
T Consensus       105 ~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108         105 NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence            4678888899999999999999874   99999999999999888999999999986643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=98.97  E-value=5.9e-09  Score=56.81  Aligned_cols=56  Identities=41%  Similarity=0.557  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus        96 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          96 GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            45778888999999999999999874   999999999999999999999999988754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=98.96  E-value=6e-09  Score=56.78  Aligned_cols=56  Identities=36%  Similarity=0.424  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus        91 ~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          91 RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            45778888889999999999999874   999999999999999999999999987643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=98.96  E-value=5.9e-09  Score=56.87  Aligned_cols=56  Identities=34%  Similarity=0.391  Sum_probs=49.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..++......++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus        91 ~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          91 RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            34667777788999999999999874   999999999999999899999999988754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=98.96  E-value=4.6e-09  Score=57.30  Aligned_cols=56  Identities=30%  Similarity=0.423  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++...
T Consensus        90 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          90 RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            45788889999999999999999874   999999999999999999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=98.96  E-value=8.5e-09  Score=54.98  Aligned_cols=57  Identities=37%  Similarity=0.602  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||.++...
T Consensus       104 ~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109         104 DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            35788899999999999999999874   9999999999999888889999999987664

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=98.95  E-value=7.1e-09  Score=55.45  Aligned_cols=58  Identities=40%  Similarity=0.460  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+..+..
T Consensus        92 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          92 PGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            45788999999999999999999874   99999999999999888999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=98.95  E-value=8.7e-09  Score=55.85  Aligned_cols=56  Identities=39%  Similarity=0.626  Sum_probs=48.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc----CCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD----HEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~----~~~~~~l~~~g~~~~~~   63 (77)
                      .++......++.|++.++.|+|..+   ++|+++++.|+++.    ....+++.|||+++.+.
T Consensus       104 ~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868         104 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            4788888999999999999999875   99999999999983    44679999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=98.94  E-value=7.3e-09  Score=55.45  Aligned_cols=56  Identities=34%  Similarity=0.621  Sum_probs=50.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       106 ~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T cd07862         106 GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS  161 (290)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence            4788899999999999999999874   9999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=98.94  E-value=7e-09  Score=56.40  Aligned_cols=57  Identities=35%  Similarity=0.393  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++....
T Consensus        93 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          93 VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            45788899999999999999999874   9999999999999999999999999887543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=98.94  E-value=6.2e-09  Score=57.89  Aligned_cols=57  Identities=28%  Similarity=0.362  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.++|..+   ++|+++++.|+++.....+++.|||++....
T Consensus       137 ~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         137 YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            35677788888999999999999874   9999999999999999999999999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=98.94  E-value=7.2e-09  Score=56.63  Aligned_cols=55  Identities=38%  Similarity=0.495  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..
T Consensus        91 ~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          91 RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEecccccee
Confidence            46788899999999999999999874   99999999999999999999999998864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=98.94  E-value=8.4e-09  Score=56.19  Aligned_cols=56  Identities=36%  Similarity=0.512  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++...
T Consensus        91 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          91 RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence            45678888889999999999999874   999999999999999999999999988754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=98.94  E-value=8.9e-09  Score=56.12  Aligned_cols=56  Identities=43%  Similarity=0.590  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++..
T Consensus        91 ~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          91 RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            45788888889999999999999874   999999999999999999999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=98.94  E-value=8.2e-09  Score=56.48  Aligned_cols=56  Identities=41%  Similarity=0.479  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++..
T Consensus        91 ~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          91 RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            45788888889999999999999874   999999999999999999999999988653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=98.94  E-value=8.2e-09  Score=56.29  Aligned_cols=55  Identities=42%  Similarity=0.582  Sum_probs=49.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..
T Consensus        96 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          96 GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            35678888889999999999999874   99999999999999999999999998764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=98.93  E-value=7.9e-09  Score=56.40  Aligned_cols=56  Identities=39%  Similarity=0.571  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||+++..
T Consensus        96 ~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          96 GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence            45788999999999999999999874   999999999999999999999999988753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=98.93  E-value=8.1e-09  Score=56.61  Aligned_cols=57  Identities=40%  Similarity=0.603  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..++++|||+++...
T Consensus       113 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878         113 QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence            46788899999999999999999874   9999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=98.93  E-value=2.1e-09  Score=55.09  Aligned_cols=56  Identities=39%  Similarity=0.670  Sum_probs=50.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      -++.+....++.|++.++.|+|+..   ++|+++++.++++..++.+++.|||+++-++
T Consensus        97 ~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   97 DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            4677788888999999999999875   9999999999999999999999999988665

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=98.93  E-value=8.7e-09  Score=56.09  Aligned_cols=55  Identities=33%  Similarity=0.414  Sum_probs=49.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..++......++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.
T Consensus        91 ~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          91 RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            45677788888999999999999874   99999999999999999999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=98.93  E-value=8.4e-09  Score=56.25  Aligned_cols=56  Identities=39%  Similarity=0.554  Sum_probs=50.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..
T Consensus        95 ~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          95 TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            346788999999999999999999874   99999999999999999999999998764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=98.93  E-value=1.2e-08  Score=54.77  Aligned_cols=56  Identities=36%  Similarity=0.478  Sum_probs=50.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          98 GFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            5788888999999999999999874   9999999999999988999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=98.92  E-value=9.1e-09  Score=56.01  Aligned_cols=55  Identities=42%  Similarity=0.591  Sum_probs=49.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++.
T Consensus        91 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          91 GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            45778888889999999999999874   99999999999999999999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=98.92  E-value=5.5e-09  Score=57.79  Aligned_cols=57  Identities=30%  Similarity=0.392  Sum_probs=50.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.+
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          95 KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            346788889999999999999999874   999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=98.92  E-value=9.9e-09  Score=57.07  Aligned_cols=57  Identities=28%  Similarity=0.351  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       137 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         137 YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            34667777888899999999999874   9999999999999999999999999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=98.92  E-value=1.1e-08  Score=54.25  Aligned_cols=56  Identities=36%  Similarity=0.584  Sum_probs=50.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.++...
T Consensus       108 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  163 (272)
T cd05075         108 YLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIY  163 (272)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccC
Confidence            4788889999999999999999874   9999999999999988899999999987653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.92  E-value=3.9e-09  Score=56.50  Aligned_cols=60  Identities=38%  Similarity=0.749  Sum_probs=53.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      .+++...+..++-++.+|+.|+|..   .++|+++++.++++..+..+++.|||+++.+..++
T Consensus       119 vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~  178 (376)
T KOG0669|consen  119 VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSK  178 (376)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceeccc
Confidence            5678889999999999999999987   59999999999999999999999999998775443

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=98.92  E-value=1.4e-08  Score=55.47  Aligned_cols=58  Identities=28%  Similarity=0.387  Sum_probs=51.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++.....+++.|||++..+..
T Consensus        97 ~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          97 DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            45788888889999999999999874   99999999999999999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=1.2e-08  Score=57.80  Aligned_cols=56  Identities=34%  Similarity=0.580  Sum_probs=49.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +++..+-.++.+++.++.|+|.++   .+||++++.+++++.++.++++|||++-.+..
T Consensus       123 l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  123 LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            566677788899999999999985   99999999999999999999999998765543

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=98.92  E-value=1e-08  Score=56.08  Aligned_cols=56  Identities=39%  Similarity=0.492  Sum_probs=50.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.
T Consensus        90 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          90 QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence            346888999999999999999999874   99999999999999999999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=98.91  E-value=7.3e-09  Score=56.48  Aligned_cols=56  Identities=34%  Similarity=0.576  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..++++|||+++..
T Consensus        98 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          98 DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            35788888999999999999999874   999999999999999999999999998754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=98.90  E-value=4.8e-09  Score=60.13  Aligned_cols=59  Identities=29%  Similarity=0.372  Sum_probs=52.1

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +...|+......++.+...++.-+|..+   ++|+++++.|++++..+.++++|||++.-+.
T Consensus       234 ~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  234 RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            4556788888889999999999999875   9999999999999999999999999986544

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=98.90  E-value=1.9e-08  Score=55.80  Aligned_cols=58  Identities=38%  Similarity=0.593  Sum_probs=51.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus        97 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          97 PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            356788889999999999999999874   9999999999999999999999999987653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=3.4e-09  Score=57.34  Aligned_cols=62  Identities=35%  Similarity=0.568  Sum_probs=52.9

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      +.+.|+..-+.-++.|++.|+.|+|+.+   ++|+++++-|++...+..+++.|||+++....++
T Consensus       149 SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  149 SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence            3456666667777899999999999874   9999999999999999999999999999765543

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=98.89  E-value=1.3e-08  Score=56.55  Aligned_cols=57  Identities=28%  Similarity=0.355  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       137 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         137 YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            34667777788899999999999874   9999999999999999999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PHA03209 serine/threonine kinase US3; Provisional

Probab=98.88  E-value=1.2e-08  Score=56.42  Aligned_cols=55  Identities=35%  Similarity=0.543  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||.+..
T Consensus       152 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        152 RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccc
Confidence            45789999999999999999999874   99999999999999989999999998864

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=98.88  E-value=1.9e-08  Score=54.93  Aligned_cols=55  Identities=33%  Similarity=0.436  Sum_probs=48.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus        96 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          96 IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            4566777778899999999999874   999999999999999999999999988754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=98.88  E-value=1.9e-08  Score=54.82  Aligned_cols=56  Identities=39%  Similarity=0.568  Sum_probs=50.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++...
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          91 HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            35778888889999999999999874   999999999999999999999999988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=98.88  E-value=2.3e-08  Score=54.99  Aligned_cols=56  Identities=38%  Similarity=0.517  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++...
T Consensus       174 ~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~  229 (343)
T cd05103         174 KVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI  229 (343)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEeccccccc
Confidence            34788888999999999999999874   999999999999998899999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=98.88  E-value=3.2e-08  Score=53.45  Aligned_cols=57  Identities=42%  Similarity=0.602  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.++...
T Consensus       132 ~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~  188 (304)
T cd05101         132 EQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVN  188 (304)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecc
Confidence            35778888899999999999999874   9999999999999988899999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.88  E-value=2.1e-08  Score=56.83  Aligned_cols=76  Identities=29%  Similarity=0.391  Sum_probs=61.5

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhh-----CCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCC--CCcccce
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHE-----DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS--EANTNRI   74 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~-----~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~--~~~~~~~   74 (77)
                      +...++-...+.++..++.|+.++|.     ++++.+.||++++.|++..++..|.+.|+|++-...++.+  ....+..
T Consensus       301 ~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~r  380 (513)
T KOG2052|consen  301 NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPR  380 (513)
T ss_pred             hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCc
Confidence            44567788899999999999999995     3566789999999999999999999999999987766542  2334455


Q ss_pred             ecC
Q 040677           75 VGT   77 (77)
Q Consensus        75 ~g~   77 (77)
                      +||
T Consensus       381 VGT  383 (513)
T KOG2052|consen  381 VGT  383 (513)
T ss_pred             cce
Confidence            676

>PTZ00036 glycogen synthase kinase; Provisional

Probab=98.88  E-value=1.5e-08  Score=57.50  Aligned_cols=58  Identities=33%  Similarity=0.422  Sum_probs=49.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.|++.++.|+|..+   ++|+++++.|+++... ..+++.|||+++.+.
T Consensus       164 ~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        164 NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            345778888889999999999999875   9999999999999865 468999999997654

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=98.87  E-value=3.1e-08  Score=54.28  Aligned_cols=57  Identities=25%  Similarity=0.314  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..+.
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          97 DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            35778888889999999999999874   9999999999999999999999999987654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=98.87  E-value=2.1e-08  Score=55.33  Aligned_cols=55  Identities=40%  Similarity=0.677  Sum_probs=48.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+......++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..+.
T Consensus       165 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        165 ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            456677788999999999999874   9999999999999999999999999987654

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=98.87  E-value=1.4e-08  Score=54.20  Aligned_cols=55  Identities=35%  Similarity=0.563  Sum_probs=49.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       120 ~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (283)
T cd05091         120 TLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREV  174 (283)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEeccccccccc
Confidence            4778888899999999999999874   999999999999998888999999987654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=98.87  E-value=1.6e-08  Score=54.28  Aligned_cols=55  Identities=35%  Similarity=0.580  Sum_probs=49.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++..
T Consensus        99 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          99 LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            4677888889999999999999874   999999999999999999999999988754

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=98.86  E-value=5.2e-09  Score=60.40  Aligned_cols=60  Identities=33%  Similarity=0.473  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..++..+...++..+..+..|+|+.+   +++++++++|++++.++.+++.|||+++.+..+.
T Consensus       515 g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  515 GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            34555566667788899999999875   9999999999999999999999999998776543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=98.86  E-value=2.9e-08  Score=53.62  Aligned_cols=56  Identities=36%  Similarity=0.539  Sum_probs=49.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..++...+..++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+...
T Consensus        98 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          98 GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            34678888889999999999999875   999999999999999899999999988654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=98.86  E-value=3.2e-08  Score=53.10  Aligned_cols=55  Identities=36%  Similarity=0.619  Sum_probs=50.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++......++.|||.+...
T Consensus       116 ~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  170 (288)
T cd05093         116 ELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDV  170 (288)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccc
Confidence            4889999999999999999999874   999999999999999999999999988644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=98.86  E-value=2.7e-08  Score=53.35  Aligned_cols=55  Identities=35%  Similarity=0.601  Sum_probs=50.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++......++.|||.++..
T Consensus       126 ~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  180 (296)
T cd05051         126 SLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNL  180 (296)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeec
Confidence            5788999999999999999999874   999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=98.86  E-value=6.8e-09  Score=56.90  Aligned_cols=59  Identities=39%  Similarity=0.590  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC----CCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE----MNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~l~~~g~~~~~~~~   65 (77)
                      ..++-..+..+++|++.|+.|+|++=   ++|+++++.|+++-.+    +.+++.|+|+++.+...
T Consensus       127 ~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~p  189 (438)
T KOG0666|consen  127 KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNP  189 (438)
T ss_pred             ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhcc
Confidence            35677788899999999999999973   9999999999999655    78999999999987644

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=98.86  E-value=2.4e-08  Score=54.37  Aligned_cols=55  Identities=47%  Similarity=0.591  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.
T Consensus        91 ~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          91 GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCee
Confidence            36788999999999999999999874   99999999999999999999999998865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=98.86  E-value=1.6e-08  Score=54.39  Aligned_cols=57  Identities=35%  Similarity=0.522  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++....
T Consensus        96 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          96 GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            45778888889999999999999874   9999999999999988899999999887553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=98.86  E-value=1.9e-08  Score=55.43  Aligned_cols=57  Identities=30%  Similarity=0.381  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||++....
T Consensus       126 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        126 KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            45778888889999999999999874   9999999999999999999999999987653

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=98.85  E-value=3e-08  Score=52.46  Aligned_cols=58  Identities=33%  Similarity=0.627  Sum_probs=51.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.++++..+..++++|||++..+.
T Consensus        89 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  146 (257)
T cd05115          89 KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALG  146 (257)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCcccccc
Confidence            345788999999999999999999874   9999999999999988999999999887554

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=98.85  E-value=2.2e-08  Score=54.82  Aligned_cols=57  Identities=32%  Similarity=0.428  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       113 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263        113 GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            35677788888999999999999874   9999999999999999999999999987654

>PHA03210 serine/threonine kinase US3; Provisional

Probab=98.85  E-value=2.3e-08  Score=57.64  Aligned_cols=54  Identities=30%  Similarity=0.546  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            8 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         8 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ......++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.+..
T Consensus       266 ~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~  319 (501)
T PHA03210        266 LKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK  319 (501)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCc
Confidence            3455678899999999999874   99999999999999999999999999986643

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=98.85  E-value=2e-08  Score=54.39  Aligned_cols=56  Identities=39%  Similarity=0.633  Sum_probs=48.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc----CCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD----HEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~----~~~~~~l~~~g~~~~~~   63 (77)
                      .+++..+..++.+++.++.|+|..+   ++|+++++.|+++.    ....+++.|||+++...
T Consensus       104 ~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867         104 QLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence            4778888899999999999999874   99999999999983    44679999999998654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=98.85  E-value=2.8e-08  Score=54.40  Aligned_cols=58  Identities=26%  Similarity=0.340  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus        97 ~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          97 DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            45778888888999999999999874   99999999999999889999999999876543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=98.85  E-value=4.3e-08  Score=52.30  Aligned_cols=56  Identities=39%  Similarity=0.593  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||+++..
T Consensus       119 ~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~  174 (283)
T cd05048         119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDI  174 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeec
Confidence            45778888999999999999999874   999999999999999889999999988754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=98.85  E-value=2.6e-08  Score=53.28  Aligned_cols=57  Identities=37%  Similarity=0.638  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       103 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863         103 PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            34788899999999999999999874   9999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=98.85  E-value=3.9e-08  Score=52.81  Aligned_cols=55  Identities=36%  Similarity=0.628  Sum_probs=49.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.++++..+..+++.|||++...
T Consensus       119 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~  173 (291)
T cd05094         119 ELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDV  173 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCccccc
Confidence            4788999999999999999999874   999999999999999999999999988644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=98.85  E-value=1e-08  Score=59.85  Aligned_cols=60  Identities=35%  Similarity=0.601  Sum_probs=53.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      +..+++..+..++.++..++.|+|..   +++|+++++.++++..+...++.|||+++....+
T Consensus        94 d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   94 DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            45688899999999999999999987   4999999999999999999999999999866543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=98.84  E-value=5.1e-09  Score=59.81  Aligned_cols=55  Identities=40%  Similarity=0.555  Sum_probs=50.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .++..+.+.++.+++.|+.|+|...   ++||++..+|+++..+..++++|||+++.-
T Consensus       258 ~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  258 SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence            4788999999999999999999875   999999999999999888999999998754

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=98.84  E-value=3.3e-08  Score=54.12  Aligned_cols=57  Identities=21%  Similarity=0.296  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||++..+.
T Consensus        97 ~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          97 DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            45778888888999999999999874   9999999999999988999999999886553

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=98.84  E-value=2.1e-08  Score=55.38  Aligned_cols=57  Identities=28%  Similarity=0.345  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..+.
T Consensus        96 ~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          96 DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            45788888999999999999999874   9999999999999999999999999887553

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=98.84  E-value=3.6e-08  Score=55.50  Aligned_cols=58  Identities=38%  Similarity=0.478  Sum_probs=51.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+...++.|||+++....
T Consensus       232 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~  289 (400)
T cd05105         232 EGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMH  289 (400)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccc
Confidence            35788899999999999999999874   99999999999999888899999999876543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=98.84  E-value=3.8e-08  Score=53.21  Aligned_cols=56  Identities=38%  Similarity=0.653  Sum_probs=50.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.++...
T Consensus       105 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110         105 NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            4678888999999999999999874   9999999999999888889999999987654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=98.83  E-value=4.1e-09  Score=63.03  Aligned_cols=60  Identities=33%  Similarity=0.644  Sum_probs=52.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+.+.++++.+++++.|+.|+...   .++||++..+|+++..+..||++|||++|.+.++.
T Consensus       726 GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  726 GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            3467778899999999999999654   59999999999999999999999999999776555

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=98.83  E-value=1.8e-08  Score=55.98  Aligned_cols=55  Identities=25%  Similarity=0.340  Sum_probs=48.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..++......++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.
T Consensus        96 ~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          96 DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccc
Confidence            45677788888999999999999875   99999999999999999999999998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.83  E-value=2.7e-08  Score=59.10  Aligned_cols=56  Identities=38%  Similarity=0.607  Sum_probs=50.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||+++...
T Consensus       100 ~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~  155 (669)
T cd05610         100 YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTL  155 (669)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence            4677888899999999999999874   9999999999999988899999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=98.83  E-value=2e-08  Score=54.90  Aligned_cols=57  Identities=30%  Similarity=0.352  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++.....+++.|||++....
T Consensus        96 ~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          96 GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            35678888889999999999999874   9999999999999999999999999887543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=98.82  E-value=1.9e-08  Score=55.56  Aligned_cols=57  Identities=30%  Similarity=0.384  Sum_probs=50.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ...++......++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||++..+
T Consensus        95 ~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          95 KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            345788888889999999999999874   999999999999999999999999987644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=98.82  E-value=2.1e-08  Score=58.38  Aligned_cols=61  Identities=38%  Similarity=0.529  Sum_probs=51.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeeecCCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIFGGNQ   66 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~~~~~   66 (77)
                      +.+|+...-..++.|++.++.|+|..+   +.|.+++++|+++....   ..++.|||+++++.+..
T Consensus       658 kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  658 KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            456777777778899999999999875   99999999999997542   57999999999887653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=98.82  E-value=3.8e-08  Score=50.35  Aligned_cols=55  Identities=20%  Similarity=0.286  Sum_probs=47.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .++......++.+++.++.++|. .   +++|+++++.|+++. +..+++.|||++....
T Consensus       113 ~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         113 PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            45666778889999999999998 6   499999999999998 7789999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=98.82  E-value=1.8e-08  Score=55.53  Aligned_cols=56  Identities=41%  Similarity=0.647  Sum_probs=49.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       115 ~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874         115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            3667778888999999999999874   9999999999999999999999999987543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=98.81  E-value=5.2e-08  Score=54.91  Aligned_cols=57  Identities=33%  Similarity=0.479  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.|+|..   +++|+++++.++++.....+++.|||+++...
T Consensus       234 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~  290 (401)
T cd05107         234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM  290 (401)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecc
Confidence            4578888999999999999999986   49999999999999988889999999987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=98.81  E-value=5.8e-08  Score=51.82  Aligned_cols=57  Identities=35%  Similarity=0.620  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..   +++|+++++.++++..+..+++.|||.++...
T Consensus       104 ~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057         104 DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            3578899999999999999999986   49999999999999988899999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=98.81  E-value=2.5e-08  Score=54.74  Aligned_cols=58  Identities=26%  Similarity=0.389  Sum_probs=51.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..++......++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus        96 ~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          96 DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            45788888889999999999999874   99999999999999999999999999876543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=98.81  E-value=2.9e-08  Score=55.31  Aligned_cols=56  Identities=27%  Similarity=0.389  Sum_probs=49.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||++..+
T Consensus        96 ~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          96 EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            45677888888999999999999874   999999999999998899999999987643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=98.81  E-value=7.9e-08  Score=50.93  Aligned_cols=56  Identities=32%  Similarity=0.567  Sum_probs=50.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.++...
T Consensus       109 ~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  164 (273)
T cd05035         109 KLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIY  164 (273)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeecc
Confidence            5788888999999999999999874   9999999999999988899999999987653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=98.81  E-value=3.9e-08  Score=52.76  Aligned_cols=57  Identities=40%  Similarity=0.560  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.++++..+...++.|||.++...
T Consensus       127 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  183 (293)
T cd05053         127 ETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIH  183 (293)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccc
Confidence            45788899999999999999999874   9999999999999998999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=98.81  E-value=5.3e-08  Score=52.39  Aligned_cols=55  Identities=33%  Similarity=0.533  Sum_probs=49.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.++++..+...+++|||.+...
T Consensus       125 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~  179 (295)
T cd05097         125 SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNL  179 (295)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEeccccccccc
Confidence            4678888899999999999999874   999999999999998888999999987654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=98.81  E-value=4.4e-08  Score=52.38  Aligned_cols=57  Identities=32%  Similarity=0.377  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++..+..++.+++.++.|+|..+   ++|+++++.++++..+..++++|||.+..+.
T Consensus        92 ~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          92 GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            45789999999999999999999874   9999999999999988999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=98.80  E-value=6.4e-08  Score=52.12  Aligned_cols=55  Identities=35%  Similarity=0.594  Sum_probs=49.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+..+
T Consensus       126 ~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  180 (296)
T cd05095         126 TISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNL  180 (296)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccc
Confidence            4677889999999999999999874   999999999999998889999999988754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=98.80  E-value=5.1e-08  Score=51.84  Aligned_cols=56  Identities=34%  Similarity=0.567  Sum_probs=49.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+...++.|||.++...
T Consensus       115 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~  170 (277)
T cd05032         115 PPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIY  170 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhc
Confidence            4678888889999999999999874   9999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=98.80  E-value=2.5e-08  Score=55.19  Aligned_cols=56  Identities=41%  Similarity=0.647  Sum_probs=49.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..++++|||+++...
T Consensus       122 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            3567788888999999999999874   9999999999999999999999999987553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=98.80  E-value=8.1e-08  Score=50.66  Aligned_cols=56  Identities=29%  Similarity=0.476  Sum_probs=50.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++..+...++.|||.++...
T Consensus        98 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          98 VLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence            3678888999999999999999874   9999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.80  E-value=8.7e-09  Score=60.54  Aligned_cols=57  Identities=40%  Similarity=0.584  Sum_probs=49.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+|..-++-.+..+++.|+.|+|+..   .+|++++.-||++...+.+++.|||.+....
T Consensus       121 KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  121 KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence            45666677778889999999999874   9999999999999999999999999987644

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=98.80  E-value=8.2e-08  Score=50.97  Aligned_cols=56  Identities=32%  Similarity=0.571  Sum_probs=49.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||+++...
T Consensus       109 ~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~  164 (273)
T cd05074         109 TLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIY  164 (273)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccccccccc
Confidence            4677888999999999999999874   9999999999999988899999999887553

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=98.79  E-value=8.1e-08  Score=51.35  Aligned_cols=56  Identities=39%  Similarity=0.550  Sum_probs=49.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus        91 ~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~  146 (277)
T cd05607          91 GLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELK  146 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence            4678888889999999999999874   9999999999999999999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=98.79  E-value=4.4e-08  Score=52.56  Aligned_cols=55  Identities=44%  Similarity=0.601  Sum_probs=49.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.++++..+...++.|||+++..
T Consensus       123 ~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~  177 (290)
T cd05045         123 ALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDV  177 (290)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccc
Confidence            4788899999999999999999874   999999999999998889999999988754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=98.79  E-value=5.4e-08  Score=52.03  Aligned_cols=55  Identities=36%  Similarity=0.596  Sum_probs=49.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++......++.|||++...
T Consensus       120 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (283)
T cd05090         120 SLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREI  174 (283)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccc
Confidence            4678888899999999999999874   999999999999998888999999988654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=98.79  E-value=3.4e-08  Score=52.78  Aligned_cols=57  Identities=40%  Similarity=0.641  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       102 ~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080         102 HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            35788999999999999999999874   9999999999999988899999999887554

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=98.79  E-value=5.8e-08  Score=51.98  Aligned_cols=56  Identities=34%  Similarity=0.625  Sum_probs=50.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||++..+.
T Consensus       105 ~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079         105 KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence            5788999999999999999999874   9999999999999988899999999887554

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=98.79  E-value=5.6e-08  Score=51.33  Aligned_cols=58  Identities=36%  Similarity=0.630  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.++....
T Consensus        90 ~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~  147 (257)
T cd05116          90 KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCC
Confidence            35788889999999999999999874   99999999999999888899999998876543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.78  E-value=2.2e-08  Score=62.04  Aligned_cols=51  Identities=41%  Similarity=0.691  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            8 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         8 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      -...+.+.++++.|+.|+|..+   ++||++++.||+++....+++.|||++..
T Consensus       696 ~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  696 RDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             hHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence            4567888999999999999875   99999999999999999999999999876

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=98.78  E-value=5.1e-08  Score=52.80  Aligned_cols=55  Identities=35%  Similarity=0.588  Sum_probs=49.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||.+...
T Consensus       100 ~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872         100 IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceec
Confidence            4677888888999999999999874   999999999999999999999999988754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=98.78  E-value=4.5e-08  Score=52.43  Aligned_cols=57  Identities=33%  Similarity=0.402  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.++|..+   ++|+++++.|+++..+...++.|||++....
T Consensus        92 ~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          92 GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            45788999999999999999999875   9999999999999988999999999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=98.78  E-value=9.2e-08  Score=51.96  Aligned_cols=57  Identities=44%  Similarity=0.605  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.++...
T Consensus       129 ~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         129 EQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVH  185 (314)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEcccccccccc
Confidence            34788888999999999999999874   9999999999999988899999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=98.78  E-value=7.2e-08  Score=51.74  Aligned_cols=56  Identities=34%  Similarity=0.442  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.++++..+..+++.|||++...
T Consensus        97 ~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          97 PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            35788999999999999999999874   999999999999998889999999988654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=98.78  E-value=7.2e-08  Score=52.81  Aligned_cols=56  Identities=45%  Similarity=0.630  Sum_probs=50.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||+++...
T Consensus       130 ~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  185 (334)
T cd05100         130 QLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVH  185 (334)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecc
Confidence            4778888999999999999999874   9999999999999988899999999887553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=98.78  E-value=8.3e-08  Score=50.82  Aligned_cols=57  Identities=28%  Similarity=0.502  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus        99 ~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          99 QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            35788888999999999999999874   9999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=98.78  E-value=8.9e-08  Score=50.26  Aligned_cols=59  Identities=37%  Similarity=0.555  Sum_probs=52.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+.....
T Consensus        99 ~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          99 KSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            366899999999999999999999874   99999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=98.78  E-value=3.1e-08  Score=55.12  Aligned_cols=55  Identities=25%  Similarity=0.366  Sum_probs=48.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..++......++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||++..
T Consensus        96 ~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          96 GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            34677778888999999999999874   99999999999999999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=98.77  E-value=2.8e-08  Score=54.90  Aligned_cols=55  Identities=40%  Similarity=0.619  Sum_probs=48.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .++......++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       119 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         119 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            3567778888999999999999874   999999999999999999999999988754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=98.77  E-value=6.2e-08  Score=51.76  Aligned_cols=56  Identities=32%  Similarity=0.648  Sum_probs=50.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++....
T Consensus       104 ~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081         104 RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            4788889999999999999999874   9999999999999988899999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=98.77  E-value=1.2e-07  Score=50.61  Aligned_cols=56  Identities=36%  Similarity=0.499  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||++...
T Consensus        98 ~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          98 RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccc
Confidence            45788999999999999999999874   999999999999998889999999987644

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=98.77  E-value=7.8e-08  Score=50.75  Aligned_cols=57  Identities=32%  Similarity=0.503  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||.++...
T Consensus        95 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          95 GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence            35788899999999999999999874   9999999999999999999999999887553

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=98.77  E-value=1.3e-08  Score=53.75  Aligned_cols=56  Identities=38%  Similarity=0.573  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..++......+..|++.++.|+|..   .++||+++++|+++.....+++.|||.+-.-
T Consensus       119 ~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  119 KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            4577788889999999999999987   4999999999999999999999999987644

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=98.76  E-value=6.8e-09  Score=60.75  Aligned_cols=57  Identities=40%  Similarity=0.582  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +.+.....+.+..+++.|+.|+|..   +++|++++..|+++..+..++++|||.++-+.
T Consensus       207 ~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  207 RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            4456677888899999999999987   59999999999999999999999999988664

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=98.76  E-value=4.5e-08  Score=54.37  Aligned_cols=54  Identities=26%  Similarity=0.427  Sum_probs=47.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      ..++......++.|++.++.|+|..+   ++|+++++.|+++.....+++.|||++.
T Consensus        96 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          96 GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            34677777888899999999999874   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=98.76  E-value=8e-08  Score=51.56  Aligned_cols=57  Identities=37%  Similarity=0.465  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++....
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          97 PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            35788899999999999999999874   9999999999999988999999999887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=98.76  E-value=2.5e-08  Score=54.47  Aligned_cols=58  Identities=31%  Similarity=0.468  Sum_probs=50.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~   63 (77)
                      .+.+++.+.-.++.++..++.|+|..+   +.||+++++|+++..   +..+++.|||+++.-.
T Consensus       155 ~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  155 DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccC
Confidence            356888899999999999999999875   999999999999854   4578999999998644

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=98.76  E-value=8.4e-08  Score=51.18  Aligned_cols=56  Identities=32%  Similarity=0.554  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++.....+++.|||+++.+
T Consensus       112 ~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~  167 (280)
T cd05043         112 QALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL  167 (280)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence            46889999999999999999999874   999999999999998899999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=98.75  E-value=2.1e-07  Score=49.01  Aligned_cols=57  Identities=39%  Similarity=0.555  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++.....+++.|||.+....
T Consensus        97 ~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          97 KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEec
Confidence            45788899999999999999999874   9999999999999988999999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=98.75  E-value=6.9e-08  Score=51.67  Aligned_cols=57  Identities=30%  Similarity=0.516  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++....
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          95 NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            34778888889999999999999874   9999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=98.75  E-value=2e-07  Score=49.31  Aligned_cols=56  Identities=38%  Similarity=0.620  Sum_probs=50.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||++....
T Consensus        99 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          99 ALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            5788999999999999999999874   9999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=98.74  E-value=6.8e-08  Score=57.17  Aligned_cols=66  Identities=33%  Similarity=0.504  Sum_probs=53.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC----CCeEEecccceeeecCCCCCCcccceecC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE----MNPKISDFGMARIFGGNQSEANTNRIVGT   77 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~l~~~g~~~~~~~~~~~~~~~~~~g~   77 (77)
                      |++.+.+.++..+..|+.|+|.++   ++||++++.||++...    ...|+.|||.|+-+..+.   .-.+++||
T Consensus       117 LpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT  186 (732)
T KOG4250|consen  117 LPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGT  186 (732)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCc
Confidence            678889999999999999999874   9999999999988532    346999999999876555   22336676

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=98.74  E-value=8.7e-08  Score=51.08  Aligned_cols=55  Identities=36%  Similarity=0.643  Sum_probs=48.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++...
T Consensus       115 ~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~  169 (277)
T cd05062         115 PPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI  169 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCcccc
Confidence            3567788888999999999999874   999999999999999899999999987644

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=98.74  E-value=6.6e-08  Score=52.99  Aligned_cols=58  Identities=41%  Similarity=0.664  Sum_probs=51.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.|+++.....+++.|||++....
T Consensus       100 ~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849         100 TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            346788888899999999999999874   9999999999999999999999999887654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=98.74  E-value=1.3e-07  Score=50.61  Aligned_cols=55  Identities=38%  Similarity=0.617  Sum_probs=49.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++.....+++.|||++...
T Consensus       118 ~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  172 (280)
T cd05092         118 QLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDI  172 (280)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEc
Confidence            4788999999999999999999874   999999999999998889999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=98.74  E-value=9.1e-08  Score=50.88  Aligned_cols=53  Identities=38%  Similarity=0.677  Sum_probs=48.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+...++.|||++.
T Consensus       108 ~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047         108 TLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCcc
Confidence            4778899999999999999999874   9999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=98.74  E-value=5.8e-08  Score=49.81  Aligned_cols=56  Identities=16%  Similarity=0.191  Sum_probs=47.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHh-hhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            3 SVQLDWKRRISIINGIARGLLYL-HEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ...++......++.+++.++.++ |..   +++|+++++.|+++. +..+++.|||++...
T Consensus       111 ~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         111 DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            34577888889999999999998 675   499999999999997 467899999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=98.74  E-value=8.4e-08  Score=51.34  Aligned_cols=54  Identities=35%  Similarity=0.512  Sum_probs=45.6

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeec
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFG   63 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~   63 (77)
                      ++...-.++.|++.++.|+|.++   ++|+++++.++++..   ...+++.+||++..+.
T Consensus       108 SEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen  108 SEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            44556677899999999999985   999999999999964   3568999999998776

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=98.73  E-value=5.7e-08  Score=52.57  Aligned_cols=53  Identities=38%  Similarity=0.677  Sum_probs=48.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.++++..+...++.|||++.
T Consensus       120 ~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~  172 (303)
T cd05088         120 TLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR  172 (303)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCc
Confidence            5788899999999999999999874   9999999999999988899999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=98.73  E-value=1.8e-07  Score=49.50  Aligned_cols=56  Identities=32%  Similarity=0.568  Sum_probs=50.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.++...
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          96 RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecC
Confidence            5788899999999999999999874   9999999999999988899999999887553

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=98.72  E-value=7.7e-08  Score=52.65  Aligned_cols=58  Identities=40%  Similarity=0.602  Sum_probs=51.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.|++.++.++|..+   ++|+++++.++++..+..+++.|||.+..+.
T Consensus        99 ~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          99 GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            345788889999999999999999874   9999999999999998899999999887654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=98.72  E-value=8.8e-08  Score=50.83  Aligned_cols=53  Identities=32%  Similarity=0.488  Sum_probs=46.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      .++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  149 (269)
T cd05042          97 AQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALE  149 (269)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccc
Confidence            356667788999999999999874   99999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=98.72  E-value=2e-07  Score=49.31  Aligned_cols=56  Identities=36%  Similarity=0.646  Sum_probs=50.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus        98 ~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          98 YLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            4678888999999999999999874   9999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=98.72  E-value=1.5e-07  Score=50.01  Aligned_cols=53  Identities=23%  Similarity=0.406  Sum_probs=45.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ++......++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++..
T Consensus        96 ~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          96 SQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence            445566778899999999999874   99999999999999888999999998653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=98.71  E-value=1e-07  Score=50.14  Aligned_cols=57  Identities=35%  Similarity=0.545  Sum_probs=51.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ...+++.....++.+++.++.++|..+   +.|+++++.|+++..+...++.|||.+...
T Consensus        92 ~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   92 NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            356788899999999999999999974   999999999999998899999999998753

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=98.71  E-value=2e-07  Score=49.67  Aligned_cols=56  Identities=36%  Similarity=0.585  Sum_probs=49.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..++++|||.+...
T Consensus       117 ~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~  172 (280)
T cd05049         117 GELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDV  172 (280)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceec
Confidence            34678888999999999999999874   999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=98.71  E-value=6.9e-08  Score=52.26  Aligned_cols=55  Identities=45%  Similarity=0.656  Sum_probs=49.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus       136 ~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~  190 (307)
T cd05098         136 QLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI  190 (307)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccc
Confidence            4788899999999999999999874   999999999999998889999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=98.71  E-value=6.7e-08  Score=50.54  Aligned_cols=61  Identities=30%  Similarity=0.452  Sum_probs=51.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      +...++...-.++..+..++.|+|.+  +.++||++++.|+++...+..++.|||.+.++..+
T Consensus       142 g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  142 GGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             CCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            34456666677788899999999975  57999999999999999999999999998877544

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=98.71  E-value=1.2e-07  Score=50.87  Aligned_cols=56  Identities=34%  Similarity=0.529  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++.. +..+++.|||.+..+
T Consensus       105 ~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837         105 RPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceec
Confidence            35788999999999999999999874   999999999999987 788999999988754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=98.70  E-value=1e-07  Score=50.80  Aligned_cols=58  Identities=33%  Similarity=0.493  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|...  +++|+++++.++++..+..+++.|||.+....
T Consensus        98 ~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          98 LTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            45788999999999999999999752  49999999999999999999999999887543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=98.70  E-value=1.3e-07  Score=50.13  Aligned_cols=56  Identities=38%  Similarity=0.539  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++...
T Consensus       106 ~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637         106 NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            35788888889999999999999874   999999999999999999999999998754

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=98.70  E-value=1e-07  Score=51.36  Aligned_cols=53  Identities=40%  Similarity=0.713  Sum_probs=48.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||++.
T Consensus       115 ~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  167 (297)
T cd05089         115 TLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR  167 (297)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCc
Confidence            4778889999999999999999874   9999999999999988889999999875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=98.70  E-value=1.8e-07  Score=49.56  Aligned_cols=57  Identities=33%  Similarity=0.674  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||++....
T Consensus       102 ~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063         102 GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            35788889999999999999999874   9999999999999988899999999887654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=98.70  E-value=1.2e-07  Score=51.40  Aligned_cols=55  Identities=42%  Similarity=0.593  Sum_probs=49.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.++.+.
T Consensus       138 l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         138 LTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccccc
Confidence            788899999999999999999874   9999999999999988889999999887554

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=98.70  E-value=9.9e-08  Score=50.96  Aligned_cols=57  Identities=35%  Similarity=0.641  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+..+.
T Consensus        94 ~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          94 GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            45788899999999999999999874   9999999999999999999999999887543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=98.70  E-value=2e-07  Score=49.52  Aligned_cols=53  Identities=36%  Similarity=0.514  Sum_probs=46.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      .++.....++.+++.++.|+|..+   ++|+++++.++++.....+++.|||.+..
T Consensus        97 ~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~  149 (269)
T cd05087          97 PDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHN  149 (269)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccc
Confidence            456667778899999999999874   99999999999999988999999998754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=98.70  E-value=1.7e-07  Score=50.32  Aligned_cols=55  Identities=36%  Similarity=0.636  Sum_probs=47.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||+++..
T Consensus       115 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~  169 (288)
T cd05061         115 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDI  169 (288)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccc
Confidence            3456677888999999999999874   999999999999999899999999987644

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=98.69  E-value=1.7e-07  Score=49.63  Aligned_cols=56  Identities=36%  Similarity=0.669  Sum_probs=50.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||++....
T Consensus       102 ~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033         102 KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            5788899999999999999999874   9999999999999998999999999887664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=98.69  E-value=1.9e-07  Score=49.24  Aligned_cols=57  Identities=39%  Similarity=0.622  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.++...
T Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~  146 (257)
T cd05060          90 REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALG  146 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceee
Confidence            35788899999999999999999874   9999999999999998999999999887654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=98.69  E-value=1.8e-07  Score=50.26  Aligned_cols=56  Identities=36%  Similarity=0.499  Sum_probs=49.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .++......++.+++.++.|+|..   +++|+++++.++++.....+++.|||++....
T Consensus        98 ~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          98 GFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            477888888999999999999987   49999999999999988899999999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=98.69  E-value=1.4e-07  Score=50.38  Aligned_cols=56  Identities=38%  Similarity=0.632  Sum_probs=50.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus        96 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          96 QYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             CcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            45788899999999999999999874   999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=98.69  E-value=1.3e-07  Score=49.66  Aligned_cols=56  Identities=41%  Similarity=0.561  Sum_probs=49.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++...
T Consensus        89 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  144 (252)
T cd05084          89 PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREE  144 (252)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccc
Confidence            35788889999999999999999874   999999999999998888999999987643

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=98.69  E-value=1.3e-07  Score=52.11  Aligned_cols=56  Identities=43%  Similarity=0.606  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++...
T Consensus       115 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877         115 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccc
Confidence            45788889999999999999999874   999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=98.69  E-value=1.2e-07  Score=51.16  Aligned_cols=56  Identities=30%  Similarity=0.576  Sum_probs=50.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+...++.|||++...
T Consensus       113 ~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658         113 TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            45788889999999999999999874   999999999999998899999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=98.69  E-value=2.2e-07  Score=49.99  Aligned_cols=57  Identities=42%  Similarity=0.597  Sum_probs=51.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||++.....
T Consensus        98 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          98 VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            5889999999999999999999874   99999999999999999999999998876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=98.69  E-value=1.8e-07  Score=49.69  Aligned_cols=57  Identities=44%  Similarity=0.653  Sum_probs=51.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ...+++.....++.+++.++.|+|...   ++|+++.+.++++..+..+++.+||+....
T Consensus        97 ~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   97 KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            457889999999999999999999874   999999999999999999999999988766

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=98.69  E-value=1.2e-07  Score=49.90  Aligned_cols=57  Identities=35%  Similarity=0.510  Sum_probs=51.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+..+..
T Consensus        93 ~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          93 HFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             cCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            5788999999999999999999874   99999999999999999999999998876643

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=98.68  E-value=1.8e-07  Score=50.84  Aligned_cols=62  Identities=32%  Similarity=0.474  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS   67 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~   67 (77)
                      +++++...-.+...+..++.|+-..  ..++|+++++.|++++..+.+++.|||.+..+..++-
T Consensus       186 ~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  186 GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            4566666666777888899998653  4799999999999999999999999999988776553

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=98.68  E-value=2e-07  Score=49.37  Aligned_cols=57  Identities=30%  Similarity=0.493  Sum_probs=50.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.|+|..+   ++|+++++.++++.....+++.|||.+....
T Consensus       101 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645         101 GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            35778888999999999999999874   9999999999999988899999999886553

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=98.68  E-value=2.9e-07  Score=48.90  Aligned_cols=57  Identities=37%  Similarity=0.656  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus       101 ~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065         101 GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence            34778888999999999999999874   9999999999999988899999999887554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=98.68  E-value=2.2e-07  Score=49.79  Aligned_cols=55  Identities=36%  Similarity=0.652  Sum_probs=49.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.++++..+...++.|||++...
T Consensus       126 ~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  180 (288)
T cd05050         126 PLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI  180 (288)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceec
Confidence            4678888999999999999999874   999999999999998889999999988754

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=98.68  E-value=3.5e-07  Score=48.36  Aligned_cols=57  Identities=25%  Similarity=0.414  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+..+.
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224         101 RLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            45788889999999999999999874   9999999999999988899999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=98.67  E-value=1.6e-07  Score=49.41  Aligned_cols=56  Identities=20%  Similarity=0.344  Sum_probs=48.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-------CeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-------NPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-------~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++....       .+++.|||.+....
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          97 NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            5788888999999999999999874   99999999999998665       68999999887643

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=98.67  E-value=2.4e-07  Score=49.15  Aligned_cols=56  Identities=32%  Similarity=0.625  Sum_probs=49.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+..+.
T Consensus        98 ~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          98 YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            4678888999999999999999874   9999999999999998899999999887654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PLN00181 protein SPA1-RELATED; Provisional

Probab=98.67  E-value=1.6e-07  Score=56.78  Aligned_cols=42  Identities=12%  Similarity=0.139  Sum_probs=37.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE   48 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~   48 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++...
T Consensus        75 ~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~  116 (793)
T PLN00181         75 RSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSF  116 (793)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEccc
Confidence            35888999999999999999999874   9999999999999543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=98.67  E-value=1.3e-07  Score=55.17  Aligned_cols=56  Identities=36%  Similarity=0.446  Sum_probs=48.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC--CCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH--EMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~l~~~g~~~~~~   63 (77)
                      -|+...+..++.|++.++.++|..   +++|.+++++|+++..  ...+|++|||.+.+..
T Consensus       285 Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  285 GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            367888999999999999999976   4999999999999964  4578999999987544

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=98.67  E-value=2.4e-07  Score=49.20  Aligned_cols=58  Identities=34%  Similarity=0.652  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||.+.....
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066         101 GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            35688888999999999999999874   99999999999999888999999998876543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=98.67  E-value=8.3e-08  Score=52.60  Aligned_cols=55  Identities=40%  Similarity=0.593  Sum_probs=49.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .++......+..|++.+++++|+.+   ++||++++.+++.......++.|||.++.-
T Consensus       114 elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen  114 ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence            3677788888999999999999875   999999999999999999999999998743

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=98.66  E-value=2.6e-07  Score=49.28  Aligned_cols=57  Identities=30%  Similarity=0.438  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus        95 ~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07847          95 RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILT  151 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecC
Confidence            35788899999999999999999874   9999999999999988899999999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=98.66  E-value=3.1e-07  Score=50.38  Aligned_cols=58  Identities=31%  Similarity=0.481  Sum_probs=50.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|...  .++|+++++.++++..+..+++.|||++....
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          98 KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            34678888889999999999999742  49999999999999988999999999887553

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=98.66  E-value=1.4e-07  Score=51.95  Aligned_cols=58  Identities=36%  Similarity=0.576  Sum_probs=51.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus       112 ~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880         112 HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            356788899999999999999999874   9999999999999988899999999887543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=98.66  E-value=2.9e-07  Score=48.87  Aligned_cols=56  Identities=32%  Similarity=0.514  Sum_probs=50.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++.....+++.|||.++...
T Consensus       103 ~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056         103 SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            5788899999999999999999874   9999999999999998999999999887553

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=98.66  E-value=1.9e-07  Score=51.13  Aligned_cols=58  Identities=38%  Similarity=0.624  Sum_probs=51.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus       101 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855         101 DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            345788999999999999999999874   9999999999999999999999999887654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=98.66  E-value=2.1e-07  Score=49.07  Aligned_cols=55  Identities=38%  Similarity=0.596  Sum_probs=49.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~  150 (256)
T cd05114          96 KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYV  150 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCcccc
Confidence            4788889999999999999999874   999999999999998889999999987654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=98.66  E-value=2.1e-07  Score=49.96  Aligned_cols=57  Identities=37%  Similarity=0.567  Sum_probs=51.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+..+..
T Consensus       102 ~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843         102 PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            4788999999999999999999874   99999999999999999999999998876543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=98.66  E-value=1.7e-07  Score=49.47  Aligned_cols=55  Identities=36%  Similarity=0.572  Sum_probs=47.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++.....+++.|||+++..
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          94 NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccc
Confidence            3566777888899999999999874   999999999999998889999999988644

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=98.66  E-value=2.1e-07  Score=49.49  Aligned_cols=55  Identities=31%  Similarity=0.452  Sum_probs=49.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+..
T Consensus       102 ~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064         102 GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence            35788999999999999999999874   99999999999999988999999987653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=98.66  E-value=1.9e-07  Score=49.47  Aligned_cols=57  Identities=25%  Similarity=0.409  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   +.|+++++.++++..+..+++.|||.+....
T Consensus       101 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229         101 RLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            45788889999999999999999874   9999999999999988999999999876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=98.65  E-value=2e-07  Score=50.29  Aligned_cols=56  Identities=34%  Similarity=0.688  Sum_probs=50.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+..+.
T Consensus       115 ~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865         115 KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence            5788999999999999999999874   9999999999999999999999999887553

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=98.65  E-value=2.3e-07  Score=51.51  Aligned_cols=64  Identities=27%  Similarity=0.418  Sum_probs=54.4

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-----CCeEEecccceeeecCCCCC
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-----MNPKISDFGMARIFGGNQSE   68 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~l~~~g~~~~~~~~~~~   68 (77)
                      ....++..++..++.|++..++++|...   .+++++++.|+++...     ..+.+.|||+++.+...++.
T Consensus       117 CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk  185 (449)
T KOG1165|consen  117 CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK  185 (449)
T ss_pred             hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence            4567888899999999999999999875   9999999999999643     35789999999998766543

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=98.65  E-value=3.2e-07  Score=49.05  Aligned_cols=56  Identities=30%  Similarity=0.461  Sum_probs=49.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus        91 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          91 KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            3567777888999999999999874   9999999999999999999999999887554

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=98.65  E-value=1.7e-07  Score=52.68  Aligned_cols=56  Identities=34%  Similarity=0.538  Sum_probs=49.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC----CCeEEecccceeeecC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE----MNPKISDFGMARIFGG   64 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~l~~~g~~~~~~~   64 (77)
                      +++.....++.+++.++.|+|..+   ++|++++++|+++...    ..+++.|||++.....
T Consensus       132 ~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  132 YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            778888999999999999999874   9999999999999643    3689999999987765

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=98.65  E-value=3.5e-07  Score=48.08  Aligned_cols=58  Identities=36%  Similarity=0.499  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..   ++.|+++++.++++..+...++.|||.+..+..
T Consensus        96 ~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          96 RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            4577888889999999999999987   499999999999999989999999998876543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=98.64  E-value=3.8e-07  Score=48.78  Aligned_cols=57  Identities=32%  Similarity=0.447  Sum_probs=49.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|...   ++|+++++.++++.....+++.|||++....
T Consensus       119 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638         119 ERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            34677788888999999999999874   9999999999999988889999999887654

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=98.64  E-value=1.9e-07  Score=54.79  Aligned_cols=51  Identities=31%  Similarity=0.385  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeeec
Q 040677           10 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIFG   63 (77)
Q Consensus        10 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~~   63 (77)
                      .+..++.|++.++.|+|..+   ++|+++++.|+++.. ...+++.|||+++.+.
T Consensus       256 ~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~  307 (566)
T PLN03225        256 IIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR  307 (566)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccc
Confidence            34567889999999999874   999999999999985 5789999999987543

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=98.64  E-value=4.9e-07  Score=48.98  Aligned_cols=57  Identities=39%  Similarity=0.578  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++....
T Consensus       110 ~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607         110 KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            45788899999999999999999874   9999999999999999999999999886543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=98.64  E-value=2.7e-07  Score=48.70  Aligned_cols=57  Identities=37%  Similarity=0.615  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||.+....
T Consensus        99 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          99 QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcC
Confidence            35788889999999999999999874   9999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=98.64  E-value=2.2e-07  Score=50.95  Aligned_cols=56  Identities=38%  Similarity=0.660  Sum_probs=49.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus       103 ~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852         103 ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            5678888889999999999999874   9999999999999999999999999887553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=98.63  E-value=8.8e-08  Score=57.34  Aligned_cols=55  Identities=36%  Similarity=0.569  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      .+|+..+.+.++.|++.|+.|+...   .++|+|+..+|.++..+..+|++|||+++.
T Consensus       598 ~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRd  652 (774)
T KOG1026|consen  598 PPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRD  652 (774)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecccccchh
Confidence            4588999999999999999999765   599999999999999999999999999874

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=98.63  E-value=2.3e-07  Score=49.79  Aligned_cols=56  Identities=39%  Similarity=0.550  Sum_probs=50.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++.....+++.|||.+...
T Consensus       123 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~  178 (291)
T cd06639         123 QRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL  178 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence            45788889999999999999999874   999999999999998888999999987654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=98.63  E-value=2.1e-07  Score=51.39  Aligned_cols=55  Identities=42%  Similarity=0.649  Sum_probs=49.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ++......++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.++...
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            677788888999999999999874   9999999999999999999999999987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=98.63  E-value=5.4e-07  Score=47.50  Aligned_cols=55  Identities=33%  Similarity=0.562  Sum_probs=48.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus        96 ~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          96 LVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceec
Confidence            4678888889999999999999874   999999999999998889999999987653

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=98.63  E-value=3.5e-07  Score=48.35  Aligned_cols=57  Identities=37%  Similarity=0.618  Sum_probs=50.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..   +++|+++++.++++.....+++.|||.+....
T Consensus        98 ~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          98 GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecC
Confidence            3467788888999999999999987   49999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PRK09188 serine/threonine protein kinase; Provisional

Probab=98.63  E-value=2e-07  Score=52.14  Aligned_cols=50  Identities=30%  Similarity=0.439  Sum_probs=43.2

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEEccC-CCCcEEEcCCCCeEEecccceeeecC
Q 040677           12 ISIINGIARGLLYLHEDSRLKIIHRDL-KASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus        12 ~~~~~~~~~~l~~~~~~~~~~~~~~~l-~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..++.+++.++.++|..+   ++|+++ ++.|+++..+..+++.|||+++.+..
T Consensus       114 ~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             HHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            356778899999999874   999999 89999998778899999999987643

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=98.63  E-value=3.4e-07  Score=48.40  Aligned_cols=57  Identities=32%  Similarity=0.600  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus        97 ~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          97 RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            34788889999999999999999874   9999999999999988889999999887653

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=98.63  E-value=3.1e-07  Score=49.01  Aligned_cols=58  Identities=40%  Similarity=0.597  Sum_probs=51.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++..+.
T Consensus        95 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          95 PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccccc
Confidence            345788888999999999999999874   9999999999999988899999999887554

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=98.63  E-value=2.2e-07  Score=50.19  Aligned_cols=56  Identities=32%  Similarity=0.557  Sum_probs=49.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..++++|||.+...
T Consensus        99 ~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          99 NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            34678888889999999999999874   999999999999999999999999987654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=98.63  E-value=8.9e-08  Score=50.85  Aligned_cols=58  Identities=29%  Similarity=0.456  Sum_probs=48.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeeecCCC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~~~~~   66 (77)
                      |+-..+..++.+++.++.|||+.+   +.|+++++.|++++. ...++++|||++.++....
T Consensus       129 l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  129 LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            344456677899999999999875   999999999999975 4689999999999887654

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=98.63  E-value=5.9e-07  Score=48.31  Aligned_cols=56  Identities=41%  Similarity=0.507  Sum_probs=49.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..   +++|+++++.++++..+..+++.|||.+...
T Consensus       105 ~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644         105 RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            3578889999999999999999986   4999999999999998889999999987643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=98.62  E-value=2.6e-07  Score=49.67  Aligned_cols=57  Identities=33%  Similarity=0.392  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.++|..+   ++|+++++.++++..+..+++.|||++....
T Consensus        96 ~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          96 GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            45788888889999999999999874   9999999999999998999999999887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=98.62  E-value=2.6e-07  Score=48.89  Aligned_cols=57  Identities=21%  Similarity=0.394  Sum_probs=50.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.|+|..+   +.|+++++.++++..+..+++.|||.+..+.
T Consensus       101 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228         101 RLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            34677888899999999999999874   9999999999999988899999999877653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=98.62  E-value=2.3e-07  Score=49.93  Aligned_cols=56  Identities=34%  Similarity=0.665  Sum_probs=50.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+..+.
T Consensus       112 ~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  167 (302)
T cd07864         112 HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYN  167 (302)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccccccccc
Confidence            5788999999999999999999874   9999999999999999999999999887653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=98.62  E-value=3e-07  Score=49.00  Aligned_cols=56  Identities=41%  Similarity=0.661  Sum_probs=50.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+....
T Consensus       105 ~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038         105 QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            4788889999999999999999874   9999999999999999999999999887655

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=98.62  E-value=4.2e-07  Score=47.71  Aligned_cols=56  Identities=39%  Similarity=0.514  Sum_probs=49.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||++...
T Consensus        88 ~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~  143 (250)
T cd05085          88 DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQE  143 (250)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceec
Confidence            34678888999999999999999874   999999999999998889999999988643

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=98.62  E-value=1.8e-07  Score=50.55  Aligned_cols=56  Identities=30%  Similarity=0.586  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||++..+
T Consensus       112 ~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659         112 TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            45788889999999999999999874   999999999999999999999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=98.62  E-value=5.9e-07  Score=47.34  Aligned_cols=57  Identities=26%  Similarity=0.479  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.++|..+   +.|+++++.++++..+...++.|||.+....
T Consensus        95 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          95 KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            34678888889999999999999874   9999999999999988899999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=98.62  E-value=1.5e-07  Score=50.84  Aligned_cols=56  Identities=29%  Similarity=0.523  Sum_probs=49.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+...
T Consensus       111 ~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654         111 TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            35678888899999999999999874   999999999999998889999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=98.62  E-value=5e-07  Score=48.20  Aligned_cols=56  Identities=38%  Similarity=0.666  Sum_probs=50.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+..+.
T Consensus       103 ~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838         103 GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            4788999999999999999999874   9999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=98.62  E-value=2.8e-07  Score=48.56  Aligned_cols=56  Identities=32%  Similarity=0.622  Sum_probs=50.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||.++...
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          98 VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            5788999999999999999999874   9999999999999988899999999887653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=98.62  E-value=4.1e-07  Score=48.24  Aligned_cols=55  Identities=40%  Similarity=0.580  Sum_probs=47.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-----CeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-----NPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-----~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++....     .+++.|||+++..
T Consensus       102 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~  161 (269)
T cd05044         102 LLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI  161 (269)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence            4678888999999999999999864   99999999999998766     7899999988654

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=98.62  E-value=2.6e-07  Score=50.05  Aligned_cols=57  Identities=46%  Similarity=0.708  Sum_probs=51.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++.....+++.|||.+....
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845         103 TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            45788899999999999999999875   9999999999999998999999999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=98.61  E-value=3.8e-07  Score=51.50  Aligned_cols=57  Identities=25%  Similarity=0.292  Sum_probs=50.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ...++.....-++.+++.+++|+|.-+   +++|+++++|+++..++.+-++||-++...
T Consensus       173 ~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  173 GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            345788888889999999999999864   999999999999999999999999876544

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=98.61  E-value=5.1e-07  Score=47.73  Aligned_cols=57  Identities=35%  Similarity=0.690  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||.+....
T Consensus        97 ~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          97 IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            35678888889999999999999874   9999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=98.61  E-value=3.1e-07  Score=48.82  Aligned_cols=56  Identities=25%  Similarity=0.367  Sum_probs=47.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC-------eEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN-------PKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~-------~~l~~~g~~~~~   62 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.++++.....       +++.|||.+...
T Consensus       100 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~  162 (262)
T cd05077         100 DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV  162 (262)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence            45788889999999999999999874   999999999999975432       788999987544

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.61  E-value=1.1e-07  Score=52.81  Aligned_cols=56  Identities=36%  Similarity=0.429  Sum_probs=48.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .++.....-+...+..++.|+|+++   +++++++.+|+++++++.+++.|||+++.-+
T Consensus       264 ~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  264 VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            3556666667888999999999975   9999999999999999999999999987433

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=98.61  E-value=3.4e-07  Score=48.75  Aligned_cols=58  Identities=34%  Similarity=0.531  Sum_probs=51.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++.....+++.|||.+..+..
T Consensus        96 ~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          96 GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            45788889999999999999999874   99999999999999999999999998876543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=98.61  E-value=2.6e-07  Score=49.86  Aligned_cols=57  Identities=40%  Similarity=0.672  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||+++...
T Consensus       110 ~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866         110 VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            45788899999999999999999874   9999999999999999999999999887553

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=98.61  E-value=3.6e-07  Score=49.45  Aligned_cols=56  Identities=36%  Similarity=0.557  Sum_probs=49.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC----CCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH----EMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~----~~~~~l~~~g~~~~~~   63 (77)
                      .++......++.|++.++.|+|..+   ++|+++++.++++..    ...+++.|||++....
T Consensus       104 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~  163 (316)
T cd07842         104 SIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN  163 (316)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccC
Confidence            5678888889999999999999874   999999999999988    7889999999887653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=98.60  E-value=2.4e-07  Score=49.70  Aligned_cols=55  Identities=35%  Similarity=0.575  Sum_probs=49.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..++++|||.++..
T Consensus        99 ~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          99 GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            5678888889999999999999874   999999999999999999999999987643

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=98.60  E-value=4.2e-07  Score=48.45  Aligned_cols=56  Identities=32%  Similarity=0.427  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++.. ..+++.|||.+....
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          95 RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            35789999999999999999999874   999999999999988 899999999887553

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=98.60  E-value=3e-07  Score=48.74  Aligned_cols=57  Identities=32%  Similarity=0.490  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||++....
T Consensus       101 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646         101 GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            35678888889999999999999874   9999999999999988889999999887553

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=98.60  E-value=6.4e-07  Score=47.39  Aligned_cols=56  Identities=34%  Similarity=0.627  Sum_probs=49.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++.....+++.|||.+..+.
T Consensus        98 ~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          98 KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            4677888889999999999999874   9999999999999998999999999887554

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=98.59  E-value=2.7e-07  Score=49.52  Aligned_cols=55  Identities=36%  Similarity=0.521  Sum_probs=48.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.++..
T Consensus        99 ~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          99 GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            4567778888999999999999874   999999999999998899999999987643

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=98.59  E-value=3.3e-07  Score=49.17  Aligned_cols=57  Identities=30%  Similarity=0.392  Sum_probs=49.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||++....
T Consensus       100 ~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613         100 ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            34677788888889999999999874   9999999999999998999999999887653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=98.59  E-value=2.9e-07  Score=48.85  Aligned_cols=56  Identities=34%  Similarity=0.526  Sum_probs=49.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||+++..
T Consensus       101 ~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651         101 GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            34678888889999999999999764   999999999999998889999999987654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=98.59  E-value=3.6e-07  Score=48.26  Aligned_cols=56  Identities=34%  Similarity=0.530  Sum_probs=49.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .++......++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus       100 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625         100 ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            4667778888999999999999874   9999999999999988899999999886543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=98.59  E-value=4.2e-07  Score=49.59  Aligned_cols=58  Identities=41%  Similarity=0.600  Sum_probs=51.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+.....
T Consensus        98 ~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          98 QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            36788888999999999999999874   99999999999999999999999998876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=98.59  E-value=5.3e-07  Score=52.36  Aligned_cols=55  Identities=33%  Similarity=0.453  Sum_probs=48.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++...
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~  359 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDM  359 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccc
Confidence            3567788889999999999999874   999999999999998889999999988654

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=98.58  E-value=5.1e-07  Score=47.55  Aligned_cols=58  Identities=28%  Similarity=0.515  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+.....
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          96 QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            45788888999999999999999864   99999999999999989999999998876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=98.58  E-value=7.2e-07  Score=47.61  Aligned_cols=58  Identities=36%  Similarity=0.478  Sum_probs=51.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+.....
T Consensus        94 ~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          94 KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            36789999999999999999999874   99999999999999999999999998876543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=98.58  E-value=4.8e-07  Score=48.35  Aligned_cols=56  Identities=34%  Similarity=0.577  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus        95 ~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          95 SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            45788889999999999999999874   999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=98.58  E-value=5.5e-07  Score=48.01  Aligned_cols=57  Identities=33%  Similarity=0.514  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-CeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-NPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++.... ..++.|||.+....
T Consensus       104 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390        104 GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            36889999999999999999999874   99999999999998877 89999999887554

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=98.58  E-value=4.8e-07  Score=48.34  Aligned_cols=56  Identities=38%  Similarity=0.590  Sum_probs=50.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   +.|+++++.++++..+..+++.|||++..+.
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          96 GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            4788999999999999999999874   9999999999999999999999999877553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=98.58  E-value=5.4e-07  Score=47.98  Aligned_cols=58  Identities=38%  Similarity=0.585  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+.....
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          93 RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            36788899999999999999999874   99999999999999889999999998876644

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=98.58  E-value=3.6e-07  Score=50.17  Aligned_cols=57  Identities=39%  Similarity=0.617  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.++|..+   ++|+++++.++++..+..+++.|||++....
T Consensus       103 ~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858         103 QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            45788889999999999999999874   9999999999999988999999999887553

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=98.58  E-value=3.4e-07  Score=50.29  Aligned_cols=54  Identities=30%  Similarity=0.418  Sum_probs=48.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-----CCeEEeccccee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-----MNPKISDFGMAR   60 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~l~~~g~~~   60 (77)
                      ..++..+.+.++.|++.++.++|..+   ++|+++++.|+.+...     ..+.+.|||+++
T Consensus       117 ~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen  117 GRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             CCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            57889999999999999999999875   9999999999999754     358999999998

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=98.57  E-value=2.7e-07  Score=49.37  Aligned_cols=61  Identities=25%  Similarity=0.414  Sum_probs=51.5

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC---CCeEEecccceeeecCC
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMARIFGGN   65 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~l~~~g~~~~~~~~   65 (77)
                      .+..++..+++.++-|++..++|+|..+   ++|+++++.|++-..+   ..+.++|||+++.+-..
T Consensus       104 C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~  167 (341)
T KOG1163|consen  104 CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI  167 (341)
T ss_pred             HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccc
Confidence            3567889999999999999999999886   9999999999988643   45789999999866443

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=98.57  E-value=4.9e-07  Score=48.10  Aligned_cols=54  Identities=28%  Similarity=0.428  Sum_probs=49.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++......++.+|+++..
T Consensus       113 ~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046         113 PLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccc
Confidence            5889999999999999999999874   99999999999999888899999988754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=1.6e-07  Score=56.03  Aligned_cols=54  Identities=33%  Similarity=0.519  Sum_probs=48.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      +.|....+..++.+++.++.|+|+..   ++|++++..|+++..++.+++.|||++.
T Consensus       125 r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  125 RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccc
Confidence            45778888889999999999999884   9999999999999999999999999864

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=98.57  E-value=5.9e-07  Score=48.79  Aligned_cols=57  Identities=28%  Similarity=0.295  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+...++.|||++....
T Consensus        98 ~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          98 KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            45788888889999999999999874   9999999999999998899999999876543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=98.57  E-value=3.2e-07  Score=49.59  Aligned_cols=57  Identities=30%  Similarity=0.512  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||++....
T Consensus       110 ~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655         110 TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            35788999999999999999999874   9999999999999988999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=98.57  E-value=5.4e-07  Score=47.57  Aligned_cols=57  Identities=37%  Similarity=0.638  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+..+.
T Consensus        98 ~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          98 KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence            35788889999999999999999874   9999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PTZ00284 protein kinase; Provisional

Probab=98.57  E-value=2.8e-07  Score=52.75  Aligned_cols=55  Identities=27%  Similarity=0.451  Sum_probs=46.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC----------------CeEEeccccee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM----------------NPKISDFGMAR   60 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~----------------~~~l~~~g~~~   60 (77)
                      ..+++.....++.|++.++.|+|..  .+++|+++++.|+++....                .+++.|||.+.
T Consensus       226 ~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~  296 (467)
T PTZ00284        226 GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC  296 (467)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccc
Confidence            4578888899999999999999963  1499999999999997543                48999999764

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=98.56  E-value=2.7e-07  Score=54.51  Aligned_cols=58  Identities=40%  Similarity=0.501  Sum_probs=51.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .++...++.++.|++.|+.|+...   +++||++..+++++..+..++++|||+++....+
T Consensus       414 ~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~  471 (609)
T KOG0200|consen  414 ALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNK  471 (609)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCC
Confidence            478889999999999999999876   5999999999999999999999999999855433

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=98.56  E-value=6.3e-07  Score=47.08  Aligned_cols=56  Identities=41%  Similarity=0.600  Sum_probs=50.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +++.....++.+++.++.++|..+   ++|+++++.++++.....+++.|||.+.....
T Consensus       100 ~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219      100 LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence            788889999999999999999874   99999999999999988999999998876543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.56  E-value=3.5e-07  Score=54.53  Aligned_cols=53  Identities=26%  Similarity=0.446  Sum_probs=45.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      .+.+.....++.++.++++.+|.-   +++|+++++.||+++.++.+++.|||++-
T Consensus       725 IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  725 IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccc
Confidence            355566666788889999999965   59999999999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=98.56  E-value=6.2e-07  Score=49.28  Aligned_cols=56  Identities=32%  Similarity=0.537  Sum_probs=48.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|...  +++|+++++.|+++..+..+++.|||++..+
T Consensus        99 ~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          99 RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            4677788888999999999999642  4999999999999998888999999988654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=98.56  E-value=3.3e-07  Score=48.58  Aligned_cols=55  Identities=35%  Similarity=0.543  Sum_probs=48.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus       102 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652         102 ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            4677778889999999999999874   999999999999998899999999987654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=98.56  E-value=1.2e-07  Score=56.23  Aligned_cols=62  Identities=26%  Similarity=0.461  Sum_probs=54.9

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ++..|+......++.|++.++.|+++.   +++|+++..+|++.......++.|||+++.+..+.
T Consensus       484 nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  484 NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            456788889999999999999999986   59999999999999999999999999999765443

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=98.55  E-value=8.2e-07  Score=48.40  Aligned_cols=57  Identities=40%  Similarity=0.608  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus       120 ~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         120 KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            45788889999999999999999874   9999999999999988999999999876443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=98.55  E-value=9.8e-07  Score=46.91  Aligned_cols=56  Identities=38%  Similarity=0.537  Sum_probs=49.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..   +++|+++++.++++..+..+++.|||.+...
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629         103 GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            3567788888899999999999987   4999999999999998899999999987644

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=98.55  E-value=3.7e-07  Score=49.32  Aligned_cols=57  Identities=28%  Similarity=0.500  Sum_probs=50.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.|+++..+..+++.|||.+....
T Consensus       110 ~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656         110 TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            45677888889999999999999874   9999999999999988999999999887554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=98.55  E-value=5.6e-07  Score=48.08  Aligned_cols=58  Identities=33%  Similarity=0.454  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+.....
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          95 GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            34778888899999999999999874   99999999999999999999999998776543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=98.55  E-value=4.8e-07  Score=47.90  Aligned_cols=56  Identities=38%  Similarity=0.633  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus       108 ~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608         108 KRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceec
Confidence            46788888899999999999999874   999999999999998889999999987654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=98.55  E-value=3.4e-07  Score=50.41  Aligned_cols=57  Identities=40%  Similarity=0.599  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..++++|||.+....
T Consensus       113 ~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851         113 QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            46788899999999999999999874   9999999999999998999999999887553

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=98.55  E-value=3.9e-07  Score=48.12  Aligned_cols=57  Identities=33%  Similarity=0.436  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.++|..+   ++|+++++.++++..+..+++.|||+++...
T Consensus        92 ~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          92 GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            35778888899999999999999874   9999999999999988899999999876543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=98.55  E-value=2.8e-07  Score=48.83  Aligned_cols=57  Identities=37%  Similarity=0.613  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.++...
T Consensus       101 ~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628         101 GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            35678888889999999999999874   9999999999999988999999999877554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=98.54  E-value=1e-06  Score=46.32  Aligned_cols=55  Identities=40%  Similarity=0.536  Sum_probs=48.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus        89 ~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~  143 (251)
T cd05041          89 RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREE  143 (251)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccc
Confidence            4677888889999999999999874   999999999999999899999999987644

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=98.54  E-value=4.5e-07  Score=47.73  Aligned_cols=55  Identities=40%  Similarity=0.612  Sum_probs=49.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||++...
T Consensus        89 ~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~  143 (265)
T cd05579          89 SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVG  143 (265)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence            5788888999999999999999874   999999999999999999999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=98.54  E-value=7.3e-07  Score=46.87  Aligned_cols=58  Identities=36%  Similarity=0.590  Sum_probs=51.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+....
T Consensus        93 ~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          93 NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            345788999999999999999999874   9999999999999988899999999877554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=98.54  E-value=3.6e-07  Score=48.43  Aligned_cols=55  Identities=35%  Similarity=0.553  Sum_probs=48.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+...++.|||+++..
T Consensus       102 ~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653         102 ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            4677888889999999999999874   999999999999998888999999988654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=98.54  E-value=5.5e-07  Score=48.52  Aligned_cols=58  Identities=34%  Similarity=0.459  Sum_probs=50.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..  .+++|+++++.++++..+..+++.|||.+..+.
T Consensus       109 ~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618         109 GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            3578888889999999999999963  149999999999999988999999999876543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=98.54  E-value=4.9e-07  Score=47.82  Aligned_cols=58  Identities=34%  Similarity=0.428  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..++......++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+.....
T Consensus        88 ~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          88 GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            45778888889999999999999874   99999999999999989999999998876543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=98.54  E-value=6.1e-07  Score=47.83  Aligned_cols=58  Identities=34%  Similarity=0.640  Sum_probs=51.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++..+..++++|||.+.....
T Consensus        95 ~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          95 VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            36788899999999999999999874   99999999999999999999999998876644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=98.54  E-value=5.6e-07  Score=47.45  Aligned_cols=57  Identities=33%  Similarity=0.532  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+....
T Consensus        96 ~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          96 GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence            46788888999999999999999874   9999999999999998999999999876543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=98.53  E-value=1.2e-06  Score=46.89  Aligned_cols=56  Identities=32%  Similarity=0.524  Sum_probs=49.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..  .+++|+++++.++++..+..+++.|||.+..+
T Consensus        98 ~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          98 GIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            678889999999999999999963  24999999999999999889999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=98.53  E-value=6e-07  Score=47.99  Aligned_cols=56  Identities=38%  Similarity=0.529  Sum_probs=48.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++......++.|||.+...
T Consensus       116 ~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636         116 NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            34677778888999999999999874   999999999999999889999999987644

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=98.53  E-value=4.3e-07  Score=47.62  Aligned_cols=55  Identities=22%  Similarity=0.250  Sum_probs=48.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++..+...++.|||.+...
T Consensus        81 ~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~  135 (237)
T cd05576          81 NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEV  135 (237)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcc
Confidence            4778888999999999999999874   999999999999999999999999865433

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=98.53  E-value=8.7e-07  Score=47.03  Aligned_cols=59  Identities=31%  Similarity=0.532  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.++|...  +++|+++++.++++.....++++|||.+.....
T Consensus       108 ~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  166 (269)
T cd08528         108 QRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP  166 (269)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecccceeeccc
Confidence            45788888999999999999999532  489999999999999999999999999876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=98.53  E-value=6.3e-07  Score=48.05  Aligned_cols=57  Identities=33%  Similarity=0.397  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..   +++|+++++.++++..+..+++.|||+++.+.
T Consensus       100 ~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583         100 EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            4577888888899999999999986   49999999999999988889999999887643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=98.53  E-value=9.8e-07  Score=46.49  Aligned_cols=57  Identities=32%  Similarity=0.538  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          95 GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            34778888899999999999999874   9999999999999988899999999887543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.53  E-value=2.2e-07  Score=54.22  Aligned_cols=59  Identities=39%  Similarity=0.613  Sum_probs=50.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ++..........|+..+++|+|..+   ++|++++.+|++++.+...+++|||++-++....
T Consensus       151 r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  151 RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc
Confidence            3444566677899999999999985   9999999999999999999999999998876543

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=98.53  E-value=8.9e-07  Score=48.09  Aligned_cols=59  Identities=37%  Similarity=0.569  Sum_probs=51.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +..+++.....++.+++.++.++|..+   ++|+++++.++++.....+++.|||.+.....
T Consensus       109 ~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634         109 KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            345788888889999999999999874   99999999999999888999999998876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=98.52  E-value=8.1e-07  Score=46.92  Aligned_cols=56  Identities=38%  Similarity=0.638  Sum_probs=49.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   +.|+++++.++++..+...++.|||++..+.
T Consensus        98 ~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          98 GLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            4788888899999999999999874   9999999999999988899999999876554

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=98.52  E-value=7.3e-07  Score=47.61  Aligned_cols=57  Identities=37%  Similarity=0.640  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus        94 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          94 RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            45788889999999999999999874   9999999999999998899999999877554

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=98.52  E-value=8.5e-07  Score=47.38  Aligned_cols=55  Identities=42%  Similarity=0.594  Sum_probs=47.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++....   .+++.|||.++..
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~  169 (277)
T cd05036         112 SLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI  169 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCcccccc
Confidence            5788899999999999999999874   99999999999997543   5799999988754

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=98.52  E-value=8.6e-07  Score=47.83  Aligned_cols=57  Identities=28%  Similarity=0.507  Sum_probs=49.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++..+..++++|||++....
T Consensus       110 ~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647         110 TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            35678888889999999999999874   9999999999999988899999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=98.52  E-value=9.9e-07  Score=46.23  Aligned_cols=57  Identities=28%  Similarity=0.525  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..   ++.|+++++.++++..+..+++.|||.+....
T Consensus        98 ~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          98 KPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            5678899999999999999999987   49999999999999988899999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=98.52  E-value=8e-07  Score=47.44  Aligned_cols=56  Identities=32%  Similarity=0.469  Sum_probs=49.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus        98 ~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          98 RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhh
Confidence            35788899999999999999999875   999999999999999999999999976543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=98.52  E-value=5.4e-07  Score=48.79  Aligned_cols=55  Identities=33%  Similarity=0.475  Sum_probs=48.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++.....+++.|||.++.
T Consensus        96 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          96 GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            34678888888999999999999874   99999999999999888999999998763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=98.52  E-value=6.6e-07  Score=48.07  Aligned_cols=56  Identities=27%  Similarity=0.548  Sum_probs=49.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.|+++..+..+++.|||.+...
T Consensus       110 ~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648         110 TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            35778888899999999999999874   999999999999999999999999976644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=98.51  E-value=8.3e-07  Score=47.94  Aligned_cols=57  Identities=28%  Similarity=0.538  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       111 ~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~  167 (292)
T cd06657         111 TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  167 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecc
Confidence            45788888899999999999999874   9999999999999988889999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=98.51  E-value=2.4e-07  Score=57.11  Aligned_cols=55  Identities=38%  Similarity=0.646  Sum_probs=50.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      ...|+...++.++.+++.|+.|++..   +++||++..+|+++......|+.|||+++
T Consensus       796 ~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  796 PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhH
Confidence            34578899999999999999999876   59999999999999999999999999998

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=98.51  E-value=1.3e-06  Score=47.48  Aligned_cols=57  Identities=35%  Similarity=0.509  Sum_probs=49.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..  .+++|+++++.|+++..+..+++.|||++...
T Consensus        94 ~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          94 GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            4567888889999999999999963  24999999999999998888999999987654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=98.51  E-value=6.5e-07  Score=55.01  Aligned_cols=54  Identities=31%  Similarity=0.418  Sum_probs=48.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      +++...+.++.+++.++.++|..+   ++|+++++.|+++......++.|||+++..
T Consensus       110 lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i  163 (932)
T PRK13184        110 TSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFK  163 (932)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceec
Confidence            456677888899999999999874   999999999999999899999999998866

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=98.51  E-value=6.8e-07  Score=47.73  Aligned_cols=56  Identities=36%  Similarity=0.630  Sum_probs=50.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          95 GALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            35789999999999999999999874   999999999999998889999999987644

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=98.50  E-value=1.1e-06  Score=46.10  Aligned_cols=58  Identities=33%  Similarity=0.519  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++.....+++.|||.+.....
T Consensus        94 ~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          94 GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            45788899999999999999999874   99999999999999888999999998876543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=98.50  E-value=5.5e-07  Score=49.60  Aligned_cols=55  Identities=36%  Similarity=0.575  Sum_probs=49.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..++++|||+++..
T Consensus       113 ~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879         113 PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            5778888889999999999999874   999999999999999999999999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02988 hypothetical protein; Provisional

Probab=98.50  E-value=4.7e-07  Score=48.73  Aligned_cols=58  Identities=19%  Similarity=0.336  Sum_probs=49.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|...  ..+|+++++.++++..+..+++.|||+++...
T Consensus       117 ~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        117 KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            45788888999999999999999742  36799999999999999999999999887543

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=98.50  E-value=1.1e-06  Score=46.85  Aligned_cols=56  Identities=43%  Similarity=0.698  Sum_probs=50.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+....
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          94 PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            5788899999999999999999874   9999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=98.50  E-value=9.8e-07  Score=46.99  Aligned_cols=57  Identities=40%  Similarity=0.621  Sum_probs=51.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.+++.++.++|..+   +.|+++++.++++..+...++.|||.+.....
T Consensus        94 ~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          94 KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            6788999999999999999999874   99999999999999999999999998876653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=98.50  E-value=8.5e-07  Score=46.70  Aligned_cols=61  Identities=33%  Similarity=0.512  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCC--CCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.++|..+  ..+++|+++++.++++..+..+++.|||.+.....
T Consensus       100 ~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217         100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            46788899999999999999999332  23599999999999999989999999998876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=98.50  E-value=9.9e-07  Score=47.12  Aligned_cols=57  Identities=39%  Similarity=0.600  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+..+++.|||++....
T Consensus        96 ~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          96 GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            45778888888999999999999874   9999999999999988899999999887654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=98.49  E-value=9.6e-07  Score=46.43  Aligned_cols=56  Identities=34%  Similarity=0.482  Sum_probs=49.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+....
T Consensus        98 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          98 SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            4778888889999999999999874   9999999999999999999999999877543

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=98.48  E-value=9.8e-07  Score=51.61  Aligned_cols=64  Identities=27%  Similarity=0.342  Sum_probs=49.2

Q ss_pred             HHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCCCcccceecC
Q 040677           10 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT   77 (77)
Q Consensus        10 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~g~   77 (77)
                      .+..+..|++.++..+|..+   ++|.++++.|+++- .+.++++|||.+..+..+.+.-.....+||
T Consensus       461 ~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT  524 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGT  524 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCc
Confidence            55667789999999999874   99999999998765 566899999999887766654333333444

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=98.48  E-value=5.7e-07  Score=48.20  Aligned_cols=58  Identities=38%  Similarity=0.495  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|...  +++|+++++.++++.....+++.|||++..+.
T Consensus       102 ~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616         102 SVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            45788888899999999999999642  49999999999999988899999999876543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=98.48  E-value=9.5e-07  Score=46.64  Aligned_cols=56  Identities=38%  Similarity=0.532  Sum_probs=49.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   +.|+++++.++++.....+++.|||.+....
T Consensus        95 ~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          95 ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            4678888888999999999999874   9999999999999999999999999876553

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=98.47  E-value=1.8e-06  Score=46.88  Aligned_cols=55  Identities=25%  Similarity=0.340  Sum_probs=48.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.+|+.+...
T Consensus        97 ~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          97 GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceee
Confidence            4677788888999999999999874   999999999999998889999999876544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=98.47  E-value=1e-06  Score=46.48  Aligned_cols=58  Identities=36%  Similarity=0.586  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..++......++.+++.++.++|. .   ++.|+++++.++++..+...++.|||.+.....
T Consensus        94 ~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          94 GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            457888889999999999999998 6   499999999999999999999999998876643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=98.47  E-value=9.1e-07  Score=48.47  Aligned_cols=57  Identities=35%  Similarity=0.551  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..++......++.+++.++.++|..+   ++|+++++.++++.....+++.|||.+....
T Consensus       114 ~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~  170 (335)
T PTZ00024        114 IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG  170 (335)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeecc
Confidence            35778888899999999999999874   9999999999999998999999999887654

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=98.47  E-value=1.4e-06  Score=46.69  Aligned_cols=55  Identities=25%  Similarity=0.370  Sum_probs=45.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-------CeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-------NPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-------~~~l~~~g~~~~   61 (77)
                      ..+++.....++.+++.++.|+|..   +++|+++++.|+++....       .+++.|||.+..
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~  173 (274)
T cd05076         112 GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT  173 (274)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCccccc
Confidence            4578888899999999999999987   499999999999986432       368899987653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=98.46  E-value=1e-06  Score=47.05  Aligned_cols=55  Identities=40%  Similarity=0.666  Sum_probs=49.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..   ++.|+++++.++++..+..+++.|||.+...
T Consensus        95 ~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          95 GLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            578999999999999999999987   4999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=98.46  E-value=1.8e-06  Score=45.47  Aligned_cols=56  Identities=30%  Similarity=0.537  Sum_probs=49.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..   +++|+++++.++++..+...++.|||.+....
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          97 LFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            467888889999999999999987   49999999999999988899999999887553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=98.46  E-value=1.2e-06  Score=46.79  Aligned_cols=58  Identities=41%  Similarity=0.614  Sum_probs=50.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +..+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||++....
T Consensus        95 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          95 PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            345788889999999999999999874   9999999999999988899999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=98.46  E-value=1.1e-06  Score=46.74  Aligned_cols=56  Identities=46%  Similarity=0.669  Sum_probs=50.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+....
T Consensus        98 ~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          98 SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            5788999999999999999999874   9999999999999988899999999887554

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=98.46  E-value=1.2e-06  Score=46.06  Aligned_cols=57  Identities=35%  Similarity=0.515  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++.....+++.|||.+....
T Consensus        98 ~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          98 KLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            45788888999999999999999874   9999999999999988889999999876553

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=98.45  E-value=1.7e-06  Score=47.15  Aligned_cols=56  Identities=39%  Similarity=0.595  Sum_probs=49.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      +..+++.....++.+++.++.|+|..+   ++|+++++.++++..+..+++.|||.+..
T Consensus       115 ~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~  170 (313)
T cd06633         115 KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK  170 (313)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcc
Confidence            345788888999999999999999874   99999999999999888999999987653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=98.45  E-value=1.9e-07  Score=55.67  Aligned_cols=63  Identities=27%  Similarity=0.479  Sum_probs=52.9

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCC
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS   67 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~   67 (77)
                      +.+.++.-.++..+.|+..++.|+...   .++|+++..+|++...+..+++.|||++++...+.-
T Consensus       358 nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  358 NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence            344555666777789999999999766   499999999999999999999999999998776653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.44  E-value=1.6e-06  Score=48.54  Aligned_cols=57  Identities=39%  Similarity=0.450  Sum_probs=50.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      +..|++.-...+...+..++.|+|.++   +++++++..|++++..+.+++.|+|+++.-
T Consensus       345 qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  345 QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            456777777778889999999999985   999999999999999999999999998754

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=98.44  E-value=2.9e-06  Score=44.49  Aligned_cols=57  Identities=37%  Similarity=0.518  Sum_probs=50.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.+++.++.++|..+   +.|.++++.++++......++.|||.+.....
T Consensus        89 ~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          89 RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            5788889999999999999999864   99999999999999988999999998765543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=98.44  E-value=9.7e-07  Score=47.15  Aligned_cols=56  Identities=41%  Similarity=0.481  Sum_probs=49.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.++++..+..++++|||.+....
T Consensus        91 ~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          91 GFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            5788888889999999999999874   9999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=98.43  E-value=8.6e-07  Score=46.96  Aligned_cols=56  Identities=34%  Similarity=0.460  Sum_probs=49.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+...
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          97 GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            45778888889999999999999874   999999999999998889999999987643

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=98.41  E-value=2.2e-06  Score=45.36  Aligned_cols=55  Identities=25%  Similarity=0.412  Sum_probs=46.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC--------eEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN--------PKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~--------~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.++++..+..        .++.|||.+...
T Consensus        96 ~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          96 LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            5788888899999999999999874   999999999999975543        588888876543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=98.41  E-value=1.8e-06  Score=45.61  Aligned_cols=56  Identities=36%  Similarity=0.508  Sum_probs=50.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .++......++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+....
T Consensus        96 ~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          96 KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            6788888899999999999999874   9999999999999999999999999876543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=98.41  E-value=1.4e-06  Score=46.14  Aligned_cols=57  Identities=39%  Similarity=0.589  Sum_probs=48.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-CeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-NPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.++++..+. .++++|||.+....
T Consensus        98 ~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          98 GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            45778888999999999999999874   99999999999997654 68999999876554

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>smart00090 RIO RIO-like kinase

Probab=98.41  E-value=2.3e-06  Score=45.39  Aligned_cols=55  Identities=16%  Similarity=0.270  Sum_probs=45.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +.......++.+++.++.++|..+  .++|+++++.|+++. ....++.|||.+....
T Consensus       145 ~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      145 PEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            444556678899999999999863  399999999999998 7788999999887544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.40  E-value=1.1e-06  Score=51.60  Aligned_cols=54  Identities=26%  Similarity=0.445  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE-cCCCCeEEecccceeeecCC
Q 040677            9 KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL-DHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         9 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .....++.+++.++.++|..+   ++|+++++.||++ .....+++.+||.++....+
T Consensus       415 ~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  415 SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            455568899999999999874   9999999999999 57788999999998876654

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=98.40  E-value=2.2e-06  Score=44.72  Aligned_cols=58  Identities=34%  Similarity=0.576  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..   ++.|+++++.++++..+..+++.|||.+.....
T Consensus        93 ~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          93 QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            3678889999999999999999986   499999999999999988999999998876543

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=98.40  E-value=1.9e-06  Score=45.14  Aligned_cols=58  Identities=36%  Similarity=0.575  Sum_probs=51.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .+++.....++.+++.++.++|..+   +.|+++++.++++..+..+++.|||.+......
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          97 KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            6788899999999999999999864   999999999999999899999999988766543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=98.39  E-value=1.7e-06  Score=46.43  Aligned_cols=56  Identities=38%  Similarity=0.573  Sum_probs=48.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..++......++.+++.++.|+|..+   ++|+++++.++++.....+++.|||++...
T Consensus       100 ~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621         100 GRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            34677788889999999999999874   999999999999998888999999987643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=98.39  E-value=2.6e-06  Score=46.66  Aligned_cols=51  Identities=24%  Similarity=0.376  Sum_probs=45.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccc
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM   58 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~   58 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+...++.+|+.
T Consensus        97 ~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~  147 (327)
T cd08227          97 GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS  147 (327)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccch
Confidence            4788889999999999999999874   99999999999998888888888764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=98.38  E-value=1.7e-06  Score=54.04  Aligned_cols=57  Identities=32%  Similarity=0.356  Sum_probs=48.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +++..-...|+..+..++.-+|.-   +++||++++.|++++..+.+++.|||.+--+..
T Consensus       171 ~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  171 RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            366666777888999999999975   599999999999999999999999998765543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=98.38  E-value=1.8e-06  Score=47.42  Aligned_cols=56  Identities=41%  Similarity=0.660  Sum_probs=48.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..++......++.+++.++.++|..+   ++|+++++.++++..+..+++.|||.+...
T Consensus       103 ~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856         103 RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            45677777788899999999999874   999999999999998889999999987644

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.38  E-value=1.8e-06  Score=52.25  Aligned_cols=54  Identities=41%  Similarity=0.588  Sum_probs=46.4

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeeec
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIFG   63 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~~   63 (77)
                      ++.+.-.+..|++.|+.|+|.+   .++|++++-.|+++.. .+.++++|||.++.+.
T Consensus       673 NEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA  727 (1226)
T KOG4279|consen  673 NESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA  727 (1226)
T ss_pred             chhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc
Confidence            4566677789999999999987   4999999999999975 5789999999988764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=98.38  E-value=2.4e-06  Score=44.84  Aligned_cols=49  Identities=29%  Similarity=0.392  Sum_probs=41.4

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEEccC-CCCcEEEcCCCCeEEecccceeeec
Q 040677           12 ISIINGIARGLLYLHEDSRLKIIHRDL-KASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        12 ~~~~~~~~~~l~~~~~~~~~~~~~~~l-~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+..++..++.++|..+   ++|+++ ++.|+++..+..++++|||++....
T Consensus        94 ~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             HHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            345678888999999875   999999 6899999888889999999997543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=98.37  E-value=4.1e-06  Score=51.11  Aligned_cols=60  Identities=37%  Similarity=0.569  Sum_probs=53.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..++.|.-+..+++.++.++.++|.+   .++|++++-.++++..++.+++.|||++..+...
T Consensus       117 g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen  117 GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST  176 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence            45678888888899999999999987   5999999999999999999999999998877543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=98.37  E-value=9.4e-07  Score=52.07  Aligned_cols=61  Identities=30%  Similarity=0.445  Sum_probs=53.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ++.+++.+...+..|++.++.++|..+   ++||+++-+|+..+.++..+++|||.+......+
T Consensus       664 kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgp  724 (772)
T KOG1152|consen  664 KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP  724 (772)
T ss_pred             cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCC
Confidence            456788899999999999999999885   9999999999999999999999999887654444

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=98.36  E-value=1.4e-06  Score=48.02  Aligned_cols=56  Identities=38%  Similarity=0.663  Sum_probs=48.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.++++.. +..+++.|||.+...
T Consensus       109 ~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~  165 (342)
T cd07854         109 GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIV  165 (342)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceec
Confidence            45788889999999999999999874   999999999999974 457899999988754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=98.36  E-value=3.6e-06  Score=44.50  Aligned_cols=56  Identities=34%  Similarity=0.540  Sum_probs=48.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   +.|+++++.++++.. ..+++.|||.+....
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222         101 KTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            45788889999999999999999874   999999999999865 458999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=98.35  E-value=5.1e-06  Score=44.73  Aligned_cols=54  Identities=37%  Similarity=0.642  Sum_probs=45.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeee
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIF   62 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~   62 (77)
                      +++.....++.+++.++.++|..+   ++|+++++.++++.. +..+++.|||.+...
T Consensus        99 ~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         99 KNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            466777788899999999999874   999999999999975 456899999988654

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=98.34  E-value=1.1e-06  Score=52.99  Aligned_cols=61  Identities=36%  Similarity=0.543  Sum_probs=52.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE   68 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~   68 (77)
                      .|.-..+..++.|++.++.|+..+   +++|+++..+|+++.....+|+.|||+.+-+..+++.
T Consensus       208 ~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  208 ILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             ceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            344566778899999999999876   5999999999999999999999999999988776643

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=98.34  E-value=3.5e-06  Score=45.17  Aligned_cols=55  Identities=33%  Similarity=0.630  Sum_probs=49.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   +.|.++++.++++..+..+++.||+.+...
T Consensus       112 ~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614         112 RMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            6788899999999999999999864   999999999999998889999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=1.6e-06  Score=49.24  Aligned_cols=66  Identities=36%  Similarity=0.567  Sum_probs=51.5

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCCCcccceecC
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT   77 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~g~   77 (77)
                      ++....-+++.++.++.|+|...   .+|+++++.++++...+..++.|||++..+.......  .+++||
T Consensus       109 ~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvGT  174 (467)
T KOG0201|consen  109 DEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFVGT  174 (467)
T ss_pred             ccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc--cccccc
Confidence            33344445788889999999874   8999999999999988999999999998776544333  346665

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=98.33  E-value=2.7e-06  Score=44.97  Aligned_cols=56  Identities=38%  Similarity=0.577  Sum_probs=49.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..++......++.+++.++.++|. .   +++|+++++.++++..+..+++.|||.+...
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          95 GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            456788888899999999999998 5   5999999999999999889999999987544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=98.32  E-value=2e-06  Score=46.85  Aligned_cols=52  Identities=27%  Similarity=0.508  Sum_probs=43.1

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC--CCCeEEecccceee
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH--EMNPKISDFGMARI   61 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~l~~~g~~~~   61 (77)
                      .+.....+..|+++++.|+|+..   ++|++++..|+++..  ...+++.|||..+-
T Consensus       119 gE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  119 GEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             cHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence            35566677899999999999875   999999999999853  35789999998764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=98.31  E-value=2.5e-06  Score=51.73  Aligned_cols=55  Identities=45%  Similarity=0.756  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-----CCeEEecccceeeecCCCCC
Q 040677           11 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-----MNPKISDFGMARIFGGNQSE   68 (77)
Q Consensus        11 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~l~~~g~~~~~~~~~~~   68 (77)
                      .+.++.|++.|+.++|..   +++||++++.|+++...     ....++|||+++.+..+++.
T Consensus       608 ~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  608 PISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             HHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence            355678899999999985   59999999999999752     45789999999988776643

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=98.30  E-value=7.1e-06  Score=43.61  Aligned_cols=53  Identities=40%  Similarity=0.621  Sum_probs=45.5

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeee
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIF   62 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~   62 (77)
                      +......++.+++.++.|+|..+   ++|+++++.++++.. ...+++.|||.+...
T Consensus       106 ~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624         106 NEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            66777778899999999999874   999999999999975 568999999987654

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=98.29  E-value=4.4e-06  Score=51.93  Aligned_cols=60  Identities=28%  Similarity=0.509  Sum_probs=48.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCC----CCeEEccCCCCcEEEcCC-----------------CCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSR----LKIIHRDLKASNVLLDHE-----------------MNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~----~~~~~~~l~~~~~~~~~~-----------------~~~~l~~~g~~~~~   62 (77)
                      ..+++..++.++.|++.++.|+|....    .+++|+++++.++++...                 ..+++.|||++..+
T Consensus       113 g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l  192 (1021)
T PTZ00266        113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI  192 (1021)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccc
Confidence            458889999999999999999997421    349999999999998532                 24799999988765


Q ss_pred             c
Q 040677           63 G   63 (77)
Q Consensus        63 ~   63 (77)
                      .
T Consensus       193 ~  193 (1021)
T PTZ00266        193 G  193 (1021)
T ss_pred             c
Confidence            3

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.29  E-value=2.6e-06  Score=48.82  Aligned_cols=51  Identities=45%  Similarity=0.610  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            8 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         8 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      +...+-++.+++.++.|+|..+   +++++++..|++++..+.+++.|||+++.
T Consensus       449 Ep~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  449 EPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             CchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence            4455667888999999999875   99999999999999999999999999864

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=98.29  E-value=3.4e-07  Score=50.43  Aligned_cols=59  Identities=37%  Similarity=0.591  Sum_probs=52.8

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ++..|++.++-.++...+.|++|+|.-   +-+|++++.-++++...+..++.|||++..+.
T Consensus       122 R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  122 RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence            567888999999999999999999964   47999999999999999999999999998765

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=98.28  E-value=7.8e-06  Score=43.92  Aligned_cols=56  Identities=36%  Similarity=0.468  Sum_probs=49.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      .-+++...+.++.+++.|+.++|... .++.|+++++.|+++.......+.|||.+.
T Consensus       122 ~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen  122 NFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             CccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            35788899999999999999999874 479999999999999998999999999754

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=98.27  E-value=2.7e-06  Score=52.06  Aligned_cols=62  Identities=32%  Similarity=0.592  Sum_probs=54.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS   67 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~   67 (77)
                      +..+..+..+.+..|++.|+.|++..   +++|+++-.+|++.......++.|||+++.+..+..
T Consensus       792 r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  792 RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            34566788899999999999999976   599999999999999999999999999998866543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.26  E-value=3.2e-06  Score=49.64  Aligned_cols=58  Identities=28%  Similarity=0.410  Sum_probs=48.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeeecCCC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~~~~~   66 (77)
                      +++.....+..|++.++.|+|+-   .++|++++++|+.+.. -+.+++.|||++.-+...+
T Consensus       115 l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen  115 LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            56677888999999999999975   5999999999998764 4789999999987665544

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=98.25  E-value=7e-06  Score=43.20  Aligned_cols=56  Identities=32%  Similarity=0.545  Sum_probs=47.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-CeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-NPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|...   +.|+++++.++++..+. ..++.|||.+....
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          97 LFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            4688889999999999999999874   99999999999998764 46899999876554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=98.24  E-value=8.3e-06  Score=42.90  Aligned_cols=56  Identities=39%  Similarity=0.589  Sum_probs=47.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   +.|+++++.++++... ..+++.|||.+....
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          97 LLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            4788888999999999999999874   9999999999999754 457999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=98.24  E-value=9.2e-06  Score=47.10  Aligned_cols=60  Identities=40%  Similarity=0.533  Sum_probs=50.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~~~   65 (77)
                      .+++.+...++.|+..++.|+... +.+++|-++++.++++..   .+.+++.|||++++...+
T Consensus       564 lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd  626 (775)
T KOG1151|consen  564 LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD  626 (775)
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence            457888888999999999999875 579999999999999864   357899999999977544

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=98.21  E-value=6.9e-06  Score=45.03  Aligned_cols=51  Identities=31%  Similarity=0.457  Sum_probs=44.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccc
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM   58 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~   58 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++......++.+|+.
T Consensus        97 ~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~  147 (328)
T cd08226          97 GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSH  147 (328)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHH
Confidence            4677888889999999999999874   99999999999999888888888753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=98.17  E-value=8.8e-06  Score=43.65  Aligned_cols=57  Identities=30%  Similarity=0.448  Sum_probs=48.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..  .+++|+++++.++++..+..+++.|||++...
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          98 GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            3567888888999999999999963  24999999999999998889999999987644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=98.15  E-value=1.4e-05  Score=50.81  Aligned_cols=56  Identities=39%  Similarity=0.530  Sum_probs=47.5

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ++....-+..|++.|+.|+|..+   ++|+++++.++++..++.+|..|||.+..+..+
T Consensus      1332 dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1332 DEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             hhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            34444556788999999999885   999999999999999999999999999876554

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.14  E-value=1.4e-05  Score=41.08  Aligned_cols=50  Identities=22%  Similarity=0.274  Sum_probs=42.2

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677           11 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        11 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...++.+++.++.++|..   +++|+++++.|+++..+..+++.|||.+..+.
T Consensus       127 ~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         127 PEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             HHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            345667888889999986   49999999999999988899999999886554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=98.13  E-value=5.4e-07  Score=48.80  Aligned_cols=59  Identities=37%  Similarity=0.503  Sum_probs=45.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +..++++.+-.+......++.|+-..  ..++|++++++|++++..+.+++.|||.+..+-
T Consensus       161 ~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  161 KSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             hccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            34455555555555566788888653  479999999999999999999999999876543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=98.12  E-value=3.7e-05  Score=38.83  Aligned_cols=57  Identities=40%  Similarity=0.703  Sum_probs=49.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.+++.++.++|..+   +.|.++.+.++++.. ....++.||+.+.....
T Consensus        88 ~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~  145 (215)
T cd00180          88 KLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTS  145 (215)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence            5778888899999999999999874   999999999999998 78899999998876543

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=98.12  E-value=2.1e-05  Score=40.76  Aligned_cols=56  Identities=41%  Similarity=0.596  Sum_probs=50.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +++.....++.+++.++.++|..   ++.|.++.+.++++..+...++.|||.+.....
T Consensus        84 ~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~  139 (244)
T smart00220       84 LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDP  139 (244)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence            67888889999999999999987   499999999999999889999999998876654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.07  E-value=1.3e-05  Score=42.66  Aligned_cols=46  Identities=26%  Similarity=0.384  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677           15 INGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        15 ~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       148 ~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        148 WQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             HHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence            467788899999875   9999999999999887789999999887644

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.02  E-value=7.8e-05  Score=37.38  Aligned_cols=50  Identities=22%  Similarity=0.179  Sum_probs=41.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +..+++..+..++.+++.++.|+|..+         ++.|+++..+..+++  ||.+....
T Consensus        11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750       11 GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeec
Confidence            456899999999999999999999863         788999888877777  88877654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=98.02  E-value=5e-05  Score=39.08  Aligned_cols=57  Identities=37%  Similarity=0.531  Sum_probs=50.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      +++.....++.+++.++.++|..   ++.|.++++.++++......++.|||.+......
T Consensus        95 ~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       95 LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            67788888899999999999987   4999999999999998899999999988776543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=98.00  E-value=1.9e-05  Score=47.03  Aligned_cols=51  Identities=43%  Similarity=0.659  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677           10 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        10 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+.++.|++.++.|+.+.   .++|+++.++|++.+.+...|+.|||+++.+=
T Consensus       638 ~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  638 PGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             hhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            3456889999999999765   49999999999999999999999999998553

>cd05119 RIO RIO kinase family, catalytic domain

Probab=97.98  E-value=3.1e-05  Score=39.32  Aligned_cols=52  Identities=21%  Similarity=0.207  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHHHhhh-CCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            9 KRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         9 ~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .....++.+++.++.++|. .   +++|+++++.|+++. +..+++.|||.+.....
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         114 EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence            3456677888999999997 5   499999999999999 78889999999876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK14879 serine/threonine protein kinase; Provisional

Probab=97.90  E-value=6.3e-05  Score=38.86  Aligned_cols=48  Identities=33%  Similarity=0.485  Sum_probs=40.8

Q ss_pred             HHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677           10 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus        10 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ....++.+++.++.++|..+   ++|+++.+.|+++. ...+.+.|||.+..
T Consensus        96 ~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         96 EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            34567788888999999874   99999999999998 67788999998765

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=97.90  E-value=3.3e-05  Score=45.29  Aligned_cols=49  Identities=22%  Similarity=0.427  Sum_probs=41.7

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677           11 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        11 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...++.+++.++.++|..+   ++|+++++.|+++ .+...++.|||+++...
T Consensus       430 ~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             HHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            4556788999999999874   9999999999999 56778999999987644

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=97.89  E-value=3.7e-05  Score=43.64  Aligned_cols=54  Identities=30%  Similarity=0.497  Sum_probs=46.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARI   61 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~   61 (77)
                      .++......+++.+..++.++|.++   ++|+++++.|+++... ..-.+.|||++..
T Consensus       128 ~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  128 SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence            3567778888999999999999875   9999999999999754 6678999999874

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=97.86  E-value=0.00011  Score=41.20  Aligned_cols=56  Identities=30%  Similarity=0.488  Sum_probs=44.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC---CCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~l~~~g~~~~~   62 (77)
                      ..+++.+.-.+...++.++.|+|..+   +.|++++++|++-...   .-+++.||-++...
T Consensus       171 ~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  171 KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence            34677777788889999999999875   9999999999988543   24688888665433

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=97.85  E-value=0.00023  Score=40.40  Aligned_cols=60  Identities=23%  Similarity=0.342  Sum_probs=47.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC--------------------CCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH--------------------EMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~--------------------~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+..+..|++.++.|+|..   +++|.+++++|+++..                    +..+++.|||.+.+-.
T Consensus       187 ~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~  263 (415)
T KOG0671|consen  187 IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH  263 (415)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec
Confidence            4577888889999999999999986   5999999999998732                    1235889999887655


Q ss_pred             CCC
Q 040677           64 GNQ   66 (77)
Q Consensus        64 ~~~   66 (77)
                      +.+
T Consensus       264 e~h  266 (415)
T KOG0671|consen  264 EHH  266 (415)
T ss_pred             cCc
Confidence            444

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=97.83  E-value=9.5e-05  Score=37.91  Aligned_cols=46  Identities=28%  Similarity=0.504  Sum_probs=39.9

Q ss_pred             HHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677           13 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus        13 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .++.+++.++.++|..+   ++|+++++.|+++. ...+.+.|||.+...
T Consensus        94 ~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        94 ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            56788889999999874   99999999999998 778899999987754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=97.77  E-value=0.00027  Score=34.08  Aligned_cols=54  Identities=28%  Similarity=0.288  Sum_probs=43.7

Q ss_pred             HHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            9 KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         9 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .....+..+++..+..+|.....+++|+++++.|+++......++.||+.+...
T Consensus        86 ~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             HHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            455666788888899999753346999999999999988788999999987643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=97.73  E-value=0.00039  Score=37.10  Aligned_cols=57  Identities=39%  Similarity=0.630  Sum_probs=49.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-CeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-NPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~l~~~g~~~~~~~   64 (77)
                      .++......+..+++.++.++|..+   ++|+++++.++++.... ..++.|||.++.+..
T Consensus        97 ~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          97 PLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            5677788889999999999999875   99999999999999877 699999999875544

>PRK10345 hypothetical protein; Provisional

Probab=97.64  E-value=0.00028  Score=37.07  Aligned_cols=45  Identities=24%  Similarity=0.473  Sum_probs=34.4

Q ss_pred             HHHHHHHHHH-HHhhhCCCCCeEEccCCCCcEEEcCC----CCeEEec-cccee
Q 040677           13 SIINGIARGL-LYLHEDSRLKIIHRDLKASNVLLDHE----MNPKISD-FGMAR   60 (77)
Q Consensus        13 ~~~~~~~~~l-~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~l~~-~g~~~   60 (77)
                      ..+.+++.++ .|+|...   ++|+++++.|+++...    ..+++.| ||...
T Consensus       108 ~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~  158 (210)
T PRK10345        108 AQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGEST  158 (210)
T ss_pred             HHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence            3456777677 8999874   9999999999999642    3689999 45443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=97.62  E-value=0.00052  Score=41.17  Aligned_cols=56  Identities=36%  Similarity=0.514  Sum_probs=47.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+.....--+..|+..|+.|+|..+   +.|++++..++++.....+++.|||.+..+.
T Consensus       416 ~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  416 KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence            4555666667889999999999875   9999999999999999999999999876553

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=97.60  E-value=0.0005  Score=42.83  Aligned_cols=49  Identities=29%  Similarity=0.599  Sum_probs=41.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEE
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKI   53 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l   53 (77)
                      .++|.....++.+++.++.|+|.....+++|+++++.+++++.....++
T Consensus       776 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        776 NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence            3688999999999999999999654457999999999999987665544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=97.54  E-value=0.00028  Score=37.61  Aligned_cols=46  Identities=17%  Similarity=0.260  Sum_probs=38.5

Q ss_pred             HHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677           14 IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        14 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...++..++..+|..+   ++|+++++.|+++..+. +.+.|||......
T Consensus       140 ~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~  185 (232)
T PRK10359        140 VKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA  185 (232)
T ss_pred             HHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCccccc
Confidence            3457788899999875   99999999999998777 9999998776553

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.53  E-value=0.00026  Score=41.47  Aligned_cols=42  Identities=40%  Similarity=0.508  Sum_probs=36.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE   48 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~   48 (77)
                      =++...+..++.|++.|+.|+|..+  +++|.+++++|+++..+
T Consensus       183 Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  183 GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence            3567788889999999999999875  79999999999998654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=97.39  E-value=0.00094  Score=42.04  Aligned_cols=54  Identities=28%  Similarity=0.269  Sum_probs=44.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-------CCCeEEeccccee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-------EMNPKISDFGMAR   60 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-------~~~~~l~~~g~~~   60 (77)
                      ..++|-..+.+..+++.-+..+|...   ++|.++++.++++..       ...++++|||.+-
T Consensus       789 ~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  789 KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            34677788888999999999999874   999999999999843       3468999999764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=97.35  E-value=0.001  Score=39.67  Aligned_cols=56  Identities=27%  Similarity=0.361  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeecCCC
Q 040677            8 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         8 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~~~~   66 (77)
                      ...+..|+.|+..++.++-.++   ++|.++++.|++.... ..+++.|||.|....+++
T Consensus       535 ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene  591 (752)
T KOG0670|consen  535 IKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENE  591 (752)
T ss_pred             ehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccccccccc
Confidence            3455667888888999887764   9999999999999754 678999999998776655

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=97.31  E-value=0.0011  Score=38.51  Aligned_cols=51  Identities=27%  Similarity=0.524  Sum_probs=40.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC----CCeEEecccce
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE----MNPKISDFGMA   59 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~l~~~g~~   59 (77)
                      .+.....-++.|+++++.|+|..+   +.|+++++.|+++..+    -.+-++|||.+
T Consensus       338 ~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  338 RSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             CchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccccee
Confidence            445556667899999999999874   9999999999998532    24678899865

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=97.24  E-value=0.00087  Score=38.70  Aligned_cols=55  Identities=22%  Similarity=0.427  Sum_probs=46.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .++-.+.+..+.|++.++.|+|..+   ++|+++..+|..++.....++.|-.++|.+
T Consensus       392 tvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDL  446 (563)
T KOG1024|consen  392 TVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDL  446 (563)
T ss_pred             chhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcccc
Confidence            3455567778899999999999874   999999999999999888899997777643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=97.21  E-value=0.0023  Score=33.43  Aligned_cols=53  Identities=17%  Similarity=0.093  Sum_probs=38.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHh-hhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            6 LDWKRRISIINGIARGLLYL-HEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ++......+..++...+..+ |..   +++|.++.+.|+++.. ..+.++||+-+-..
T Consensus       121 ~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         121 LNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence            33334455567788788777 665   4999999999999964 56789999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.00  E-value=0.0011  Score=40.36  Aligned_cols=56  Identities=34%  Similarity=0.534  Sum_probs=47.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +|+..++-..++..+.++.|+|..+   =+||+++-.++++...+..++.|||.+..+.
T Consensus       108 plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen  108 PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh
Confidence            4566777777888999999999874   6899999999999999999999999876543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=96.98  E-value=0.01  Score=32.88  Aligned_cols=47  Identities=30%  Similarity=0.446  Sum_probs=34.8

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677           11 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus        11 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      .+.+..|+...+.++|..+   ++|.++++.++++..++...+.+|+...
T Consensus       147 rl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~  193 (288)
T PF14531_consen  147 RLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLV  193 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred             HHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHe
Confidence            3445577788889999875   9999999999999999999999997654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=96.82  E-value=0.0082  Score=31.37  Aligned_cols=54  Identities=30%  Similarity=0.402  Sum_probs=43.0

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeeec
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIFG   63 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~~   63 (77)
                      +......++.+++..+.-+|..+   +.|.++.+.|+++....   .+.++||..++...
T Consensus       116 ~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  116 DPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             chhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            34455666777888888999875   99999999999998776   78899998776543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=96.82  E-value=0.0064  Score=31.84  Aligned_cols=48  Identities=27%  Similarity=0.446  Sum_probs=36.3

Q ss_pred             HHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677           13 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus        13 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .++..+-.-+.-+|..+   ++|.++...|+.+.... +.++|||++.+-..
T Consensus        96 ~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~  143 (204)
T COG3642          96 DLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE  143 (204)
T ss_pred             HHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccccc
Confidence            34455555577788875   99999999999887655 77899999975443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=96.80  E-value=0.0085  Score=29.85  Aligned_cols=47  Identities=32%  Similarity=0.355  Sum_probs=36.3

Q ss_pred             HHHHHHHHHHHhhhCC--CCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677           14 IINGIARGLLYLHEDS--RLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus        14 ~~~~~~~~l~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ...+++..+..+|...  ...++|.++++.|+++. +..+.+.||+.+..
T Consensus        88 ~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          88 NLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            4567777888899764  22369999999999998 55688999988764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=96.70  E-value=0.012  Score=32.14  Aligned_cols=50  Identities=24%  Similarity=0.338  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-------CCCeEEecccceee
Q 040677            9 KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-------EMNPKISDFGMARI   61 (77)
Q Consensus         9 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-------~~~~~l~~~g~~~~   61 (77)
                      .....++.+++..+.-+|..+   +.|.++.+.|+++..       ...+.++||+.+..
T Consensus       138 ~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        138 RLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            345566777888888999875   999999999999974       35678999987753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=96.21  E-value=0.016  Score=34.28  Aligned_cols=59  Identities=36%  Similarity=0.595  Sum_probs=50.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....+...++.|+.|+|...  ...|..+...+.+.+....+++++||+.....
T Consensus        42 ~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   42 DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeeeEEEEechhhhccccc
Confidence            456788888888999999999999863  34899999999999999999999999887653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=96.19  E-value=0.044  Score=32.03  Aligned_cols=40  Identities=23%  Similarity=0.330  Sum_probs=33.3

Q ss_pred             HHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677           22 LLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus        22 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +..+|..   +++|+++++.|+++..+..+.+.|||++..+..
T Consensus       270 l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       270 LNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            4556655   499999999999998888999999999887653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=95.85  E-value=0.11  Score=31.62  Aligned_cols=61  Identities=16%  Similarity=0.296  Sum_probs=49.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      +..+++..+|.++.|+..++..+|..+   ..-+.+....++...+..++++..|....+.+++
T Consensus       387 ~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  387 NLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence            345678899999999999999999875   6668888889888877788888888777666555

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=95.42  E-value=0.13  Score=27.31  Aligned_cols=48  Identities=33%  Similarity=0.559  Sum_probs=35.8

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeee
Q 040677           12 ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIF   62 (77)
Q Consensus        12 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~   62 (77)
                      ..++..+-..+.-+|.+.   ++|.++..+|+++..+.   ...+.|||++..-
T Consensus       116 ~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            344555666678899874   99999999999986543   3478999987643

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=95.39  E-value=0.034  Score=36.35  Aligned_cols=47  Identities=21%  Similarity=0.248  Sum_probs=39.8

Q ss_pred             HHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccce
Q 040677           10 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA   59 (77)
Q Consensus        10 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~   59 (77)
                      +..=++.|++.++.-+|..+   +.|.+++.+|+++..=.++.++||+..
T Consensus       121 EKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsF  167 (1431)
T KOG1240|consen  121 EKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASF  167 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhccccc
Confidence            34446789999999999874   999999999999998889999999643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=95.14  E-value=0.063  Score=30.89  Aligned_cols=48  Identities=29%  Similarity=0.303  Sum_probs=38.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEE
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKI   53 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l   53 (77)
                      .+......+++.|+.+++.|+|++ ..+++|.++....+++..+..+++
T Consensus       172 a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIki  219 (458)
T KOG1266|consen  172 ALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKI  219 (458)
T ss_pred             hhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEe
Confidence            445556677889999999999997 468999999988888876665554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=94.90  E-value=0.013  Score=35.36  Aligned_cols=55  Identities=33%  Similarity=0.280  Sum_probs=45.1

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ++.....+....+.++.+.|..+   +++++++..++++...+.+++.|||+++....
T Consensus        95 ~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   95 DELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             HHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh
Confidence            44555556677788899998764   99999999999999999999999999886643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=94.08  E-value=0.42  Score=24.96  Aligned_cols=46  Identities=33%  Similarity=0.494  Sum_probs=30.3

Q ss_pred             HHHHHHHHHHH-hhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677           14 IINGIARGLLY-LHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        14 ~~~~~~~~l~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +..++...+.. +|..   +++|.++...|+++..+ .+.++||+-+....
T Consensus       111 ~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  111 LLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            34455543444 4454   59999999999999877 88999998775443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=94.05  E-value=0.4  Score=25.75  Aligned_cols=51  Identities=14%  Similarity=0.152  Sum_probs=38.6

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC--eEEeccccee
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN--PKISDFGMAR   60 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~l~~~g~~~   60 (77)
                      +......++..++..+.-+|..+   +.|.++-+.+|+++....  +.++||-.++
T Consensus       126 ~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        126 SDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             chHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            34444567778888899999875   999999999999974444  7888875443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=93.85  E-value=0.049  Score=35.34  Aligned_cols=40  Identities=38%  Similarity=0.659  Sum_probs=35.0

Q ss_pred             HHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677           19 ARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus        19 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      +.+++|+|..+   +.|+++++.+.++...+..++.|||+++.
T Consensus       153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence            45799999874   99999999999999999999999998763

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=93.49  E-value=0.57  Score=24.43  Aligned_cols=53  Identities=17%  Similarity=0.137  Sum_probs=43.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccc
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM   58 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~   58 (77)
                      -+|..+..++.+++..+.++.......+...++++.++.+..+..+++.|...
T Consensus        56 ~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~  108 (188)
T PF12260_consen   56 SPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDD  108 (188)
T ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechh
Confidence            47999999999999988888765434577788999999988888888888653

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=92.14  E-value=0.2  Score=30.36  Aligned_cols=33  Identities=18%  Similarity=0.365  Sum_probs=28.7

Q ss_pred             CeEEccCCCCcEEEcCCC----CeEEecccceeeecC
Q 040677           32 KIIHRDLKASNVLLDHEM----NPKISDFGMARIFGG   64 (77)
Q Consensus        32 ~~~~~~l~~~~~~~~~~~----~~~l~~~g~~~~~~~   64 (77)
                      ++.|.+.++.|+++..+.    .+.+.|||+...+.+
T Consensus       280 GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        280 GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            599999999999998776    789999999887654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=91.54  E-value=0.082  Score=31.61  Aligned_cols=54  Identities=31%  Similarity=0.527  Sum_probs=40.9

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ++.....+..|+..++.|   +   +.+|+++++.++++..+...++.|||+.-......
T Consensus       357 s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~  410 (516)
T KOG1033|consen  357 SLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDE  410 (516)
T ss_pred             chhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhheeecccCC
Confidence            455566667777777777   2   48999999999999888888999999875554433

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=90.23  E-value=2.1  Score=25.57  Aligned_cols=52  Identities=27%  Similarity=0.404  Sum_probs=39.1

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      .|.+.+.++++.+.-+.-+..  +.++-|+++..-+++++ ++.+.++||.++|.
T Consensus       319 ~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         319 RSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             cHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence            467777777766553333332  45789999999999999 88889999998883

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=89.98  E-value=0.12  Score=31.57  Aligned_cols=53  Identities=40%  Similarity=0.645  Sum_probs=42.6

Q ss_pred             HHHHHHHHHHHHHHHHhh-hCCCCCeEEccCCCCcEEEcCCC-CeEEecccceeeecC
Q 040677            9 KRRISIINGIARGLLYLH-EDSRLKIIHRDLKASNVLLDHEM-NPKISDFGMARIFGG   64 (77)
Q Consensus         9 ~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~l~~~~~~~~~~~-~~~l~~~g~~~~~~~   64 (77)
                      ...-.+..+...++.|.| ..   .+.|+++++.+.++.... ..+..||+++..+..
T Consensus       123 ~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  123 SSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            344556788888999999 55   489999999998888777 889999998876654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=89.71  E-value=1.3  Score=27.77  Aligned_cols=43  Identities=16%  Similarity=0.373  Sum_probs=36.2

Q ss_pred             HHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccce
Q 040677           15 INGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA   59 (77)
Q Consensus        15 ~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~   59 (77)
                      +.|++.++.|+|..+  .+.|.++...++++...+..++.+|-+.
T Consensus       110 l~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v  152 (690)
T KOG1243|consen  110 LFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELV  152 (690)
T ss_pred             HHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence            578899999998654  6999999999999999888888877544

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=89.12  E-value=0.45  Score=29.74  Aligned_cols=43  Identities=21%  Similarity=0.551  Sum_probs=36.0

Q ss_pred             HHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677           16 NGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus        16 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      .+++.|+.|+|...  +++|.++.+..+....+...++..|+++-
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v  148 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCV  148 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhh
Confidence            44557889999875  69999999999999999999999887654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=88.83  E-value=2.6  Score=23.91  Aligned_cols=41  Identities=22%  Similarity=0.324  Sum_probs=29.7

Q ss_pred             HHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccc
Q 040677           14 IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG   57 (77)
Q Consensus        14 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g   57 (77)
                      ++..++..+.-....   +++|.+++.-|++...++...++||-
T Consensus       207 il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwP  247 (304)
T COG0478         207 ILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWP  247 (304)
T ss_pred             HHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCc
Confidence            334444444433333   49999999999999999899999973

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=87.01  E-value=0.75  Score=27.96  Aligned_cols=55  Identities=24%  Similarity=0.381  Sum_probs=42.0

Q ss_pred             CHHHHHHHHHHHHH----HHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeecC
Q 040677            7 DWKRRISIINGIAR----GLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGG   64 (77)
Q Consensus         7 ~~~~~~~~~~~~~~----~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~~   64 (77)
                      +...++........    ++.+.|...   +.|.++++.+++...+ ..+++.+|+....+..
T Consensus       216 p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~  275 (524)
T KOG0601|consen  216 PDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISD  275 (524)
T ss_pred             CchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccC
Confidence            34445555555555    899999875   9999999999999888 7888999987765543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=86.63  E-value=4.7  Score=24.69  Aligned_cols=48  Identities=17%  Similarity=0.361  Sum_probs=39.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISD   55 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~   55 (77)
                      ..+|...+...+.++.+...+|..+   ....++...+++........+.|
T Consensus       113 ~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248         113 HCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence            3579999999999999999999875   77888999999988777666655

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=85.99  E-value=4  Score=22.31  Aligned_cols=41  Identities=24%  Similarity=0.312  Sum_probs=31.4

Q ss_pred             HHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677           16 NGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus        16 ~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      -.+...+.-+|..+   +.|.+..+.|+++..+. +.+.|++..+
T Consensus       142 ~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  142 EKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcccc
Confidence            34556688889875   99999999998887544 7788886554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=85.97  E-value=4.4  Score=22.70  Aligned_cols=48  Identities=21%  Similarity=0.328  Sum_probs=33.0

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677           11 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus        11 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ...+.-++...+.-+...+  +.+|.+++.-|++.. ...+.++|++-+-.
T Consensus       168 ~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         168 AEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             HHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECccccc
Confidence            3444445555555454422  599999999999999 77788899876543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=84.49  E-value=2  Score=22.88  Aligned_cols=30  Identities=27%  Similarity=0.367  Sum_probs=24.6

Q ss_pred             CCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677           31 LKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus        31 ~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      ..++|.++.+.|+++.......+.||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            358999999999999876666789998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=84.42  E-value=1.9  Score=22.27  Aligned_cols=31  Identities=23%  Similarity=0.392  Sum_probs=25.0

Q ss_pred             CCeEEccCCCCcEEEcC--CCCeEEecccceee
Q 040677           31 LKIIHRDLKASNVLLDH--EMNPKISDFGMARI   61 (77)
Q Consensus        31 ~~~~~~~l~~~~~~~~~--~~~~~l~~~g~~~~   61 (77)
                      ..++|.++.+.|+++..  .....+.||..+..
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            46899999999999987  45578899877653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=81.03  E-value=2.5  Score=22.57  Aligned_cols=31  Identities=23%  Similarity=0.329  Sum_probs=25.6

Q ss_pred             CCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677           31 LKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus        31 ~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..++|.++.+.|+++.......+.||..+..
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            3589999999999998876678999977653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK05231 homoserine kinase; Provisional

Probab=80.84  E-value=2.1  Score=23.90  Aligned_cols=30  Identities=33%  Similarity=0.390  Sum_probs=24.6

Q ss_pred             CCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677           31 LKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus        31 ~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      ..++|.++.+.|+++..+....+.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            369999999999999876666899987653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	77
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-12
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-10
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-10
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-07
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-06
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-06
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-06
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-06
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-05
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-05
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-05
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-04
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-04
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-04
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-04
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-04
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-04
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-04
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-04
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-04
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-04
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 30/56 (53%), Positives = 39/56 (69%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           LDW +R  I  G ARGL YLH+    KIIHRD+KA+N+LLD E    + DFG+A++
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 30/56 (53%), Positives = 39/56 (69%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           LDW +R  I  G ARGL YLH+    KIIHRD+KA+N+LLD E    + DFG+A++
Sbjct: 136 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 191

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 32/72 (44%), Positives = 41/72 (56%), Gaps = 3/72 (4%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR     
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 66  QSEANTNRIVGT 77
                 +RIVGT
Sbjct: 178 AQXVXXSRIVGT 189

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 32/72 (44%), Positives = 41/72 (56%), Gaps = 3/72 (4%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 66  QSEANTNRIVGT 77
                 +RIVGT
Sbjct: 187 AQTVMXSRIVGT 198

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 32/72 (44%), Positives = 40/72 (55%), Gaps = 3/72 (4%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR     
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 66  QSEANTNRIVGT 77
                  RIVGT
Sbjct: 181 AQXVMXXRIVGT 192

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 32/72 (44%), Positives = 40/72 (55%), Gaps = 3/72 (4%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 66  QSEANTNRIVGT 77
                  RIVGT
Sbjct: 187 AQTVMXXRIVGT 198

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 42/60 (70%), Gaps = 3/60 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + ++ + W++R+ I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 42/60 (70%), Gaps = 3/60 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + ++ + W++R+ I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 7/84 (8%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED-------SRLKIIHRDLKASNVLLDHEMNPKI 53
           +++  + W     I   +ARGL YLHED        +  I HRD+K+ NVLL + +   I
Sbjct: 113 LKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172
Query: 54  SDFGMARIFGGNQSEANTNRIVGT 77
           +DFG+A  F   +S  +T+  VGT
Sbjct: 173 ADFGLALKFEAGKSAGDTHGQVGT 196

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 25/57 (43%), Positives = 41/57 (71%), Gaps = 1/57 (1%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           QLD +RR+S+   +A+G+ YLH +    I+HRDLK+ N+L+D +   K+ DFG++R+
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 28/71 (39%), Positives = 47/71 (66%), Gaps = 5/71 (7%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI--- 61
           QLD +RR+S+   +A+G+ YLH +    I+HR+LK+ N+L+D +   K+ DFG++R+   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 62  -FGGNQSEANT 71
            F  ++S A T
Sbjct: 192 TFLSSKSAAGT 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 24/55 (43%), Positives = 38/55 (69%), Gaps = 3/55 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           IA+G++YL E    +++HRDL A NVL+    + KI+DFG+AR+  G++ E N +
Sbjct: 149 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 200

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 24/55 (43%), Positives = 38/55 (69%), Gaps = 3/55 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           IA+G++YL E    +++HRDL A NVL+    + KI+DFG+AR+  G++ E N +
Sbjct: 126 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 177

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           G++YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N++ GT
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 24/57 (42%), Positives = 34/57 (59%), Gaps = 3/57 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           Q  W +R+S    IA G+ YLH    + IIHRDL + N L+    N  ++DFG+AR+
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARL 157

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 27/80 (33%), Positives = 41/80 (51%), Gaps = 8/80 (10%)
Query: 6   LDWKRRISIINGIARGLLYLHED--------SRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + W     +   ++RGL YLHED         +  I HRD K+ NVLL  ++   ++DFG
Sbjct: 109 ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFG 168
Query: 58  MARIFGGNQSEANTNRIVGT 77
           +A  F   +   +T+  VGT
Sbjct: 169 LAVRFEPGKPPGDTHGQVGT 188

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 24/62 (38%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG+AR+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT 206
Query: 72  NR 73
            R
Sbjct: 207 TR 208

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 30/72 (41%), Positives = 42/72 (58%), Gaps = 5/72 (6%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DFG+A      
Sbjct: 121 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 66  QSEANTNRIVGT 77
           Q + NT   VGT
Sbjct: 178 QIKRNT--FVGT 187

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 30/72 (41%), Positives = 42/72 (58%), Gaps = 5/72 (6%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DFG+A      
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 66  QSEANTNRIVGT 77
           Q + NT   VGT
Sbjct: 158 QIKRNT--FVGT 167

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 24/51 (47%), Positives = 36/51 (70%), Gaps = 8/51 (15%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--------KISDFGMAR 60
           IARG+ YLH+++ + IIHRDLK+SN+L+  ++          KI+DFG+AR
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 151 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 198

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 132 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 179

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 136 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 183

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 130 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 177

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 160 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 207

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 120 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 127 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 127 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NR 73
            R
Sbjct: 207 TR 208

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 35/51 (68%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 129 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 29/77 (37%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +R+   D  +  +++  I +GL YLH + +   IHRD+KA+NVLL  + + K++DFG+A 
Sbjct: 112 LRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG 168
Query: 61  IFGGNQSEANTNRIVGT 77
                Q + NT   VGT
Sbjct: 169 QLTDTQIKRNT--FVGT 183

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GI  G+ YL   S +  +HRDL A N+L++  +  K+SDFGM+R+   +   A T
Sbjct: 134 VGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 190
Query: 72  NR 73
            R
Sbjct: 191 TR 192

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 148 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 204
Query: 72  NR 73
            R
Sbjct: 205 TR 206

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 138 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 72  NR 73
            R
Sbjct: 195 TR 196

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NR 73
            R
Sbjct: 207 TR 208

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NR 73
            R
Sbjct: 207 TR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NR 73
            R
Sbjct: 207 TR 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 121 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 72  NR 73
            R
Sbjct: 178 TR 179

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NR 73
            R
Sbjct: 207 TR 208

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NR 73
            R
Sbjct: 207 TR 208

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 121 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 72  NR 73
            R
Sbjct: 178 TR 179

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 26/65 (40%), Positives = 40/65 (61%), Gaps = 6/65 (9%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG---GNQSEAN 70
           ++  +  GL Y+H   R KI+HRD+KA+NVL+  +   K++DFG+AR F     +Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 71  TNRIV 75
            NR+V
Sbjct: 187 XNRVV 191

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 72  NR 73
            R
Sbjct: 207 TR 208

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 23/65 (35%), Positives = 38/65 (58%), Gaps = 3/65 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL E   +  +HRDL A N+L++  +  K+SDFG++R    N S+   
Sbjct: 121 VGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTE 177
Query: 72  NRIVG 76
              +G
Sbjct: 178 TSSLG 182

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 26/65 (40%), Positives = 40/65 (61%), Gaps = 6/65 (9%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG---GNQSEAN 70
           ++  +  GL Y+H   R KI+HRD+KA+NVL+  +   K++DFG+AR F     +Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 71  TNRIV 75
            NR+V
Sbjct: 187 XNRVV 191

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 26/65 (40%), Positives = 40/65 (61%), Gaps = 6/65 (9%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG---GNQSEAN 70
           ++  +  GL Y+H   R KI+HRD+KA+NVL+  +   K++DFG+AR F     +Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 71  TNRIV 75
            NR+V
Sbjct: 187 XNRVV 191

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 26/65 (40%), Positives = 40/65 (61%), Gaps = 6/65 (9%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG---GNQSEAN 70
           ++  +  GL Y+H   R KI+HRD+KA+NVL+  +   K++DFG+AR F     +Q    
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 71  TNRIV 75
            NR+V
Sbjct: 186 XNRVV 190

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GI  G+ YL   S +  +HRDL A N+L++  +  K+SDFGM+R+   +   A T
Sbjct: 113 VGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 169
Query: 72  NR 73
            R
Sbjct: 170 TR 171

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 23/65 (35%), Positives = 38/65 (58%), Gaps = 3/65 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL E   +  +HRDL A N+L++  +  K+SDFG++R    N S+   
Sbjct: 119 VGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 72  NRIVG 76
              +G
Sbjct: 176 TSSLG 180

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 25/57 (43%), Positives = 34/57 (59%), Gaps = 3/57 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           +LD K    +   I  G+ Y H   R  ++HRDLK  NVLLD  MN KI+DFG++ +
Sbjct: 112 RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GI  G+ YL   S +  +HRDL A N+L++  +  K+SDFGM+R+   +   A T
Sbjct: 119 VGMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 175
Query: 72  NR 73
            R
Sbjct: 176 TR 177

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG+ R+   +   A T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 72  NR 73
            R
Sbjct: 207 TR 208

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA G+ YL ED RL  +HRDL A NVL+    + KI+DFG+A++ G  + E
Sbjct: 123 IAEGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 170

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG A++ G  + E
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG A++ G  + E
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG A++ G  + E
Sbjct: 128 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG A++ G  + E
Sbjct: 130 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 177

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG A++ G  + E
Sbjct: 133 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 180

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/51 (49%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG A++ G  + E
Sbjct: 126 IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 173

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 3/58 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
            + + K+ I I    ARG+ YLH  S   IIHRDLK++N+ L  +   KI DFG+A +
Sbjct: 103 TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATV 157

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 22/62 (35%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GI+ G+ YL   S +  +HRDL A N+L++  +  K+SDFG++R+   +   A T
Sbjct: 127 VGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 183
Query: 72  NR 73
            R
Sbjct: 184 TR 185

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 28/72 (38%), Positives = 41/72 (56%), Gaps = 5/72 (6%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DFG+A      
Sbjct: 116 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--T 170
Query: 66  QSEANTNRIVGT 77
            ++   N  VGT
Sbjct: 171 DTQIKRNXFVGT 182

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 28/72 (38%), Positives = 41/72 (56%), Gaps = 5/72 (6%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LD  +  +I+  I +GL YLH + +   IHRD+KA+NVLL      K++DFG+A      
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--T 155
Query: 66  QSEANTNRIVGT 77
            ++   N  VGT
Sbjct: 156 DTQIKRNXFVGT 167

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 26/65 (40%), Positives = 40/65 (61%), Gaps = 5/65 (7%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           +I+  I +GL YLH + +   IHRD+KA+NVLL  + + K++DFG+A       ++   N
Sbjct: 120 TILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRN 174
Query: 73  RIVGT 77
             VGT
Sbjct: 175 XFVGT 179

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA---- 59
            + + K+ I I    ARG+ YLH  S   IIHRDLK++N+ L  +   KI DFG+A    
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 60  RIFGGNQSEANTNRIV 75
           R  G +Q E  +  I+
Sbjct: 172 RWSGSHQFEQLSGSIL 187

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA---- 59
            + + K+ I I    ARG+ YLH  S   IIHRDLK++N+ L  +   KI DFG+A    
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 60  RIFGGNQSEANTNRIV 75
           R  G +Q E  +  I+
Sbjct: 172 RWSGSHQFEQLSGSIL 187

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 23/52 (44%), Positives = 33/52 (63%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R   IHRDL+A+NVL+   +  KI+DFG+AR+   N+  A
Sbjct: 119 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 167

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 23/52 (44%), Positives = 33/52 (63%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R   IHRDL+A+NVL+   +  KI+DFG+AR+   N+  A
Sbjct: 118 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 166

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 23/52 (44%), Positives = 35/52 (67%), Gaps = 7/52 (13%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + ++NGIA    Y H+    +++HRDLK  N+L++ E   KI+DFG+AR FG
Sbjct: 107 LQLLNGIA----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 23/52 (44%), Positives = 35/52 (67%), Gaps = 7/52 (13%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + ++NGIA    Y H+    +++HRDLK  N+L++ E   KI+DFG+AR FG
Sbjct: 107 LQLLNGIA----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 23/52 (44%), Positives = 35/52 (67%), Gaps = 7/52 (13%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + ++NGIA    Y H+    +++HRDLK  N+L++ E   KI+DFG+AR FG
Sbjct: 107 LQLLNGIA----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ G+  G+ YL   S L  +HRDL A NVL+D  +  K+SDFG++R+   +   A T
Sbjct: 154 VGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 25/55 (45%), Positives = 38/55 (69%), Gaps = 3/55 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           IA+G+ YL ED RL  +HRDL A NVL+    + KI+DFG+AR+   +++E + +
Sbjct: 128 IAKGMSYL-EDVRL--VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD 179

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 112 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 168
Query: 64  GNQSEA 69
            N+  A
Sbjct: 169 DNEXTA 174

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 64  GNQSEA 69
            N+  A
Sbjct: 161 DNEXTA 166

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 64  GNQSEA 69
            N+  A
Sbjct: 161 DNEXTA 166

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 110 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 166
Query: 64  GNQSEA 69
            N+  A
Sbjct: 167 DNEXTA 172

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 105 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 161
Query: 64  GNQSEA 69
            N+  A
Sbjct: 162 DNEXTA 167

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 106 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 162
Query: 64  GNQSEA 69
            N+  A
Sbjct: 163 DNEXTA 168

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 113 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 169
Query: 64  GNQSEA 69
            N+  A
Sbjct: 170 DNEXTA 175

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 25/61 (40%), Positives = 37/61 (60%), Gaps = 3/61 (4%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++S QL        +  I RGL Y+H  +   ++HRDLK SN+L++   + KI DFG+AR
Sbjct: 136 LKSQQLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLAR 192
Query: 61  I 61
           I
Sbjct: 193 I 193

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + RGL Y+H     ++IHRDLK SN+L++     KI DFGMAR
Sbjct: 168 LLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + RGL Y+H     ++IHRDLK SN+L++     KI DFGMAR
Sbjct: 167 LLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +ARG+ YL E    K +HRDL A N +LD     K++DFG+AR
Sbjct: 133 VARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ G+  G+ YL   S L  +HRDL A NVL+D  +  K+SDFG++R+   +   A T
Sbjct: 154 VGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I   L++LH+     II+RDLK  NVLLDHE + K++DFGM +
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 110 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 166
Query: 64  GNQSEA 69
            N+  A
Sbjct: 167 DNEYTA 172

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 114 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 170
Query: 64  GNQSEA 69
            N+  A
Sbjct: 171 DNEYTA 176

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 64  GNQSEA 69
            N+  A
Sbjct: 161 DNEYTA 166

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 99  IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 155
Query: 64  GNQSEA 69
            N+  A
Sbjct: 156 DNEYTA 161

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/66 (33%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 109 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 165
Query: 64  GNQSEA 69
            N+  A
Sbjct: 166 DNEYTA 171

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 26/67 (38%), Positives = 42/67 (62%), Gaps = 9/67 (13%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE--AN 70
           +I+    +GL YLH    ++ IHRD+KA N+LL+ E + K++DFG+A    G  ++  A 
Sbjct: 129 TILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDXMAK 181
Query: 71  TNRIVGT 77
            N ++GT
Sbjct: 182 RNXVIGT 188

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARV 193

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I   + Y H+    +I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 123 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 113 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTA 161

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTA 171

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 139 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 179

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 130 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 170

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARV 175

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARV 173

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 141 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 181

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 193

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I   + Y H+    +I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 120 IVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 161

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 2/45 (4%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           ++HRDLK +NV LD + N K+ DFG+ARI   + S A T   VGT
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 25/53 (47%), Positives = 34/53 (64%), Gaps = 4/53 (7%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG-GNQSEA 69
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DFG +  F  GN+ +A
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA 171

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 21/46 (45%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + HE+   KI+HRDLK  N+L++     K+ DFG+AR FG
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 26/60 (43%), Positives = 39/60 (65%), Gaps = 5/60 (8%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           + +G+ YLH     KIIHRD+K SN+L+  + + KI+DFG++  F G  S+A  +  VGT
Sbjct: 146 LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGT 200

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 23/56 (41%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           V L  K    I+  +   +  LH   +L I+HRDLK  N+LLD +MN K++DFG +
Sbjct: 119 VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 23/56 (41%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           V L  K    I+  +   +  LH   +L I+HRDLK  N+LLD +MN K++DFG +
Sbjct: 119 VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 23/56 (41%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           V L  K    I+  +   +  LH   +L I+HRDLK  N+LLD +MN K++DFG +
Sbjct: 106 VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 158

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 120 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 168

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 289 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 289 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 289 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 112 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 160

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 114 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 162

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 123 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 372 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 116 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 164

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 21/65 (32%), Positives = 38/65 (58%), Gaps = 3/65 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL +   +  +HRDL A N+L++  +  K+SDFG++R    + S+   
Sbjct: 138 VGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 194
Query: 72  NRIVG 76
              +G
Sbjct: 195 TSALG 199

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 3/50 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 134 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 180

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 23/52 (44%), Positives = 33/52 (63%), Gaps = 3/52 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           + I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 110 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 3/50 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 181

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 23/52 (44%), Positives = 33/52 (63%), Gaps = 3/52 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           + I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 105 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 19/51 (37%), Positives = 34/51 (66%), Gaps = 3/51 (5%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           + ++ GIA G+ YL   + +  +HRDL A N+L++  +  K+SDFG++R+ 
Sbjct: 150 VGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 39/68 (57%), Gaps = 7/68 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA----RIFGGNQS 67
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A    R  G +Q 
Sbjct: 127 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 183
Query: 68  EANTNRIV 75
           E  +  I+
Sbjct: 184 EQLSGSIL 191

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/52 (44%), Positives = 33/52 (63%), Gaps = 3/52 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           + I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 105 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 3/50 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 112 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/70 (40%), Positives = 40/70 (57%), Gaps = 7/70 (10%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA----RIFGGN 65
           + I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A    R  G +
Sbjct: 105 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH 161
Query: 66  QSEANTNRIV 75
           Q E  +  I+
Sbjct: 162 QFEQLSGSIL 171

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 39/68 (57%), Gaps = 7/68 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA----RIFGGNQS 67
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A    R  G +Q 
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 191
Query: 68  EANTNRIV 75
           E  +  I+
Sbjct: 192 EQLSGSIL 199

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 3/50 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I I    A+G+ YLH  S   IIHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 109 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 155

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 26/56 (46%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL  K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 187 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 26/56 (46%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL  K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/56 (46%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL  K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/56 (46%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL  K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 131 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/56 (46%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL  K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 138 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/56 (46%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL  K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 139 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/56 (46%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL  K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 135 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 120 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTA 168

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/56 (46%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL  K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 28/45 (62%), Gaps = 2/45 (4%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           ++HRDLK +NV LD + N K+ DFG+ARI   N  E      VGT
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVGT 179

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 140 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 22/44 (50%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           +GL YLH+     I+HRDLK +N+LLD     K++DFG+A+ FG
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 145 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 142 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/56 (46%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           QL  K  +S    +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 146 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 35/52 (67%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           +A G+ Y+    R+  IHRDL+++N+L+ + +  KI+DFG+AR+   N+  A
Sbjct: 114 VAAGMAYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTA 162

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/66 (36%), Positives = 38/66 (57%), Gaps = 4/66 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           I+  N I  G+ + H+   ++I+HRD+K  N+L+D     KI DFG+A+      S   T
Sbjct: 114 INFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQT 169
Query: 72  NRIVGT 77
           N ++GT
Sbjct: 170 NHVLGT 175

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 19/32 (59%), Positives = 25/32 (78%)
Query: 30  RLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           R KI+HRDLK  N+LLD  +N KI+DFG++ I
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 164 VGTRSYMSPERLQGT 178

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 170 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 225
Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 226 VGTRSYMSPERLQGT 240

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 164 VGTRSYMSPERLQGT 178

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 19/50 (38%), Positives = 34/50 (68%), Gaps = 3/50 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           + ++ GIA G+ YL +   +  +HRDL A N+L++  +  K+SDFG++R+
Sbjct: 148 VGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 194

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 164 VGTRSYMSPERLQGT 178

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 115 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 156

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 135 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190
Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 191 VGTRSYMSPERLQGT 205

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 164 VGTRSYMSPERLQGT 178

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 108 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 164 VGTRSYMSPERLQGT 178

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I   + Y H+     I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF 164

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 11/59 (18%)
Query: 9   KRRISIINGIAR--------GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           KRR ++    AR        G+ YLH +   ++IHRDLK  N+ L+ +M+ KI DFG+A
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 11/59 (18%)
Query: 9   KRRISIINGIAR--------GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           KRR ++    AR        G+ YLH +   ++IHRDLK  N+ L+ +M+ KI DFG+A
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 11/59 (18%)
Query: 9   KRRISIINGIAR--------GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           KRR ++    AR        G+ YLH +   ++IHRDLK  N+ L+ +M+ KI DFG+A
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 11/59 (18%)
Query: 9   KRRISIINGIAR--------GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           KRR ++    AR        G+ YLH +   ++IHRDLK  N+ L+ +M+ KI DFG+A
Sbjct: 118 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 21/66 (31%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++L   + + +   IA G+ ++ E +    IHR+L+A+N+L+   ++ KI+DFG+AR+  
Sbjct: 100 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIE 156
Query: 64  GNQSEA 69
            N+  A
Sbjct: 157 DNEYTA 162

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 33/52 (63%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL A+N+L+   +  K++DFG+AR+   N+  A
Sbjct: 123 IASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTA 171

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+ GL +LH+     II+RDLK  NV+LD E + KI+DFGM +
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 168

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 19/34 (55%), Positives = 24/34 (70%)
Query: 26  HEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           H    LKIIHRD+K SN+LLD   N K+ DFG++
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/44 (50%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I   + Y H   R KI+HRDLK  N+LLD  +N KI+DFG++ I
Sbjct: 122 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI 162

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 20/58 (34%), Positives = 38/58 (65%), Gaps = 3/58 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           ++L   + + +   IA G+ ++ E +    IHRDL+A+N+L+   ++ KI+DFG+AR+
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/44 (50%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I   + Y H   R KI+HRDLK  N+LLD  +N KI+DFG++ I
Sbjct: 121 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI 161

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 21/54 (38%), Positives = 34/54 (62%), Gaps = 3/54 (5%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           +++ ++ G+ YL E +    +HRDL A NVLL +    KISDFG+++  G + S
Sbjct: 115 LLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + RGL Y H   R K++HRDLK  N+L++     K++DFG+AR
Sbjct: 109 LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 18/32 (56%), Positives = 24/32 (75%)
Query: 30  RLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           R  ++HRDLK  NVLLD  MN KI+DFG++ +
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 111 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEF 166
Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 167 VGTRSYMSPERLQGT 181

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 19/52 (36%), Positives = 33/52 (63%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+ R+   N+  A
Sbjct: 290 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTA 338

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/46 (50%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
            ++ I  G+LYLH      I+HRDL  SN+LL   MN KI+DFG+A
Sbjct: 117 FMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA 159

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/44 (50%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I   + Y H   R KI+HRDLK  N+LLD  +N KI+DFG++ I
Sbjct: 112 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI 152

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/56 (42%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      +I+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 18/32 (56%), Positives = 24/32 (75%)
Query: 30  RLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           R  ++HRDLK  NVLLD  MN KI+DFG++ +
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/44 (50%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           I   + Y H   R KI+HRDLK  N+LLD  +N KI+DFG++ I
Sbjct: 116 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI 156

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 2/45 (4%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           ++HRDLK +NV LD + N K+ DFG+ARI   + S A     VGT
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGT 179

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/45 (42%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/45 (42%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/45 (42%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 26/68 (38%), Positives = 37/68 (54%), Gaps = 7/68 (10%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA----RIFGGNQS 67
           I I    A+G+ YLH  +   IIHRD+K++N+ L   +  KI DFG+A    R  G  Q 
Sbjct: 135 IDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 68  EANTNRIV 75
           E  T  ++
Sbjct: 192 EQPTGSVL 199

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 140 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 129 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 161 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 140 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 139 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 134 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 137 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 114 MELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 170

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ YL   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 160 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/56 (39%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           V L  K   SI+  +   + +LH ++   I+HRDLK  N+LLD  M  ++SDFG +
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS 247

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 38/58 (65%), Gaps = 3/58 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           +LD  R +   + I +G+ YL   SR + +HRDL A N+L++ E + KI+DFG+A++ 
Sbjct: 110 RLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLL 164

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 38/58 (65%), Gaps = 3/58 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           +LD  R +   + I +G+ YL   SR + +HRDL A N+L++ E + KI+DFG+A++ 
Sbjct: 107 RLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLL 161

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 38/58 (65%), Gaps = 3/58 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           +LD  R +   + I +G+ YL   SR + +HRDL A N+L++ E + KI+DFG+A++ 
Sbjct: 111 RLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLL 165

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 38/58 (65%), Gaps = 3/58 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           +LD  R +   + I +G+ YL   SR + +HRDL A N+L++ E + KI+DFG+A++ 
Sbjct: 123 RLDASRLLLYSSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLL 177

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + +GL YL E  + KI+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 127 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 182
Query: 63  GGNQSEANTNRIVGT 77
            G +S  +  R+ GT
Sbjct: 183 VGTRSYMSPERLQGT 197

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/47 (48%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 24/53 (45%), Positives = 33/53 (62%), Gaps = 4/53 (7%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG-GNQSEA 69
           I   + Y H+     I+HRDLKA N+LLD + N KI+DFG +  F  GN+ +A
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA 171

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ ++ + +    IHRDL+A+N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 120 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 168

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA 69
           IA G+ ++ + +    IHRDL+A+N+L+   +  KI+DFG+AR+   N+  A
Sbjct: 293 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 32/46 (69%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + RG+ + H+    +I+HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH       IHRDL A NVLLD++   KI DFG+A+
Sbjct: 143 ICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 32/46 (69%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + RG+ + H+    +I+HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 156

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 157

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 154

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 41/75 (54%), Gaps = 12/75 (16%)
Query: 11  RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG--------MARIF 62
           ++SI   + RGL YL E  + +I+HRD+K SN+L++     K+ DFG        MA  F
Sbjct: 118 KVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 173
Query: 63  GGNQSEANTNRIVGT 77
            G +S     R+ GT
Sbjct: 174 VGTRSYMAPERLQGT 188

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 25/59 (42%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           R I     I  GL +LH+ +   II+RDLK  NVLLD + N +ISD G+A      Q++
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 25/59 (42%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           R I     I  GL +LH+ +   II+RDLK  NVLLD + N +ISD G+A      Q++
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 25/59 (42%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           R I     I  GL +LH+ +   II+RDLK  NVLLD + N +ISD G+A      Q++
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 25/59 (42%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           R I     I  GL +LH+ +   II+RDLK  NVLLD + N +ISD G+A      Q++
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 23/66 (34%), Positives = 35/66 (53%), Gaps = 6/66 (9%)
Query: 7   DWKRRISIINGIARGLLYLHED------SRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           DW     + + + RGL YLH +       +  I HRDL + NVL+ ++    ISDFG++ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 61  IFGGNQ 66
              GN+
Sbjct: 169 RLTGNR 174

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 26/65 (40%), Positives = 35/65 (53%), Gaps = 9/65 (13%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           ++ +G  +GL YLH  +   +IHRD+KA N+LL      K+ DFG A I       A  N
Sbjct: 158 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 208
Query: 73  RIVGT 77
             VGT
Sbjct: 209 XFVGT 213

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 39/75 (52%), Gaps = 9/75 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IF 62
           + D  R       I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +  + 
Sbjct: 115 KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 171
Query: 63  GGNQSEANTNRIVGT 77
           G    +A TN   GT
Sbjct: 172 G----DAKTNEFCGT 182

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 112 LLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 33/54 (61%), Gaps = 3/54 (5%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
           +I+  +  G  ++HE     IIHRDLK +N LL+ + + KI DFG+AR    ++
Sbjct: 135 TILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 22/49 (44%), Positives = 32/49 (65%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IS    I++G+ YL E   +K++HRDL A N+L+      KISDFG++R
Sbjct: 153 ISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           +S  LD     +I+  +  GL YLH++ +   IHRD+KA N+LL  + + +I+DFG++  
Sbjct: 109 KSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAF 165
Query: 62  F--GGNQSEANTNR-IVGT 77
              GG+ +     +  VGT
Sbjct: 166 LATGGDITRNKVRKTFVGT 184

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           +S  LD     +I+  +  GL YLH++ +   IHRD+KA N+LL  + + +I+DFG++  
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAF 170
Query: 62  F--GGNQSEANTNR-IVGT 77
              GG+ +     +  VGT
Sbjct: 171 LATGGDITRNKVRKTFVGT 189

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 26/65 (40%), Positives = 35/65 (53%), Gaps = 9/65 (13%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           ++ +G  +GL YLH  +   +IHRD+KA N+LL      K+ DFG A I       A  N
Sbjct: 119 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169
Query: 73  RIVGT 77
             VGT
Sbjct: 170 XFVGT 174

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 469 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 470 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 127 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 127 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 111 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 125 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 25/70 (35%), Positives = 38/70 (54%), Gaps = 4/70 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+L+      K+ DFG+AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNS 172
Query: 68  EANTNRIVGT 77
              T  ++GT
Sbjct: 173 VXQTAAVIGT 182

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 22/49 (44%), Positives = 32/49 (65%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IS    I++G+ YL E   +K++HRDL A N+L+      KISDFG++R
Sbjct: 153 ISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 117 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 107 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 111 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           K  I +++ ++ G+ YL E +    +HRDL A NVLL  +   KISDFG+++    +++
Sbjct: 105 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++  + RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR
Sbjct: 128 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 21/43 (48%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A GL +LH    L II+RDLK  N+LLD E + K++DFG+++
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 178

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 39/75 (52%), Gaps = 9/75 (12%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IF 62
           + D  R       I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +  + 
Sbjct: 114 KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 63  GGNQSEANTNRIVGT 77
           G    +A TN   GT
Sbjct: 171 G----DAKTNXFCGT 181

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA GL +L       II+RDLK  NV+LD E + KI+DFGM +
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA GL +L       II+RDLK  NV+LD E + KI+DFGM +
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +   IA G+ YL+     K +HRDL A N ++ H+   KI DFGM R
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +   IA G+ YL+     K +HRDL A N ++ H+   KI DFGM R
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 120 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 176

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 126 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 182

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 22/47 (46%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D+G+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++  + RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +   IA G+ YL+     K +HRDL A N ++ H+   KI DFGM R
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 123 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 179

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/65 (30%), Positives = 37/65 (56%), Gaps = 3/65 (4%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + ++ GIA G+ YL +   +  +HR L A N+L++  +  K+SDFG++R    + S+   
Sbjct: 112 VGMLRGIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 168
Query: 72  NRIVG 76
              +G
Sbjct: 169 TSALG 173

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++  + RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +   IA G+ YL+     K +HRDL A N ++ H+   KI DFGM R
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 22/54 (40%), Positives = 30/54 (55%), Gaps = 3/54 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +  G+ YL E S   +IHRDL A N L+      K+SDFGM R    +Q  ++T
Sbjct: 112 VCEGMAYLEEAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 4/70 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DFG+AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 68  EANTNRIVGT 77
              T  ++GT
Sbjct: 173 VTQTAAVIGT 182

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 36/60 (60%), Gaps = 6/60 (10%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           +I+  +  G  ++HE     IIHRDLK +N LL+ + + K+ DFG+AR      SE +TN
Sbjct: 133 TILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI---NSEKDTN 186

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  G  YLH   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 148 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  G  YLH   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 126 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  G  YLH   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 126 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +   IA G+ YL+     K +HRDL A N ++ H+   KI DFGM R
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  G  YLH   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 130 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  G  YLH   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  G  YLH   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+  L YLHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 24/68 (35%), Positives = 37/68 (54%), Gaps = 4/68 (5%)
Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFGG 64
           L    ++ I   +A G+ YL E    K +HRDL   N L+   M  KI+DFG++R I+  
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 65  NQSEANTN 72
           +  +A+ N
Sbjct: 228 DYYKADGN 235

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 18/43 (41%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 140 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 18/43 (41%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+  L YLHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 18/43 (41%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 147 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 18/43 (41%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 21/49 (42%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +   IA G+ YL+     K +HRDL A N ++ H+   KI DFGM R
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 18/43 (41%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 18/43 (41%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 201 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 4/70 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DFG+AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 68  EANTNRIVGT 77
              T  ++GT
Sbjct: 173 VTQTAAVIGT 182

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+  L YLHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 115 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 154

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 4/70 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DFG+AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 68  EANTNRIVGT 77
              T  ++GT
Sbjct: 173 VTQTAAVIGT 182

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 20/54 (37%), Positives = 34/54 (62%), Gaps = 3/54 (5%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
           +++ ++ G+ YL E +    +HR+L A NVLL +    KISDFG+++  G + S
Sbjct: 441 LLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 4/70 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DFG+AR I     S
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 68  EANTNRIVGT 77
              T  ++GT
Sbjct: 173 VTQTAAVIGT 182

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 18/43 (41%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+  L YLHE     II+RDLK  NVLLD E + K++D+GM +
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 169

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 4/70 (5%)
Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQS 67
           KR I +I    + L + H++    IIHRD+K +N+++      K+ DFG+AR I     S
Sbjct: 133 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 68  EANTNRIVGT 77
              T  ++GT
Sbjct: 190 VTQTAAVIGT 199

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/43 (48%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH       IHR+L A NVLLD++   KI DFG+A+
Sbjct: 126 ICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +ARG+ +L   S  K IHRDL A N+LL      KI DFG+AR
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLAR 247

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 3/62 (4%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR   
Sbjct: 119 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAS 175
Query: 64  GN 65
            N
Sbjct: 176 TN 177

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/47 (46%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+ R
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +ARG+ YL   S+ + IHRDL A N+L+      KI+DFG++R
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 38/74 (51%), Gaps = 16/74 (21%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL--------DHEMNPK-----ISDFGM 58
           IS++  IA G+ +LH    LKIIHRDLK  N+L+        D +   +     ISDFG+
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 59  ARIFGGNQSEANTN 72
            +     QS   TN
Sbjct: 175 CKKLDSGQSSFRTN 188

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +ARG+ YL   S+ + IHRDL A N+L+      KI+DFG++R
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/43 (48%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH       IHR+L A NVLLD++   KI DFG+A+
Sbjct: 126 ICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/57 (38%), Positives = 35/57 (61%), Gaps = 3/57 (5%)
Query: 4   VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++LD +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/51 (41%), Positives = 33/51 (64%), Gaps = 3/51 (5%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           S +  + +GL + H  SR  ++HRDLK  N+L++     K++DFG+AR FG
Sbjct: 105 SFLFQLLKGLGFCH--SR-NVLHRDLKPQNLLINRNGELKLADFGLARAFG 152

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 19/44 (43%), Positives = 30/44 (68%), Gaps = 2/44 (4%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVG 76
           +IHRDLK SN+L++   + K+ DFG+ARI   ++S A+ +   G
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTG 174

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 19/44 (43%), Positives = 30/44 (68%), Gaps = 2/44 (4%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVG 76
           +IHRDLK SN+L++   + K+ DFG+ARI   ++S A+ +   G
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTG 174

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 19/44 (43%), Positives = 30/44 (68%), Gaps = 2/44 (4%)
Query: 33  IIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVG 76
           +IHRDLK SN+L++   + K+ DFG+ARI   ++S A+ +   G
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTG 174

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/44 (40%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           IA G+ ++ + +    IHRDL+A+N+L+   +  KI+DFG+AR+
Sbjct: 287 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 5/64 (7%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I   I RGL +LH+    K+IHRD+K  NVLL      K+ DFG++     +++    N 
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNT 188
Query: 74  IVGT 77
            +GT
Sbjct: 189 FIGT 192

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 21/53 (39%), Positives = 35/53 (66%), Gaps = 6/53 (11%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMARIF 62
           +I+  I  G+ YLH+ +   I+HRD+K  N+LL+++   +N KI DFG++  F
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/49 (36%), Positives = 33/49 (67%), Gaps = 3/49 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           ++  + + + YLH      ++HRD+K SN+LL+ E + K++DFG++R F
Sbjct: 114 VVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 130 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 129 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 21/49 (42%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IS    I++G+ YL E   + ++HRDL A N+L+      KISDFG++R
Sbjct: 153 ISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/47 (46%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI  FG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 161 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +    IHRDL A N+LL H    KI DFG+AR
Sbjct: 154 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 193

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +    IHRDL A N+LL H    KI DFG+AR
Sbjct: 172 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 211

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +    IHRDL A N+LL H    KI DFG+AR
Sbjct: 170 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 209

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +    IHRDL A N+LL H    KI DFG+AR
Sbjct: 177 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 216

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +    IHRDL A N+LL H    KI DFG+AR
Sbjct: 177 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 216

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 32/53 (60%), Gaps = 3/53 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + D +R  + +  +A  L Y HE    K+IHRD+K  N+L+ ++   KI+DFG
Sbjct: 110 RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 6/43 (13%)
Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFG 63
           YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 6/43 (13%)
Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFG 63
           YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 6/43 (13%)
Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFG 63
           YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 167

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 6/43 (13%)
Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFG 63
           YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 307

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 6/43 (13%)
Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFG 63
           YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 6/43 (13%)
Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFG 63
           YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 27/43 (62%), Gaps = 6/43 (13%)
Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFG 63
           YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 174

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 20/49 (40%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +   IA G+ YL+     K +HR+L A N ++ H+   KI DFGM R
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A  L +LH    L II+RDLK  N+LLD E + K++DFG+++
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 20/49 (40%), Positives = 28/49 (57%), Gaps = 3/49 (6%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I +   IA G+ YL+     K +HR+L A N ++ H+   KI DFGM R
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 32/53 (60%), Gaps = 3/53 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + D +R  + +  +A  L Y HE    K+IHRD+K  N+L+ ++   KI+DFG
Sbjct: 111 RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I   L Y+H      IIHRDLK  N+ +D   N KI DFG+A+
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 22/47 (46%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 21/52 (40%), Positives = 33/52 (63%), Gaps = 6/52 (11%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIF 62
           II  +  G+ Y+H++   KI+HRDLK  N+LL+    + N +I DFG++  F
Sbjct: 137 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 185

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 22/57 (38%), Positives = 31/57 (54%), Gaps = 3/57 (5%)
Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM 58
           R  +LD    + +   I +G+ Y+H     K+IHRDLK SN+ L      KI DFG+
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGL 182

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 21/54 (38%), Positives = 29/54 (53%), Gaps = 3/54 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +  G+ YL E     +IHRDL A N L+      K+SDFGM R    +Q  ++T
Sbjct: 110 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 21/54 (38%), Positives = 29/54 (53%), Gaps = 3/54 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +  G+ YL E     +IHRDL A N L+      K+SDFGM R    +Q  ++T
Sbjct: 115 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 21/54 (38%), Positives = 29/54 (53%), Gaps = 3/54 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +  G+ YL E     +IHRDL A N L+      K+SDFGM R    +Q  ++T
Sbjct: 112 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 21/54 (38%), Positives = 29/54 (53%), Gaps = 3/54 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +  G+ YL E     +IHRDL A N L+      K+SDFGM R    +Q  ++T
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 21/54 (38%), Positives = 29/54 (53%), Gaps = 3/54 (5%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +  G+ YL E     +IHRDL A N L+      K+SDFGM R    +Q  ++T
Sbjct: 132 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 182

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 20/43 (46%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I   L Y+H      IIHRDLK  N+ +D   N KI DFG+A+
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 21/43 (48%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH       IHR L A NVLLD++   KI DFG+A+
Sbjct: 120 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 21/43 (48%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I  G+ YLH       IHR L A NVLLD++   KI DFG+A+
Sbjct: 121 ICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 22/47 (46%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A  L +LH    L II+RDLK  N+LLD E + K++DFG+++
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 2/43 (4%)
Query: 17  GIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
            I + L YL E  +  +IHRD+K SN+LLD     K+ DFG++
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 19/39 (48%), Positives = 28/39 (71%), Gaps = 3/39 (7%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
            L YLH++   KIIHRDLKA N+L   + + K++DFG++
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 19/39 (48%), Positives = 28/39 (71%), Gaps = 3/39 (7%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
            L YLH++   KIIHRDLKA N+L   + + K++DFG++
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 19/39 (48%), Positives = 28/39 (71%), Gaps = 3/39 (7%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
            L YLH++   KIIHRDLKA N+L   + + K++DFG++
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A  L +LH    L II+RDLK  N+LLD E + K++DFG+++
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 175

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 22/47 (46%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 22/47 (46%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           M+  +L   R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 120 MKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 21/48 (43%), Positives = 31/48 (64%), Gaps = 4/48 (8%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFGG 64
           I  GL YLH++   +I+HRD+K  NVL++ +    KISDFG ++   G
Sbjct: 117 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 161

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 21/48 (43%), Positives = 31/48 (64%), Gaps = 4/48 (8%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFGG 64
           I  GL YLH++   +I+HRD+K  NVL++ +    KISDFG ++   G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 18/43 (41%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +  G+ +L      + IHRDL A N L+D ++  K+SDFGM R
Sbjct: 113 VCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTR 152

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/55 (38%), Positives = 33/55 (60%), Gaps = 6/55 (10%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGN 65
           II  +  G+ Y+H+ +   I+HRDLK  N+LL   + + + KI DFG++  F  N
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 24/56 (42%), Positives = 33/56 (58%), Gaps = 8/56 (14%)
Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP----KISDFGMARIFG 63
           I +I  I  G+ YLH+++   I+H DLK  N+LL   + P    KI DFGM+R  G
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIG 185

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 246

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 194 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 248

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 239

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 159 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 21/52 (40%), Positives = 33/52 (63%), Gaps = 6/52 (11%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIF 62
           II  +  G+ Y+H++   KI+HRDLK  N+LL+    + N +I DFG++  F
Sbjct: 154 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 202

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +ARG+ YL   S+ + IHR+L A N+L+      KI+DFG++R
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 21/52 (40%), Positives = 33/52 (63%), Gaps = 6/52 (11%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIF 62
           II  +  G+ Y+H++   KI+HRDLK  N+LL+    + N +I DFG++  F
Sbjct: 155 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 203

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 21/52 (40%), Positives = 33/52 (63%), Gaps = 6/52 (11%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIF 62
           II  +  G+ Y+H++   KI+HRDLK  N+LL+    + N +I DFG++  F
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 28/51 (54%), Gaps = 3/51 (5%)
Query: 10  RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           + I +   IA G+ YL+ +   K +HRDL A N  +  +   KI DFGM R
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 3/53 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + D +R  + I  +A  L Y H     K+IHRD+K  N+LL      KI+DFG
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/40 (50%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 21  GLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            L YLH      II+RDLK  N+LLD   + KI+DFG A+
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           IA  L YLH    L I++RDLK  N+LLD + +  ++DFG+ +
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 187

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 20/51 (39%), Positives = 33/51 (64%), Gaps = 3/51 (5%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           S +  + +GL + H  SR  ++HRDLK  N+L++     K+++FG+AR FG
Sbjct: 105 SFLFQLLKGLGFCH--SR-NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 19/42 (45%), Positives = 29/42 (69%), Gaps = 2/42 (4%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I + L +LH  S+L +IHRD+K SNVL++     K+ DFG++
Sbjct: 162 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 201

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 19/42 (45%), Positives = 29/42 (69%), Gaps = 2/42 (4%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I + L +LH  S+L +IHRD+K SNVL++     K+ DFG++
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 21/54 (38%), Positives = 32/54 (59%), Gaps = 6/54 (11%)
Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFG 63
           ++I  +   + YLH   R+ I+HRDLK  N+L    D E    ISDFG++++ G
Sbjct: 124 TLIRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEG 174

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/43 (39%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+  L +LH+     II+RDLK  N++L+H+ + K++DFG+ +
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 38.9 bits (89), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/43 (39%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I+  L +LH+     II+RDLK  N++L+H+ + K++DFG+ +
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   S    +HRDL A NVL+ H    KI DFG+AR
Sbjct: 181 VAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 21/55 (38%), Positives = 33/55 (60%), Gaps = 6/55 (10%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGN 65
           II  +  G+ Y+H+ +   I+HRDLK  N+LL   + + + KI DFG++  F  N
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 21/55 (38%), Positives = 33/55 (60%), Gaps = 6/55 (10%)
Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGN 65
           II  +  G+ Y+H+ +   I+HRDLK  N+LL   + + + KI DFG++  F  N
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 19/43 (44%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I   L Y+H      IIHR+LK  N+ +D   N KI DFG+A+
Sbjct: 125 ILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 29/53 (54%), Gaps = 3/53 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + D +R  + I  +A  L Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 130 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 29/53 (54%), Gaps = 3/53 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + D +R  + I  +A  L Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 130 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 38.5 bits (88), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 21/56 (37%), Positives = 35/56 (62%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +++ K+++     I +G+ YL   SR + +HRDL A NVL++ E   KI DFG+ +
Sbjct: 122 KINLKQQLKYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTK 174

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 38.5 bits (88), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 21/56 (37%), Positives = 35/56 (62%), Gaps = 3/56 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +++ K+++     I +G+ YL   SR + +HRDL A NVL++ E   KI DFG+ +
Sbjct: 110 KINLKQQLKYAVQICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTK 162

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 38.5 bits (88), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 29/53 (54%), Gaps = 3/53 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + D +R  + I  +A  L Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 38.5 bits (88), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 29/53 (54%), Gaps = 3/53 (5%)
Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           + D +R  + I  +A  L Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 104 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	77
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-38
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-35
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-31
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-28
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-25
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-23
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-21
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-21
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-21
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-21
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-21
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-21
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-20
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-20
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-20
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-20
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-20
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-20
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-16
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-16
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-16
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-16
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-15
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-15
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-15
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-15
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-15
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-14
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-14
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-14
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-14
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-14
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-14
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-14
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-14
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-14
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-14
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-14
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-14
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-14
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-14
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-14
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-14
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-14
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-14
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-14
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-14
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-14
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-14
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-13
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-13
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-13
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-13
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-13
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-13
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-13
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-13
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-13
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-13
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-13
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-13
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-13
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-13
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-13
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-13
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-13
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-13
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-13
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-13
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-13
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-13
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-13
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-13
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-13
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-13
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-12
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-12
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-12
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-12
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-12
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-12
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-12
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-12
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-12
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-12
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-12
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-12
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-12
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-12
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-12
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-12
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-12
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-12
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-12
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-12
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-11
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-11
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-10
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-10
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-10
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-10
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-10
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-10
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-10
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-10
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-10
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-10
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-10
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-10
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-10
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-10
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-09
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-09
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-09
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-09
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-09
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-09
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-09
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-09
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-09
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-09
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-09
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-09
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-07
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-06
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  128 bits (323), Expect = 2e-38
 Identities = 33/76 (43%), Positives = 43/76 (56%), Gaps = 3/76 (3%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
            +  L W  R  I  G A G+ +LHE+     IHRD+K++N+LLD     KISDFG+AR 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 62  FGGNQSEANTNRIVGT 77
                    T+RIVGT
Sbjct: 183 SEKFAQTVMTSRIVGT 198

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  120 bits (303), Expect = 3e-35
 Identities = 33/73 (45%), Positives = 44/73 (60%), Gaps = 1/73 (1%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
            LDW +R  I  G ARGL YLH+    KIIHRD+KA+N+LLD E    + DFG+A++   
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186

Query: 65  NQSEANTNRIVGT 77
             +   T  + GT
Sbjct: 187 KDTHVTT-AVRGT 198

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  109 bits (273), Expect = 6e-31
 Identities = 31/80 (38%), Positives = 43/80 (53%), Gaps = 7/80 (8%)

Query: 5   QLDWKRRISIINGIARGLLYLHED-------SRLKIIHRDLKASNVLLDHEMNPKISDFG 57
            + W     I   +ARGL YLHED        +  I HRD+K+ NVLL + +   I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176

Query: 58  MARIFGGNQSEANTNRIVGT 77
           +A  F   +S  +T+  VGT
Sbjct: 177 LALKFEAGKSAGDTHGQVGT 196

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  102 bits (257), Expect = 1e-28
 Identities = 31/73 (42%), Positives = 47/73 (64%), Gaps = 5/73 (6%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF-GG 64
           + W++R+ I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192

Query: 65  NQSEANTNRIVGT 77
           +Q+  +T  + GT
Sbjct: 193 DQTHLST-VVKGT 204

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 93.8 bits (233), Expect = 4e-25
 Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 12/89 (13%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED------SRLKIIHRDLKASNVLLDHEMNPKIS 54
           +     DW     + + + RGL YLH +       +  I HRDL + NVL+ ++    IS
Sbjct: 103 LSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162

Query: 55  DFGMARIFGGN------QSEANTNRIVGT 77
           DFG++    GN      + +      VGT
Sbjct: 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGT 191

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 87.4 bits (217), Expect = 7e-23
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 3/72 (4%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
              Q  W +R+S    IA G+ YLH    + IIHRDL + N L+    N  ++DFG+AR+
Sbjct: 101 MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARL 157

Query: 62  FGGNQSEANTNR 73
               +++    R
Sbjct: 158 MVDEKTQPEGLR 169

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 83.5 bits (207), Expect = 2e-21
 Identities = 26/73 (35%), Positives = 44/73 (60%), Gaps = 3/73 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           QLD +RR+S+   +A+G+ YLH      I+HR+LK+ N+L+D +   K+ DFG++R+   
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191

Query: 65  NQSEANTNRIVGT 77
               + +    GT
Sbjct: 192 TFLSSKSA--AGT 202

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 82.7 bits (205), Expect = 3e-21
 Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 3/76 (3%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
              + + K+ I I    ARG+ YLH      IIHRDLK++N+ L  +   KI DFG+A  
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169

Query: 62  FGGNQSEANTNRIVGT 77
                      ++ G+
Sbjct: 170 KSRWSGSHQFEQLSGS 185

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 83.2 bits (206), Expect = 4e-21
 Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 7/84 (8%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKASNVLLDHEMNPKISD 55
           ++S  LD K  + +      GL +LH +      +  I HRDLK+ N+L+       I+D
Sbjct: 126 LKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185

Query: 56  FGMARIF--GGNQSEANTNRIVGT 77
            G+A  F    N+ +   N  VGT
Sbjct: 186 LGLAVKFISDTNEVDIPPNTRVGT 209

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 82.4 bits (204), Expect = 6e-21
 Identities = 20/61 (32%), Positives = 26/61 (42%), Gaps = 1/61 (1%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN-PKISDFGMAR 60
                     +S     ++G+ YLH      +IHRDLK  N+LL       KI DFG A 
Sbjct: 95  PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154

Query: 61  I 61
            
Sbjct: 155 D 155

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 82.0 bits (203), Expect = 7e-21
 Identities = 27/84 (32%), Positives = 41/84 (48%), Gaps = 7/84 (8%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKASNVLLDHEMNPKISD 55
           ++   LD    + I+  IA GL +LH +      +  I HRDLK+ N+L+       I+D
Sbjct: 97  LQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156

Query: 56  FGMARIF--GGNQSEANTNRIVGT 77
            G+A +     NQ +   N  VGT
Sbjct: 157 LGLAVMHSQSTNQLDVGNNPRVGT 180

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 80.8 bits (200), Expect = 2e-20
 Identities = 24/79 (30%), Positives = 43/79 (54%), Gaps = 8/79 (10%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--------K 52
           +   ++     ++    IARG+ YLH+++ + IIHRDLK+SN+L+  ++          K
Sbjct: 97  LSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156

Query: 53  ISDFGMARIFGGNQSEANT 71
           I+DFG+AR +      +  
Sbjct: 157 ITDFGLAREWHRTTKMSAA 175

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 80.4 bits (199), Expect = 2e-20
 Identities = 16/65 (24%), Positives = 36/65 (55%), Gaps = 6/65 (9%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD-----HEMNPKISDF 56
           ++  + W  ++ ++  IA G+ Y+  +    I+HRDL++ N+ L        +  K++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 57  GMARI 61
           G+++ 
Sbjct: 174 GLSQQ 178

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 80.9 bits (200), Expect = 3e-20
 Identities = 23/72 (31%), Positives = 35/72 (48%), Gaps = 4/72 (5%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
             + LD  +   I   I +G+ YLH      I+H+DLK+ NV  D      I+DFG+  I
Sbjct: 123 AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178

Query: 62  FGGNQSEANTNR 73
            G  Q+    ++
Sbjct: 179 SGVLQAGRREDK 190

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 79.2 bits (196), Expect = 5e-20
 Identities = 14/61 (22%), Positives = 28/61 (45%), Gaps = 1/61 (1%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
            +  +D  + +     +ARG+ +LH      I    L + +V++D +M  +IS   +   
Sbjct: 104 TNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162

Query: 62  F 62
           F
Sbjct: 163 F 163

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 79.8 bits (197), Expect = 7e-20
 Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 7/84 (8%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKASNVLLDHEMNPKISD 55
           +    +  +  I +    A GL +LH +      +  I HRDLK+ N+L+       I+D
Sbjct: 131 LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190

Query: 56  FGMARIF--GGNQSEANTNRIVGT 77
            G+A       +  +   N  VGT
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGT 214

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 70.0 bits (172), Expect = 3e-16
 Identities = 17/60 (28%), Positives = 32/60 (53%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   L ++H     +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT
Sbjct: 145 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 69.7 bits (171), Expect = 3e-16
 Identities = 19/60 (31%), Positives = 32/60 (53%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L ++H+    KI+HRD+K+ N+ L  +   ++ DFG+AR+       A     +GT
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 69.6 bits (171), Expect = 3e-16
 Identities = 25/59 (42%), Positives = 38/59 (64%), Gaps = 6/59 (10%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEAN---TNRIV 75
            GL Y+H +   KI+HRD+KA+NVL+  +   K++DFG+AR F   ++      TNR+V
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 69.1 bits (169), Expect = 6e-16
 Identities = 24/64 (37%), Positives = 36/64 (56%), Gaps = 6/64 (9%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           +   + +GL YL E    KI+HRD+K SN+L++     K+ DFG++       S AN+  
Sbjct: 136 VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF- 190

Query: 74  IVGT 77
            VGT
Sbjct: 191 -VGT 193

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 68.1 bits (167), Expect = 9e-16
 Identities = 26/62 (41%), Positives = 34/62 (54%), Gaps = 4/62 (6%)

Query: 18  IARGLLYLHE--DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           +   L   H   D    ++HRDLK +NV LD + N K+ DFG+ARI   + S A T   V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FV 177

Query: 76  GT 77
           GT
Sbjct: 178 GT 179

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 68.1 bits (167), Expect = 1e-15
 Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 6/60 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I +G+ Y+H     K+I+RDLK SN+ L      KI DFG+       +++    R  GT
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGT 184

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 67.4 bits (165), Expect = 3e-15
 Identities = 16/48 (33%), Positives = 24/48 (50%), Gaps = 2/48 (4%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           +     Y+H  +   I HRD+K SN+L+D     K+SDFG +      
Sbjct: 160 VLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 66.5 bits (163), Expect = 4e-15
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 3/60 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 66.1 bits (162), Expect = 5e-15
 Identities = 21/64 (32%), Positives = 34/64 (53%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I   I + L +LH  S+L +IHRD+K SNVL++     K+ DFG++     +    + + 
Sbjct: 114 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID- 169

Query: 74  IVGT 77
             G 
Sbjct: 170 -AGC 172

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 66.1 bits (162), Expect = 7e-15
 Identities = 22/56 (39%), Positives = 34/56 (60%), Gaps = 4/56 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           +GL + HE+   KI+HRDLK  N+L++     K+ DFG+AR F G      ++ +V
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 65.8 bits (161), Expect = 8e-15
 Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I     + L +L E+  LKIIHRD+K SN+LLD   N K+ DFG++     + ++     
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-- 185

Query: 74  IVGT 77
             G 
Sbjct: 186 -AGC 188

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 65.7 bits (161), Expect = 9e-15
 Identities = 19/44 (43%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+ 
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 65.6 bits (161), Expect = 9e-15
 Identities = 18/56 (32%), Positives = 31/56 (55%), Gaps = 4/56 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           +GL + H      ++HRDLK  N+L++     K+++FG+AR F G      +  +V
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 65.4 bits (160), Expect = 9e-15
 Identities = 20/55 (36%), Positives = 27/55 (49%), Gaps = 3/55 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           I   L Y+H      IIHRDLK  N+ +D   N KI DFG+A+    +      +
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 65.6 bits (161), Expect = 9e-15
 Identities = 21/56 (37%), Positives = 34/56 (60%), Gaps = 4/56 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           +GL + H     +++HRDLK  N+L++ E   K++DFG+AR F G      T+ +V
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 165

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 65.4 bits (160), Expect = 9e-15
 Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 7/58 (12%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +I GI     YLH     KIIHRD+K SN+L+  + + KI+DFG++  F G+ +  + 
Sbjct: 146 LIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 65.7 bits (161), Expect = 1e-14
 Identities = 21/56 (37%), Positives = 36/56 (64%), Gaps = 4/56 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           RG+ + H+    +I+HRDLK  N+L++ +   K++DFG+AR F G    + T+ +V
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 65.1 bits (159), Expect = 1e-14
 Identities = 22/65 (33%), Positives = 30/65 (46%), Gaps = 3/65 (4%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
               +   + +     I  G+ YLH       IHRDL A NVLLD++   KI DFG+A+ 
Sbjct: 127 PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183

Query: 62  FGGNQ 66
                
Sbjct: 184 VPEGH 188

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 64.9 bits (159), Expect = 1e-14
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  G  YLH   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 65.0 bits (159), Expect = 1e-14
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  G  YLH   R ++IHRDLK  N+ L+ ++  KI DFG+A
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 65.0 bits (159), Expect = 2e-14
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 65.0 bits (159), Expect = 2e-14
 Identities = 14/60 (23%), Positives = 22/60 (36%), Gaps = 6/60 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
               L +LH      ++H D+K +N+ L      K+ DFG+     G           G 
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGD 219

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 64.6 bits (158), Expect = 2e-14
 Identities = 19/64 (29%), Positives = 35/64 (54%), Gaps = 3/64 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           +++ K+++     I +G+ YL      + +HRDL A NVL++ E   KI DFG+ +    
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

Query: 65  NQSE 68
           ++  
Sbjct: 179 DKEY 182

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 65.0 bits (159), Expect = 2e-14
 Identities = 22/57 (38%), Positives = 30/57 (52%), Gaps = 3/57 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           +L  K  + ++   A G+ YL        IHRDL A N L+  +   KISDFGM+R 
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 64.5 bits (158), Expect = 2e-14
 Identities = 20/44 (45%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           RGL +LH +    I+HRDLK  N+L+      K++DFG+ARI+ 
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 64.6 bits (158), Expect = 2e-14
 Identities = 24/67 (35%), Positives = 38/67 (56%), Gaps = 3/67 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           Q    + + ++ G+  G+ YL   S L  +HRDL A NVL+D  +  K+SDFG++R+   
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203

Query: 65  NQSEANT 71
           +   A T
Sbjct: 204 DPDAAYT 210

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 64.5 bits (158), Expect = 2e-14
 Identities = 21/56 (37%), Positives = 32/56 (57%), Gaps = 4/56 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           RGL Y H     K++HRDLK  N+L++     K++DFG+AR      ++   N +V
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 64.1 bits (157), Expect = 2e-14
 Identities = 23/42 (54%), Positives = 28/42 (66%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I  G+LYLH      I+HRDL  SN+LL   MN KI+DFG+A
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 64.3 bits (157), Expect = 3e-14
 Identities = 25/64 (39%), Positives = 33/64 (51%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I   I RGL +LH+    K+IHRD+K  NVLL      K+ DFG++          NT  
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 188

Query: 74  IVGT 77
            +GT
Sbjct: 189 FIGT 192

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 64.3 bits (157), Expect = 3e-14
 Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           Q+ +K  +S    +ARG+ YL   +  K IHRDL A NVL+      KI+DFG+AR
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 64.2 bits (157), Expect = 3e-14
 Identities = 21/56 (37%), Positives = 33/56 (58%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            L  ++ +     +ARG+ YL   S+ + IHRDL A N+L+      KI+DFG++R
Sbjct: 138 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 64.3 bits (156), Expect = 3e-14
 Identities = 13/72 (18%), Positives = 26/72 (36%), Gaps = 4/72 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L    R+ +   + R L  LH      ++H  L+  +++LD      ++ F       G 
Sbjct: 208 LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GA 263

Query: 66  QSEANTNRIVGT 77
            + +   R    
Sbjct: 264 SAVSPIGRGFAP 275

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 64.1 bits (157), Expect = 3e-14
 Identities = 23/56 (41%), Positives = 34/56 (60%), Gaps = 4/56 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
            G+ Y H+    +++HRDLK  N+L++ E   KI+DFG+AR F G      T+ IV
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 64.1 bits (157), Expect = 3e-14
 Identities = 25/56 (44%), Positives = 39/56 (69%), Gaps = 4/56 (7%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           +GL YLH+     I+HRDLK +N+LLD     K++DFG+A+ F G+ + A T+++V
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 63.8 bits (156), Expect = 3e-14
 Identities = 27/64 (42%), Positives = 37/64 (57%), Gaps = 7/64 (10%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           ++ G+     YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N+
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 74  IVGT 77
           + GT
Sbjct: 167 MCGT 170

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 63.8 bits (156), Expect = 4e-14
 Identities = 22/56 (39%), Positives = 31/56 (55%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            L  +  I     +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 64.1 bits (156), Expect = 4e-14
 Identities = 16/55 (29%), Positives = 26/55 (47%), Gaps = 3/55 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           IA  + +LH      ++HRDLK SN+    +   K+ DFG+      ++ E    
Sbjct: 173 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 63.9 bits (156), Expect = 4e-14
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 6/61 (9%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFGGNQSEANTNRIVG 76
           I  GL YLH++   +I+HRD+K  NVL++ +    KISDFG ++   G      T    G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTG 185

Query: 77  T 77
           T
Sbjct: 186 T 186

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 63.9 bits (156), Expect = 4e-14
 Identities = 16/54 (29%), Positives = 26/54 (48%), Gaps = 3/54 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           IA  + +LH      ++HRDLK SN+    +   K+ DFG+      ++ E   
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 63.9 bits (156), Expect = 4e-14
 Identities = 27/64 (42%), Positives = 37/64 (57%), Gaps = 7/64 (10%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           ++ G+     YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  E   N+
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 74  IVGT 77
           + GT
Sbjct: 167 MCGT 170

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 63.8 bits (156), Expect = 4e-14
 Identities = 21/68 (30%), Positives = 38/68 (55%), Gaps = 3/68 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
            +  +  ++    IA+G+ YL      +++HRDL A NVL+    + KI+DFG+A++ G 
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 65  NQSEANTN 72
            + E +  
Sbjct: 170 EEKEYHAE 177

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 63.9 bits (156), Expect = 5e-14
 Identities = 21/64 (32%), Positives = 38/64 (59%), Gaps = 3/64 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           +LD  R +   + I +G+ YL      + +HRDL A N+L++ E + KI+DFG+A++   
Sbjct: 123 RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

Query: 65  NQSE 68
           ++  
Sbjct: 180 DKDY 183

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 63.4 bits (155), Expect = 5e-14
 Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           I++G+ YL   + +K++HRDL A N+L+      KISDFG++R
Sbjct: 159 ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 63.5 bits (155), Expect = 5e-14
 Identities = 20/56 (35%), Positives = 28/56 (50%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
                + I +   IA G+ YL+     K +HRDL A N ++  +   KI DFGM R
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 63.5 bits (155), Expect = 5e-14
 Identities = 18/62 (29%), Positives = 35/62 (56%), Gaps = 3/62 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           ++D  + +   + I +G+ YL      + IHRDL   N+L+++E   KI DFG+ ++   
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

Query: 65  NQ 66
           ++
Sbjct: 167 DK 168

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 63.5 bits (155), Expect = 6e-14
 Identities = 20/67 (29%), Positives = 38/67 (56%), Gaps = 3/67 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           +    + + ++ GIA G+ YL   + +  +HRDL A N+L++  +  K+SDFG++R+   
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199

Query: 65  NQSEANT 71
           +     T
Sbjct: 200 DPEATYT 206

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 63.6 bits (155), Expect = 6e-14
 Identities = 23/64 (35%), Positives = 31/64 (48%), Gaps = 7/64 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-KISDFGMARIF---GGNQSEANTNR 73
              GL YLH     +I+H D+KA NVLL  + +   + DFG A      G  +S    + 
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 74  IVGT 77
           I GT
Sbjct: 216 IPGT 219

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 63.5 bits (155), Expect = 6e-14
 Identities = 19/56 (33%), Positives = 32/56 (57%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            L   + +++ + +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R
Sbjct: 154 PLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 63.0 bits (154), Expect = 6e-14
 Identities = 20/64 (31%), Positives = 34/64 (53%), Gaps = 3/64 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           ++       +++ ++ G+ YL        +HRDL A NVLL +    KISDFG+++  G 
Sbjct: 106 EIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162

Query: 65  NQSE 68
           + S 
Sbjct: 163 DDSY 166

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 63.5 bits (155), Expect = 6e-14
 Identities = 22/65 (33%), Positives = 37/65 (56%), Gaps = 3/65 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           Q    + + ++ GIA G+ YL   S +  +HRDL A N+L++  +  K+SDFG+ R+   
Sbjct: 143 QFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199

Query: 65  NQSEA 69
           +   A
Sbjct: 200 DPEAA 204

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 63.1 bits (154), Expect = 7e-14
 Identities = 17/49 (34%), Positives = 25/49 (51%), Gaps = 7/49 (14%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           +I+G+     YLH      I+H+D+K  N+LL      KIS  G+A   
Sbjct: 118 LIDGLE----YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 63.2 bits (154), Expect = 7e-14
 Identities = 18/64 (28%), Positives = 35/64 (54%), Gaps = 3/64 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           ++D  + +   + I +G+ YL      + IHRDL   N+L+++E   KI DFG+ ++   
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197

Query: 65  NQSE 68
           ++  
Sbjct: 198 DKEY 201

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 63.0 bits (154), Expect = 7e-14
 Identities = 20/64 (31%), Positives = 35/64 (54%), Gaps = 3/64 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
            +  K  I +++ ++ G+ YL        +HRDL A NVLL  +   KISDFG+++    
Sbjct: 113 HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169

Query: 65  NQSE 68
           +++ 
Sbjct: 170 DENY 173

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 63.0 bits (154), Expect = 8e-14
 Identities = 23/56 (41%), Positives = 32/56 (57%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            LD +  +S    +A+G+ +L   +    IHRDL A N+LL H    KI DFG+AR
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 63.1 bits (154), Expect = 8e-14
 Identities = 21/56 (37%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            L    ++ I   +A G+ YL   S  K +HRDL   N L+   M  KI+DFG++R
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 63.2 bits (154), Expect = 8e-14
 Identities = 19/46 (41%), Positives = 27/46 (58%), Gaps = 2/46 (4%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           +   I + L YL E     +IHRD+K SN+LLD     K+ DFG++
Sbjct: 129 MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 63.4 bits (154), Expect = 8e-14
 Identities = 19/64 (29%), Positives = 34/64 (53%), Gaps = 3/64 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           ++       +++ ++ G+ YL        +HR+L A NVLL +    KISDFG+++  G 
Sbjct: 432 EIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488

Query: 65  NQSE 68
           + S 
Sbjct: 489 DDSY 492

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 63.2 bits (154), Expect = 9e-14
 Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 3/62 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           +    + I     IA G+ ++    +   IHRDL+A+N+L+   +  KI+DFG+AR+   
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336

Query: 65  NQ 66
           N+
Sbjct: 337 NE 338

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 63.2 bits (154), Expect = 9e-14
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +ARG+ YL   +  K IHRDL A NVL+  +   KI+DFG+AR
Sbjct: 200 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 63.1 bits (154), Expect = 9e-14
 Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L        +HRDL A NVL+ H    KI DFG+AR
Sbjct: 181 VAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 62.7 bits (153), Expect = 9e-14
 Identities = 17/56 (30%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            +  +  +  +  IA G+ YL   S    +HRDL A N +L  +M   ++DFG+++
Sbjct: 143 HIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 63.1 bits (154), Expect = 1e-13
 Identities = 19/56 (33%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
               +  +   + +A+G+ +L   +    IHRD+ A NVLL +    KI DFG+AR
Sbjct: 160 TASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 62.8 bits (153), Expect = 1e-13
 Identities = 18/48 (37%), Positives = 24/48 (50%), Gaps = 3/48 (6%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           ++ GI RGL  +H        HRDLK +N+LL  E  P + D G    
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 62.7 bits (153), Expect = 1e-13
 Identities = 22/73 (30%), Positives = 38/73 (52%), Gaps = 4/73 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           +  KR I +I    + L + H   +  IIHRD+K +N+++      K+ DFG+AR    +
Sbjct: 113 MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

Query: 66  QSE-ANTNRIVGT 77
            +    T  ++GT
Sbjct: 170 GNSVTQTAAVIGT 182

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 62.7 bits (153), Expect = 1e-13
 Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 4/59 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQSEANTNRIV 75
           + R +  LH  S + + HRD+K  NVL++      K+ DFG A+    + SE N   I 
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYIC 193

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 62.7 bits (153), Expect = 1e-13
 Identities = 21/68 (30%), Positives = 38/68 (55%), Gaps = 3/68 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
            +  +  ++    IA+G+ YL      +++HRDL A NVL+    + KI+DFG+A++ G 
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 65  NQSEANTN 72
            + E +  
Sbjct: 170 EEKEYHAE 177

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 62.2 bits (152), Expect = 1e-13
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 4/72 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L     I+  N I  G+ + H    ++I+HRD+K  N+L+D     KI DFG+A+     
Sbjct: 108 LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SE 163

Query: 66  QSEANTNRIVGT 77
            S   TN ++GT
Sbjct: 164 TSLTQTNHVLGT 175

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 62.2 bits (152), Expect = 1e-13
 Identities = 20/56 (35%), Positives = 32/56 (57%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            L+    + ++  IA G+ YL   S   ++H+DL   NVL+  ++N KISD G+ R
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 62.5 bits (152), Expect = 2e-13
 Identities = 21/75 (28%), Positives = 36/75 (48%), Gaps = 9/75 (12%)

Query: 9   KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL-----DHEMNPKISDFGMARIFG 63
              I+++     GL +LH    L I+HRDLK  N+L+       ++   ISDFG+ +   
Sbjct: 118 LEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 64  GNQSE-ANTNRIVGT 77
             +   +  + + GT
Sbjct: 175 VGRHSFSRRSGVPGT 189

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 62.5 bits (152), Expect = 2e-13
 Identities = 16/62 (25%), Positives = 31/62 (50%), Gaps = 3/62 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           ++     + +   I+  + YL    +   IHR+L A N L+      K++DFG++R+  G
Sbjct: 314 EVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370

Query: 65  NQ 66
           + 
Sbjct: 371 DT 372

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 62.0 bits (151), Expect = 2e-13
 Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            L  +  +  +  IA G+ YL   S    IHRDL A N +L  +M   ++DFG++R
Sbjct: 133 NLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 61.9 bits (151), Expect = 2e-13
 Identities = 20/56 (35%), Positives = 31/56 (55%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +L   + + I + IA G++YL   +    +HRDL   N L+   +  KI DFGM+R
Sbjct: 129 ELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 61.9 bits (151), Expect = 2e-13
 Identities = 18/71 (25%), Positives = 33/71 (46%), Gaps = 3/71 (4%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
              ++     + +   I+  + YL    +   IHRDL A N L+      K++DFG++R+
Sbjct: 104 NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160

Query: 62  FGGNQSEANTN 72
             G+   A+  
Sbjct: 161 MTGDTYTAHAG 171

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 61.6 bits (150), Expect = 2e-13
 Identities = 20/64 (31%), Positives = 35/64 (54%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           +   +   L +LH     +IIHRDLKA NVL+  E + +++DFG++        + ++  
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-- 176

Query: 74  IVGT 77
            +GT
Sbjct: 177 FIGT 180

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 61.5 bits (150), Expect = 2e-13
 Identities = 23/56 (41%), Positives = 31/56 (55%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
               K  IS    +ARG+ YL   +  K +HRDL A N +LD     K++DFG+AR
Sbjct: 120 NPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 62.1 bits (151), Expect = 2e-13
 Identities = 19/48 (39%), Positives = 28/48 (58%), Gaps = 7/48 (14%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP----KISDFGMARIFG 63
            G+ YLH +    ++HRDLK +N+L+  E       KI+D G AR+F 
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 61.8 bits (150), Expect = 2e-13
 Identities = 20/61 (32%), Positives = 36/61 (59%), Gaps = 3/61 (4%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A  
Sbjct: 366 VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422

Query: 72  N 72
            
Sbjct: 423 G 423

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 61.9 bits (150), Expect = 3e-13
 Identities = 12/66 (18%), Positives = 25/66 (37%), Gaps = 3/66 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L    R+ +   + R L  LH      ++H  L+  +++LD      ++ F      G  
Sbjct: 203 LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259

Query: 66  QSEANT 71
              + +
Sbjct: 260 VVSSVS 265

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 61.7 bits (150), Expect = 3e-13
 Identities = 20/56 (35%), Positives = 31/56 (55%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
               K  I     +A+G+ +L   +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 61.6 bits (149), Expect = 3e-13
 Identities = 6/59 (10%), Positives = 14/59 (23%), Gaps = 3/59 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
                    +   + R    L       ++H      N+ +  +    + D       G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 61.5 bits (150), Expect = 3e-13
 Identities = 21/56 (37%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
               K  I     +A+G+ YL      K +HRDL A N +LD +   K++DFG+AR
Sbjct: 124 NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 61.6 bits (150), Expect = 3e-13
 Identities = 25/64 (39%), Positives = 39/64 (60%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I+    +GL YLH     + IHRD+KA N+LL+ E + K++DFG+A       ++ NT  
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-- 184

Query: 74  IVGT 77
           ++GT
Sbjct: 185 VIGT 188

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 61.6 bits (150), Expect = 3e-13
 Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            L     +     +   + YL        +HRDL A NVL+  +   K+SDFG+ +
Sbjct: 285 VLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 61.3 bits (149), Expect = 3e-13
 Identities = 14/45 (31%), Positives = 22/45 (48%), Gaps = 3/45 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           +   + YL       IIHRD+K  N+++  +   K+ DFG A   
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 61.3 bits (149), Expect = 4e-13
 Identities = 18/49 (36%), Positives = 26/49 (53%), Gaps = 1/49 (2%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I     R + ++H   +  IIHRDLK  N+LL ++   K+ DFG A   
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 61.3 bits (149), Expect = 4e-13
 Identities = 22/49 (44%), Positives = 31/49 (63%), Gaps = 7/49 (14%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I++G+     Y H   R  ++HRDLK  NVLLD  MN KI+DFG++ + 
Sbjct: 125 ILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 61.3 bits (149), Expect = 4e-13
 Identities = 25/60 (41%), Positives = 33/60 (55%), Gaps = 5/60 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I  GL +LH+     II+RDLK  NVLLD + N +ISD G+A      Q++       GT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 61.2 bits (149), Expect = 4e-13
 Identities = 22/45 (48%), Positives = 30/45 (66%), Gaps = 3/45 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I   + Y H   + +I+HRDLKA N+LLD +MN KI+DFG +  F
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 60.9 bits (148), Expect = 5e-13
 Identities = 20/61 (32%), Positives = 36/61 (59%), Gaps = 3/61 (4%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+  A  
Sbjct: 283 VDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339

Query: 72  N 72
            
Sbjct: 340 G 340

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 60.7 bits (148), Expect = 5e-13
 Identities = 18/58 (31%), Positives = 26/58 (44%), Gaps = 4/58 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIV 75
           I  G+ + H      IIHRD+K  N+L+      K+ DFG AR       E   + + 
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA 186

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 60.7 bits (148), Expect = 5e-13
 Identities = 18/63 (28%), Positives = 30/63 (47%), Gaps = 4/63 (6%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           SI     + + + H   +   IHRD+K  N+L+      K+ DFG AR+  G  S+   +
Sbjct: 106 SITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDD 161

Query: 73  RIV 75
            + 
Sbjct: 162 EVA 164

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 60.8 bits (148), Expect = 5e-13
 Identities = 24/49 (48%), Positives = 30/49 (61%), Gaps = 7/49 (14%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           II  I     Y H   R KI+HRDLK  N+LLD  +N KI+DFG++ I 
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 60.3 bits (147), Expect = 6e-13
 Identities = 20/65 (30%), Positives = 38/65 (58%), Gaps = 3/65 (4%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
             ++L   + + +   IA G+ ++        IHRDL+A+N+L+   ++ KI+DFG+AR+
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARL 158

Query: 62  FGGNQ 66
              N+
Sbjct: 159 IEDNE 163

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 60.8 bits (148), Expect = 6e-13
 Identities = 29/64 (45%), Positives = 38/64 (59%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           I+  I +GL YLH +   K IHRD+KA+NVLL      K++DFG+A      Q + NT  
Sbjct: 124 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-- 178

Query: 74  IVGT 77
            VGT
Sbjct: 179 FVGT 182

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 60.3 bits (147), Expect = 6e-13
 Identities = 21/49 (42%), Positives = 30/49 (61%), Gaps = 7/49 (14%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
           I++ +     Y H   R  ++HRDLK  NVLLD  MN KI+DFG++ + 
Sbjct: 120 ILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 60.8 bits (148), Expect = 6e-13
 Identities = 18/67 (26%), Positives = 33/67 (49%), Gaps = 3/67 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
            L  +  ++    IA+G+ YL       ++HR+L A NVLL      +++DFG+A +   
Sbjct: 111 ALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167

Query: 65  NQSEANT 71
           +  +   
Sbjct: 168 DDKQLLY 174

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 61.0 bits (148), Expect = 6e-13
 Identities = 18/56 (32%), Positives = 27/56 (48%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            LD    I     ++  L YL      + +HRD+ A NVL+      K+ DFG++R
Sbjct: 487 SLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 60.4 bits (147), Expect = 6e-13
 Identities = 16/60 (26%), Positives = 29/60 (48%), Gaps = 4/60 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   +  +H+     I+H DLK +N L+  +   K+ DFG+A     + +    +  VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 60.4 bits (147), Expect = 6e-13
 Identities = 22/65 (33%), Positives = 34/65 (52%), Gaps = 6/65 (9%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
            I+  +   +  LH+   L I+HRDLK  N+LLD +MN K++DFG +      +      
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LR 181

Query: 73  RIVGT 77
            + GT
Sbjct: 182 EVCGT 186

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 60.3 bits (147), Expect = 6e-13
 Identities = 18/57 (31%), Positives = 27/57 (47%), Gaps = 3/57 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
            LD    I     ++  L YL      + +HRD+ A NVL+      K+ DFG++R 
Sbjct: 112 SLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 60.5 bits (147), Expect = 7e-13
 Identities = 16/60 (26%), Positives = 29/60 (48%), Gaps = 4/60 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   +  +H+     I+H DLK +N L+  +   K+ DFG+A     + +    +  VGT
Sbjct: 117 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 59.9 bits (146), Expect = 8e-13
 Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 3/56 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            L     +     +   + YL        +HRDL A NVL+  +   K+SDFG+ +
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 60.0 bits (146), Expect = 8e-13
 Identities = 21/64 (32%), Positives = 37/64 (57%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           +     + L +LH +   ++IHRD+K+ N+LL  + + K++DFG        QS+ +T  
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-- 175

Query: 74  IVGT 77
           +VGT
Sbjct: 176 MVGT 179

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 60.6 bits (147), Expect = 8e-13
 Identities = 15/60 (25%), Positives = 28/60 (46%), Gaps = 4/60 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   +  +H+     I+H DLK +N L+  +   K+ DFG+A     + +    +  VG 
Sbjct: 164 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 60.3 bits (147), Expect = 9e-13
 Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 9/63 (14%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-----KISDFGMARIFGGNQSEANTN 72
           +  G+ + H     + +HRDLK  N+LL           KI DFG+AR F G      T+
Sbjct: 141 LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTH 196

Query: 73  RIV 75
            I+
Sbjct: 197 EII 199

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 60.1 bits (146), Expect = 9e-13
 Identities = 21/59 (35%), Positives = 30/59 (50%), Gaps = 6/59 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQSEANTNRIV 75
           + R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + I 
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYIC 218

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 60.1 bits (146), Expect = 1e-12
 Identities = 25/64 (39%), Positives = 34/64 (53%), Gaps = 9/64 (14%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           + +G  +GL YLH      +IHRD+KA N+LL      K+ DFG A       + AN+  
Sbjct: 159 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS-- 209

Query: 74  IVGT 77
            VGT
Sbjct: 210 FVGT 213

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 60.2 bits (146), Expect = 1e-12
 Identities = 23/60 (38%), Positives = 31/60 (51%), Gaps = 6/60 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I  GL  LH     +I++RDLK  N+LLD   + +ISD G+A      Q+       VGT
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 60.3 bits (146), Expect = 1e-12
 Identities = 21/60 (35%), Positives = 33/60 (55%), Gaps = 7/60 (11%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I  GL ++H      +++RDLK +N+LLD   + +ISD G+A  F   +     +  VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 59.6 bits (145), Expect = 1e-12
 Identities = 22/64 (34%), Positives = 26/64 (40%), Gaps = 3/64 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
                        +A G+ YL E  R   IHRDL A N+LL      KI DFG+ R    
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYL-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173

Query: 65  NQSE 68
           N   
Sbjct: 174 NDDH 177

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 59.9 bits (145), Expect = 1e-12
 Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 7/53 (13%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLL----DHEMNPKISDFGMARIFGGNQ 66
           +  G+ +L E     I+HR++K  N++     D +   K++DFG AR    ++
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 59.1 bits (144), Expect = 2e-12
 Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 3/62 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
            L     +     I + + YL     +  +HRD+   N+L+      K+ DFG++R    
Sbjct: 109 SLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165

Query: 65  NQ 66
             
Sbjct: 166 ED 167

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 59.4 bits (144), Expect = 2e-12
 Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 7/53 (13%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLL----DHEMNPKISDFGMARIFGGNQ 66
           +  G+ +L E     I+HR++K  N++     D +   K++DFG AR    ++
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 59.3 bits (144), Expect = 2e-12
 Identities = 21/65 (32%), Positives = 32/65 (49%), Gaps = 6/65 (9%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           SI+  +   + +LH      I+HRDLK  N+LLD  M  ++SDFG +      +      
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LR 257

Query: 73  RIVGT 77
            + GT
Sbjct: 258 ELCGT 262

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 59.4 bits (144), Expect = 2e-12
 Identities = 19/59 (32%), Positives = 31/59 (52%), Gaps = 6/59 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQSEANTNRIV 75
           + R + ++H    L I HRD+K  N+L++ + N  K+ DFG A+      SE +   I 
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC 203

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 59.7 bits (144), Expect = 2e-12
 Identities = 20/52 (38%), Positives = 27/52 (51%), Gaps = 6/52 (11%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIFGGNQ 66
           I+  L YLHE    +IIHRDLK  N++L      +  KI D G A+     +
Sbjct: 130 ISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 59.1 bits (144), Expect = 2e-12
 Identities = 17/42 (40%), Positives = 24/42 (57%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           +A  L Y H     ++IHRD+K  N+LL      KI+DFG +
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 59.3 bits (144), Expect = 2e-12
 Identities = 22/59 (37%), Positives = 30/59 (50%), Gaps = 6/59 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQSEANTNRIV 75
           + R L Y+H    + I HRD+K  N+LLD      K+ DFG A+I      E N + I 
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYIC 203

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 59.3 bits (144), Expect = 2e-12
 Identities = 26/68 (38%), Positives = 39/68 (57%), Gaps = 6/68 (8%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGM-ARIFGGNQSEANT 71
           +I+  +  GL YLH++     IHRD+KA N+LL  + + +I+DFG+ A +  G     N 
Sbjct: 125 TILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181

Query: 72  NR--IVGT 77
            R   VGT
Sbjct: 182 VRKTFVGT 189

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 59.3 bits (144), Expect = 2e-12
 Identities = 19/64 (29%), Positives = 33/64 (51%), Gaps = 5/64 (7%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           +   + + L YLH      +IHRD+K+ ++LL  +   K+SDFG       +  +  +  
Sbjct: 146 VCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-- 200

Query: 74  IVGT 77
           +VGT
Sbjct: 201 LVGT 204

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 58.9 bits (143), Expect = 2e-12
 Identities = 22/61 (36%), Positives = 32/61 (52%), Gaps = 6/61 (9%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-NPKISDFGMARIFGGNQSEANTNRIVG 76
           I +GL +LH  +   IIHRDLK  N+ +     + KI D G+A +     S A    ++G
Sbjct: 138 ILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA--VIG 192

Query: 77  T 77
           T
Sbjct: 193 T 193

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 59.4 bits (144), Expect = 2e-12
 Identities = 29/81 (35%), Positives = 37/81 (45%), Gaps = 18/81 (22%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-------------KISDFGM 58
           IS++  IA G+ +LH    LKIIHRDLK  N+L+                    ISDFG+
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174

Query: 59  ARIFGGNQS--EANTNRIVGT 77
            +     QS    N N   GT
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGT 195

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 58.8 bits (143), Expect = 2e-12
 Identities = 15/62 (24%), Positives = 32/62 (51%), Gaps = 3/62 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           +   ++ + +   +   + YL      + +HRDL A N L++ +   K+SDFG++R    
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172

Query: 65  NQ 66
           ++
Sbjct: 173 DE 174

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 58.7 bits (143), Expect = 2e-12
 Identities = 20/62 (32%), Positives = 33/62 (53%), Gaps = 3/62 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
            L+  + + +   +  G+ +L      + IHRDL A N L+D ++  K+SDFGM R    
Sbjct: 100 GLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156

Query: 65  NQ 66
           +Q
Sbjct: 157 DQ 158

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 59.2 bits (143), Expect = 2e-12
 Identities = 13/69 (18%), Positives = 25/69 (36%), Gaps = 8/69 (11%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT-- 71
           I+ G+ + L Y+H       +HR +KAS++L+  +    +S          +        
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189

Query: 72  ---NRIVGT 77
                 V  
Sbjct: 190 DFPKYSVKV 198

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 58.8 bits (143), Expect = 2e-12
 Identities = 17/40 (42%), Positives = 25/40 (62%), Gaps = 3/40 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG 57
           +A  L Y H     K+IHRD+K  N+L+ ++   KI+DFG
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG 159

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 59.1 bits (143), Expect = 2e-12
 Identities = 18/72 (25%), Positives = 28/72 (38%), Gaps = 10/72 (13%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L     I+ +  I   L YLH    + +++ DLK  N++L  E   K+ D G        
Sbjct: 179 LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS- 233

Query: 66  QSEANTNRIVGT 77
                   + GT
Sbjct: 234 -----FGYLYGT 240

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 58.4 bits (142), Expect = 3e-12
 Identities = 19/55 (34%), Positives = 27/55 (49%), Gaps = 3/55 (5%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
           + +   +  G+ YL       +IHRDL A N L+      K+SDFGM R    +Q
Sbjct: 107 LGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 58.4 bits (142), Expect = 4e-12
 Identities = 19/72 (26%), Positives = 29/72 (40%), Gaps = 4/72 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L   R ++I+  I   L   H        HRD+K  N+L+  +    + DFG+A      
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187

Query: 66  QSEANTNRIVGT 77
           +        VGT
Sbjct: 188 KLTQ-LGNTVGT 198

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 58.3 bits (141), Expect = 5e-12
 Identities = 17/55 (30%), Positives = 31/55 (56%), Gaps = 3/55 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
           +  G+ Y+H      I+HRDLK +N L++ + + K+ DFG+AR     ++  +  
Sbjct: 165 LLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.0 bits (140), Expect = 6e-12
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +A+G+ +L   +  K IHRDL A N+LL  +   KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 57.4 bits (139), Expect = 8e-12
 Identities = 22/59 (37%), Positives = 25/59 (42%), Gaps = 6/59 (10%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMAR 60
            L     + +   IA G  YL        IHRD+ A N LL         KI DFGMAR
Sbjct: 177 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 57.5 bits (139), Expect = 9e-12
 Identities = 20/69 (28%), Positives = 29/69 (42%), Gaps = 7/69 (10%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL--DHEMNPKISDFGMARIFGGNQSEAN 70
           +I+  I   L YLH      I HRD+K  N L   +     K+ DFG+++ F    +   
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228

Query: 71  T--NRIVGT 77
                  GT
Sbjct: 229 YGMTTKAGT 237

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 56.9 bits (138), Expect = 1e-11
 Identities = 22/59 (37%), Positives = 25/59 (42%), Gaps = 6/59 (10%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMAR 60
            L     + +   IA G  YL        IHRD+ A N LL         KI DFGMAR
Sbjct: 136 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 56.6 bits (137), Expect = 2e-11
 Identities = 19/60 (31%), Positives = 28/60 (46%), Gaps = 6/60 (10%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   L YL      +IIHRD+K  N+LLD   +  I+DF +A +            + GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 56.1 bits (136), Expect = 3e-11
 Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           IA  L YLH    L I++RDLK  N+LLD + +  ++DFG+ 
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 56.3 bits (136), Expect = 3e-11
 Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           +  G  ++HE     IIHRDLK +N LL+ + + K+ DFG+AR     +     N 
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 55.8 bits (135), Expect = 4e-11
 Identities = 23/68 (33%), Positives = 30/68 (44%), Gaps = 8/68 (11%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQSEA 69
             +  I   L Y H+     IIHRD+K   VLL  + N    K+  FG+A   G +   A
Sbjct: 134 HYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190

Query: 70  NTNRIVGT 77
                VGT
Sbjct: 191 GG--RVGT 196

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 55.4 bits (134), Expect = 4e-11
 Identities = 12/46 (26%), Positives = 22/46 (47%), Gaps = 4/46 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-KISDFGMARIF 62
           +   + + H      ++HRD+K  N+L+D      K+ DFG   + 
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 55.4 bits (134), Expect = 4e-11
 Identities = 12/46 (26%), Positives = 22/46 (47%), Gaps = 4/46 (8%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIF 62
           +   + + H      ++HRD+K  N+L+D      K+ DFG   + 
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 55.2 bits (134), Expect = 5e-11
 Identities = 18/54 (33%), Positives = 34/54 (62%), Gaps = 3/54 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           I+  L +LH+     II+RDLK  N++L+H+ + K++DFG+ +    + +  +T
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 55.2 bits (134), Expect = 5e-11
 Identities = 21/54 (38%), Positives = 35/54 (64%), Gaps = 3/54 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           +A  L +LH    L II+RDLK  N+LLD E + K++DFG+++    ++ +A +
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 54.9 bits (133), Expect = 6e-11
 Identities = 24/54 (44%), Positives = 32/54 (59%), Gaps = 3/54 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           I   L++LH+     II+RDLK  NVLLDHE + K++DFGM +    N     T
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 54.9 bits (133), Expect = 6e-11
 Identities = 22/54 (40%), Positives = 32/54 (59%), Gaps = 3/54 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +      ++ NT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 55.0 bits (133), Expect = 6e-11
 Identities = 22/69 (31%), Positives = 32/69 (46%), Gaps = 9/69 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL-DHEMNP---KISDFGMARIFGGNQSE 68
           +++  I + + YLH      ++HRDLK SN+L  D   NP   +I DFG A+        
Sbjct: 120 AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176

Query: 69  ANTNRIVGT 77
             T     T
Sbjct: 177 LMT--PCYT 183

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 55.0 bits (133), Expect = 6e-11
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 3/54 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           I+  L YLHE     II+RDLK  NVLLD E + K++D+GM +         +T
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 54.9 bits (133), Expect = 6e-11
 Identities = 19/55 (34%), Positives = 32/55 (58%), Gaps = 3/55 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
             R +  LH  +   +IHRDLK SN+L++   + K+ DFG+ARI   + ++ +  
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 55.0 bits (133), Expect = 7e-11
 Identities = 22/53 (41%), Positives = 32/53 (60%), Gaps = 3/53 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEAN 70
           I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+   +     
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 54.9 bits (133), Expect = 7e-11
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 3/54 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           I+  L YLHE     II+RDLK  NVLLD E + K++D+GM +         +T
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 55.0 bits (133), Expect = 7e-11
 Identities = 22/68 (32%), Positives = 35/68 (51%), Gaps = 3/68 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           M+  +L   R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 120 MKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

Query: 61  IFGGNQSE 68
                 + 
Sbjct: 177 QADSEMTG 184

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 54.9 bits (133), Expect = 7e-11
 Identities = 16/42 (38%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           I   L YLH      +++RD+K  N++LD + + KI+DFG+ 
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLC 152

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 55.0 bits (132), Expect = 7e-11
 Identities = 22/42 (52%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           IA GL +L       II+RDLK  NV+LD E + KI+DFGM 
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 54.6 bits (132), Expect = 9e-11
 Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 9/63 (14%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEANTNRI 74
           +   + YLHE     IIHRDLK  NVLL   + +   KI+DFG ++I G          +
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176

Query: 75  VGT 77
            GT
Sbjct: 177 CGT 179

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 54.7 bits (132), Expect = 9e-11
 Identities = 18/51 (35%), Positives = 27/51 (52%), Gaps = 9/51 (17%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH--EMNPKISDFGMARIF 62
           +++G++    Y H    ++I HRDLK  N LLD       KI DFG ++  
Sbjct: 125 LLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 54.5 bits (132), Expect = 1e-10
 Identities = 22/42 (52%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           IA GL +L       II+RDLK  NV+LD E + KI+DFGM 
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 54.4 bits (131), Expect = 1e-10
 Identities = 19/54 (35%), Positives = 31/54 (57%), Gaps = 2/54 (3%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANT 71
           I   L YLH  S   +++RDLK  N++LD + + KI+DFG+ +    + +   T
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 54.3 bits (131), Expect = 1e-10
 Identities = 17/60 (28%), Positives = 28/60 (46%), Gaps = 4/60 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I   +  +H    L  +HRD+K  N+LLD   + +++DFG       +     +   VGT
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGT 226

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 54.3 bits (131), Expect = 1e-10
 Identities = 20/56 (35%), Positives = 34/56 (60%), Gaps = 3/56 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNR 73
           + + + YLH  S   ++HRD+K SN+LL+ E + K++DFG++R F   +   N   
Sbjct: 118 LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 53.8 bits (130), Expect = 1e-10
 Identities = 13/64 (20%), Positives = 29/64 (45%), Gaps = 11/64 (17%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--------KISDF 56
            ++   ++ +   +A  + +L       +IH ++ A N+LL  E +         K+SD 
Sbjct: 109 CINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165

Query: 57  GMAR 60
           G++ 
Sbjct: 166 GISI 169

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 54.3 bits (131), Expect = 1e-10
 Identities = 24/63 (38%), Positives = 31/63 (49%), Gaps = 9/63 (14%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQSEANTNRI 74
           +   + YLHE     IIHRDLK  NVLL  +      KI+DFG ++I G          +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301

Query: 75  VGT 77
            GT
Sbjct: 302 CGT 304

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 53.9 bits (130), Expect = 2e-10
 Identities = 22/51 (43%), Positives = 29/51 (56%), Gaps = 3/51 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      + 
Sbjct: 141 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 53.4 bits (129), Expect = 2e-10
 Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 8/62 (12%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQSEANTNRIV 75
           I   L +LH+   L II+RD+K  N+LLD   +  ++DFG+++  +    +         
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDFC 221

Query: 76  GT 77
           GT
Sbjct: 222 GT 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 53.5 bits (129), Expect = 2e-10
 Identities = 17/51 (33%), Positives = 28/51 (54%), Gaps = 3/51 (5%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR      + 
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 53.5 bits (129), Expect = 2e-10
 Identities = 18/49 (36%), Positives = 24/49 (48%), Gaps = 3/49 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
           I  GL  LHE     ++HRDL   N+LL    +  I DF +AR    + 
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 53.0 bits (128), Expect = 3e-10
 Identities = 23/68 (33%), Positives = 35/68 (51%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEA 69
            II  +  G+ Y+H+     I+HRDLK  N+LL   + + + KI DFG++  F  N    
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179

Query: 70  NTNRIVGT 77
                +GT
Sbjct: 180 -MKDRIGT 186

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 53.2 bits (128), Expect = 3e-10
 Identities = 15/60 (25%), Positives = 30/60 (50%), Gaps = 4/60 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   +  +H+   L  +HRD+K  N+L+D   + +++DFG       +     ++  VGT
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGT 239

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 53.1 bits (128), Expect = 3e-10
 Identities = 18/68 (26%), Positives = 32/68 (47%), Gaps = 8/68 (11%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEA 69
            I+  +   + ++H+   + ++HRDLK  N+L    +  +  KI DFG AR+   +    
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166

Query: 70  NTNRIVGT 77
            T     T
Sbjct: 167 KT--PCFT 172

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 53.3 bits (128), Expect = 3e-10
 Identities = 20/49 (40%), Positives = 29/49 (59%), Gaps = 3/49 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
           +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G + 
Sbjct: 173 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 52.9 bits (128), Expect = 3e-10
 Identities = 20/42 (47%), Positives = 25/42 (59%), Gaps = 3/42 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMA 59
           +   L YLH      II+RDLK  N+LLD   + KI+DFG A
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 53.2 bits (128), Expect = 3e-10
 Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 4/60 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           +   L  +H    +  IHRD+K  N+LLD   + K++DFG              +  VGT
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGT 232

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 53.0 bits (128), Expect = 3e-10
 Identities = 21/54 (38%), Positives = 33/54 (61%), Gaps = 4/54 (7%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQSEAN 70
           + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI   + S   
Sbjct: 129 LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 53.0 bits (128), Expect = 3e-10
 Identities = 21/70 (30%), Positives = 29/70 (41%), Gaps = 10/70 (14%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQS 67
              +  I  G+ YLH     +I H DLK  N++L  +  P    K+ DFG+A        
Sbjct: 111 TQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167

Query: 68  EANTNRIVGT 77
                 I GT
Sbjct: 168 ---FKNIFGT 174

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 52.8 bits (127), Expect = 4e-10
 Identities = 20/49 (40%), Positives = 29/49 (59%), Gaps = 3/49 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
           +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G + 
Sbjct: 136 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 52.3 bits (126), Expect = 5e-10
 Identities = 18/79 (22%), Positives = 25/79 (31%), Gaps = 28/79 (35%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-------------------KISDFGM 58
           + RGL Y+H      ++H D+K SN+ +     P                   KI D G 
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 59  ARIFGGNQSEANTNRIVGT 77
                  Q E       G 
Sbjct: 181 VTRISSPQVE------EGD 193

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 52.7 bits (127), Expect = 5e-10
 Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 8/60 (13%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT 77
           I     YLH    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGT 201

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 52.2 bits (126), Expect = 5e-10
 Identities = 18/68 (26%), Positives = 30/68 (44%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEA 69
            ++  +   L Y H      ++H+DLK  N+L          KI DFG+A +F  ++   
Sbjct: 128 ELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-- 182

Query: 70  NTNRIVGT 77
            +    GT
Sbjct: 183 -STNAAGT 189

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 52.2 bits (126), Expect = 5e-10
 Identities = 20/68 (29%), Positives = 29/68 (42%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEA 69
            I+  +   + Y H+   L + HRDLK  N L      +   K+ DFG+A  F   +   
Sbjct: 110 RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--- 163

Query: 70  NTNRIVGT 77
                VGT
Sbjct: 164 MMRTKVGT 171

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 52.4 bits (126), Expect = 5e-10
 Identities = 20/68 (29%), Positives = 32/68 (47%), Gaps = 8/68 (11%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQSEA 69
           I  +  I  G+ ++H+   + I+H DLK  N+L  +      KI DFG+AR +   +   
Sbjct: 190 ILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243

Query: 70  NTNRIVGT 77
                 GT
Sbjct: 244 KLKVNFGT 251

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 52.2 bits (126), Expect = 5e-10
 Identities = 19/68 (27%), Positives = 31/68 (45%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQSEA 69
             I  I   + Y H      I+HR+LK  N+LL  +      K++DFG+A     +++  
Sbjct: 109 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163

Query: 70  NTNRIVGT 77
             +   GT
Sbjct: 164 -WHGFAGT 170

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 52.3 bits (126), Expect = 6e-10
 Identities = 23/70 (32%), Positives = 29/70 (41%), Gaps = 10/70 (14%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQS 67
              +  I  G+ YLH    L+I H DLK  N++L     P    KI DFG+A        
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

Query: 68  EANTNRIVGT 77
                 I GT
Sbjct: 174 ---FKNIFGT 180

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 51.9 bits (125), Expect = 8e-10
 Identities = 24/70 (34%), Positives = 30/70 (42%), Gaps = 10/70 (14%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQS 67
            S I  I  G+ YLH     KI H DLK  N++L  +  P    K+ DFG+A        
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 68  EANTNRIVGT 77
                 I GT
Sbjct: 175 ---FKNIFGT 181

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 52.0 bits (125), Expect = 8e-10
 Identities = 24/70 (34%), Positives = 30/70 (42%), Gaps = 10/70 (14%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQS 67
            S I  I  G+ YLH     KI H DLK  N++L  +  P    K+ DFG+A        
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 68  EANTNRIVGT 77
                 I GT
Sbjct: 175 ---FKNIFGT 181

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 51.9 bits (125), Expect = 9e-10
 Identities = 19/68 (27%), Positives = 31/68 (45%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQSEA 69
             I  I   + Y H      I+HR+LK  N+LL  +      K++DFG+A     +++  
Sbjct: 132 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 186

Query: 70  NTNRIVGT 77
             +   GT
Sbjct: 187 -WHGFAGT 193

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 51.5 bits (124), Expect = 1e-09
 Identities = 18/49 (36%), Positives = 28/49 (57%), Gaps = 4/49 (8%)

Query: 20  RGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQS 67
           + L Y H  S   I+HRD+K  NV++DHE    ++ D+G+A  +   Q 
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 51.3 bits (123), Expect = 1e-09
 Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 8/68 (11%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQSEA 69
           I+ +     GL ++HE     I+H D+K  N++ + +     KI DFG+A     ++   
Sbjct: 152 INYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 205

Query: 70  NTNRIVGT 77
                  T
Sbjct: 206 IVKVTTAT 213

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 51.2 bits (123), Expect = 1e-09
 Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEA 69
            II  +  G+ Y+H+    KI+HRDLK  N+LL     + N +I DFG++  F  ++   
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-- 184

Query: 70  NTNRIVGT 77
                +GT
Sbjct: 185 -MKDKIGT 191

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 51.1 bits (123), Expect = 1e-09
 Identities = 19/73 (26%), Positives = 29/73 (39%), Gaps = 11/73 (15%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQSEA 69
            ++  +A  L +LH      I HRDLK  N+L +H       KI DF +      N   +
Sbjct: 115 VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 70  NTNR-----IVGT 77
             +        G+
Sbjct: 172 PISTPELLTPCGS 184

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 50.9 bits (122), Expect = 2e-09
 Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEA 69
           +I+  I  G+ YLH+     I+HRD+K  N+LL   +  +N KI DFG++  F  +    
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-- 204

Query: 70  NTNRIVGT 77
                +GT
Sbjct: 205 -LRDRLGT 211

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 50.9 bits (122), Expect = 2e-09
 Identities = 23/68 (33%), Positives = 35/68 (51%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEA 69
            II  +  G+ YLH+     I+HRDLK  N+LL   + +   KI DFG++ +F   +   
Sbjct: 140 VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-- 194

Query: 70  NTNRIVGT 77
                +GT
Sbjct: 195 -MKERLGT 201

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 50.7 bits (122), Expect = 2e-09
 Identities = 26/69 (37%), Positives = 34/69 (49%), Gaps = 9/69 (13%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSE 68
           I +I  I  G+ YLH+     I+H DLK  N+LL       + KI DFGM+R  G     
Sbjct: 134 IRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189

Query: 69  ANTNRIVGT 77
                I+GT
Sbjct: 190 --LREIMGT 196

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 50.8 bits (122), Expect = 2e-09
 Identities = 17/57 (29%), Positives = 27/57 (47%), Gaps = 6/57 (10%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQ 66
            I+  I   + +LH      I HRD+K  N+L    + +   K++DFG A+    N 
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 50.8 bits (122), Expect = 2e-09
 Identities = 20/68 (29%), Positives = 33/68 (48%), Gaps = 8/68 (11%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQSEA 69
             I  I   +L+ H+   + ++HR+LK  N+LL  ++     K++DFG+A    G Q   
Sbjct: 114 HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 70  NTNRIVGT 77
                 GT
Sbjct: 171 FG--FAGT 176

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 50.7 bits (122), Expect = 2e-09
 Identities = 15/68 (22%), Positives = 27/68 (39%), Gaps = 8/68 (11%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQSEA 69
           +S ++ +   L +LH      I H D++  N++     +   KI +FG AR         
Sbjct: 105 VSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158

Query: 70  NTNRIVGT 77
           N   +   
Sbjct: 159 NFRLLFTA 166

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 50.8 bits (122), Expect = 2e-09
 Identities = 23/68 (33%), Positives = 35/68 (51%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEA 69
            II  +  G+ Y+H+     I+HRDLK  N+LL   + + + KI DFG++  F  N    
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179

Query: 70  NTNRIVGT 77
                +GT
Sbjct: 180 -MKDRIGT 186

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 51.0 bits (122), Expect = 2e-09
 Identities = 16/68 (23%), Positives = 30/68 (44%), Gaps = 8/68 (11%)

Query: 12  ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQSEA 69
           +  +  + +GL ++HE      +H DLK  N++   + +   K+ DFG+       Q   
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311

Query: 70  NTNRIVGT 77
           +     GT
Sbjct: 312 SVKVTTGT 319

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 50.0 bits (120), Expect = 4e-09
 Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 9/68 (13%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEA 69
             +  I   + YLHE     I+HRDLK  N+L      +   KI+DFG+++I        
Sbjct: 152 DAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-- 206

Query: 70  NTNRIVGT 77
               + GT
Sbjct: 207 -MKTVCGT 213

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 49.9 bits (120), Expect = 4e-09
 Identities = 19/67 (28%), Positives = 31/67 (46%), Gaps = 10/67 (14%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQSEAN 70
           +I  +   + YLHE     I+HRDLK  N+L    +      I+DFG++++         
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---- 163

Query: 71  TNRIVGT 77
            +   GT
Sbjct: 164 MSTACGT 170

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 49.7 bits (119), Expect = 6e-09
 Identities = 18/58 (31%), Positives = 27/58 (46%), Gaps = 6/58 (10%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQS 67
            I+  I   + YLH    + I HRD+K  N+L          K++DFG A+    + S
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.0 bits (113), Expect = 2e-08
 Identities = 15/63 (23%), Positives = 22/63 (34%), Gaps = 2/63 (3%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           MR+         SI++ +   L        L+  HRDL   NVLL      K+      +
Sbjct: 153 MRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

Query: 61  IFG 63
              
Sbjct: 211 SST 213

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 45.4 bits (108), Expect = 2e-07
 Identities = 17/50 (34%), Positives = 25/50 (50%), Gaps = 6/50 (12%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMA 59
            I+  I   + YLH    + I HRD+K  N+L   +      K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 42.3 bits (99), Expect = 2e-06
 Identities = 12/66 (18%), Positives = 23/66 (34%), Gaps = 14/66 (21%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-----------KIS 54
           +     IS    +   +  +H+    +IIH D+K  N +L +                + 
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225

Query: 55  DFGMAR 60
           D G + 
Sbjct: 226 DLGQSI 231

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 41.2 bits (97), Expect = 5e-06
 Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 12/58 (20%)

Query: 12  ISIINGIAR----GLLYLHEDSRLKIIHRDLKASNVLLDHEMNP------KISDFGMA 59
           +  +  I++    GL Y+H   R  IIH D+K  NVL++   +P      KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 41.3 bits (97), Expect = 5e-06
 Identities = 6/55 (10%), Positives = 14/55 (25%), Gaps = 3/55 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
                 I  +  +A      H   R  +       S V +  + +  ++      
Sbjct: 126 PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 39.7 bits (93), Expect = 2e-05
 Identities = 18/44 (40%), Positives = 23/44 (52%), Gaps = 3/44 (6%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--KISDFGMA 59
           +   LL+L     L IIH DLK  N+LL +      KI DFG +
Sbjct: 166 MCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 37.8 bits (88), Expect = 8e-05
 Identities = 17/44 (38%), Positives = 24/44 (54%), Gaps = 5/44 (11%)

Query: 18  IARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--KISDFGMA 59
           I + L  LH   + +IIH DLK  N+LL  +     K+ DFG +
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 37.4 bits (87), Expect = 1e-04
 Identities = 14/41 (34%), Positives = 26/41 (63%), Gaps = 5/41 (12%)

Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNPKI--SDFGMARIF 62
           Y+HE      +H D+KASN+LL+++   ++   D+G+A  +
Sbjct: 167 YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 37.4 bits (87), Expect = 1e-04
 Identities = 12/41 (29%), Positives = 27/41 (65%), Gaps = 5/41 (12%)

Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNPKI--SDFGMARIF 62
           Y+HE+     +H D+KA+N+LL ++   ++  +D+G++  +
Sbjct: 166 YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 37.0 bits (86), Expect = 1e-04
 Identities = 10/41 (24%), Positives = 22/41 (53%), Gaps = 5/41 (12%)

Query: 24  YLHEDSRLKIIHRDLKASNVLLDHEMNPKI--SDFGMARIF 62
           +LHE+     +H ++ A N+ +D E   ++  + +G A  +
Sbjct: 174 FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 36.4 bits (84), Expect = 2e-04
 Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 2/63 (3%)

Query: 13  SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTN 72
            II  + +GL YLH  ++ +IIH D+K  N+LL             A  +  + +   + 
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 73  RIV 75
             V
Sbjct: 208 SAV 210

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	77
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.6
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.57
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.54
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.53
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.52
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.52
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.5
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.49
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.48
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.47
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.46
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.44
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.43
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.37
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.35
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.28
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.26
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.19
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.15
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.14
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.11
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.11
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.1
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.1
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.1
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.1
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.1
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.1
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.09
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.09
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.08
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.07
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.06
3niz_A	311	Rhodanese family protein; structural genomics, str	99.06
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.06
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.05
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.05
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.05
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.04
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.04
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.04
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.04
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.04
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.04
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.04
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.04
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.03
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.03
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.03
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.03
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.03
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.02
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.02
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.02
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.02
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.02
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.02
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.01
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.01
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	98.99
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	98.99
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	98.98
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	98.98
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	98.98
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	98.98
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	98.98
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	98.98
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	98.98
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	98.97
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	98.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	98.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	98.97
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	98.97
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	98.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	98.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	98.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	98.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	98.96
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	98.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	98.96
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	98.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	98.96
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	98.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	98.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	98.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	98.95
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	98.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	98.95
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	98.95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	98.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	98.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	98.94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	98.94
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	98.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	98.93
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	98.93
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	98.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	98.93
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	98.92
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	98.92
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	98.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	98.92
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	98.92
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	98.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	98.91
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	98.91
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	98.91
2a19_B	284	Interferon-induced, double-stranded RNA-activated	98.91
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	98.91
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	98.91
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	98.9
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	98.9
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	98.9
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	98.9
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	98.9
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	98.9
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	98.9
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	98.9
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	98.9
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	98.9
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	98.89
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	98.89
3fme_A	290	Dual specificity mitogen-activated protein kinase;	98.89
3pls_A	298	Macrophage-stimulating protein receptor; protein k	98.89
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	98.89
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	98.89
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	98.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	98.89
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	98.88
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	98.88
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	98.88
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	98.87
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	98.87
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	98.87
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	98.87
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	98.87
3an0_A	340	Dual specificity mitogen-activated protein kinase;	98.87
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	98.87
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	98.87
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	98.87
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	98.86
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	98.86
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	98.86
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	98.86
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	98.86
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	98.86
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	98.86
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	98.86
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	98.86
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	98.86
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	98.86
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	98.85
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	98.85
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	98.85
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	98.85
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	98.85
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	98.85
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	98.85
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	98.84
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	98.84
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	98.84
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	98.84
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	98.83
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	98.83
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	98.83
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	98.82
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	98.82
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	98.82
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	98.82
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	98.81
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	98.81
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	98.81
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	98.8
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	98.8
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	98.8
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	98.8
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	98.79
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	98.79
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	98.79
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	98.78
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	98.78
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	98.78
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	98.78
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	98.77
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	98.77
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	98.77
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	98.77
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	98.77
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	98.76
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	98.76
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	98.76
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	98.76
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	98.76
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	98.76
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	98.75
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	98.75
3bhy_A	283	Death-associated protein kinase 3; death associate	98.74
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	98.73
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	98.73
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	98.72
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	98.72
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	98.71
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	98.71
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	98.71
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	98.69
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	98.68
3aln_A	327	Dual specificity mitogen-activated protein kinase;	98.68
2dyl_A	318	Dual specificity mitogen-activated protein kinase	98.68
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	98.67
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	98.66
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	98.66
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	98.65
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	98.65
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	98.64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	98.6
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	98.6
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	98.59
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	98.57
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	98.57
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	98.54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	98.53
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	98.44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	98.42
3uqc_A	286	Probable conserved transmembrane protein; structur	98.14
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	97.34
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	91.81
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	91.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	90.45
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	84.11

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.60  E-value=5.3e-15  Score=79.45  Aligned_cols=71  Identities=38%  Similarity=0.583  Sum_probs=59.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCCCcccceecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEANTNRIVGT   77 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~g~   77 (77)
                      ..+++.....++.|++.++.|+|..+   ++||++++.|+++..+..+++.|||+++.+..+.......++.||
T Consensus       127 ~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GT  197 (311)
T 4aw0_A          127 GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT  197 (311)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccC
Confidence            46889999999999999999999985   999999999999999999999999999987654443334445565

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.57  E-value=5.2e-15  Score=79.39  Aligned_cols=59  Identities=36%  Similarity=0.624  Sum_probs=52.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+..++++|||+++....
T Consensus       126 ~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          126 ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            356899999999999999999999874   99999999999999999999999999986643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.54  E-value=2.4e-14  Score=77.89  Aligned_cols=59  Identities=27%  Similarity=0.512  Sum_probs=54.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..++.++++|||+++.+..+
T Consensus       165 ~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          165 TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            46889999999999999999999985   999999999999999999999999999877543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.53  E-value=5.3e-14  Score=78.19  Aligned_cols=59  Identities=27%  Similarity=0.512  Sum_probs=53.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++||++++.|+++..++.++++|||+++.+...
T Consensus       242 ~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          242 TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            46889999999999999999999985   999999999999999999999999999877543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.52  E-value=2.1e-14  Score=77.64  Aligned_cols=59  Identities=31%  Similarity=0.503  Sum_probs=48.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .+++|...+.++.|++.|+.|+|...   ++|+++++.|++++.+..++++|||+++.....
T Consensus       153 ~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~  211 (329)
T 4aoj_A          153 GPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST  211 (329)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCC
Confidence            46899999999999999999999874   999999999999999999999999999866443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.52  E-value=1.8e-14  Score=78.54  Aligned_cols=63  Identities=33%  Similarity=0.427  Sum_probs=55.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSEA   69 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~   69 (77)
                      ..+++...+.++.|++.|+.|+|...   ++||++++.|+++..+..+|++|||+++.+..+....
T Consensus       180 ~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~  242 (353)
T 4ase_A          180 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  242 (353)
T ss_dssp             TCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSE
T ss_pred             ccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCce
Confidence            45889999999999999999999874   9999999999999999999999999998776554433

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.50  E-value=2.8e-14  Score=76.57  Aligned_cols=59  Identities=32%  Similarity=0.509  Sum_probs=53.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..++|...+.++.|++.|+.|+|...   ++|+++++.|++++.+..++++|||+++.....
T Consensus       140 ~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~  198 (308)
T 4gt4_A          140 SALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA  198 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGG
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCC
Confidence            45899999999999999999999874   999999999999999999999999999866443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.49  E-value=1.7e-14  Score=77.18  Aligned_cols=58  Identities=34%  Similarity=0.567  Sum_probs=53.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..++|...+.++.|++.|+.|+|..+   ++|+++++.|+++..+..++++|||+++....
T Consensus       123 ~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  180 (299)
T 4asz_A          123 TELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYS  180 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCC
Confidence            46899999999999999999999874   99999999999999999999999999986543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.48  E-value=1e-13  Score=74.33  Aligned_cols=58  Identities=34%  Similarity=0.387  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.|++.|+.|+|..+   ++||++++.|+++..+..+++.|||+++....
T Consensus       121 ~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          121 VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            46889999999999999999999985   99999999999999999999999999986543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.47  E-value=3.4e-13  Score=73.19  Aligned_cols=59  Identities=34%  Similarity=0.473  Sum_probs=51.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-CeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-NPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++||++++.|+++..++ .+++.|||+++.+..+
T Consensus       145 ~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          145 GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            46899999999999999999999875   99999999999998776 6999999999877543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.46  E-value=2.3e-13  Score=72.83  Aligned_cols=64  Identities=28%  Similarity=0.364  Sum_probs=55.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDS-----RLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ...++|.....++.+++.|+.|+|...     ..+++|+++++.|++++.+..++++|||+++......
T Consensus        94 ~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  162 (303)
T 3hmm_A           94 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT  162 (303)
T ss_dssp             HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence            356889999999999999999999751     2369999999999999999999999999998775443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.44  E-value=3e-13  Score=71.66  Aligned_cols=59  Identities=34%  Similarity=0.582  Sum_probs=50.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.|++.|+.|+|+.+   ++||++++.|+++..+..+++.|||+++....
T Consensus       106 ~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A          106 RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            456899999999999999999999985   99999999999999999999999999986543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.43  E-value=6.9e-14  Score=76.19  Aligned_cols=57  Identities=28%  Similarity=0.533  Sum_probs=51.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.|+|..+   ++||++++.|+++..++.+++.|||+++.+.
T Consensus       120 ~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          120 VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            34688889999999999999999985   9999999999999999999999999998654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.41  E-value=1.2e-12  Score=72.40  Aligned_cols=60  Identities=40%  Similarity=0.603  Sum_probs=53.6

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +...+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+..+++.|||+++.+..
T Consensus       151 ~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          151 SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            3567899999999999999999999985   99999999999999999999999999987643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.37  E-value=1.3e-12  Score=69.89  Aligned_cols=57  Identities=28%  Similarity=0.506  Sum_probs=46.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .++.....++.|++.|+.|+|..+   ++|+++++.|+++..+..+++.|||+++.+..+
T Consensus       115 ~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~  171 (299)
T 4g31_A          115 RERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  171 (299)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC------
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCC
Confidence            345667788999999999999985   999999999999999999999999999877543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.35  E-value=4.1e-12  Score=74.07  Aligned_cols=60  Identities=30%  Similarity=0.361  Sum_probs=54.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++.....++.|++.|+.|+|..+   ++||++++.|+++..++.++++|||+++.+....
T Consensus       287 ~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          287 GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            46889999999999999999999875   9999999999999999999999999998776544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.34  E-value=2.2e-12  Score=68.83  Aligned_cols=58  Identities=34%  Similarity=0.484  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.|++.|+.|+|..+ .+++||++++.|+++.. +..++++|||+++..
T Consensus       124 ~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          124 KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            46889999999999999999999863 35999999999999974 678999999999754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.28  E-value=2.1e-11  Score=66.30  Aligned_cols=58  Identities=21%  Similarity=0.223  Sum_probs=52.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-----------CCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-----------EMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-----------~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..           ...+++.|||+++.+.
T Consensus       166 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~  234 (365)
T 3e7e_A          166 EKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK  234 (365)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhh
Confidence            456899999999999999999999874   999999999999987           7889999999997654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.26  E-value=8.9e-12  Score=71.42  Aligned_cols=56  Identities=23%  Similarity=0.424  Sum_probs=46.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .+++..   .++.|++.++.|+|..+   ++||++++.|+++..++.+++.|||+++....+
T Consensus       337 ~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          337 EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            345544   36789999999999985   999999999999999999999999999866543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.26  E-value=2.8e-11  Score=66.22  Aligned_cols=57  Identities=26%  Similarity=0.417  Sum_probs=50.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~~   64 (77)
                      .+++..+..++.|++.|+.|+|..+   ++||++++.|+++..+ ..+++.|||+++....
T Consensus       113 ~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          113 SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            4788899999999999999999985   9999999999999866 6899999999986643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.19  E-value=2.4e-10  Score=62.48  Aligned_cols=58  Identities=41%  Similarity=0.598  Sum_probs=52.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++....
T Consensus       198 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  255 (370)
T 2psq_A          198 EQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINN  255 (370)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCc
Confidence            35789999999999999999999875   99999999999999999999999999986654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.19  E-value=7.4e-11  Score=63.25  Aligned_cols=63  Identities=41%  Similarity=0.704  Sum_probs=53.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCC-------CCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDS-------RLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++.....++.+++.++.|+|...       ..+++|+++++.|+++..+..+++.|||+++.+....
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~  185 (322)
T 3soc_A          116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK  185 (322)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccccc
Confidence            45788999999999999999999750       0149999999999999999999999999998775443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.17  E-value=1.1e-10  Score=67.11  Aligned_cols=59  Identities=22%  Similarity=0.474  Sum_probs=51.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC--CCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE--MNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++...  ..+++.|||+++.+...
T Consensus       250 ~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          250 NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            35788899999999999999999985   9999999999999754  68999999999877543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.16  E-value=4.3e-10  Score=65.60  Aligned_cols=57  Identities=39%  Similarity=0.493  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++...
T Consensus       437 ~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          437 GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            45788999999999999999999875   9999999999999999999999999998643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.15  E-value=2.2e-10  Score=61.58  Aligned_cols=57  Identities=39%  Similarity=0.635  Sum_probs=52.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..+.
T Consensus       100 ~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A          100 IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            45889999999999999999999875   9999999999999999999999999997654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.15  E-value=3.4e-10  Score=63.27  Aligned_cols=59  Identities=20%  Similarity=0.298  Sum_probs=53.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++....+
T Consensus       170 ~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          170 DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            56889999999999999999999875   999999999999999999999999999866543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.15  E-value=7.1e-10  Score=59.31  Aligned_cols=56  Identities=48%  Similarity=0.885  Sum_probs=51.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       135 ~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGT  190 (321)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred             ccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            5889999999999999999999874   9999999999999999999999999987654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.13  E-value=1.3e-10  Score=62.32  Aligned_cols=59  Identities=32%  Similarity=0.511  Sum_probs=52.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.....
T Consensus       110 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A          110 GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            46788889999999999999999875   999999999999999999999999999866443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.13  E-value=3.9e-10  Score=62.69  Aligned_cols=58  Identities=36%  Similarity=0.617  Sum_probs=52.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++....
T Consensus       124 ~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          124 IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            45889999999999999999999985   99999999999999999999999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.13  E-value=5.7e-10  Score=59.11  Aligned_cols=59  Identities=36%  Similarity=0.576  Sum_probs=53.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus       131 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  189 (298)
T 2zv2_A          131 LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG  189 (298)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            456889999999999999999999875   99999999999999999999999999886643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.12  E-value=8.6e-10  Score=58.28  Aligned_cols=58  Identities=34%  Similarity=0.607  Sum_probs=52.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus        95 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           95 NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            356889999999999999999999985   9999999999999999999999999998664

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.12  E-value=1.2e-10  Score=62.94  Aligned_cols=57  Identities=37%  Similarity=0.489  Sum_probs=51.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus       189 ~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          189 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence            3889999999999999999999975   99999999999999889999999999876543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.12  E-value=3.9e-10  Score=62.38  Aligned_cols=56  Identities=41%  Similarity=0.479  Sum_probs=51.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++..
T Consensus       148 ~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          148 RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            46788999999999999999999875   999999999999999999999999998753

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.11  E-value=4.6e-10  Score=61.04  Aligned_cols=58  Identities=29%  Similarity=0.434  Sum_probs=52.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc--CCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD--HEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++..+..++.+++.++.|+|..+   ++|+++++.|+++.  ....+++.|||+++.+..
T Consensus       147 ~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~  206 (364)
T 3op5_A          147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP  206 (364)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceeccc
Confidence            56899999999999999999999874   99999999999998  778899999999987643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.11  E-value=9.1e-10  Score=58.46  Aligned_cols=58  Identities=47%  Similarity=0.797  Sum_probs=52.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       128 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          128 PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            45889999999999999999999875   99999999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.10  E-value=7.7e-10  Score=59.38  Aligned_cols=59  Identities=31%  Similarity=0.574  Sum_probs=53.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus       135 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          135 QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  193 (321)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence            446889999999999999999999874   99999999999999999999999999886654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.10  E-value=3.1e-10  Score=61.81  Aligned_cols=56  Identities=43%  Similarity=0.581  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       119 ~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          119 RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            45788899999999999999999875   999999999999999999999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.10  E-value=9.6e-10  Score=60.60  Aligned_cols=58  Identities=33%  Similarity=0.502  Sum_probs=52.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus       110 ~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A          110 VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            46889999999999999999999875   99999999999999999999999999987643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.10  E-value=9.7e-10  Score=62.94  Aligned_cols=59  Identities=41%  Similarity=0.501  Sum_probs=53.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..++.+++.|||+++.+...
T Consensus       284 ~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          284 PGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            46889999999999999999999875   999999999999999999999999999876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.10  E-value=4.6e-10  Score=59.65  Aligned_cols=59  Identities=27%  Similarity=0.486  Sum_probs=52.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++......
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A          111 TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            35788899999999999999999875   999999999999999999999999998766543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.10  E-value=8.1e-10  Score=59.33  Aligned_cols=60  Identities=25%  Similarity=0.380  Sum_probs=52.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC-----eEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN-----PKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~-----~~l~~~g~~~~~~~~   65 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..     +++.|||+++.+...
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           99 DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            356889999999999999999999875   999999999999987665     999999999876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.09  E-value=8.5e-10  Score=61.28  Aligned_cols=59  Identities=22%  Similarity=0.326  Sum_probs=53.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++....+
T Consensus       157 ~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          157 ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            36888899999999999999999875   999999999999999999999999999876543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.09  E-value=5.7e-10  Score=61.12  Aligned_cols=58  Identities=43%  Similarity=0.556  Sum_probs=52.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..++++|||+++....
T Consensus       186 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  243 (382)
T 3tt0_A          186 EQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHH  243 (382)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSC
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCccccccc
Confidence            35899999999999999999999874   99999999999999999999999999876543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.09  E-value=4.1e-10  Score=62.87  Aligned_cols=57  Identities=33%  Similarity=0.598  Sum_probs=52.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       151 ~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          151 VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            45889999999999999999999875   9999999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.09  E-value=4.2e-10  Score=60.58  Aligned_cols=57  Identities=37%  Similarity=0.552  Sum_probs=51.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus       168 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~  224 (344)
T 1rjb_A          168 VLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMS  224 (344)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGG
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCccccc
Confidence            4789999999999999999999975   99999999999999999999999999876543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.09  E-value=6.6e-10  Score=60.40  Aligned_cols=56  Identities=39%  Similarity=0.578  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       113 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A          113 HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            45788899999999999999999975   999999999999999999999999998754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.08  E-value=1.3e-10  Score=62.39  Aligned_cols=60  Identities=33%  Similarity=0.603  Sum_probs=53.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.....
T Consensus       111 ~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A          111 KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            346888999999999999999999874   999999999999999899999999998766443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.08  E-value=6.7e-10  Score=60.52  Aligned_cols=56  Identities=39%  Similarity=0.529  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       116 ~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A          116 GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            45788899999999999999999875   999999999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.08  E-value=4.5e-10  Score=59.38  Aligned_cols=60  Identities=35%  Similarity=0.484  Sum_probs=53.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLH--------EDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~--------~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++...+.++.+++.++.|+|        ..   +++|+++++.|+++..+..+++.|||+++.....
T Consensus        99 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  166 (301)
T 3q4u_A           99 LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS  166 (301)
T ss_dssp             TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeecccc
Confidence            456889999999999999999999        55   5999999999999999999999999999766543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.08  E-value=1.9e-09  Score=56.91  Aligned_cols=59  Identities=22%  Similarity=0.375  Sum_probs=51.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC-----eEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN-----PKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~-----~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..     +++.|||.+......
T Consensus       101 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A          101 RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            45889999999999999999999874   999999999999976554     999999999876543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.08  E-value=1.9e-10  Score=61.91  Aligned_cols=58  Identities=24%  Similarity=0.271  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhh-hCCCCCeEEccCCCCcEEEcCCC--------------------CeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLH-EDSRLKIIHRDLKASNVLLDHEM--------------------NPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~l~~~~~~~~~~~--------------------~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.|++.++.|+| ..+   ++|+++++.|+++..+.                    .+++.|||+++..
T Consensus       156 ~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~  232 (336)
T 2vuw_A          156 KLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE  232 (336)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence            46789999999999999999999 764   99999999999998765                    7899999999876


Q ss_pred             cC
Q 040677           63 GG   64 (77)
Q Consensus        63 ~~   64 (77)
                      ..
T Consensus       233 ~~  234 (336)
T 2vuw_A          233 RD  234 (336)
T ss_dssp             ET
T ss_pred             CC
Confidence            53

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.07  E-value=3.9e-10  Score=62.58  Aligned_cols=58  Identities=28%  Similarity=0.338  Sum_probs=52.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++....
T Consensus       163 ~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          163 YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence            45788888999999999999999875   99999999999999999999999999986654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.07  E-value=9.3e-10  Score=59.73  Aligned_cols=56  Identities=41%  Similarity=0.479  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       105 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A          105 RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            45788899999999999999999875   999999999999999999999999998753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.07  E-value=8.2e-10  Score=59.86  Aligned_cols=56  Identities=30%  Similarity=0.423  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       100 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A          100 RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            45788889999999999999999875   999999999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.07  E-value=3.8e-10  Score=61.82  Aligned_cols=57  Identities=33%  Similarity=0.608  Sum_probs=51.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.+.
T Consensus       104 ~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A          104 NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            45778888889999999999999875   9999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.06  E-value=6.7e-10  Score=59.02  Aligned_cols=57  Identities=39%  Similarity=0.531  Sum_probs=51.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       146 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~  202 (314)
T 2ivs_A          146 ALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYE  202 (314)
T ss_dssp             EECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTT
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccc
Confidence            4788899999999999999999875   99999999999999999999999999986644

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.06  E-value=1.7e-09  Score=61.14  Aligned_cols=60  Identities=27%  Similarity=0.498  Sum_probs=53.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE---cCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++..++.++.+++.++.|+|..+   ++|+++++.|+++   .....+++.|||+++.+...
T Consensus        97 ~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           97 SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            456899999999999999999999875   9999999999999   46788999999999877544

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.06  E-value=1.9e-09  Score=57.61  Aligned_cols=57  Identities=35%  Similarity=0.588  Sum_probs=51.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       114 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A          114 TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            45788999999999999999999875   9999999999999999999999999998654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.06  E-value=2.4e-09  Score=56.42  Aligned_cols=60  Identities=27%  Similarity=0.475  Sum_probs=53.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE---cCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++   .....+++.|||.+......
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           99 SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            356889999999999999999999885   9999999999999   67788999999999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.05  E-value=1.7e-09  Score=57.57  Aligned_cols=59  Identities=41%  Similarity=0.740  Sum_probs=52.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       102 ~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A          102 DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            356889999999999999999999875   99999999999999999999999999986643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.05  E-value=4.4e-10  Score=61.84  Aligned_cols=57  Identities=28%  Similarity=0.390  Sum_probs=48.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++. +..+++.|||+++.+..
T Consensus       150 ~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          150 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            45788888999999999999999874   99999999999995 56799999999986643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.05  E-value=2.1e-09  Score=58.03  Aligned_cols=59  Identities=29%  Similarity=0.444  Sum_probs=53.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       125 ~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  183 (335)
T 3dls_A          125 PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG  183 (335)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence            46889999999999999999999875   999999999999999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.04  E-value=7.7e-10  Score=59.08  Aligned_cols=58  Identities=24%  Similarity=0.369  Sum_probs=52.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++..+..++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||++.....
T Consensus       152 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          152 ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            45899999999999999999999874   99999999999999999999999999876643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.04  E-value=1.8e-09  Score=58.05  Aligned_cols=57  Identities=42%  Similarity=0.619  Sum_probs=52.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       153 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  209 (334)
T 2pvf_A          153 QMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINN  209 (334)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTT
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccc
Confidence            4889999999999999999999875   99999999999999999999999999986654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.04  E-value=2.9e-09  Score=56.42  Aligned_cols=58  Identities=29%  Similarity=0.447  Sum_probs=52.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       103 ~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C          103 EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            456889999999999999999999875   9999999999999999999999999987654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.04  E-value=3.6e-10  Score=62.58  Aligned_cols=56  Identities=21%  Similarity=0.286  Sum_probs=49.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       207 ~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~  262 (413)
T 3dzo_A          207 SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  262 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecC
Confidence            3566778888899999999999875   9999999999999999999999999987543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.04  E-value=2.4e-09  Score=57.29  Aligned_cols=61  Identities=49%  Similarity=0.849  Sum_probs=53.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|.....+++|+++++.|+++..+..+++.|||.+.....
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY  186 (326)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence            3488999999999999999999987223499999999999999999999999999987643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.04  E-value=3.6e-10  Score=61.04  Aligned_cols=57  Identities=28%  Similarity=0.390  Sum_probs=49.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++. +..+++.|||+++....
T Consensus       103 ~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A          103 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            46788899999999999999999875   99999999999996 46689999999876643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.04  E-value=4.6e-10  Score=60.38  Aligned_cols=58  Identities=34%  Similarity=0.618  Sum_probs=48.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       112 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A          112 DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            45788999999999999999999875   99999999999999888999999999976643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.04  E-value=7e-10  Score=58.94  Aligned_cols=58  Identities=40%  Similarity=0.625  Sum_probs=52.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       141 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  198 (313)
T 1t46_A          141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND  198 (313)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSC
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEcccccccccccc
Confidence            4889999999999999999999874   999999999999999999999999998766543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.03  E-value=5.1e-10  Score=59.12  Aligned_cols=57  Identities=44%  Similarity=0.697  Sum_probs=46.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       115 ~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A          115 TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence            45788999999999999999999875   9999999999999999999999999887544

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.03  E-value=1.1e-09  Score=60.07  Aligned_cols=56  Identities=34%  Similarity=0.391  Sum_probs=50.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       134 ~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          134 RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            35778888889999999999999875   999999999999999999999999998753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.03  E-value=7.9e-10  Score=59.10  Aligned_cols=57  Identities=33%  Similarity=0.563  Sum_probs=48.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.++....
T Consensus       133 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~  189 (323)
T 3qup_A          133 NLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYS  189 (323)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccc
Confidence            5889999999999999999999975   99999999999999999999999999876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.03  E-value=1.9e-09  Score=57.98  Aligned_cols=59  Identities=34%  Similarity=0.653  Sum_probs=52.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.....
T Consensus       146 ~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          146 GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            46889999999999999999999875   999999999999999999999999999876543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.03  E-value=2.1e-09  Score=59.22  Aligned_cols=60  Identities=32%  Similarity=0.412  Sum_probs=52.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc-CCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++.....++.|++.++.|+|..+   ++|+++++.|+++. .+..+++.|||+++.+...
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          135 KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            356788899999999999999999875   99999999999998 6788999999999876443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.02  E-value=1.1e-09  Score=60.00  Aligned_cols=57  Identities=39%  Similarity=0.547  Sum_probs=51.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++...
T Consensus       208 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          208 ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            35788899999999999999999875   9999999999999999999999999987644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.02  E-value=4.4e-10  Score=61.41  Aligned_cols=54  Identities=20%  Similarity=0.255  Sum_probs=48.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      +++...+.++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       203 l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~  256 (377)
T 3byv_A          203 LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD  256 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheec
Confidence            345777889999999999999975   999999999999999999999999998753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.02  E-value=2.1e-09  Score=59.60  Aligned_cols=59  Identities=32%  Similarity=0.414  Sum_probs=51.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.|++.++.|+|..+   ++|+++++.|+++..+ ..+++.|||+++.+..
T Consensus       150 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          150 KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            356888899999999999999999874   9999999999999855 5679999999987643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.02  E-value=8e-10  Score=61.60  Aligned_cols=56  Identities=32%  Similarity=0.428  Sum_probs=50.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|. .+   ++|+++++.|+++..+..+++.|||+++..
T Consensus       243 ~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          243 RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            457888999999999999999997 64   999999999999999999999999998753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.02  E-value=1.1e-09  Score=59.63  Aligned_cols=58  Identities=40%  Similarity=0.640  Sum_probs=52.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       123 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          123 QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            45788999999999999999999875   99999999999999999999999999986653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.02  E-value=4.1e-09  Score=56.44  Aligned_cols=56  Identities=38%  Similarity=0.643  Sum_probs=51.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       104 ~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A          104 GLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            4788889999999999999999874   9999999999999999999999999998664

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.01  E-value=1.2e-09  Score=58.21  Aligned_cols=57  Identities=28%  Similarity=0.532  Sum_probs=49.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       142 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~  198 (313)
T 3brb_A          142 KHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIY  198 (313)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecc
Confidence            45889999999999999999999874   9999999999999999999999999987654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.01  E-value=4.8e-10  Score=60.14  Aligned_cols=58  Identities=33%  Similarity=0.495  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus       159 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  216 (333)
T 2i1m_A          159 STASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN  216 (333)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGG
T ss_pred             cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECcccccccccc
Confidence            45788999999999999999999874   99999999999999888999999999876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.00  E-value=1.5e-09  Score=61.00  Aligned_cols=57  Identities=40%  Similarity=0.630  Sum_probs=48.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++....
T Consensus       160 ~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          160 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            4788889999999999999999975   99999999999999999999999999986543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.00  E-value=2.3e-09  Score=58.00  Aligned_cols=56  Identities=23%  Similarity=0.405  Sum_probs=51.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC--CeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM--NPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+.  .+++.|||+++.+.
T Consensus       147 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~  204 (345)
T 2v62_A          147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC  204 (345)
T ss_dssp             BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecc
Confidence            6889999999999999999999874   99999999999998766  89999999998764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.00  E-value=4.8e-09  Score=56.95  Aligned_cols=58  Identities=31%  Similarity=0.444  Sum_probs=50.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~~~~   65 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++....   .+++.|||++......
T Consensus       126 ~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~  186 (351)
T 3c0i_A          126 VYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES  186 (351)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCC
Confidence            4788899999999999999999875   99999999999997543   4899999999876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.00  E-value=2.7e-09  Score=55.84  Aligned_cols=57  Identities=39%  Similarity=0.635  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       100 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A          100 IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            45788999999999999999999875   9999999999999999999999999987553

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.00  E-value=4.6e-09  Score=56.80  Aligned_cols=57  Identities=37%  Similarity=0.699  Sum_probs=52.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..+.
T Consensus       119 ~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A          119 VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            45889999999999999999999875   9999999999999999999999999998764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=98.99  E-value=3.6e-09  Score=57.96  Aligned_cols=60  Identities=25%  Similarity=0.375  Sum_probs=52.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc-CCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~l~~~g~~~~~~~~   65 (77)
                      +..+++..+..++.|++.++.|+|..+   ++|+++++.|+++. .+..+++.|||.++.+...
T Consensus       135 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  195 (383)
T 3eb0_A          135 GRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS  195 (383)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence            356889999999999999999999874   99999999999997 5778999999999876443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=98.99  E-value=2.7e-09  Score=57.38  Aligned_cols=57  Identities=35%  Similarity=0.467  Sum_probs=51.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       101 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A          101 QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            45788889999999999999999874   9999999999999999999999999998654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=98.98  E-value=4.4e-10  Score=60.39  Aligned_cols=56  Identities=36%  Similarity=0.624  Sum_probs=51.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+...
T Consensus       169 ~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  224 (343)
T 1luf_A          169 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI  224 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCccc
Confidence            56889999999999999999999875   999999999999998889999999988654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=98.98  E-value=5.7e-09  Score=57.07  Aligned_cols=59  Identities=34%  Similarity=0.477  Sum_probs=51.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC----CeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM----NPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++....    .+++.|||++.....
T Consensus       109 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A          109 KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            356889999999999999999999875   99999999999997655    699999999987654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=98.98  E-value=7e-10  Score=58.99  Aligned_cols=57  Identities=37%  Similarity=0.517  Sum_probs=51.3

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      +++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       145 ~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  201 (316)
T 2xir_A          145 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  201 (316)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccC
Confidence            788899999999999999999874   999999999999998889999999998765443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=98.98  E-value=2.4e-09  Score=56.96  Aligned_cols=56  Identities=38%  Similarity=0.659  Sum_probs=51.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       116 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  171 (308)
T 3g33_A          116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS  171 (308)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTST
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccC
Confidence            3889999999999999999999985   9999999999999999999999999987554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=98.98  E-value=5.2e-09  Score=59.12  Aligned_cols=59  Identities=41%  Similarity=0.673  Sum_probs=53.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus       110 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A          110 NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            456889999999999999999999874   99999999999999999999999999987654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=98.98  E-value=1.4e-09  Score=58.33  Aligned_cols=61  Identities=36%  Similarity=0.633  Sum_probs=51.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCC------CCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDS------RLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...++.....++.+++.++.|+|...      ..+++|+++++.|+++..+..+++.|||++..+..
T Consensus       106 ~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~  172 (336)
T 3g2f_A          106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG  172 (336)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccc
Confidence            34577888899999999999999761      11499999999999999999999999999987653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=98.98  E-value=1.2e-09  Score=58.48  Aligned_cols=61  Identities=33%  Similarity=0.445  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDS-----RLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.|+|...     ..+++|+++++.|+++..+..+++.|||++..+..
T Consensus       129 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~  194 (337)
T 3mdy_A          129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS  194 (337)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence            45788899999999999999999761     11499999999999999999999999999976644

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=98.97  E-value=5.5e-09  Score=56.17  Aligned_cols=58  Identities=26%  Similarity=0.466  Sum_probs=51.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC--CCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH--EMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..  +..+++.|||++..+..
T Consensus        97 ~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           97 FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            35889999999999999999999875   999999999999986  67899999999987654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=98.97  E-value=2.9e-09  Score=57.29  Aligned_cols=57  Identities=30%  Similarity=0.378  Sum_probs=48.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       116 ~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A          116 GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            35778888899999999999999875   9999999999999999999999999987543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=98.97  E-value=2.8e-09  Score=58.86  Aligned_cols=57  Identities=30%  Similarity=0.477  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..   +..+++.|||+++...
T Consensus       156 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~  215 (400)
T 1nxk_A          156 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  215 (400)
T ss_dssp             -CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence            35889999999999999999999874   999999999999986   6789999999998654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=98.97  E-value=1.6e-09  Score=59.70  Aligned_cols=57  Identities=39%  Similarity=0.631  Sum_probs=48.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE----cCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL----DHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~----~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++..+..++.+++.++.|+|..+   ++|+++++.|+++    .....+++.|||+++.+..
T Consensus       124 ~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  184 (405)
T 3rgf_A          124 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  184 (405)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCC
Confidence            4888999999999999999999975   9999999999999    5567899999999976643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=98.97  E-value=4.3e-09  Score=57.27  Aligned_cols=58  Identities=29%  Similarity=0.408  Sum_probs=52.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++....
T Consensus       136 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          136 GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            45788899999999999999999875   99999999999999999999999999986643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=98.97  E-value=4.7e-09  Score=56.34  Aligned_cols=57  Identities=32%  Similarity=0.555  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus        95 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           95 NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            45788899999999999999999875   9999999999999999999999999987543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=98.97  E-value=5.2e-09  Score=56.01  Aligned_cols=60  Identities=37%  Similarity=0.579  Sum_probs=53.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       128 ~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          128 RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             hCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            345889999999999999999999975   999999999999999999999999999876543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=98.97  E-value=2.1e-09  Score=58.41  Aligned_cols=57  Identities=30%  Similarity=0.402  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.+.
T Consensus       154 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          154 ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            45788889999999999999999874   9999999999999999999999999998654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=98.96  E-value=6.4e-09  Score=54.29  Aligned_cols=58  Identities=33%  Similarity=0.589  Sum_probs=52.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       100 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A          100 GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            5788999999999999999999875   999999999999999999999999999866443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=98.96  E-value=8.5e-09  Score=55.57  Aligned_cols=57  Identities=35%  Similarity=0.559  Sum_probs=51.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       136 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          136 KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            45788999999999999999999875   9999999999999999999999999988664

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=98.96  E-value=4.9e-09  Score=55.99  Aligned_cols=57  Identities=28%  Similarity=0.505  Sum_probs=50.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            345667889999999999999875   999999999999999999999999999876544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=98.96  E-value=5.9e-09  Score=56.97  Aligned_cols=57  Identities=37%  Similarity=0.584  Sum_probs=51.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       123 ~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          123 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            45788889999999999999999875   9999999999999999999999999998654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=98.96  E-value=1.8e-09  Score=59.07  Aligned_cols=58  Identities=41%  Similarity=0.589  Sum_probs=46.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       126 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          126 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            356889999999999999999999875   9999999999999999999999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=98.96  E-value=5.2e-09  Score=55.64  Aligned_cols=58  Identities=28%  Similarity=0.401  Sum_probs=52.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus        96 ~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           96 QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            345788999999999999999999875   9999999999999999999999999987654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=98.96  E-value=6.1e-09  Score=54.95  Aligned_cols=60  Identities=27%  Similarity=0.473  Sum_probs=52.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc---CCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++.   .+..+++.|||.+......
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           99 SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            346889999999999999999999875   99999999999994   6778999999999876544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=98.96  E-value=2.8e-09  Score=60.25  Aligned_cols=58  Identities=28%  Similarity=0.507  Sum_probs=52.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++....
T Consensus       313 ~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          313 QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            45788899999999999999999875   99999999999999889999999999986643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=98.95  E-value=9.1e-09  Score=55.36  Aligned_cols=59  Identities=32%  Similarity=0.429  Sum_probs=51.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC----CeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM----NPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++....    .+++.|||++.....
T Consensus       108 ~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A          108 KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            346889999999999999999999874   99999999999997665    789999999987643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=98.95  E-value=7.7e-10  Score=60.39  Aligned_cols=56  Identities=41%  Similarity=0.560  Sum_probs=49.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC---CCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~l~~~g~~~~~   62 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++...   ..+++.|||+++..
T Consensus       176 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~  234 (367)
T 3l9p_A          176 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI  234 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCcccccc
Confidence            45889999999999999999999985   9999999999999843   45999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=98.95  E-value=6.1e-09  Score=60.10  Aligned_cols=58  Identities=34%  Similarity=0.440  Sum_probs=52.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..++.++++|||+++.....
T Consensus       282 ~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          282 GFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            4889999999999999999999975   999999999999999999999999999876543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=98.95  E-value=7.6e-09  Score=54.87  Aligned_cols=59  Identities=41%  Similarity=0.604  Sum_probs=53.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       113 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          113 PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence            456889999999999999999999875   99999999999999999999999999876654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=98.95  E-value=2.2e-09  Score=58.79  Aligned_cols=58  Identities=34%  Similarity=0.674  Sum_probs=46.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++....
T Consensus       142 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          142 AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            36889999999999999999999874   99999999999999999999999999886653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=98.95  E-value=6.5e-09  Score=58.25  Aligned_cols=58  Identities=29%  Similarity=0.411  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc---CCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++.   .+..+++.|||++.....
T Consensus       105 ~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A          105 EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            45788999999999999999999975   99999999999997   346799999999976543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=98.94  E-value=2.5e-09  Score=57.05  Aligned_cols=58  Identities=33%  Similarity=0.575  Sum_probs=49.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+..+..
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A          111 GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            45788999999999999999999875   99999999999999999999999999876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=98.94  E-value=2e-09  Score=58.22  Aligned_cols=57  Identities=40%  Similarity=0.604  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..+.
T Consensus       107 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A          107 LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            35778888999999999999999975   9999999999999999999999999987654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=98.94  E-value=2e-09  Score=57.51  Aligned_cols=57  Identities=33%  Similarity=0.580  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       133 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~  189 (322)
T 1p4o_A          133 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY  189 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGG
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccc
Confidence            34678899999999999999999975   9999999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=98.93  E-value=1.3e-08  Score=53.74  Aligned_cols=57  Identities=35%  Similarity=0.559  Sum_probs=51.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       110 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A          110 KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            45788999999999999999999875   9999999999999999999999999987654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=98.93  E-value=2.8e-09  Score=57.56  Aligned_cols=57  Identities=42%  Similarity=0.631  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       109 ~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A          109 GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            45788889999999999999999875   9999999999999999999999999987554

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=98.93  E-value=8.3e-09  Score=54.10  Aligned_cols=57  Identities=40%  Similarity=0.654  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       107 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A          107 KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            46889999999999999999999874   9999999999999999999999999987654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=98.93  E-value=2.4e-09  Score=56.83  Aligned_cols=57  Identities=35%  Similarity=0.556  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A          106 GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            35788999999999999999999875   9999999999999999999999999887553

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=98.92  E-value=6.6e-09  Score=55.54  Aligned_cols=57  Identities=28%  Similarity=0.506  Sum_probs=50.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE----cCCCCeEEecccceeeecCC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL----DHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~----~~~~~~~l~~~g~~~~~~~~   65 (77)
                      +++.....++.+++.++.|+|..+   ++|+++++.|+++    .....+++.|||.++.....
T Consensus       109 ~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A          109 LPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            889999999999999999999975   9999999999988    55567899999999876543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=98.92  E-value=3.8e-09  Score=57.28  Aligned_cols=58  Identities=34%  Similarity=0.587  Sum_probs=52.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus       103 ~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B          103 KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            46788999999999999999999875   99999999999999999999999999875543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=98.92  E-value=4.5e-09  Score=56.56  Aligned_cols=58  Identities=29%  Similarity=0.455  Sum_probs=49.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++....   .+++.|||++.....
T Consensus       101 ~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A          101 KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            46889999999999999999999875   99999999999997544   789999999986543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=98.92  E-value=6.1e-09  Score=55.14  Aligned_cols=59  Identities=32%  Similarity=0.588  Sum_probs=52.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       121 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          121 NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            45788999999999999999999875   999999999999998899999999999876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=98.92  E-value=1.7e-09  Score=57.14  Aligned_cols=58  Identities=31%  Similarity=0.600  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++.....
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A          109 ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            34888999999999999999999874   99999999999999899999999999886643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=98.92  E-value=7.9e-09  Score=55.77  Aligned_cols=57  Identities=37%  Similarity=0.545  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       107 ~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A          107 QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            45788899999999999999999875   9999999999999999999999999998664

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=98.91  E-value=4.1e-09  Score=57.48  Aligned_cols=49  Identities=12%  Similarity=0.189  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677           12 ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        12 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       197 ~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~  245 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG  245 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETT
T ss_pred             HHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecC
Confidence            556689999999999875   9999999999999999999999999998654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=98.91  E-value=3.2e-09  Score=57.03  Aligned_cols=59  Identities=31%  Similarity=0.403  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLH--------EDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~--------~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++...+.++.+++.++.++|        ..   +++|+++++.|+++..+..+++.|||++......
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  200 (342)
T 1b6c_B          134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  200 (342)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceecccc
Confidence            45788899999999999999999        54   5999999999999999999999999998776543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=98.91  E-value=3.4e-09  Score=58.11  Aligned_cols=57  Identities=33%  Similarity=0.515  Sum_probs=46.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       187 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          187 HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            45778889999999999999999875   9999999999999999999999999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=98.91  E-value=8.1e-09  Score=54.14  Aligned_cols=59  Identities=32%  Similarity=0.573  Sum_probs=52.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       117 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  175 (284)
T 2a19_B          117 EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND  175 (284)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccc
Confidence            46889999999999999999999874   999999999999998889999999998876543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=98.91  E-value=2.2e-09  Score=56.44  Aligned_cols=58  Identities=31%  Similarity=0.502  Sum_probs=45.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.++....
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A          111 YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            35889999999999999999999875   99999999999999888999999999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=98.90  E-value=1.8e-08  Score=54.64  Aligned_cols=60  Identities=30%  Similarity=0.522  Sum_probs=50.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC----CCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE----MNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++...    ..+++.|||++......
T Consensus       110 ~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A          110 QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            345789999999999999999999875   9999999999998533    24899999999876543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=98.90  E-value=1e-08  Score=54.47  Aligned_cols=58  Identities=31%  Similarity=0.507  Sum_probs=51.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..   +..+++.|||++.....
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  172 (299)
T 3m2w_A          112 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG  172 (299)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccccccc
Confidence            35889999999999999999999875   999999999999987   67899999999986653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=98.90  E-value=1.1e-08  Score=53.65  Aligned_cols=57  Identities=35%  Similarity=0.695  Sum_probs=51.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A          105 KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            5788999999999999999999875   99999999999999999999999999886643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=98.90  E-value=5.1e-09  Score=55.37  Aligned_cols=58  Identities=34%  Similarity=0.530  Sum_probs=51.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       122 ~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          122 THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            345788899999999999999999875   9999999999999999999999999987654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=98.90  E-value=1.7e-08  Score=55.07  Aligned_cols=58  Identities=38%  Similarity=0.642  Sum_probs=52.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++..+..
T Consensus       195 ~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          195 VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            35788899999999999999999875   99999999999999999999999999887654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=98.90  E-value=2.9e-09  Score=56.24  Aligned_cols=57  Identities=39%  Similarity=0.663  Sum_probs=51.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           95 GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            45788899999999999999999874   9999999999999999999999999886543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=98.90  E-value=8.4e-09  Score=54.39  Aligned_cols=58  Identities=34%  Similarity=0.629  Sum_probs=52.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       105 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A          105 EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            45889999999999999999999875   99999999999999888999999999987643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=98.90  E-value=7.2e-09  Score=55.57  Aligned_cols=59  Identities=36%  Similarity=0.608  Sum_probs=52.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       122 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          122 ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            35789999999999999999999874   999999999999998999999999999876543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=98.90  E-value=8.4e-09  Score=57.69  Aligned_cols=56  Identities=29%  Similarity=0.471  Sum_probs=50.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++...
T Consensus       285 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          285 VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            3688889999999999999999875   9999999999999999999999999987543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=98.90  E-value=2.2e-08  Score=53.31  Aligned_cols=59  Identities=37%  Similarity=0.551  Sum_probs=52.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          119 NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            356889999999999999999999875   99999999999999999999999999876643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=98.89  E-value=1.5e-08  Score=54.55  Aligned_cols=57  Identities=25%  Similarity=0.408  Sum_probs=50.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE-------------------cCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL-------------------DHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~-------------------~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++                   .....+++.|||.+....
T Consensus       118 ~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~  193 (355)
T 2eu9_A          118 QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH  193 (355)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccc
Confidence            46889999999999999999999874   9999999999999                   456789999999987643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=98.89  E-value=7.6e-09  Score=57.59  Aligned_cols=57  Identities=30%  Similarity=0.342  Sum_probs=50.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC--eEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN--PKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..  +++.|||++....
T Consensus       195 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~  253 (429)
T 3kvw_A          195 QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH  253 (429)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence            34889999999999999999999874   999999999999987765  9999999987544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=98.89  E-value=2e-09  Score=56.64  Aligned_cols=60  Identities=30%  Similarity=0.376  Sum_probs=47.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.|+|...  +++|+++++.|+++.....+++.|||.+.....
T Consensus       103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A          103 GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            356889999999999999999999851  399999999999999989999999999876543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=98.89  E-value=3.7e-09  Score=55.83  Aligned_cols=58  Identities=40%  Similarity=0.551  Sum_probs=51.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       118 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          118 QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            345788899999999999999999975   9999999999999999999999999987543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=98.89  E-value=1.4e-08  Score=54.39  Aligned_cols=58  Identities=24%  Similarity=0.361  Sum_probs=51.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc-CCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++. ....+++.|||++.....
T Consensus       144 ~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~  202 (320)
T 3a99_A          144 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD  202 (320)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence            45788899999999999999999875   99999999999998 667899999999887653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=98.89  E-value=1.6e-08  Score=54.81  Aligned_cols=56  Identities=32%  Similarity=0.406  Sum_probs=49.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-------------------------CCCeEEecccce
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-------------------------EMNPKISDFGMA   59 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-------------------------~~~~~l~~~g~~   59 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..                         ...+++.|||++
T Consensus       133 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a  209 (360)
T 3llt_A          133 GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA  209 (360)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCc
Confidence            4788999999999999999999875   999999999999964                         678999999999


Q ss_pred             eeec
Q 040677           60 RIFG   63 (77)
Q Consensus        60 ~~~~   63 (77)
                      ....
T Consensus       210 ~~~~  213 (360)
T 3llt_A          210 TFKS  213 (360)
T ss_dssp             EETT
T ss_pred             eecC
Confidence            7644

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=98.89  E-value=1.3e-08  Score=55.55  Aligned_cols=59  Identities=29%  Similarity=0.433  Sum_probs=50.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC---CCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++...   ..+++.|||++.....
T Consensus       122 ~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          122 REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            346789999999999999999999975   9999999999999754   3589999999876653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=98.89  E-value=3.3e-09  Score=57.44  Aligned_cols=57  Identities=21%  Similarity=0.405  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC--CeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM--NPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+.  .+++.|||+++.+.
T Consensus       154 ~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~  212 (352)
T 2jii_A          154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC  212 (352)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeecc
Confidence            56899999999999999999999985   99999999999999887  89999999997654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=98.88  E-value=4.5e-09  Score=58.79  Aligned_cols=56  Identities=34%  Similarity=0.627  Sum_probs=50.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++...
T Consensus       280 ~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          280 KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            5678888899999999999999875   9999999999999999999999999987654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=98.88  E-value=5.3e-09  Score=56.83  Aligned_cols=58  Identities=38%  Similarity=0.588  Sum_probs=52.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||++....
T Consensus       148 ~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          148 KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            346889999999999999999999975   9999999999999999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=98.88  E-value=1.4e-08  Score=55.66  Aligned_cols=59  Identities=32%  Similarity=0.456  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE--cCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL--DHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++  .....+++.|||+++.+...
T Consensus       182 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          182 YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            35788899999999999999999875   9999999999998  45567999999999876543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=98.87  E-value=8.3e-09  Score=55.46  Aligned_cols=58  Identities=33%  Similarity=0.548  Sum_probs=49.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       118 ~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          118 PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            345788999999999999999999875   9999999999999999999999999987554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=98.87  E-value=1.5e-08  Score=53.98  Aligned_cols=57  Identities=33%  Similarity=0.479  Sum_probs=51.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ...+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+...
T Consensus       128 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          128 GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            356889999999999999999999874   999999999999999999999999987643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=98.87  E-value=6.7e-09  Score=55.96  Aligned_cols=58  Identities=33%  Similarity=0.636  Sum_probs=48.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       142 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          142 GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            46889999999999999999999875   99999999999999999999999999876543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=98.87  E-value=1.1e-08  Score=54.02  Aligned_cols=59  Identities=36%  Similarity=0.613  Sum_probs=52.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A          112 RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            35788899999999999999999875   999999999999998889999999998876543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=98.87  E-value=1.1e-08  Score=54.83  Aligned_cols=59  Identities=31%  Similarity=0.603  Sum_probs=52.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+......
T Consensus       140 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          140 ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            35788999999999999999999874   999999999999998889999999999876543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=98.87  E-value=8e-09  Score=55.39  Aligned_cols=55  Identities=36%  Similarity=0.619  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      ..+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||+++.
T Consensus       137 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~  191 (327)
T 1fvr_A          137 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRG  191 (327)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEES
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcc
Confidence            46889999999999999999999875   99999999999999888999999998863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=98.87  E-value=1.8e-08  Score=55.62  Aligned_cols=58  Identities=29%  Similarity=0.476  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC--CCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH--EMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..  ...+++.|||++.....
T Consensus       144 ~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          144 YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            36789999999999999999999875   999999999999974  46799999999987654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=98.87  E-value=7.7e-09  Score=56.09  Aligned_cols=57  Identities=32%  Similarity=0.448  Sum_probs=48.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       129 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (362)
T 3pg1_A          129 IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDT  185 (362)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC-----
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCcccccc
Confidence            46889999999999999999999975   9999999999999999999999999987443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=98.86  E-value=2.5e-09  Score=61.84  Aligned_cols=57  Identities=33%  Similarity=0.622  Sum_probs=51.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       431 ~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          431 EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            45889999999999999999999875   9999999999999988999999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=98.86  E-value=2.2e-08  Score=52.49  Aligned_cols=59  Identities=27%  Similarity=0.424  Sum_probs=51.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE---cCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++   ..+..+++.|||.+......
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A          101 RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            45788899999999999999999875   9999999999999   66778999999998766543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=98.86  E-value=1.6e-08  Score=54.12  Aligned_cols=58  Identities=31%  Similarity=0.480  Sum_probs=50.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC-CeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM-NPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~l~~~g~~~~~~~~   65 (77)
                      .++......++.+++.++.|+|..+   ++|+++++.|+++..+. .+++.|||.++.....
T Consensus       126 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          126 TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            4678888899999999999999875   99999999999998665 7999999999876543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=98.86  E-value=1.2e-08  Score=56.17  Aligned_cols=57  Identities=28%  Similarity=0.506  Sum_probs=50.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE----cCCCCeEEecccceeeecCC
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL----DHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~----~~~~~~~l~~~g~~~~~~~~   65 (77)
                      +++.....++.+++.++.|+|..+   ++|+++++.|+++    .....+++.|||.++.....
T Consensus       109 l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A          109 LPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (396)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence            889999999999999999999975   9999999999998    55566899999999876543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=98.86  E-value=6.7e-09  Score=55.54  Aligned_cols=60  Identities=32%  Similarity=0.452  Sum_probs=52.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++...+.++.+++.++.|+|..+ .+++|+++++.|+++..+..+++.|||.+.....
T Consensus       131 ~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  190 (337)
T 3ll6_A          131 GPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH  190 (337)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccc
Confidence            45889999999999999999999762 2499999999999999999999999999876543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=98.86  E-value=3.2e-08  Score=52.05  Aligned_cols=57  Identities=33%  Similarity=0.517  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A          109 GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            35788899999999999999999874   9999999999999988999999999886554

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=98.86  E-value=2.4e-08  Score=53.79  Aligned_cols=59  Identities=31%  Similarity=0.505  Sum_probs=52.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.++|. .   +++|+++++.|+++..+..+++.|||.+.....
T Consensus       145 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  204 (348)
T 2pml_X          145 TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD  204 (348)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCCcEEEecccccccccc
Confidence            4568899999999999999999998 6   499999999999999999999999999886543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=98.86  E-value=6.4e-09  Score=54.66  Aligned_cols=57  Identities=26%  Similarity=0.494  Sum_probs=51.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       115 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A          115 HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            46889999999999999999999875   9999999999999999999999999987543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=98.86  E-value=1.7e-08  Score=55.14  Aligned_cols=44  Identities=36%  Similarity=0.526  Sum_probs=38.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM   49 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~   49 (77)
                      ..+++.....++.|++.++.|+|...  +++|+++++.|+++..+.
T Consensus       141 ~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~  184 (397)
T 1wak_A          141 QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence            45889999999999999999999861  399999999999997653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=98.86  E-value=1.5e-09  Score=62.99  Aligned_cols=58  Identities=36%  Similarity=0.611  Sum_probs=52.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.+..
T Consensus       464 ~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          464 RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            45788999999999999999999875   99999999999999989999999999876643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=98.86  E-value=8.4e-09  Score=53.87  Aligned_cols=63  Identities=38%  Similarity=0.564  Sum_probs=49.2

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC--------CCCeEEecccceeeecC
Q 040677            2 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH--------EMNPKISDFGMARIFGG   64 (77)
Q Consensus         2 ~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~--------~~~~~l~~~g~~~~~~~   64 (77)
                      ++..+++.....++.+++.++.++|..+..+++|+++++.|+++..        ...+++.|||.+.....
T Consensus        98 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  168 (271)
T 3dtc_A           98 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR  168 (271)
T ss_dssp             TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccc
Confidence            3467889999999999999999999974334899999999999975        56789999999876543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=98.85  E-value=1.8e-08  Score=54.11  Aligned_cols=58  Identities=40%  Similarity=0.625  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..   ...+++.|||.+.....
T Consensus       126 ~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          126 EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            45889999999999999999999875   999999999999987   67899999999986643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=98.85  E-value=2.7e-08  Score=52.12  Aligned_cols=58  Identities=26%  Similarity=0.449  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-------------------CCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-------------------EMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-------------------~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..                   ...+++.|||.+.....
T Consensus       110 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  186 (289)
T 1x8b_A          110 SYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS  186 (289)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC
Confidence            45789999999999999999999975   999999999999973                   34689999999876653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=98.85  E-value=1.7e-08  Score=53.01  Aligned_cols=56  Identities=36%  Similarity=0.543  Sum_probs=50.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+...
T Consensus       104 ~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A          104 SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence            35788889999999999999999874   999999999999999999999999987543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=98.85  E-value=8e-09  Score=56.42  Aligned_cols=56  Identities=41%  Similarity=0.647  Sum_probs=47.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       123 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            4778888999999999999999875   9999999999999999999999999987654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=98.85  E-value=2.5e-08  Score=53.38  Aligned_cols=59  Identities=39%  Similarity=0.552  Sum_probs=50.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++....   .+++.|||.+.....
T Consensus       108 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  169 (322)
T 2ycf_A          108 NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE  169 (322)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence            356788999999999999999999875   99999999999997654   499999999886643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=98.85  E-value=7.7e-09  Score=55.31  Aligned_cols=57  Identities=40%  Similarity=0.768  Sum_probs=46.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +++...+.++.+++.++.|+|..+ .+++|+++++.|+++..+..+++.|||+++...
T Consensus       134 ~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          134 LDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            788899999999999999999862 239999999999999999999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=98.85  E-value=2.2e-08  Score=54.91  Aligned_cols=56  Identities=21%  Similarity=0.320  Sum_probs=50.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+...
T Consensus       123 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          123 DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            45788999999999999999999875   999999999999999999999999987543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=98.84  E-value=2e-08  Score=58.67  Aligned_cols=56  Identities=29%  Similarity=0.433  Sum_probs=50.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+ .+++.|||+++....
T Consensus       178 ~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          178 KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhccc
Confidence            6889999999999999999999875   9999999999999875 789999999986643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=98.84  E-value=1e-08  Score=55.97  Aligned_cols=57  Identities=30%  Similarity=0.584  Sum_probs=49.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.++...
T Consensus       139 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          139 MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence            34788999999999999999999875   9999999999999999999999999987554

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=98.84  E-value=6.6e-09  Score=54.31  Aligned_cols=57  Identities=33%  Similarity=0.516  Sum_probs=51.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A          101 GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccc
Confidence            45789999999999999999999875   9999999999999888899999999987543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=98.84  E-value=1.4e-08  Score=53.49  Aligned_cols=58  Identities=33%  Similarity=0.413  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       116 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A          116 GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence            35788899999999999999999874   99999999999999888999999999887643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=98.83  E-value=3.5e-08  Score=52.75  Aligned_cols=56  Identities=25%  Similarity=0.415  Sum_probs=49.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-------------------CCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-------------------EMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-------------------~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..                   +..+++.|||.+....
T Consensus       114 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~  188 (339)
T 1z57_A          114 PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD  188 (339)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETT
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCc
Confidence            5788999999999999999999875   999999999999976                   5578999999987644

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=98.83  E-value=2.6e-08  Score=53.36  Aligned_cols=58  Identities=34%  Similarity=0.484  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC----CeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM----NPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+.    .+++.|||.+.....
T Consensus       110 ~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A          110 ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            45778889999999999999999874   99999999999998766    789999999987654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=98.83  E-value=5.1e-09  Score=58.59  Aligned_cols=57  Identities=32%  Similarity=0.604  Sum_probs=49.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..++++|||+++...
T Consensus       275 ~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          275 KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            34788899999999999999999875   9999999999999988899999999987654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=98.82  E-value=1.4e-08  Score=54.05  Aligned_cols=57  Identities=23%  Similarity=0.406  Sum_probs=46.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       131 ~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          131 RLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            45788899999999999999999875   9999999999999999999999999887654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=98.82  E-value=2.4e-08  Score=53.16  Aligned_cols=58  Identities=22%  Similarity=0.383  Sum_probs=51.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc-CCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++. .+..+++.|||.+.....
T Consensus       134 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~  192 (312)
T 2iwi_A          134 GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD  192 (312)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhccc
Confidence            35788999999999999999999874   99999999999998 678899999999887654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=98.82  E-value=7.5e-09  Score=55.16  Aligned_cols=57  Identities=28%  Similarity=0.376  Sum_probs=48.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++.. ..+++.|||++.....
T Consensus       122 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          122 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            45788899999999999999999874   999999999999964 6789999999876543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=98.82  E-value=4.6e-08  Score=51.67  Aligned_cols=58  Identities=38%  Similarity=0.582  Sum_probs=52.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+.....
T Consensus       119 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  176 (298)
T 1phk_A          119 VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  176 (298)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence            35788899999999999999999875   99999999999999999999999999876643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=98.81  E-value=1.9e-08  Score=54.45  Aligned_cols=59  Identities=27%  Similarity=0.354  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhh--hCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLH--EDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~--~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.++|  ..   +++|+++++.|+++.. +..+++.|||++......
T Consensus       124 ~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~  185 (360)
T 3e3p_A          124 VAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS  185 (360)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC
Confidence            45678888889999999999999  65   4999999999999986 788999999999866543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=98.81  E-value=1.6e-08  Score=54.07  Aligned_cols=56  Identities=34%  Similarity=0.621  Sum_probs=51.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       116 ~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  171 (326)
T 1blx_A          116 GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS  171 (326)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCccccccc
Confidence            4789999999999999999999875   9999999999999999999999999987554

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=98.81  E-value=5.5e-09  Score=59.59  Aligned_cols=57  Identities=32%  Similarity=0.604  Sum_probs=51.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++...
T Consensus       358 ~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          358 KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            34788999999999999999999875   9999999999999988899999999987553

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=98.80  E-value=1.2e-08  Score=56.62  Aligned_cols=58  Identities=40%  Similarity=0.572  Sum_probs=50.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC---CCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++...   ..+++.|||+++...
T Consensus       233 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  293 (419)
T 3i6u_A          233 NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  293 (419)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence            456889999999999999999999875   9999999999999654   359999999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=98.80  E-value=1.2e-08  Score=55.19  Aligned_cols=57  Identities=30%  Similarity=0.584  Sum_probs=50.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       121 ~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          121 LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            35789999999999999999999875   9999999999999999999999999886543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=98.80  E-value=3.4e-08  Score=55.87  Aligned_cols=59  Identities=37%  Similarity=0.684  Sum_probs=51.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++....   .+++.|||++......
T Consensus       141 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  202 (504)
T 3q5i_A          141 HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD  202 (504)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC
Confidence            45789999999999999999999875   99999999999997654   6899999999876543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=98.80  E-value=1.5e-08  Score=54.18  Aligned_cols=57  Identities=37%  Similarity=0.531  Sum_probs=49.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       124 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          124 NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            45788889999999999999999875   9999999999999999999999999887553

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=98.79  E-value=5.6e-08  Score=54.91  Aligned_cols=59  Identities=36%  Similarity=0.650  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC---CCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++...   ..+++.|||++..+...
T Consensus       131 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          131 MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            45788889999999999999999875   9999999999999653   45899999999876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=98.79  E-value=1.4e-08  Score=53.62  Aligned_cols=58  Identities=29%  Similarity=0.540  Sum_probs=48.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc---CCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++.   ....+++.|||.+..+..
T Consensus       119 ~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          119 KALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            56888999999999999999999875   99999999999994   446799999999876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=98.79  E-value=1.9e-08  Score=54.59  Aligned_cols=58  Identities=33%  Similarity=0.562  Sum_probs=46.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++..   +..+++.|||+++...
T Consensus       142 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          142 KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            345789999999999999999999874   999999999999975   6789999999987654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=98.78  E-value=1.1e-08  Score=54.92  Aligned_cols=56  Identities=41%  Similarity=0.558  Sum_probs=48.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~   62 (77)
                      ..+++...+.++.+++.++.|+|..+   ++|+++++.|+++..   ...+++.|||.+...
T Consensus       135 ~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~  193 (327)
T 2yfx_A          135 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI  193 (327)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECcccccccc
Confidence            35889999999999999999999875   999999999999983   456899999988644

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=98.78  E-value=3.6e-08  Score=53.22  Aligned_cols=58  Identities=28%  Similarity=0.483  Sum_probs=49.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..   ...+++.|||.+.....
T Consensus       123 ~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          123 QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            36889999999999999999999985   999999999999975   34589999999876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=98.78  E-value=1.8e-08  Score=54.96  Aligned_cols=56  Identities=32%  Similarity=0.418  Sum_probs=47.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC--eEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN--PKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..  +++.|||+++..
T Consensus       111 ~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A          111 GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            45788999999999999999999875   999999999999976654  999999988743

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=98.78  E-value=7.2e-08  Score=50.83  Aligned_cols=56  Identities=36%  Similarity=0.529  Sum_probs=49.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-CCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-EMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~l~~~g~~~~~~   63 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++.. +..+++.|||.+....
T Consensus       118 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          118 KDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             TTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             CccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            4567888888999999999999874   999999999999987 7889999999987654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=98.77  E-value=3.5e-08  Score=51.93  Aligned_cols=60  Identities=27%  Similarity=0.597  Sum_probs=50.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC-----eEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN-----PKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~-----~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.|+|..+ .+++|+++++.|+++.....     +++.|||.++...
T Consensus       116 ~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~  180 (287)
T 4f0f_A          116 AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV  180 (287)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS
T ss_pred             cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc
Confidence            346889999999999999999999862 23999999999999976554     8999999886443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=98.77  E-value=1.4e-08  Score=54.01  Aligned_cols=58  Identities=34%  Similarity=0.620  Sum_probs=50.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc-CCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~l~~~g~~~~~~   63 (77)
                      +..+++.....++.+++.++.++|..+   ++|+++++.|+++. .+..+++.|||.++...
T Consensus       114 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~  172 (320)
T 2i6l_A          114 QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD  172 (320)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC-
T ss_pred             cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccC
Confidence            456788899999999999999999875   99999999999997 45688999999987653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=98.77  E-value=8.4e-09  Score=54.27  Aligned_cols=58  Identities=28%  Similarity=0.482  Sum_probs=51.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       105 ~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A          105 RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            345889999999999999999999875   9999999999999988899999999987554

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=98.77  E-value=1.1e-08  Score=53.75  Aligned_cols=57  Identities=25%  Similarity=0.395  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       108 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A          108 NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            35788899999999999999999875   9999999999999988899999999887554

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=98.77  E-value=1.5e-08  Score=56.93  Aligned_cols=59  Identities=34%  Similarity=0.639  Sum_probs=51.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc---CCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.+++.++.|+|..+   ++|+++++.|+++.   ....+++.|||++..+..
T Consensus       120 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          120 RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            456788999999999999999999975   99999999999994   557899999999876543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=98.76  E-value=1.3e-08  Score=59.42  Aligned_cols=58  Identities=31%  Similarity=0.509  Sum_probs=52.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++....
T Consensus       486 ~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          486 FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            35788999999999999999999875   99999999999999889999999999876543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=98.76  E-value=3.3e-08  Score=53.69  Aligned_cols=59  Identities=31%  Similarity=0.437  Sum_probs=49.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc------CCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD------HEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~------~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|...  +++|+++++.|+++.      ....+++.|||++.....
T Consensus       126 ~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~  190 (373)
T 1q8y_A          126 RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE  190 (373)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred             cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC
Confidence            45888999999999999999999861  399999999999994      234689999999976543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=98.76  E-value=7e-08  Score=50.68  Aligned_cols=58  Identities=29%  Similarity=0.441  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+.   .+++.|||.+.....
T Consensus       100 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A          100 EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            45788899999999999999999875   99999999999997554   489999999876543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=98.76  E-value=6.9e-09  Score=55.79  Aligned_cols=57  Identities=35%  Similarity=0.560  Sum_probs=48.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-----CCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-----EMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-----~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..     ...+++.|||.+....
T Consensus       127 ~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          127 PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            45788999999999999999999975   999999999999953     3458999999886543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=98.76  E-value=2e-08  Score=53.06  Aligned_cols=57  Identities=37%  Similarity=0.616  Sum_probs=51.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       116 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A          116 GVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            45889999999999999999999875   9999999999999999999999999876543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=98.76  E-value=1.7e-08  Score=52.53  Aligned_cols=57  Identities=33%  Similarity=0.516  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus        99 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           99 GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence            45788999999999999999999875   9999999999999988899999999887543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=98.75  E-value=2.1e-08  Score=52.87  Aligned_cols=56  Identities=36%  Similarity=0.589  Sum_probs=49.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       112 ~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  167 (303)
T 1zy4_A          112 NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVH  167 (303)
T ss_dssp             GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTT
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcc
Confidence            4567788889999999999999875   9999999999999999999999999887553

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=98.75  E-value=3.1e-08  Score=52.39  Aligned_cols=57  Identities=35%  Similarity=0.611  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  154 (299)
T 2r3i_A           98 TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG  154 (299)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence            35788889999999999999999875   9999999999999999999999999876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=98.74  E-value=7.7e-08  Score=50.50  Aligned_cols=58  Identities=31%  Similarity=0.464  Sum_probs=50.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC----CeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM----NPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++....    .+++.|||.+.....
T Consensus       103 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A          103 ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            45788999999999999999999874   99999999999997665    789999999876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=98.73  E-value=3.3e-08  Score=52.73  Aligned_cols=57  Identities=28%  Similarity=0.377  Sum_probs=48.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       129 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          129 GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            35788899999999999999999875   9999999999999999999999999886554

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=98.73  E-value=3e-08  Score=52.04  Aligned_cols=55  Identities=29%  Similarity=0.489  Sum_probs=46.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            6 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         6 l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       114 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A          114 LGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            677888899999999999999875   9999999999999999999999999887543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=98.72  E-value=3.9e-08  Score=52.93  Aligned_cols=54  Identities=35%  Similarity=0.531  Sum_probs=46.8

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC--CeEEecccceeeec
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM--NPKISDFGMARIFG   63 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~l~~~g~~~~~~   63 (77)
                      ++.....++.+++.++.|+|..+   ++|+++++.|+++..+.  .+++.|||.+..+.
T Consensus       166 ~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~  221 (345)
T 3hko_A          166 REKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY  221 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGG
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeecccccccc
Confidence            45667788999999999999875   99999999999997655  79999999998653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=98.72  E-value=2.6e-08  Score=52.42  Aligned_cols=55  Identities=25%  Similarity=0.441  Sum_probs=48.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC--------eEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN--------PKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~--------~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..        +++.|||.+...
T Consensus       109 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~  171 (289)
T 4fvq_A          109 CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV  171 (289)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccc
Confidence            3788889999999999999999875   999999999999977665        899999987543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=98.71  E-value=1e-07  Score=52.27  Aligned_cols=60  Identities=32%  Similarity=0.436  Sum_probs=50.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc--CCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD--HEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|.. ..+++|+++++.|+++.  ....++++|||++.....
T Consensus       152 ~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~  213 (382)
T 2vx3_A          152 RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ  213 (382)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence            3578999999999999999999953 23599999999999995  356799999999987643

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=98.71  E-value=5.4e-08  Score=51.72  Aligned_cols=49  Identities=27%  Similarity=0.300  Sum_probs=43.6

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677           11 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        11 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...++.+++.++.++|..+   ++|+++++.|+++. +..++++|||+++...
T Consensus       195 ~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~~~  243 (282)
T 1zar_A          195 PDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG  243 (282)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEETT
T ss_pred             HHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeECC
Confidence            4468899999999999875   99999999999999 8889999999998654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=98.71  E-value=4.5e-08  Score=52.13  Aligned_cols=57  Identities=30%  Similarity=0.480  Sum_probs=47.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC---eEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN---PKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~---~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++..+..   +++.|||++....
T Consensus       106 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A          106 RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            45788899999999999999999974   999999999999986654   8999999887553

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=98.69  E-value=4.1e-08  Score=55.29  Aligned_cols=58  Identities=34%  Similarity=0.652  Sum_probs=49.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc---CCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.|+|..+   ++|+++++.|+++.   ....+++.|||++..+..
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          116 KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            45788899999999999999999875   99999999999995   345799999999875543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=98.68  E-value=4.3e-08  Score=51.89  Aligned_cols=54  Identities=35%  Similarity=0.523  Sum_probs=49.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||++.
T Consensus       112 ~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A          112 RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            45788999999999999999999874   9999999999999988999999999764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=98.68  E-value=3e-08  Score=53.15  Aligned_cols=58  Identities=34%  Similarity=0.420  Sum_probs=50.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.+++.++.++|.. +   ++|+++++.|+++..+..+++.|||+++...
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          119 DDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             cccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            45678899999999999999999986 4   9999999999999999999999999887554

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=98.68  E-value=4.6e-08  Score=52.07  Aligned_cols=58  Identities=33%  Similarity=0.478  Sum_probs=48.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.|+|...  +++|+++++.|+++..+..+++.|||.+....
T Consensus       119 ~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          119 GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            46788899999999999999999731  39999999999999999999999999886554

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=98.67  E-value=3.8e-08  Score=51.49  Aligned_cols=57  Identities=35%  Similarity=0.602  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++..+..+++.|||.+....
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A          106 GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence            35788889999999999999999875   9999999999999999999999999887554

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=98.66  E-value=3.7e-08  Score=55.01  Aligned_cols=55  Identities=33%  Similarity=0.534  Sum_probs=43.7

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-----CCCeEEecccceeeecC
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-----EMNPKISDFGMARIFGG   64 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-----~~~~~l~~~g~~~~~~~   64 (77)
                      .......++.+++.++.|+|..+   ++|+++++.|+++..     ...++++|||+++....
T Consensus       116 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          116 LGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             cchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            34455678899999999999875   999999999999942     24578999999886643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=98.66  E-value=8.9e-08  Score=50.50  Aligned_cols=58  Identities=34%  Similarity=0.486  Sum_probs=49.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc-CCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|..+ .+++|+++++.|+++. .+..+++.|||.+...
T Consensus       124 ~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          124 KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            45788899999999999999999862 2499999999999997 6789999999988644

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=98.65  E-value=3.1e-08  Score=51.90  Aligned_cols=60  Identities=37%  Similarity=0.553  Sum_probs=49.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCC--CCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.++.++|..+  ..+++|+++++.|+++..+..+++.|||.+....
T Consensus       106 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~  167 (279)
T 2w5a_A          106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  167 (279)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeec
Confidence            34889999999999999999999863  1239999999999999999999999999886543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=98.65  E-value=6.2e-08  Score=51.64  Aligned_cols=54  Identities=39%  Similarity=0.629  Sum_probs=46.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .+++.....++.+++.++.++|..+   ++|+++++.|+++. +..+++.|||++...
T Consensus       126 ~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          126 VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            5788999999999999999999875   99999999999997 567899999987644

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=98.64  E-value=1e-07  Score=54.61  Aligned_cols=48  Identities=33%  Similarity=0.515  Sum_probs=43.2

Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677           12 ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus        12 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..++.|++.++.|+|..+   ++|+++++.|+++..  .+++.|||+++....
T Consensus       434 ~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          434 LDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             THHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             HHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            467899999999999875   999999999999988  999999999987754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=98.60  E-value=1.4e-07  Score=50.26  Aligned_cols=59  Identities=34%  Similarity=0.385  Sum_probs=46.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCC-eEEecccceeeec
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMN-PKISDFGMARIFG   63 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~l~~~g~~~~~~   63 (77)
                      .+++...+.++.+++.++.|+|.....+++|+++++.|+++..+.. +++.|||.+....
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           98 YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            3678888899999999999999832235999999999999987765 7999999886543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=98.60  E-value=2.6e-07  Score=48.45  Aligned_cols=49  Identities=22%  Similarity=0.313  Sum_probs=42.6

Q ss_pred             HHHHHHHHHHHHHHHhh-hCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677           10 RRISIINGIARGLLYLH-EDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus        10 ~~~~~~~~~~~~l~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ....++.+++.++.++| ..   +++|+++++.|+++..  .++++|||++....
T Consensus       171 ~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          171 DVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             CHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            45677889999999999 76   4999999999999987  89999999997653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=98.57  E-value=1.3e-07  Score=51.31  Aligned_cols=57  Identities=32%  Similarity=0.508  Sum_probs=49.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.|+|...  +++|+++++.|+++..+..+++.|||.+...
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          126 GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            35788888999999999999999741  3999999999999999999999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=98.57  E-value=1.1e-07  Score=50.46  Aligned_cols=56  Identities=32%  Similarity=0.538  Sum_probs=49.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEE---cCCCCeEEecccceeee
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---DHEMNPKISDFGMARIF   62 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~l~~~g~~~~~   62 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++   ..+..+++.|||.+...
T Consensus       101 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A          101 GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            35788889999999999999999875   9999999999999   56678999999988644

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=98.54  E-value=4.3e-07  Score=47.87  Aligned_cols=58  Identities=34%  Similarity=0.639  Sum_probs=49.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC---CCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE---MNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.+++.++.++|..+   ++|+++++.|+++...   ..+++.|||.+.....
T Consensus       116 ~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          116 KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            45788899999999999999999874   9999999999999653   4689999998875543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=98.53  E-value=1.7e-07  Score=52.31  Aligned_cols=53  Identities=40%  Similarity=0.641  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-------------CCeEEecccceeeecCC
Q 040677           10 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-------------MNPKISDFGMARIFGGN   65 (77)
Q Consensus        10 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-------------~~~~l~~~g~~~~~~~~   65 (77)
                      ..+.++.+++.++.|+|..+   ++|+++++.|+++...             ..++++|||++......
T Consensus       116 ~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~  181 (434)
T 2rio_A          116 NPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG  181 (434)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-
T ss_pred             hHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCC
Confidence            34568899999999999874   9999999999999643             47899999999876543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=98.44  E-value=6.5e-07  Score=52.74  Aligned_cols=57  Identities=37%  Similarity=0.525  Sum_probs=49.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC---CeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM---NPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~l~~~g~~~~~~~   64 (77)
                      .+++.....++.+++.++.|+|..+   ++|+++++.|+++..+.   .+++.|||.+.....
T Consensus       117 ~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~  176 (676)
T 3qa8_A          117 GLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ  176 (676)
T ss_dssp             CCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccc
Confidence            5778888999999999999999875   99999999999998554   389999999876543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=98.42  E-value=8.5e-07  Score=46.14  Aligned_cols=56  Identities=23%  Similarity=0.353  Sum_probs=48.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      .+++.....++.+++.++.|+|..+ ..++|+++++.|+++..+...++.+++++..
T Consensus       107 ~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A          107 VVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceee
Confidence            5899999999999999999999752 3489999999999999888889988877643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=98.14  E-value=8.5e-06  Score=43.25  Aligned_cols=48  Identities=10%  Similarity=-0.035  Sum_probs=41.2

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEeccc
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFG   57 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g   57 (77)
                      .......++.+++.++.|+|..+   ++|+++++.|+++..+...++.+.+
T Consensus       127 ~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          127 SPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             ChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc
Confidence            45567788999999999999985   9999999999999988888877544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=97.34  E-value=0.00031  Score=39.41  Aligned_cols=46  Identities=26%  Similarity=0.396  Sum_probs=36.6

Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC----------CeEEecccce
Q 040677           11 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM----------NPKISDFGMA   59 (77)
Q Consensus        11 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~----------~~~l~~~g~~   59 (77)
                      ...+..+++.++.++|..+   ++|+++++.|+++..+.          .+.++||+-+
T Consensus       207 ~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          207 PASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTC
T ss_pred             HHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCc
Confidence            3456788999999999875   99999999999997554          2667887644

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=91.81  E-value=0.39  Score=24.86  Aligned_cols=30  Identities=23%  Similarity=0.302  Sum_probs=24.3

Q ss_pred             CeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677           32 KIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus        32 ~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      .++|.++.+.|+++.......+.||+.+..
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence            589999999999997665567899987653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=91.50  E-value=0.97  Score=24.65  Aligned_cols=31  Identities=16%  Similarity=0.381  Sum_probs=24.8

Q ss_pred             CCeEEccCCCCcEEEcCCC--CeEEecccceee
Q 040677           31 LKIIHRDLKASNVLLDHEM--NPKISDFGMARI   61 (77)
Q Consensus        31 ~~~~~~~l~~~~~~~~~~~--~~~l~~~g~~~~   61 (77)
                      ..++|.++.+.|+++..+.  ...+.||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            4689999999999998654  358999987753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=90.45  E-value=0.16  Score=26.03  Aligned_cols=31  Identities=16%  Similarity=0.232  Sum_probs=25.4

Q ss_pred             CeEEccCCCCcEEEcCCCCeEEecccceeee
Q 040677           32 KIIHRDLKASNVLLDHEMNPKISDFGMARIF   62 (77)
Q Consensus        32 ~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~   62 (77)
                      .++|.++.+.|+++..+....+.||+.+...
T Consensus       185 ~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          185 VVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             EEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence            4899999999999977655679999887643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=84.11  E-value=1.1  Score=23.93  Aligned_cols=30  Identities=20%  Similarity=0.285  Sum_probs=25.5

Q ss_pred             CCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677           31 LKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus        31 ~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      ..++|.++.+.|+++..+....+.||..+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            469999999999999766778899998765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	77
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-20
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-19
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-18
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-18
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-18
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-18
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-18
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-17
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-17
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-17
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-17
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-16
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-16
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-16
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-16
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-16
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-16
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-15
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-14
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-14
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-14
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-14
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-14
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-14
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-13
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-13
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-13
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-13
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-13
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-13
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-13
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-13
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-12
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-12
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-12
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-12
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-12
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-12
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-11
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-11
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-11
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-11
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-11
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-11
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-11
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-11
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-10
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-10
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-10
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-10
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-09
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-09
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-09
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-09
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-09
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-08
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-08
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-08
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-08
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-07
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-06
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-05
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.0 bits (197), Expect = 1e-20
 Identities = 23/76 (30%), Positives = 38/76 (50%), Gaps = 3/76 (3%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
              + +  + I I    A+G+ YLH      IIHRDLK++N+ L  ++  KI DFG+A +
Sbjct: 97  IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153

Query: 62  FGGNQSEANTNRIVGT 77
                      ++ G+
Sbjct: 154 KSRWSGSHQFEQLSGS 169

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.0 bits (184), Expect = 8e-19
 Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 3/76 (3%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
             + +         + +  G++YLH    + I HRD+K  N+LLD   N KISDFG+A +
Sbjct: 96  PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV 152

Query: 62  FGGNQSEANTNRIVGT 77
           F  N  E   N++ GT
Sbjct: 153 FRYNNRERLLNKMCGT 168

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.3 bits (182), Expect = 2e-18
 Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 3/66 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L   +   +       L YLH+    KIIHRDLKA N+L   + + K++DFG++      
Sbjct: 107 LTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163

Query: 66  QSEANT 71
               ++
Sbjct: 164 IQRRDS 169

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.6 bits (180), Expect = 4e-18
 Identities = 21/77 (27%), Positives = 39/77 (50%), Gaps = 6/77 (7%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            ++ ++  +    +   + +GL YL    + KI+HRD+K SN+L++     K+ DFG++ 
Sbjct: 96  KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153

Query: 61  IFGGNQSEANTNRIVGT 77
               +      N  VGT
Sbjct: 154 QLIDSM----ANSFVGT 166

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 73.3 bits (179), Expect = 4e-18
 Identities = 21/72 (29%), Positives = 30/72 (41%), Gaps = 3/72 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L    ++ I   +A G+ YL E    K +HRDL   N L+   M  KI+DFG++R     
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 66  QSEANTNRIVGT 77
                       
Sbjct: 194 DYYKADGNDAIP 205

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.1 bits (179), Expect = 5e-18
 Identities = 24/68 (35%), Positives = 36/68 (52%), Gaps = 2/68 (2%)

Query: 6   LDWKRRISIINGIARGLLYLHE--DSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG 63
           LD +  + ++  +   L   H   D    ++HRDLK +NV LD + N K+ DFG+ARI  
Sbjct: 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165

Query: 64  GNQSEANT 71
            + S A  
Sbjct: 166 HDTSFAKA 173

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.7 bits (180), Expect = 5e-18
 Identities = 20/72 (27%), Positives = 32/72 (44%), Gaps = 3/72 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L ++  +     +A+G+ +L        +HRDL A NVL+ H    KI DFG+AR    +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 66  QSEANTNRIVGT 77
            +          
Sbjct: 218 SNYVVRGNARLP 229

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.8 bits (175), Expect = 2e-17
 Identities = 22/72 (30%), Positives = 31/72 (43%), Gaps = 3/72 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L  +  I     +A+G+ +L      K IHRDL A N+LL  +   KI DFG+AR    +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 66  QSEANTNRIVGT 77
                       
Sbjct: 188 PDYVRKGDARLP 199

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 71.2 bits (174), Expect = 3e-17
 Identities = 27/72 (37%), Positives = 35/72 (48%), Gaps = 9/72 (12%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L      ++ +G  +GL YLH      +IHRD+KA N+LL      K+ DFG A I    
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM--- 165

Query: 66  QSEANTNRIVGT 77
              A  N  VGT
Sbjct: 166 ---APANSFVGT 174

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 70.9 bits (173), Expect = 4e-17
 Identities = 21/70 (30%), Positives = 38/70 (54%), Gaps = 3/70 (4%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
              + + ++ GIA G+ YL     +  +HRDL A N+L++  +  K+SDFG++R    + 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 67  SEANTNRIVG 76
           S+      +G
Sbjct: 183 SDPTYTSALG 192

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.5 bits (172), Expect = 4e-17
 Identities = 22/71 (30%), Positives = 40/71 (56%), Gaps = 3/71 (4%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
             ++L   + + +   IA G+ ++ E      IHRDL+A+N+L+   ++ KI+DFG+AR+
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARL 158

Query: 62  FGGNQSEANTN 72
              N+  A   
Sbjct: 159 IEDNEYTAREG 169

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (169), Expect = 1e-16
 Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 7/84 (8%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKASNVLLDHEMNPKISD 55
           +    +  +  I +    A GL +LH +      +  I HRDLK+ N+L+       I+D
Sbjct: 92  LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151

Query: 56  FGMARIF--GGNQSEANTNRIVGT 77
            G+A       +  +   N  VGT
Sbjct: 152 LGLAVRHDSATDTIDIAPNHRVGT 175

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.4 bits (169), Expect = 2e-16
 Identities = 21/71 (29%), Positives = 37/71 (52%), Gaps = 3/71 (4%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
             +  ++    IA+G+ YL      +++HRDL A NVL+    + KI+DFG+A++ G  +
Sbjct: 109 GSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

Query: 67  SEANTNRIVGT 77
            E +       
Sbjct: 166 KEYHAEGGKVP 176

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.5 bits (167), Expect = 2e-16
 Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 7/72 (9%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
            D +R  + I  +A  L Y H     ++IHRD+K  N+LL      KI+DFG +     +
Sbjct: 103 FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159

Query: 66  QSEANTNRIVGT 77
           +       + GT
Sbjct: 160 R----RTTLCGT 167

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (166), Expect = 3e-16
 Identities = 23/75 (30%), Positives = 34/75 (45%), Gaps = 3/75 (4%)

Query: 3   SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIF 62
            + LD +  +S    +A+G+ +L        IHRDL A N+LL H    KI DFG+AR  
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 63  GGNQSEANTNRIVGT 77
             + +          
Sbjct: 196 KNDSNYVVKGNARLP 210

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.3 bits (164), Expect = 6e-16
 Identities = 23/77 (29%), Positives = 35/77 (45%), Gaps = 6/77 (7%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMAR 60
           R   +  K   S    I +GL +LH  +   IIHRDLK  N+ +     + KI D G+A 
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163

Query: 61  IFGGNQSEANTNRIVGT 77
           +   +        ++GT
Sbjct: 164 LKRASF----AKAVIGT 176

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.0 bits (163), Expect = 9e-16
 Identities = 20/68 (29%), Positives = 37/68 (54%), Gaps = 3/68 (4%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
             + + +   IA G+ Y+    R+  +HRDL+A+N+L+   +  K++DFG+AR+   N+ 
Sbjct: 112 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168

Query: 68  EANTNRIV 75
            A      
Sbjct: 169 TARQGAKF 176

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 66.7 bits (162), Expect = 1e-15
 Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 3/68 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           ++     + +   I+  + YL    +   IHRDL A N L+      K++DFG++R+  G
Sbjct: 111 EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167

Query: 65  NQSEANTN 72
           +   A+  
Sbjct: 168 DTYTAHAG 175

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.1 bits (155), Expect = 1e-14
 Identities = 21/72 (29%), Positives = 34/72 (47%), Gaps = 6/72 (8%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L  ++ +     +ARG+ YL +    + IHRDL A N+L+      KI+DFG++R   G 
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQ 177

Query: 66  QSEANTNRIVGT 77
           +           
Sbjct: 178 EVYVKKTMGRLP 189

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.8 bits (152), Expect = 3e-14
 Identities = 20/78 (25%), Positives = 37/78 (47%), Gaps = 4/78 (5%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            ++  +  K  I +++ ++ G+ YL        +HRDL A NVLL  +   KISDFG+++
Sbjct: 99  QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 155

Query: 61  IFGGNQSEANTN-RIVGT 77
               +++           
Sbjct: 156 ALRADENYYKAQTHGKWP 173

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 62.8 bits (152), Expect = 3e-14
 Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 6/76 (7%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
             V L  K    I+  +   +  LH+   L I+HRDLK  N+LLD +MN K++DFG +  
Sbjct: 103 EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159

Query: 62  FGGNQSEANTNRIVGT 77
               +       + GT
Sbjct: 160 LDPGEK---LREVCGT 172

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.4 bits (151), Expect = 4e-14
 Identities = 20/74 (27%), Positives = 35/74 (47%), Gaps = 4/74 (5%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           ++       +++ ++ G+ YL        +HRDL A NVLL +    KISDFG+++  G 
Sbjct: 105 EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161

Query: 65  NQSEAN-TNRIVGT 77
           + S     +     
Sbjct: 162 DDSYYTARSAGKWP 175

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.5 bits (149), Expect = 9e-14
 Identities = 22/71 (30%), Positives = 39/71 (54%), Gaps = 5/71 (7%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
           D  +  ++     + L +LH     ++IHRD+K+ N+LL  + + K++DFG        Q
Sbjct: 114 DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 67  SEANTNRIVGT 77
           S+ +T  +VGT
Sbjct: 171 SKRST--MVGT 179

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.4 bits (148), Expect = 9e-14
 Identities = 20/70 (28%), Positives = 38/70 (54%), Gaps = 3/70 (4%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
           +  +    + + ++ GIA G+ YL     +  +HRDL A N+L++  +  K+SDFG++R+
Sbjct: 103 KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159

Query: 62  FGGNQSEANT 71
              +     T
Sbjct: 160 LEDDPEATYT 169

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.4 bits (148), Expect = 1e-13
 Identities = 27/73 (36%), Positives = 34/73 (46%), Gaps = 3/73 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           QL  K  +S    +ARG+ YL      K IHRDL A NVL+  +   KI+DFG+AR    
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 65  NQSEANTNRIVGT 77
                 T      
Sbjct: 188 IDYYKKTTNGRLP 200

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 61.3 bits (148), Expect = 2e-13
 Identities = 18/60 (30%), Positives = 29/60 (48%), Gaps = 3/60 (5%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
                     I  GL ++H      +++RDLK +N+LLD   + +ISD G+A  F   + 
Sbjct: 106 EADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.4 bits (146), Expect = 2e-13
 Identities = 17/62 (27%), Positives = 26/62 (41%), Gaps = 3/62 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           L     +     +   + YL        +HRDL A NVL+  +   K+SDFG+ +     
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156

Query: 66  QS 67
           Q 
Sbjct: 157 QD 158

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.6 bits (146), Expect = 2e-13
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 3/76 (3%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
                   + I +   IA G+ YL+ +   K +HRDL A N ++  +   KI DFGM R 
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182

Query: 62  FGGNQSEANTNRIVGT 77
                      + +  
Sbjct: 183 IYETDYYRKGGKGLLP 198

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (145), Expect = 3e-13
 Identities = 23/72 (31%), Positives = 36/72 (50%), Gaps = 3/72 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           +++  L        +  I RGL Y+H      ++HRDLK SN+LL+   + KI DFG+AR
Sbjct: 101 LKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157

Query: 61  IFGGNQSEANTN 72
           +   +       
Sbjct: 158 VADPDHDHTGFL 169

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.8 bits (144), Expect = 3e-13
 Identities = 18/72 (25%), Positives = 30/72 (41%), Gaps = 4/72 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           LD    I     ++  L YL      + +HRD+ A NVL+      K+ DFG++R    +
Sbjct: 105 LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

Query: 66  QSEANTNRIVGT 77
                 ++    
Sbjct: 162 TYY-KASKGKLP 172

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.6 bits (144), Expect = 5e-13
 Identities = 26/76 (34%), Positives = 36/76 (47%), Gaps = 3/76 (3%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            +    D          I   L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+
Sbjct: 100 RKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK 156

Query: 61  IFGGNQSEANTNRIVG 76
           +      +A  N  VG
Sbjct: 157 VLSPESKQARANSFVG 172

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.4 bits (143), Expect = 6e-13
 Identities = 20/73 (27%), Positives = 25/73 (34%), Gaps = 3/73 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
                        +A G+ YL      + IHRDL A N+LL      KI DFG+ R    
Sbjct: 107 HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163

Query: 65  NQSEANTNRIVGT 77
           N            
Sbjct: 164 NDDHYVMQEHRKV 176

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.5 bits (141), Expect = 1e-12
 Identities = 20/71 (28%), Positives = 31/71 (43%), Gaps = 4/71 (5%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
             +  + +   +  G+ YL E     +IHRDL A N L+      K+SDFGM R    +Q
Sbjct: 99  AAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155

Query: 67  SEANTNRIVGT 77
              ++      
Sbjct: 156 YT-SSTGTKFP 165

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.5 bits (141), Expect = 1e-12
 Identities = 15/77 (19%), Positives = 34/77 (44%), Gaps = 4/77 (5%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
               +   ++ + +   +   + YL      + +HRDL A N L++ +   K+SDFG++R
Sbjct: 92  EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148

Query: 61  IFGGNQSEANTNRIVGT 77
               ++  ++       
Sbjct: 149 YVLDDEYTSSVG-SKFP 164

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 57.8 bits (139), Expect = 3e-12
 Identities = 21/67 (31%), Positives = 29/67 (43%), Gaps = 3/67 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            +S +            +   L YLH      II+RDLK  N+LLD   + KI+DFG A+
Sbjct: 96  RKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK 152

Query: 61  IFGGNQS 67
                  
Sbjct: 153 YVPDVTY 159

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 56.7 bits (136), Expect = 5e-12
 Identities = 19/67 (28%), Positives = 29/67 (43%), Gaps = 3/67 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            R  +            I     YLH    L +I+RDLK  N+L+D +   +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189

Query: 61  IFGGNQS 67
              G   
Sbjct: 190 RVKGRTW 196

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 56.6 bits (136), Expect = 7e-12
 Identities = 16/74 (21%), Positives = 31/74 (41%), Gaps = 5/74 (6%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--KISDFGMARIF 62
           ++     +  +  + +GL ++HE      +H DLK  N++   + +   K+ DFG+    
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176

Query: 63  GGNQSEANTNRIVG 76
              QS   T     
Sbjct: 177 DPKQSVKVTTGTAE 190

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.4 bits (135), Expect = 7e-12
 Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 5/79 (6%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
              V+        ++  +  GL Y+H +   KI+HRD+KA+NVL+  +   K++DFG+AR
Sbjct: 109 NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165

Query: 61  IFGGNQSEANTNR--IVGT 77
            F   ++         V T
Sbjct: 166 AFSLAKNSQPNRYTNRVVT 184

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (133), Expect = 1e-11
 Identities = 21/72 (29%), Positives = 38/72 (52%), Gaps = 6/72 (8%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           +  +    ++  + RGL +LH     +++HRDLK  N+L+      K++DFG+ARI+   
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 169

Query: 66  QSEANTNRIVGT 77
            +      +V T
Sbjct: 170 MA---LTSVVVT 178

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (133), Expect = 1e-11
 Identities = 20/73 (27%), Positives = 35/73 (47%), Gaps = 3/73 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
             +     K  I     +A+G+      +  K +HRDL A N +LD +   K++DFG+AR
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 61  IFGGNQSEANTNR 73
                + ++  N+
Sbjct: 179 DMYDKEFDSVHNK 191

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 55.5 bits (133), Expect = 1e-11
 Identities = 16/67 (23%), Positives = 31/67 (46%), Gaps = 5/67 (7%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--KISDFGMA 59
              ++     I+ +     GL ++HE     I+H D+K  N++ + +     KI DFG+A
Sbjct: 120 EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLA 176

Query: 60  RIFGGNQ 66
                ++
Sbjct: 177 TKLNPDE 183

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (132), Expect = 3e-11
 Identities = 15/68 (22%), Positives = 31/68 (45%), Gaps = 5/68 (7%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP--KISDFGMA 59
            + +L+ +  +S ++ +   L +LH      I H D++  N++     +   KI +FG A
Sbjct: 95  SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151

Query: 60  RIFGGNQS 67
           R      +
Sbjct: 152 RQLKPGDN 159

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.4 bits (130), Expect = 4e-11
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 5/73 (6%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
           + D  R       I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +    
Sbjct: 99  KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155

Query: 65  NQSEANTNRIVGT 77
             ++ NT    GT
Sbjct: 156 GDAKTNT--FCGT 166

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 54.1 bits (129), Expect = 5e-11
 Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 3/67 (4%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG 64
            L+     S +  +  G+ Y H+    +++HRDLK  N+L++ E   KI+DFG+AR FG 
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152

Query: 65  NQSEANT 71
              +   
Sbjct: 153 PVRKYTH 159

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (129), Expect = 6e-11
 Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 5/77 (6%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
            R      +R       I   L YLH      +++RD+K  N++LD + + KI+DFG+ +
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

Query: 61  IFGGNQSEANTNRIVGT 77
              G    A      GT
Sbjct: 154 E--GISDGATMKTFCGT 168

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (128), Expect = 8e-11
 Identities = 19/67 (28%), Positives = 29/67 (43%), Gaps = 4/67 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGG 64
           L        +  + R L Y+H      I HRD+K  N+LLD +    K+ DFG A+    
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

Query: 65  NQSEANT 71
            +   + 
Sbjct: 176 GEPNVSY 182

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.6 bits (125), Expect = 2e-10
 Identities = 16/63 (25%), Positives = 30/63 (47%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
                 + + + + L  L       ++HRDLK  N+L++     K+++FG+AR FG    
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156

Query: 68  EAN 70
             +
Sbjct: 157 CYS 159

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.8 bits (123), Expect = 3e-10
 Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 3/66 (4%)

Query: 2   RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARI 61
            S+ L      + +    +GL YLH+     I+HRDLK +N+LLD     K++DFG+A+ 
Sbjct: 93  NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 149

Query: 62  FGGNQS 67
           FG    
Sbjct: 150 FGSPNR 155

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (123), Expect = 3e-10
 Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 6/65 (9%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP---KISDFGMARIF 62
              +    I+  I   + YLH    + I HRD+K  N+L   +      K++DFG A+  
Sbjct: 108 FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164

Query: 63  GGNQS 67
             + S
Sbjct: 165 TSHNS 169

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.4 bits (122), Expect = 4e-10
 Identities = 20/66 (30%), Positives = 34/66 (51%), Gaps = 3/66 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
           +      S +  + +GL + H     +++HRDLK  N+L++ E   K++DFG+AR FG  
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

Query: 66  QSEANT 71
                 
Sbjct: 156 VRTYTH 161

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.2 bits (119), Expect = 1e-09
 Identities = 23/73 (31%), Positives = 36/73 (49%), Gaps = 3/73 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           M+  +L   R   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR
Sbjct: 113 MKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169

Query: 61  IFGGNQSEANTNR 73
                 +     R
Sbjct: 170 QADSEMTGYVVTR 182

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 48.6 bits (115), Expect = 3e-09
 Identities = 15/68 (22%), Positives = 24/68 (35%), Gaps = 4/68 (5%)

Query: 8   WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS 67
            +    +++ I   +   +      I+H DL   NVL+  E    I DF  +   G    
Sbjct: 102 VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157

Query: 68  EANTNRIV 75
                R V
Sbjct: 158 REILERDV 165

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 48.7 bits (115), Expect = 5e-09
 Identities = 14/83 (16%), Positives = 31/83 (37%), Gaps = 13/83 (15%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP-----KISDFGMA 59
           +   K        +   +  +HE     +++RD+K  N L+    +       + DFGM 
Sbjct: 97  KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153

Query: 60  RIFGGNQSEAN-----TNRIVGT 77
           + +    ++ +        + GT
Sbjct: 154 KFYRDPVTKQHIPYREKKNLSGT 176

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 48.2 bits (114), Expect = 6e-09
 Identities = 23/73 (31%), Positives = 37/73 (50%), Gaps = 4/73 (5%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG-G 64
           +  KR I +I    + L + H+     IIHRD+K +N+++      K+ DFG+AR     
Sbjct: 108 MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164

Query: 65  NQSEANTNRIVGT 77
             S   T  ++GT
Sbjct: 165 GNSVTQTAAVIGT 177

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (113), Expect = 9e-09
 Identities = 16/73 (21%), Positives = 28/73 (38%), Gaps = 8/73 (10%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGG 64
           L  +   S    +   + + H      ++HRD+K  N+L+D      K+ DFG   +   
Sbjct: 107 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 161

Query: 65  NQSEANTNRIVGT 77
              +       GT
Sbjct: 162 --KDTVYTDFDGT 172

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 46.8 bits (110), Expect = 2e-08
 Identities = 21/73 (28%), Positives = 34/73 (46%), Gaps = 7/73 (9%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGG 64
           L        +  I + L Y H    + I+HRD+K  NV++DHE    ++ D+G+A  +  
Sbjct: 126 LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182

Query: 65  NQSEANTNRIVGT 77
            Q     N  V +
Sbjct: 183 GQE---YNVRVAS 192

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.8 bits (110), Expect = 2e-08
 Identities = 17/55 (30%), Positives = 33/55 (60%)

Query: 14  IINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQSE 68
           +   +   +L L    +L II+RD+K  N+LLD   +  ++DFG+++ F  +++E
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.4 bits (109), Expect = 3e-08
 Identities = 15/76 (19%), Positives = 29/76 (38%), Gaps = 6/76 (7%)

Query: 5   QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL---LDHEMNPKISDFGMARI 61
           +   K  + + + +   + Y+H       IHRD+K  N L           I DFG+A+ 
Sbjct: 99  KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155

Query: 62  FGGNQSEANTNRIVGT 77
           +   ++  +       
Sbjct: 156 YRDARTHQHIPYRENK 171

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 8e-08
 Identities = 24/71 (33%), Positives = 36/71 (50%), Gaps = 6/71 (8%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 66
           D +R   ++  +  G+ +LH      IIHRDLK SN+++  +   KI DFG+AR  G + 
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 67  SEANTNRIVGT 77
                   V T
Sbjct: 174 M---MTPYVVT 181

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.1 bits (101), Expect = 3e-07
 Identities = 13/72 (18%), Positives = 26/72 (36%), Gaps = 3/72 (4%)

Query: 6   LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN 65
              +    +I  +   + YLH+   +    +        LD +    ISDFG++++    
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163

Query: 66  QSEANTNRIVGT 77
                 +   GT
Sbjct: 164 S---VLSTACGT 172

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (95), Expect = 2e-06
 Identities = 25/74 (33%), Positives = 36/74 (48%), Gaps = 3/74 (4%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMAR 60
           ++  +L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

Query: 61  IFGGNQSEANTNRI 74
                 +     R 
Sbjct: 170 HTDDEMTGYVATRW 183

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 1e-05
 Identities = 24/81 (29%), Positives = 31/81 (38%), Gaps = 10/81 (12%)

Query: 1   MRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP----KISDF 56
                L  +     +  I  G+ YLH    L+I H DLK  N++L     P    KI DF
Sbjct: 105 AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161

Query: 57  GMARIFGGNQSEANTNRIVGT 77
           G+A              I GT
Sbjct: 162 GLAHKIDFGNE---FKNIFGT 179

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 38.1 bits (87), Expect = 2e-05
 Identities = 21/73 (28%), Positives = 32/73 (43%), Gaps = 8/73 (10%)

Query: 7   DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNP------KISDFGMAR 60
                  I   +  GL Y+H   R  IIH D+K  NVL++   +P      KI+D G A 
Sbjct: 123 PLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 61  IFGGNQSEANTNR 73
            +  + + +   R
Sbjct: 181 WYDEHYTNSIQTR 193

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	77
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.53
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.5
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.5
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.46
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.43
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.42
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.38
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.38
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.36
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.35
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.34
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.34
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.32
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.32
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.32
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.31
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.3
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.3
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.3
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.29
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.29
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.29
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.28
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.28
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.28
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.26
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.26
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.26
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.26
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.25
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.25
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.24
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.23
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.22
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.21
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.21
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.21
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.2
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.19
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.19
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.19
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.18
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.18
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.16
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.15
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.15
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.15
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.14
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.14
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.13
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.11
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.11
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.1
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.09
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.09
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.08
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.03
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	98.98
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	98.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	98.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	98.74
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	98.73
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	98.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	81.74
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	81.51

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=2.6e-14  Score=74.27  Aligned_cols=60  Identities=38%  Similarity=0.605  Sum_probs=54.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+..+++.|||+++.+..+
T Consensus        97 ~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          97 DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            456899999999999999999999875   999999999999999899999999999876543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=1.9e-14  Score=75.37  Aligned_cols=61  Identities=34%  Similarity=0.455  Sum_probs=48.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQS   67 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~~   67 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+..++++|||+++.......
T Consensus       129 ~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  189 (299)
T d1ywna1         129 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  189 (299)
T ss_dssp             -CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTT
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhcccccc
Confidence            35789999999999999999999874   99999999999999999999999999987654443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=2.8e-14  Score=74.26  Aligned_cols=59  Identities=39%  Similarity=0.682  Sum_probs=51.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +..+++.....++.|++.|+.|+|..+   ++|+++++.|++++.+..++++|||+++....
T Consensus        98 ~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          98 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            356899999999999999999999874   99999999999999999999999999976654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=1e-13  Score=73.44  Aligned_cols=60  Identities=35%  Similarity=0.525  Sum_probs=52.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++...+.++.|++.|+.|+|..+   ++|+++++.|+++..+..++++|||+++......
T Consensus       159 ~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  218 (325)
T d1rjba_         159 NVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS  218 (325)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCC
Confidence            35889999999999999999999874   9999999999999999999999999998665443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=2.4e-13  Score=71.12  Aligned_cols=60  Identities=37%  Similarity=0.567  Sum_probs=52.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.+....
T Consensus       103 ~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_         103 GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence            46889999999999999999999985   9999999999999999999999999998775443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=7.1e-13  Score=69.47  Aligned_cols=59  Identities=27%  Similarity=0.486  Sum_probs=53.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+..+++.|||+++.+..+
T Consensus       111 ~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1         111 TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            46889999999999999999999875   999999999999999999999999999877543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=1.4e-12  Score=67.59  Aligned_cols=58  Identities=36%  Similarity=0.705  Sum_probs=53.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .+++..++.++.+++.|+.|+|..+   ++|+++++.|+++..+..++++|||+++....+
T Consensus       105 ~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_         105 KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence            5889999999999999999999874   999999999999999999999999999877544

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.38  E-value=5.6e-13  Score=69.97  Aligned_cols=59  Identities=34%  Similarity=0.639  Sum_probs=47.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|++++.+..++++|||+++.+...
T Consensus       123 ~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         123 GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence            46899999999999999999999874   999999999999999999999999999876543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=3.6e-13  Score=71.09  Aligned_cols=61  Identities=33%  Similarity=0.602  Sum_probs=54.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ...+++...+.++.|++.|+.|+|..+   ++|+++++.|+++..+..++++|||+++......
T Consensus       105 ~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_         105 KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            456889999999999999999999974   9999999999999999999999999998765433

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=1.2e-12  Score=69.71  Aligned_cols=58  Identities=29%  Similarity=0.385  Sum_probs=52.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..++.+++.|||+++....
T Consensus       100 ~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_         100 RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            45788889999999999999999985   99999999999999999999999999986543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.34  E-value=5.8e-13  Score=69.56  Aligned_cols=60  Identities=28%  Similarity=0.515  Sum_probs=53.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++..+..++.|++.|+.|+|..+   ++|+++++.|+++..+..++++|||+++....+
T Consensus       109 ~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_         109 RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            356789999999999999999999874   999999999999999999999999999866543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=1.6e-12  Score=67.64  Aligned_cols=59  Identities=32%  Similarity=0.638  Sum_probs=49.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.+++.|+.|+|..+   ++|+++++.|++++.+..++++|||+++....+
T Consensus       105 ~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_         105 GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            56889999999999999999999874   999999999999999999999999999876543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=4.6e-12  Score=66.13  Aligned_cols=60  Identities=33%  Similarity=0.619  Sum_probs=54.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      +..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+..+++.|||+++.+...
T Consensus       103 ~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_         103 REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence            356899999999999999999999874   999999999999999999999999999877543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=2.4e-12  Score=66.93  Aligned_cols=60  Identities=35%  Similarity=0.608  Sum_probs=54.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++...+.++.|++.|+.|+|..+   ++|+++++.|+++..+...+++|||+++.+...
T Consensus       101 ~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_         101 NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            356899999999999999999999874   999999999999999999999999999876544

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.32  E-value=2.5e-12  Score=67.80  Aligned_cols=58  Identities=38%  Similarity=0.588  Sum_probs=53.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +..+++..+..++.|++.|+.|+|..+   ++|+++++.|+++..+..++++|||++....
T Consensus       109 ~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_         109 KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence            456899999999999999999999985   9999999999999999999999999997654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.31  E-value=5.9e-12  Score=67.62  Aligned_cols=60  Identities=30%  Similarity=0.361  Sum_probs=53.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++.....++.+++.|+.|+|..+   ++|+++++.|+++...+.++++|||+++.+....
T Consensus       102 ~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3         102 GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            45778889999999999999999875   9999999999999999999999999998776543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=1.3e-12  Score=68.30  Aligned_cols=57  Identities=33%  Similarity=0.482  Sum_probs=52.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+...+++|||+++...
T Consensus       105 ~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1         105 RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC
Confidence            45899999999999999999999885   9999999999999999999999999987653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=1.9e-12  Score=66.79  Aligned_cols=59  Identities=32%  Similarity=0.512  Sum_probs=47.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++...+.++.|++.|+.|+|..+   ++|+++++.|++++.+..++++|||+++.....
T Consensus        96 ~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          96 GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCC
Confidence            56789999999999999999999875   999999999999999999999999999866543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=2e-12  Score=66.83  Aligned_cols=59  Identities=34%  Similarity=0.514  Sum_probs=53.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+..+++.|||++.....+
T Consensus       101 ~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1         101 SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            46889999999999999999999875   999999999999999999999999999765443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=1.5e-12  Score=67.52  Aligned_cols=62  Identities=35%  Similarity=0.539  Sum_probs=46.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCC--CCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++..++.++.|++.|+.|+|..+  ..+++|+++++.|+++..+..+++.|||+++.+..+
T Consensus       104 ~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  167 (269)
T d2java1         104 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD  167 (269)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence            46889999999999999999999753  125999999999999999999999999999876543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.29  E-value=1.2e-11  Score=64.32  Aligned_cols=59  Identities=37%  Similarity=0.575  Sum_probs=53.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+...+++|||+++.....
T Consensus       105 ~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  163 (277)
T d1phka_         105 VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG  163 (277)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCC
Confidence            46899999999999999999999875   999999999999999999999999999877543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=5.1e-12  Score=67.28  Aligned_cols=60  Identities=38%  Similarity=0.639  Sum_probs=53.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++.....++.|++.|+.|+|..+   ++|+++++.|++++.+..+++.|||++......
T Consensus       103 ~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_         103 TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            346889999999999999999999875   999999999999999999999999999876543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.28  E-value=1.3e-12  Score=68.54  Aligned_cols=57  Identities=35%  Similarity=0.589  Sum_probs=51.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++...+.++.+++.|+.|+|..+   ++|+++++.|++++.+..++++|||+++...
T Consensus       135 ~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~  191 (301)
T d1lufa_         135 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY  191 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheecc
Confidence            35789999999999999999999874   9999999999999999999999999987654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.28  E-value=7.3e-12  Score=65.61  Aligned_cols=60  Identities=42%  Similarity=0.527  Sum_probs=54.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++...+.++.|++.|+.|+|..+   ++|+++++.|+++..+...++.|||+++......
T Consensus       130 ~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~  189 (299)
T d1fgka_         130 EQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID  189 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccc
Confidence            45899999999999999999999985   9999999999999999999999999998765443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.28  E-value=2.2e-12  Score=67.33  Aligned_cols=60  Identities=32%  Similarity=0.605  Sum_probs=50.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..++|..++.++.+++.|+.|+|..+   ++|+++++.|++++.+..++++|||+++....+.
T Consensus       108 ~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3         108 KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            45899999999999999999999875   9999999999999988999999999998765443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=5.1e-12  Score=65.55  Aligned_cols=60  Identities=33%  Similarity=0.426  Sum_probs=53.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++...+.++.|++.|+.|+|..+   ++|+++++.|+++..+..+++.|||+++.+..+.
T Consensus       106 ~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_         106 GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            45889999999999999999999874   9999999999999999999999999999775543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.26  E-value=1.8e-11  Score=64.60  Aligned_cols=59  Identities=36%  Similarity=0.464  Sum_probs=52.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...++......++.|++.++.|+|..+   ++|+++++.|+++..++.+++.|||+++....
T Consensus        98 ~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          98 SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence            345678888889999999999999875   99999999999999999999999999987653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.26  E-value=1e-11  Score=66.36  Aligned_cols=58  Identities=29%  Similarity=0.408  Sum_probs=52.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++..+..++.|++.|+.|+|..+   ++|+++++.|+++..+..++++|||+++....
T Consensus       136 ~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         136 GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            46888999999999999999999875   99999999999999999999999999987653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=5.8e-12  Score=65.86  Aligned_cols=59  Identities=41%  Similarity=0.599  Sum_probs=52.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      +..+++..+..++.|++.|+.|+|..+   ++|+++++.|+++.....++++|||.++....
T Consensus        94 ~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          94 SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCC
Confidence            456788889999999999999999975   99999999999999999999999999976543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=3.3e-11  Score=64.22  Aligned_cols=60  Identities=32%  Similarity=0.409  Sum_probs=52.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~~~   65 (77)
                      +..+++..+..++.|++.|+.|+|..+   ++|+++++.|+++..+ ..+++.|||++......
T Consensus       116 ~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_         116 KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            346889999999999999999999874   9999999999999866 48899999999876543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=8.7e-12  Score=65.24  Aligned_cols=59  Identities=34%  Similarity=0.560  Sum_probs=53.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++..+..++.|++.|+.|+|..+   ++|+++++.|+++..+...++.|||.++....
T Consensus        96 ~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          96 LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC
Confidence            456899999999999999999999875   99999999999999999999999999876543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=2e-11  Score=63.27  Aligned_cols=58  Identities=24%  Similarity=0.346  Sum_probs=51.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+ ..+++.|||+++....
T Consensus       105 ~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_         105 GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccc
Confidence            46889999999999999999999975   9999999999999854 6899999999986543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.23  E-value=3.2e-11  Score=64.51  Aligned_cols=59  Identities=29%  Similarity=0.485  Sum_probs=52.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc--CCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD--HEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++..+..++.|++.|+.|+|..+   ++|+++++.|+++.  ....++++|||++..+..+
T Consensus       122 ~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         122 YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            46899999999999999999999875   99999999999997  4578999999999877644

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.22  E-value=1.1e-11  Score=65.17  Aligned_cols=58  Identities=33%  Similarity=0.568  Sum_probs=51.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      .+++..+..++.+++.|+.|+|...   ++|+++++.|++++.+..++++|||+++.....
T Consensus       129 ~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~  186 (308)
T d1p4oa_         129 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  186 (308)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCC
Confidence            4678889999999999999999874   999999999999999999999999999866443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.21  E-value=4.1e-11  Score=64.04  Aligned_cols=59  Identities=22%  Similarity=0.468  Sum_probs=51.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC--CCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH--EMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++..+..++.|++.|+.|+|..+   ++|+++++.|+++..  +..+++.|||+++.+...
T Consensus       119 ~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         119 NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            45899999999999999999999985   999999999999963  467999999999876543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=1.8e-11  Score=64.39  Aligned_cols=60  Identities=38%  Similarity=0.615  Sum_probs=53.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ   66 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~~   66 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++.....+++.|||.++......
T Consensus       140 ~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~  199 (311)
T d1t46a_         140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS  199 (311)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCC
Confidence            35889999999999999999999885   9999999999999999999999999998665443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=1.2e-11  Score=64.05  Aligned_cols=59  Identities=31%  Similarity=0.494  Sum_probs=46.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++...+.++.|++.|+.|+|..+   ++|+++++.|+++.....++++|||+++....
T Consensus       102 ~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_         102 KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence            346889999999999999999999975   99999999999999999999999999986643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=1.5e-11  Score=63.70  Aligned_cols=59  Identities=34%  Similarity=0.472  Sum_probs=50.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc-CCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD-HEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++.....++.|++.|+.|+|..+ .+++|+++++.|+++. .+..++++|||+++...
T Consensus       107 ~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_         107 KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            46788999999999999999999862 3599999999999996 46789999999997543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.19  E-value=5.4e-11  Score=61.26  Aligned_cols=60  Identities=25%  Similarity=0.481  Sum_probs=53.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++..+..++.|++.|+.|+|..+   ++|+++++.|+++..+...+++|||+++.....
T Consensus        94 ~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          94 RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            346788899999999999999999874   999999999999999999999999999866543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.19  E-value=1.4e-10  Score=60.51  Aligned_cols=60  Identities=22%  Similarity=0.356  Sum_probs=51.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC-----CCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH-----EMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~-----~~~~~l~~~g~~~~~~~~   65 (77)
                      ...++......++.+++.++.++|..+   ++|+++++.|+++..     ...+++.|||+++.+...
T Consensus        95 ~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          95 GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            356889999999999999999999875   999999999999964     456899999999987543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.19  E-value=8.8e-11  Score=61.30  Aligned_cols=60  Identities=27%  Similarity=0.459  Sum_probs=52.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++..+..++.|++.++.|+|..+   ++|+++++.|+++..   +..++++|||+++.+...
T Consensus        97 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          97 SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            456899999999999999999999975   999999999998753   456899999999987644

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.18  E-value=3.6e-12  Score=67.40  Aligned_cols=58  Identities=31%  Similarity=0.474  Sum_probs=51.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ..+++..+..++.|++.|+.|+|...  +++|+++++.|+++..+..+++.|||+++.+.
T Consensus        99 ~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          99 GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            46889999999999999999999631  39999999999999999999999999998654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.18  E-value=4.3e-11  Score=63.29  Aligned_cols=58  Identities=38%  Similarity=0.513  Sum_probs=52.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++......++.|||+++....
T Consensus        98 ~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          98 HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            46788899999999999999999975   99999999999999999999999999986543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.16  E-value=4.7e-11  Score=62.83  Aligned_cols=60  Identities=28%  Similarity=0.419  Sum_probs=45.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEc---CCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLD---HEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++.....++.|++.|+.|+|..+   ++|+++++.|+++.   .+..+++.|||+++.....
T Consensus       101 ~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_         101 KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            456899999999999999999999875   99999999999995   3568999999999866433

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.15  E-value=2.9e-11  Score=62.80  Aligned_cols=58  Identities=38%  Similarity=0.653  Sum_probs=52.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...++......++.|++.|+.|+|..+   ++|+++++.|+++..+...+++|||.+....
T Consensus        94 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          94 EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecc
Confidence            466899999999999999999999874   9999999999999999999999999987654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=4.7e-11  Score=62.64  Aligned_cols=63  Identities=29%  Similarity=0.370  Sum_probs=54.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDS-----RLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      +..++|...+.++.+++.++.|+|...     ..+++|+++++.|++++.+..++++|||+++.....
T Consensus        94 ~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          94 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            346889999999999999999999631     236999999999999999999999999999877543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=1.4e-10  Score=61.62  Aligned_cols=59  Identities=29%  Similarity=0.470  Sum_probs=51.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcC---CCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDH---EMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..   ...+++.|||+++.....
T Consensus       106 ~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1         106 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCC
Confidence            46889999999999999999999875   999999999999975   346899999999876543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=1.5e-10  Score=61.48  Aligned_cols=59  Identities=36%  Similarity=0.566  Sum_probs=53.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+...++.|||.++....
T Consensus       115 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_         115 HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence            356899999999999999999999875   99999999999999999999999999987654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=2.6e-10  Score=59.16  Aligned_cols=60  Identities=33%  Similarity=0.557  Sum_probs=53.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ...+++.....++.|++.++.|+|..+   ++|+++++.|+++..+...++.|||.++.....
T Consensus        95 ~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          95 NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence            456788899999999999999999874   999999999999999999999999999876543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.13  E-value=2.5e-10  Score=60.23  Aligned_cols=59  Identities=31%  Similarity=0.461  Sum_probs=51.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC-CCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE-MNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~l~~~g~~~~~~~~   65 (77)
                      +.+++..+..++.|++.|+.|+|..+   ++|+++++.|+++... ..+++.|||.+......
T Consensus       124 ~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         124 QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence            46889999999999999999999885   9999999999999865 46899999999876543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.11  E-value=4.2e-10  Score=59.09  Aligned_cols=59  Identities=36%  Similarity=0.639  Sum_probs=52.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ...++......++.|++.++.|+|..+   ++|++++++|+++..+..+++.|||+++.+..
T Consensus       111 ~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~  169 (318)
T d3blha1         111 LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSL  169 (318)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeeccc
Confidence            345778888899999999999999874   99999999999999999999999999986653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.11  E-value=1.2e-10  Score=61.17  Aligned_cols=58  Identities=34%  Similarity=0.574  Sum_probs=52.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++...+.++.|++.|+.|+|..+   ++|+++++.|+++..+...++.|||+++...
T Consensus       121 ~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~  178 (309)
T d1fvra_         121 ASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQE  178 (309)
T ss_dssp             SCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEcccccccccc
Confidence            356899999999999999999999874   9999999999999999999999999987543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.10  E-value=1.2e-10  Score=60.84  Aligned_cols=58  Identities=33%  Similarity=0.591  Sum_probs=51.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++.....++.|++.++.|+|..+   ++|+++++.|+++......++.|||+++...
T Consensus       110 ~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~  167 (305)
T d1blxa_         110 EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS  167 (305)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhc
Confidence            345788889999999999999999875   9999999999999999999999999987543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.09  E-value=2.7e-10  Score=58.98  Aligned_cols=58  Identities=33%  Similarity=0.575  Sum_probs=51.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.|++.++.|+|..+   ++|+++++.|+++..+...++.+||.+.....
T Consensus       106 ~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_         106 GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcc
Confidence            46889999999999999999999875   99999999999999999999999998876543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.09  E-value=2e-10  Score=60.49  Aligned_cols=59  Identities=32%  Similarity=0.503  Sum_probs=52.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~~   65 (77)
                      ..+++...+.++.|++.|+.|+|..+   ++|+++++.|++++.+..++++|||+++.....
T Consensus       125 ~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         125 HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            34667888899999999999999874   999999999999999999999999999876543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.08  E-value=4.9e-10  Score=59.19  Aligned_cols=58  Identities=26%  Similarity=0.468  Sum_probs=50.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCC--CCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHE--MNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+  ..+++.|||+++....
T Consensus        97 ~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          97 FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            36899999999999999999999875   9999999999999743  5789999999987654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.03  E-value=7.4e-10  Score=57.75  Aligned_cols=59  Identities=32%  Similarity=0.430  Sum_probs=51.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC----CeEEecccceeeecCC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM----NPKISDFGMARIFGGN   65 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~~l~~~g~~~~~~~~   65 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++....    .+++.|||++......
T Consensus       108 ~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~  170 (293)
T d1jksa_         108 ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG  170 (293)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS
T ss_pred             cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCC
Confidence            46889999999999999999999875   99999999999997654    4899999999876543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.98  E-value=5.5e-10  Score=59.25  Aligned_cols=58  Identities=41%  Similarity=0.587  Sum_probs=49.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      ...+++..+..++.|++.|+.|+|..+   ++|+++++.|+++..+...++.|||.+....
T Consensus       115 ~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1         115 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC
Confidence            457899999999999999999999885   9999999999999999999999999986543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=5.7e-10  Score=58.96  Aligned_cols=58  Identities=29%  Similarity=0.398  Sum_probs=51.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..++......++.|++.++.|+|..+   ++|+++++.|+++..+..+++.|||+++.+..
T Consensus       124 ~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         124 ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            34567778888999999999999875   99999999999999999999999999987643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=7.4e-10  Score=57.09  Aligned_cols=57  Identities=28%  Similarity=0.465  Sum_probs=48.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            5 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         5 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      .+++..++.++.+++.|+.|+|...   ++|+++++.++++..+...++.|||+++....
T Consensus        99 ~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          99 VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC
Confidence            4789999999999999999999874   99999999999999999999999999986543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.74  E-value=1.6e-08  Score=53.89  Aligned_cols=58  Identities=40%  Similarity=0.628  Sum_probs=48.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeecC
Q 040677            4 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFGG   64 (77)
Q Consensus         4 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~~   64 (77)
                      ..+++.....++.|++.|+.|+|..+   ++|+++++.|+++..+...++.+||.++....
T Consensus       114 ~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1         114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc
Confidence            45788899999999999999999975   99999999999999999999999998775543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=98.73  E-value=9.9e-09  Score=50.44  Aligned_cols=53  Identities=25%  Similarity=0.284  Sum_probs=43.4

Q ss_pred             CHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCCCeEEecccceeeec
Q 040677            7 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEMNPKISDFGMARIFG   63 (77)
Q Consensus         7 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~~~   63 (77)
                      +......++.+++.++.++|..+   ++|+++++.|+++..+ .+++.|||.+....
T Consensus       101 ~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2         101 RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred             hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence            33445567899999999999875   9999999999999854 47889999987654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.50  E-value=2.8e-07  Score=48.83  Aligned_cols=59  Identities=31%  Similarity=0.387  Sum_probs=48.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEEccCCCCcEEEcCCC------CeEEecccceeeec
Q 040677            3 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLDHEM------NPKISDFGMARIFG   63 (77)
Q Consensus         3 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~------~~~l~~~g~~~~~~   63 (77)
                      ...+++..+..++.+++.++.++|..  .+++|+++++.|+++....      ..++.|||.+....
T Consensus       119 ~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~  183 (362)
T d1q8ya_         119 HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD  183 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccceeeEeecccccccc
Confidence            35677888999999999999999973  2599999999999996432      37899999987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=81.74  E-value=0.33  Score=24.73  Aligned_cols=30  Identities=30%  Similarity=0.326  Sum_probs=25.6

Q ss_pred             CCeEEccCCCCcEEEcCCCCeEEeccccee
Q 040677           31 LKIIHRDLKASNVLLDHEMNPKISDFGMAR   60 (77)
Q Consensus        31 ~~~~~~~l~~~~~~~~~~~~~~l~~~g~~~   60 (77)
                      .+++|.++...|+++..+....+.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            468999999999999988777899997654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=81.51  E-value=0.64  Score=22.77  Aligned_cols=30  Identities=23%  Similarity=0.302  Sum_probs=24.5

Q ss_pred             CeEEccCCCCcEEEcCCCCeEEecccceee
Q 040677           32 KIIHRDLKASNVLLDHEMNPKISDFGMARI   61 (77)
Q Consensus        32 ~~~~~~l~~~~~~~~~~~~~~l~~~g~~~~   61 (77)
                      .++|.++.+.|+++..+....+.||..+..
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhccc
Confidence            478999999999998776667899876653